
<html lang="en"     class="pb-page"  data-request-id="97655c80-099b-4bb2-bf28-e83e520ee473"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm500672y;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-4"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies" /></meta><meta name="dc.Creator" content="Céline  Gloaguen" /></meta><meta name="dc.Creator" content="Anne Sophie  Voisin-Chiret" /></meta><meta name="dc.Creator" content="Jana  Sopkova-de Oliveira Santos" /></meta><meta name="dc.Creator" content="Jade  Fogha" /></meta><meta name="dc.Creator" content="Fabien  Gautier" /></meta><meta name="dc.Creator" content="Marcella  De Giorgi" /></meta><meta name="dc.Creator" content="Grégory  Burzicki" /></meta><meta name="dc.Creator" content="Serge  Perato" /></meta><meta name="dc.Creator" content="Cécile  Pétigny-Lechartier" /></meta><meta name="dc.Creator" content="Karin  Simonin-Le Jeune" /></meta><meta name="dc.Creator" content="Emilie  Brotin" /></meta><meta name="dc.Creator" content="Didier  Goux" /></meta><meta name="dc.Creator" content="Monique  N’Diaye" /></meta><meta name="dc.Creator" content="Bernard  Lambert" /></meta><meta name="dc.Creator" content="Marie-Hélène  Louis" /></meta><meta name="dc.Creator" content="Laetitia  Ligat" /></meta><meta name="dc.Creator" content="Frédéric  Lopez" /></meta><meta name="dc.Creator" content="Philippe  Juin" /></meta><meta name="dc.Creator" content="Ronan  Bureau" /></meta><meta name="dc.Creator" content="Sylvain  Rault" /></meta><meta name="dc.Creator" content="Laurent  Poulain" /></meta><meta name="dc.Description" content="Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl..." /></meta><meta name="Description" content="Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 4, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500672y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500672y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500672y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500672y" /></link>
        
    
    

<title>First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500672y" /></meta><meta property="og:title" content="First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0013.jpeg" /></meta><meta property="og:description" content="Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy. Whereas Bcl-xL inhibitors are now available, Mcl-1 inhibition, required to sensitize cells to Bcl-xL-targeting strategies, remains problematic. In this context, we designed and synthesized oligopyridines potentially targeting the Mcl-1 hydrophobic pocket, evaluated their capacity to inhibit Mcl-1 in live cells, and implemented a functional screening assay to evaluate their ability to sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies. We established structure–activity relationships and focused our attention on MR29072, named Pyridoclax. Surface plasmon resonance assay demonstrated that pyridoclax directly binds to Mcl-1. Without cytotoxic activity when administered as a single agent, pyridoclax induced apoptosis in combination with Bcl-xL-targeting siRNA or with ABT-737 in ovarian, lung, and mesothelioma cancer cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500672y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500672y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500672y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500672y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500672y&amp;href=/doi/10.1021/jm500672y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1644-1668</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5017768" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501185j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-x<sub>L</sub>-Targeting Strategies</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Gloaguen">Céline Gloaguen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+Sophie++Voisin-Chiret">Anne Sophie Voisin-Chiret</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Sopkova-de+Oliveira+Santos">Jana Sopkova-de Oliveira Santos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jade++Fogha">Jade Fogha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabien++Gautier">Fabien Gautier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcella++De+Giorgi">Marcella De Giorgi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gr%C3%A9gory++Burzicki">Grégory Burzicki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Serge++Perato">Serge Perato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9cile++P%C3%A9tigny-Lechartier">Cécile Pétigny-Lechartier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Simonin-Le+Jeune">Karin Simonin-Le Jeune</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emilie++Brotin">Emilie Brotin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Didier++Goux">Didier Goux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monique++N%E2%80%99Diaye">Monique N’Diaye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Lambert">Bernard Lambert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-H%C3%A9l%C3%A8ne++Louis">Marie-Hélène Louis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laetitia++Ligat">Laetitia Ligat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fr%C3%A9d%C3%A9ric++Lopez">Frédéric Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Juin">Philippe Juin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronan++Bureau">Ronan Bureau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvain++Rault">Sylvain Rault</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Poulain">Laurent Poulain</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Normandie Université, 14032 Caen, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">UNICAEN, BioTICLA Unit (Biologie et Thérapies Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span></div><div class="aff-info" id="aff11"><span class="aff-symbol">∞</span> <span class="aff-text">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Team 8, Nantes-Angers Centre for Cancer Research, UMR 892 Inserm 6299 CNRS, 44007 Nantes, France</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Institut de Cancérologie de l’Ouest, Comprehensive Cancer Center René Gauducheau, 44805 Nantes, France</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">UNICAEN, Centre de Microscopie Appliquée à la Biologie, IBFA, SF4206 ICORE, 14032 Caen, France</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">¶</span> <span class="aff-text">CNRS (placed at the disposition of EA4656 by CNRS, Délégation régionale Ile-de-France Est), 94532 Thiais cedex, France</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">○</span> <span class="aff-text">INSERM UMR1037-Plateforme Protéomique-Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse, 2 avenue Hubert Curien, 31100 Toulouse, France</span></div><div class="aff-info" id="aff10"><span class="aff-symbol">◆</span> <span class="aff-text">Université Toulouse III-Paul Sabatier, UMR1037 CRCT, 31000 Toulouse, France</span></div><div class="corresp-info"><strong>*</strong>Dr. Anne Sophie Voisin-Chiret. Mailing address: CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), UPRES EA 4258 - FR CNRS 3038 INC3M, Université de Caen Basse-Normandie, Boulevard Becquerel, 14032 caen Cedex, France. Phone: 33 (0)2 31 56 68 04 for international call. E-mail: anne-<a href="/cdn-cgi/l/email-protection#097a667961606c277f66607a6067497c67606a686c67276f7b"><span class="__cf_email__" data-cfemail="42312d322a2b276c342d2b312b2c02372c2b2123272c6c2430">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Dr. Laurent Poulain. Mailing address: Inserm U1199, Unité “Biologie et Thérapies Innovantes des Cancers Localement Agressifs” (BioTICLA), Université de Caen Basse-Normandie, Centre de Lutte Contre le Cancer François Baclesse, 3, Avenue du Général Harris, BP 5026 14 076 Caen cedex 05, France. Phone: 02 31 45 52 05. E-mail: <a href="/cdn-cgi/l/email-protection#0e62207e617b626f67604e6c6f6d626b7d7d6b20687c"><span class="__cf_email__" data-cfemail="85e9abf5eaf0e9e4ecebc5e7e4e6e9e0f6f6e0abe3f7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500672y&amp;href=/doi/10.1021%2Fjm500672y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1644–1668</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 13, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 April 2014</li><li><span class="item_label"><b>Published</b> online</span>4 February 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 February 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500672y" title="DOI URL">https://doi.org/10.1021/jm500672y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1644%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DC%25C3%25A9line%2BGloaguen%252C%2BAnne%2BSophie%2BVoisin-Chiret%252C%2BJana%2BSopkova-de%2BOliveira%2BSantos%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D4%26contentID%3Djm500672y%26title%3DFirst%2BEvidence%2BThat%2BOligopyridines%252C%2B%25CE%25B1-Helix%2BFoldamers%252C%2BInhibit%2BMcl-1%2Band%2BSensitize%2BOvarian%2BCarcinoma%2BCells%2Bto%2BBcl-xL-Targeting%2BStrategies%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1668%26publicationDate%3DFebruary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500672y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1965</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500672y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Gloaguen&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Sophie Voisin-Chiret&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Sopkova-de Oliveira Santos&quot;},{&quot;first_name&quot;:&quot;Jade&quot;,&quot;last_name&quot;:&quot;Fogha&quot;},{&quot;first_name&quot;:&quot;Fabien&quot;,&quot;last_name&quot;:&quot;Gautier&quot;},{&quot;first_name&quot;:&quot;Marcella&quot;,&quot;last_name&quot;:&quot;De Giorgi&quot;},{&quot;first_name&quot;:&quot;Grégory&quot;,&quot;last_name&quot;:&quot;Burzicki&quot;},{&quot;first_name&quot;:&quot;Serge&quot;,&quot;last_name&quot;:&quot;Perato&quot;},{&quot;first_name&quot;:&quot;Cécile&quot;,&quot;last_name&quot;:&quot;Pétigny-Lechartier&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Simonin-Le Jeune&quot;},{&quot;first_name&quot;:&quot;Emilie&quot;,&quot;last_name&quot;:&quot;Brotin&quot;},{&quot;first_name&quot;:&quot;Didier&quot;,&quot;last_name&quot;:&quot;Goux&quot;},{&quot;first_name&quot;:&quot;Monique&quot;,&quot;last_name&quot;:&quot;N’Diaye&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Lambert&quot;},{&quot;first_name&quot;:&quot;Marie-Hélène&quot;,&quot;last_name&quot;:&quot;Louis&quot;},{&quot;first_name&quot;:&quot;Laetitia&quot;,&quot;last_name&quot;:&quot;Ligat&quot;},{&quot;first_name&quot;:&quot;Frédéric&quot;,&quot;last_name&quot;:&quot;Lopez&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Juin&quot;},{&quot;first_name&quot;:&quot;Ronan&quot;,&quot;last_name&quot;:&quot;Bureau&quot;},{&quot;first_name&quot;:&quot;Sylvain&quot;,&quot;last_name&quot;:&quot;Rault&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Poulain&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;1644-1668&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500672y&quot;},&quot;abstract&quot;:&quot;Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy. Whereas Bcl-xL inhibitors are now available, Mcl-1 inhibition, required to sensitize cells to Bcl-xL-targeting strategies, remains problematic. In this context, we designed and synthesized oligopyridines potentially targeting the Mcl-1 hydrophobic pocket, evaluated their capacity to inhibit Mcl-1 in live cells, and implemented a functional screening assay to evaluate their ability to sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies. We established structure–activity relationships and focused our attention on MR29072, named Pyridoclax. Surface plasmon resonance assay demonstrated that pyridoclax directly binds to Mcl-1. Without cytotoxic activity when &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500672y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500672y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500672y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500672y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500672y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500672y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500672y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500672y&amp;href=/doi/10.1021/jm500672y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500672y" /></input><a href="/doi/pdf/10.1021/jm500672y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500672y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500672y%26sid%3Dliteratum%253Aachs%26pmid%3D25585174%26genre%3Darticle%26aulast%3DGloaguen%26date%3D2015%26atitle%3DFirst%2BEvidence%2BThat%2BOligopyridines%252C%2B%25CE%25B1-Helix%2BFoldamers%252C%2BInhibit%2BMcl-1%2Band%2BSensitize%2BOvarian%2BCarcinoma%2BCells%2Bto%2BBcl-xL-Targeting%2BStrategies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D4%26spage%3D1644%26epage%3D1668%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292548" title="Stress">Stress</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290865" title="Nitrogen">Nitrogen</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jmcmar.2015.58.issue-4/20150226/jmcmar.2015.58.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-x<sub>L</sub> and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy. Whereas Bcl-x<sub>L</sub> inhibitors are now available, Mcl-1 inhibition, required to sensitize cells to Bcl-x<sub>L</sub>-targeting strategies, remains problematic. In this context, we designed and synthesized oligopyridines potentially targeting the Mcl-1 hydrophobic pocket, evaluated their capacity to inhibit Mcl-1 in live cells, and implemented a functional screening assay to evaluate their ability to sensitize ovarian carcinoma cells to Bcl-x<sub>L</sub>-targeting strategies. We established structure–activity relationships and focused our attention on MR29072, named Pyridoclax. Surface plasmon resonance assay demonstrated that pyridoclax directly binds to Mcl-1. Without cytotoxic activity when administered as a single agent, pyridoclax induced apoptosis in combination with Bcl-x<sub>L</sub>-targeting siRNA or with ABT-737 in ovarian, lung, and mesothelioma cancer cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis control defects are frequently involved in chemoresistance in both hematological malignancies and solid tumors, and the deregulation of Bcl-2 family member expression constitutes one of the most frequent and important events. These proteins share Bcl-2 homology domains (named BH domains). Antiapoptotic proteins (Bcl-2, Bcl-x<sub>L</sub>, etc.) contain the BH1 to BH4 domains, whereas pro-apoptotic proteins contain either the BH1 to BH3 domains (multidomain members such as Bax and Bak) or only the BH3 domain (BH3-only group such as Bad, Bid, Noxa, Puma, and Hrk).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Under cellular stress, BH3-only proteins initiate apoptosis by either blocking the activity of antiapoptotic members or directly activating multidomain pro-apoptotic members, which is mediated via interaction of the BH3 domain of one protein with the hydrophobic pocket of another.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Constant efforts are made to impede the activity of antiapoptotic members such as Bcl-2 or Bcl-x<sub>L</sub>, among which the development of potent BH3-mimetic molecules represent a promising way.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> These molecules bind to the BH3-binding groove in antiapoptotic proteins of the Bcl-2 family and promote cell death through the release of pro-apoptotic Bcl-2 family members.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> ABT-737 (and its orally available derivative ABT-263, navitoclax, currently under phase II clinical investigations) allows efficient inhibition of the antiapoptotic activity of Bcl-2 and Bcl-x<sub>L</sub>.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> It has been shown to be able to induce apoptotic cell death as a single agent in hematologic malignancies<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> and, to a lesser extent, in solid tumor cells.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> ABT-737 can also sensitize cancer cells to chemotherapy.<a onclick="showRef(event, 'ref6 ref8 ref14'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref14">(6, 8, 14)</a> However, its activity has been conditioned to the absence or inactivation of Mcl-1,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> whereas the strong expression and activity of Mcl-1 is associated with the absence of response to ABT-737.<a onclick="showRef(event, 'ref15 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref17 ref18">(15, 17, 18)</a> The expression and activity of the antiapoptotic protein Mcl-1 thus constitutes a major hurdle for the activity of ABT-737.</div><div class="NLM_p">Mcl-1 is overexpressed in ovarian carcinoma, and its expression has also been associated with chemoresistance.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We previously demonstrated that Bcl-x<sub>L</sub> and Mcl-1 cooperate to protect tumor cells against apoptosis, and that their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy, whereas the down-regulation of either Bcl-x<sub>L</sub> or Mcl-1 remains ineffective.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In this context, we also showed that Mcl-1 down regulation or inactivation was required to sensitize ovarian cancer cells to Bcl-x<sub>L</sub>-targeting BH3-mimetic molecules such as HA14-1<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> or ABT-737.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Importantly, the MCL1 locus is one of the most frequently amplified in human cancers, further pointing to its centrality in carcinogenesis and increasingly its importance as a high priority therapeutic target.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Many strategies have been developed to inhibit Mcl-1 expression or to impede its activity through the activation of its endogenous inhibitors (i.e., BH3-only proteins such as Bim, Noxa, or Puma), in order to restore ABT-737 sensitivity. These strategies include the use of Mcl-1-targeting siRNA,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Noxa gene transfer,<a onclick="showRef(event, 'ref13 ref25'); return false;" href="javascript:void(0);" class="ref ref13 ref25">(13, 25)</a> or signaling pathway inhibition.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> As we previously demonstrated, platinum compound-based chemotherapy is also able to decrease Mcl-1 protein levels as well as to induce BH3-only proteins in ovarian carcinoma, leading to a sensitization to ABT-737.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> However, the difficult application of such strategies in clinical practice, in part due to cumulative toxicities (conventional chemotherapies) or to <i>in vivo</i> inefficiency (siRNA, gene therapy), incites researchers to identify specific and potent Mcl-1 inhibitors.</div><div class="NLM_p">Like other antiapoptotic Bcl-2 proteins, Mcl-1 is able to sequester an α-helical fold but differs in the exposed surface of its binding groove. A number of residues in the binding groove differentiate Mcl-1 from its homologues,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and its groove appears more electropositive than other antiapoptotic proteins (Bcl-x<sub>L</sub>’s groove is almost completely uncharged).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Moreover, crystallographic comparative analysis of the hydrophobic grooves of Mcl-1 and Bcl-x<sub>L</sub> suggested that whereas the groove of Bcl-x<sub>L</sub> is extremely flexible allowing the interaction with various BH3 ligands, the groove of Mcl-1 is conformationally rigid.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Such structural differences have strong impact on the development of specific Mcl-1 inhibitors and are probably responsible for the difficulties for the scientific community to design such inhibitors.</div><div class="NLM_p">The recent discovery of two BH3 peptides, one (BimS2A) constituted by a Bim variant<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the other constituted by the BH3 domain of Mcl-1,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> both able to specifically inhibit Mcl-1 function through a Noxa-like mechanism, established a proof of concept that such specific inhibitors could be designed.</div><div class="NLM_p">Other approaches such as fragment nuclear magnetic resonance-based methods, screening structure–activity relationships, and library screening or stapled peptide-base competitive screening led to the discovery of some synthetic compounds.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These molecules are either poorly specific such as the S1<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> or 4g<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> compounds or more specific and more active such as marinopyrrole A (maritoclax)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> or MIM1 compound.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> NMR-based screening of a large fragment library also identified a chemically distinct hit series that binds to different sites on Mcl-1.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Very recently, Nikolovska-Coleska et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> disclosed a novel series of small-molecule Mcl-1 inhibitors as sulfonamides, discovered through high-throughput screening followed by the utilization of structure-based design. Few data are yet available concerning these molecules, and none of these Mcl-1 inhibitors have entered clinical trials, but their discovery provides a new basis for the development of future Mcl-1 inhibiting molecules.</div><div class="NLM_p">The BH3 domains correspond to an α helix. Mimicking of the BH3 domain could thus be realized by foldamers bearing substituents as recognition motifs able to interact with the hydrophobic pocket of the targeted antiapoptotic protein.</div><div class="NLM_p last">By computational modeling, we thus designed small compounds based on a pyridyl scaffold, abiotic foldamers<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> that potentially target the Mcl-1 hydrophobic binding pocket. These molecules were synthesized, and we evaluated their capacity to physically interact with Mcl-1 <i>in cellulo</i> (BRET assay) and designed a screening assay in order to evaluate their ability to sensitize ovarian carcinoma cells to Bcl-x<sub>L</sub> targeting strategies. Here, we present the results of these investigations and establish the first structure–activity relationships among 18 of these molecules. We focused our interest in the most promising of them, MR29072, which we named pyridoclax.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Computational Modeling</h3><div class="NLM_p">BH3-only proteins, Mcl-1 natural inhibitors, anchor in the Mcl-1 cavity principally by hydrophobic residues situated on the contact face of the BH3-only helix, that is, by the residues at positions <i>i</i>, <i>i</i> + 4, <i>i</i> + 7, and <i>i</i> + 11, and by an aspartic acid residue (<i>i</i> + 9) on the opposite side. This aspartic acid interacts with Arg263 of Mcl-1, which is fully conserved among the antiapoptotic proteins. Previously, our laboratory was interested in the synthesis<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46">(42-46)</a> and characterization of oligopyridyl abiotic foldamers, potential α-helical mimetics.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> Results of our studies have confirmed that these compounds are able to mimic selected side chain positions of an α helix. Among those oligopyridyl foldamers, MR29004 consisted of four pyridine rings substituted by methyl group on the <i>ortho</i> position of the two middle rings (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). The preferential twist angles between the two substituted rings were predicted between 30° and 60° with a small energy barrier (3 kcal/mol), which can easily be comparable to the angle between side chains at positions <i>i</i> + 4 and <i>i</i> + 7 of a polyalanyl α helix (60°). Moreover, we observed that its two methyl substituents mimic well side chains at the desired positions, <i>i</i> + 4 and <i>i</i> + 7.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In this study, starting from the modulation of MR29004, a potential Mcl-1 inhibitor (pyridoclax) was designed by conserving the MR29004 methyl substituent on the second ring and replacing the methyl group on the third ring by a bulkier hydrophobic substituent (a styryl substituent; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A), drawing inspiration from Noxa, a selective Mcl-1 ligand, which has a phenylalanine in this position, not conserved among all BH3-only proteins.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Computational modeling of pyridoclax. (A) ORTEP representation of MR29004 and pyridoclax MR29072 X-ray structures (left) and superposition of a polyalanyl α helix (in blue) and X-ray structure (in purple) of MR29004 and pyridoclax MR29072 (right). (B) Representative docking poses of pyridoclax in hMcl-1 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW">2KBW</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>). (C) The minimized average complex from MR29072/hMcl-1 dynamic study. The protein is presented in gray as surface (left) and as ribbon (right) and pyridoclax as stick.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>Ab initio</i> simulations and solved X-ray structure confirmed that despite introduction of the styryl group, pyridoclax has conserved the preferential twist angle values between successive rings, compared with its inferior analogue (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Predicted Minimum Energy Conformers Obtained from PES at HF/2-31G Level between the Neighboring Rings</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0012.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">Recently, Fesik and collaborators have identified a small molecule (6-chloro-3-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1<i>H</i>-indole-2-carboxylic acid) with a significant binding affinity to Mcl-1 (<i>K</i><sub>i</sub> = 55 nM). The co-crystal structure of this compound bound to Mcl-1 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HW2">4HW2</a><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a>) showed that it occupies two hydrophobic pockets in Mcl-1 (corresponding to the hydrophobic pocket for <i>i</i> + 4 and <i>i</i> + 7), thus forming interactions with Met231, Thr266, Val253, Leu267, Phe270, Phe228, and Met250. The ligand carboxylic acid moiety of the compound interacts with Arg263.</div><div class="NLM_p last">To predict potential pyridoclax/Mcl-1 interactions, docking studies were performed on human Mcl-1 protein (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW">2KBW</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>). Different docking protocols were tested: pyridoclax docked with relatively good fitness scores, and it positioned well into the hydrophobic groove of Mcl-1. Two principals orientations emerged from the docking studies (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). We observed that the styryl group of pyridoclax is always anchored in the same Mcl-1 pocket in all poses even if the orientations of pyridoclax in the binding cavity changed. It establishes π–π interactions with Phe228 and His224 and a hydrophobic interaction with Met231 of Mcl-1. The methyl group points to different pockets or it is exposed on the surface in different poses. Moreover, one of the pyridines at the pyridoclax extremity was always close to Arg263 of Mcl-1. At the other extremity, the pyridine ring is located on a Mcl-1 pocket near Phe270. Interestingly, Mcl-1 residues involved in pyridoclax fixation are close to one observed in the Fesik’s inhibitor/Mcl-1 complex. The molecular dynamics simulation of 1 ns carried out on the two selected poses (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) showed that pyridoclax fluctuated strongly in the binding cavity for the first pose in contrast to the second one, which stays stable along whole dynamic. For this second pose, interactions observed in the docking study were maintained along the whole dynamic (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">Recently, we have developed the Garlanding concept,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> which allows building a long linear chain from one ring by the implementation of iterative cross-coupling reactions between boronic species and dihalogenated compounds. This regioselective, flexible, highly reproducible, and efficient methodology permitted us to obtain oligopyridyl,<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> oligophenylpyridyl,<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> and oligothienylpyridyl foldamers.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This Garlanding approach was applied to synthesize an original series of molecules belonging to the oligopyridine family that are of interest as Mcl-1 inhibitors.</div><div class="NLM_p">Pyridoclax (MR29072) was the first in the series to be synthesized according to the sequence shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. In a second step, a family of new derivatives was prepared to define the first structure–activity relationships.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Procedure To Synthesize MR29072 (Pyridoclax)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS (1.1 equiv), CH<sub>3</sub>CN, rfx, 4 h; (b) PhPOCl<sub>2</sub>, 160 °C, 4 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), 1,4-dioxane, rfx, 24 h; (d) NaI (10 equiv), CH<sub>3</sub>COCl (1.5 equiv), CH<sub>3</sub>CN, 100 °C, 1 h, <i>C</i> = 0.25 M, microwave; (e) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), K<sub>3</sub>PO<sub>4</sub> (2.5 equiv), DME, rfx, 20 h; (f) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub> (5 equiv), 1,4-dioxane, rfx, 24 h.</p></p></figure><div class="NLM_p">In order to introduce the styryl group on the pyridine ring, a Suzuki–Miyaura cross-coupling (SMC) reaction between a trihalopyridine and the commercially available <i>trans</i>-2-phenylvinyl boronic acid was used. The 5-bromo-3-iodo-2-hydroxypyridine, <b>2</b>, was prepared from the 5-bromo-2-hydroxypyridine, <b>1</b>, by an iodination reaction with <i>N</i>-iodosuccinimide (NIS) in acetonitrile under reflux during 4 h. Then, the 5-bromo-3-iodo-2-hydroxypyridine (<b>2</b>) underwent a chlorodehydroxylation reaction using dichlorophenylphosphonic acid at 160 °C for 3 h. The obtained compound <b>3</b> was then engaged in a SMC reaction with the <i>trans</i>-2-phenylvinyl boronic acid (<b>4</b>), commercially available, to obtain compound <b>5</b> in 93% yield.</div><div class="NLM_p">Compound <b>5</b> could be engaged directly in a first SMC reaction that will occurs on the 5 position rather than on the 2 position due to the reactivity of halogens toward SMC reaction (I > Br > Cl).</div><div class="NLM_p last">In order to realize a coupling reaction selectively at the α position of the nitrogen atom, compound <b>5</b> could be engaged in a halogen–halogen exchange reaction<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with sodium iodide and acetyl chloride in acetonitrile under microwave irradiation at 100 °C for 1 h with the aim to introduce an iodine atom in position α to nitrogen atom (compound <b>6</b>) (the choice of one or another pathway depends on the product desired and on the selectivity of the het(aryl)boronic acid used in successive SMC reactions). The iodine compound <b>6</b> was engaged in a SMC reaction with the 6-bromo-5-methylpyridin-3-ylboronic acid (<b>7</b>) to afford selectively compound <b>8</b> in 86% yield. Finally, compound <b>8</b> is engaged in a SMC reaction by increasing the number of equivalents of boronic acid, which allows the expected derivative to be obtained in one step: MR29072 was therefore obtained in six steps with an overall yield of 39%.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Surface Plasmon Resonance</h3><div class="NLM_p">We used surface plasmon resonance (SPR) technology to verify the direct interaction between Mcl-1 and pyridoclax and determine affinity constant (<i>K</i><sub>d</sub>). SPR experiments were performed in three independent conditions. With a first batch of pyridoclax, specificity of the interaction was evaluated in comparison with binding of pyridoclax to immobilized Bcl-x<sub>L</sub>. Binding studies were realized in duplicate with either 1000 RU (not shown) or 5000 RU of immobilized proteins. We thus verify that no interaction occurs between the antiapoptotic protein Bcl-x<sub>L</sub> and pyridoclax (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). The sensorgram in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A shows a dose-dependent interaction between His-Mcl-1 coated on the BIAcore sensor chip (5000 RU) and pyridoclax used as an analyte. Specific binding kinetics parameters of pyridoclax to the immobilized His-Mcl-1 determine affinities between pyridoclax and the His-tagged Mcl-1 protein of 1.55 and 3.6 nM over 5000 and 1000 RU of immobilized Mcl-1, respectively, while affinity for Bcl-x<sub>L</sub> could not be determined. A second set of experiments was performed with a second batch of pyridoclax. With immobilized Bcl-x<sub>L</sub> used as reference surface for nonspecific binding measurements, a differential interaction about 10 RU was observed with pyridoclax, whereas no interaction occurs with MR29004 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). In these conditions, a calculated <i>K</i><sub>d</sub> of 25 nM (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) confirmed an affinity of binding in the nanomolar range. Binding parameters from three kinetic experiments are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Real-time binding of pyridoclax and MR29004 on immobilized His fusion proteins. (A) Low mass weight-single cycle kinetics analysis was simultaneously performed on immobilized His fusion Mcl-1 (5000 RU) and His fusion Bcl-x<sub>L</sub> (5000 RU) with five injections of analyte at 1, 2, 4, 8, and 16 nM. Analyte injections lasted for 120 s each and were separated by 10 s dissociation phases. An extended dissociation period of 10 min followed the last injection. The pyridoclax sensorgram recorded for Mcl-1 was fitted globally to a 1:1 interaction (black curves). (B) Low mass weight-single cycle kinetics analysis was simultaneously performed on immobilized His fusion Mcl-1 (3500 RU) and His fusion Bcl-x<sub>L</sub> (3500 RU) with five injections of analytes (pyridoclax and MR29004) at 70, 140, 280, 560, and 1120 nM. Analyte injections lasted for 120 s each and were separated by 10 s dissociation phases. An extended dissociation period of 10 min followed the last injection. The MR29004 sensorgram was not fitted. Each sensorgram represents a differential response where response on an empty reference channel (A) or Bcl-x<sub>L</sub>-coated reference channel (B) has been subtracted and is expressed in RU as a function of time in seconds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Rate Constants and Affinities for Binding of Pyridoclax on Immobilized His-Mcl-1 Fusion Proteins</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">immobilized ligand (RU)</th><th class="colsep0 rowsep0" align="center">analyte</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>a</sub>, M<sup>–1</sup> s<sup>–1</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>d</sub>, s<sup>–1</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>d</sub>, nM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCl-1 (1000 RU)</td><td class="colsep0 rowsep0" align="left">pyridoclax (batch 1)</td><td class="colsep0 rowsep0" align="char" char=".">7.6 × 10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char=".">2.7 × 10<sup>–2</sup></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCl-1 (5000 RU)</td><td class="colsep0 rowsep0" align="left">pyridoclax (batch 1)</td><td class="colsep0 rowsep0" align="char" char=".">4.89 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char=".">7.5 × 10<sup>–2</sup></td><td class="colsep0 rowsep0" align="char" char=".">1.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCl-1 (3500 RU) with subtracted Bcl-x<sub>L</sub></td><td class="colsep0 rowsep0" align="left">pyridoclax (batch 2)</td><td class="colsep0 rowsep0" align="char" char=".">4.79 × 10<sup>2</sup></td><td class="colsep0 rowsep0" align="char" char=".">1.23 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pyridoclax Disrupts Mcl-1/Bim Interaction</h3><div class="NLM_p">Bioluminescence resonance energy transfer (BRET) technology was used to monitor the effect of pyridoclax on the binding properties of Mcl-1 within live cells. This technique allows us to detect and quantify specific protein–protein interactions by measuring energy transfer between a donor luciferase fusion protein and an acceptor YFP fusion protein. After activation by coelenterazine H, luciferase can promote emission of light from YFP provided that donor and acceptor are less than 10 nm apart. We measured interaction between luciferase fused BimL and YFP-fused Mcl-1.</div><div class="NLM_p">We first ensured the specificity of the interaction evaluated by BRET by carrying out a donor saturating assay (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) where the BRET signal is measured using a constant amount of donor and an increasing amount of acceptor. A saturation BRET level is clearly achieved for the untreated condition, thus attesting the specificity of the BRET signal, whereas pyridoclax treatment leads to a much flattened curve, underscoring the inhibitory effect of the compound. Histograms in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B show the influence of pyridoclax treatment on BimL/Mcl-1 interaction when measured under conditions that roughly yield 50% of the maximal BRET signal corresponding to the relative affinity between the two proteins. It clearly indicates that pyridoclax is able to disrupt BimL/Mcl-1 interaction in whole living cells. This experiment has been performed with 10, 25, and 50 μM in a second cell line, MCF7. It showed a concentration-dependent effect, beginning at 10 μM and reaching a maximum intensity at 25 μM since 50 μM did not increase the observed effect (Supplementary Data 1, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of pyridoclax in whole living cells using BRET assay. (A) Donor saturation assay. Saturation curves were measured in Hela cells transiently cotransfected with increasing acceptor/donor (peYFP-Mcl-1/pRluc-BimL) ratio as described in <a class="ref internalNav" href="#sec6" aria-label="Experimental Procedures">Experimental Procedures</a> and untreated or treated with pyridoclax. (B) Effect of pyridoclax treatment on a single ratio acceptor/donor (yielding 50% of the maximal BRET signal) after a 16 h exposure at 50 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effect of Pyridoclax as Single Agent or Combined with siRNA-Mediated Bcl-x<sub>L</sub> Inhibition</h3><div class="NLM_p">To demonstrate the interest of pyridoclax as a Mcl-1 inhibitor, we used a model of selective dependence on both Bcl-x<sub>L</sub> and Mcl-1 in which Bcl-x<sub>L</sub> expression was silenced by RNA interference 48 h before exposure. We used the ovarian carcinoma cell line IGROV1-R10, since we previously demonstrated that this cell line was highly sensitive to the concomitant inhibition of Bcl-x<sub>L</sub> and Mcl-1<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> but remained viable when only one of these targets was inhibited.</div><div class="NLM_p">As expected, neither 24 h of pyridoclax treatment alone nor the Bcl-x<sub>L</sub> targeting siRNA (siXL1) alone induced massive cell death on their own. We observed a slowed proliferation but neither cell detachment, strong sub-G1 peak, caspase 3 activation, nor condensed or fragmented nuclei were detected (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A,B,C) in these conditions.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of pyridoclax on IGROV1-R10 ovarian cancer cells, alone or associated with a Bcl-x<sub>L</sub> targeting siRNA (siXL1). Cells were transfected with 10 nM siRNA for 48 h before a 24 h (A, B, C, D) or 2, 4, or 6 h (E) exposure to 25 μM pyridoclax. (A) Cellular morphology, DNA content histograms, and annexin V/propidium iodide biparametric histograms. (B) Trypan blue exclusion assay. (C) Bcl-x<sub>L</sub> expression and PARP and caspase 3 cleavage assessed by western blot. (D) Nuclear morphology studied after DAPI staining (top) and cellular morphology studied by electron microscopy. (E) Short time effects of the combination pyridoclax/siXL1 (assessed 2, 4, and 6 h after the beginning of the exposure to pyridoclax). Cellular morphology and DNA content histograms (left panel) and PARP and caspase 3 cleavage assessed by western blot (right panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast, their combination led to massive cell death, as demonstrated by strong cell detachment, by the appearance of a strong sub-G1 peak on the DNA content histogram (over 50%), and by the appearance of a 60% fraction of annexin V positive cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). It should be noted that this fraction is mainly double positive; that could be due to the time of analysis, since we studied annexin V/PI staining after a 24 h exposure, whereas apoptosis induction is observable as soon as 2 h after the beginning of the exposure, as demonstrated in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>E. It should therefore be considered that these double-positive cells have undergone postapoptotic necrosis. Moreover, the viability evaluation showed that this combination led to a drastic decrease of the number of viable cells and to a concomitant increase of dead cell number (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), and western blot showed a complete cleavage of PARP and caspase 3 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). DAPI staining and electron microscopy showed that this combination led to nuclear condensations and fragmentations highly evocative of apoptotic cell death (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D). We showed that these effects were optimal after exposure to 25 μM pyridoclax but were also observed to a lower extent in response to 10 μM (data not shown). The kinetic study of the effect of this combination showed that apoptosis was observed as soon as 2 to 4 h after the beginning of the exposure (37% of events in sub-G1 fraction after 4 h), and this observation is compatible with a pharmacologic Mcl-1 inhibition through BH3-mimetic activity (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>E).</div><div class="NLM_p last">Altogether, these elements show that pyridoclax strongly sensitizes ovarian cancer chemoresistant IGROV1-R10 cells to Bcl-x<sub>L</sub> targeting siRNA, their combination leading to massive apoptosis.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pyridoclax Sensitizes Various Cancer Cell Types to Bcl-x<sub>L</sub> Targeting siRNA</h3><div class="NLM_p">We therefore studied the effect of the combination of MR29072 with siXL1 in other ovarian carcinoma cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A), as well as in other cancer cell types (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). We observed a similar response to this combination in all ovarian carcinoma cell lines, as well as in lung carcinoma (A549) and mesothelioma (MSTO-211H) cell lines.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of pyridoclax alone or combined with a Bcl-x<sub>L</sub> targeting siRNA (siXL1) on ovarian, lung, and mesothelial cancer cell lines. Cells were transfected with 10 nM siRNA for 48 h before a 24 h exposure to 25 μM pyridoclax. Cell detachment and sub-G1 proportion on DNA histograms were assessed by the observation of cellular morphology and by flow cytometry, respectively, in ovarian carcinoma cells (A) and lung or mesothelioma cancer cells (B). (C) expression of Bcl-x<sub>L</sub> and Mcl-1 in a panel of ovarian cancer cell lines. Note the strong ratio of Mcl-1/Bcl-x<sub>L</sub> expression in A2780 cells. (D and E) Effects of Mcl-1-targeting siRNA (siMCL1) and pyridoclax, respectively, on apoptotic cell death in Mcl-1-dependent ovarian cancer cell line A2780.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Otherwise, we used another ovarian cancer cell line, A2780, in which Mcl-1 expression is higher than in other ones, whereas Bcl-x<sub>L</sub> expression is clearly lower than in other cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). As demonstrated by siRNA-mediated Mcl-1 silencing, this cell line is dependent on Mcl-1 for its survival since we observed apoptosis induction after transfection of Mcl-1-targeting siRNA in a concentration dependent manner. It should be noticed that we had to use a more elevated concentration of siRNA (30 nM) to efficiently silence Mcl-1 in this cell line compared with that for SKOV3 or IGROV1 cells, for instance (10–20 nM), probably due to the very high level of Mcl-1 expression in A2780 compared with these two other cell lines.</div><div class="NLM_p last">As expected, in this Mcl-1-dependent cell line, the exposure to pyridoclax as single agent induced massive cell death, although it should be noticed that the more active concentration of pyridoclax was then 50 μM, probably also due to the high level of Mcl-1 expression.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pyridoclax Sensitizes Chemoresistant Ovarian Cancer Cells to ABT-737</h3><div class="NLM_p">Because ABT-737 is one of the most potent Bcl-x<sub>L</sub> inhibiting BH3-mimetic molecules and because the response of ovarian cancer cells to ABT-737 is conditioned by the inhibition of Mcl-1, we evaluated the effect of the combination of ABT-737 with pyridoclax (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). As described previously with siXL1, we observed that neither ABT-737 nor pyridoclax induced cell death as single agents, whereas their combination led to massive apoptotic cell death in both IGROV1-R10 and SKOV3 chemoresistant ovarian cancer cell lines. Indeed, when the two molecules were combined, cellular activity was drastically decreased in both cell lines as assessed by impedancemetry (xCELLigence technology) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A,F). We also observed a strong cell detachment and an important sub-G1 fraction on DNA content histograms (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C), as well as complete PARP and caspase 3 cleavages after 24 h treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>D,F, right panel). It should be noticed that these effects were similar in concomitant exposure experiments and in sequential exposure (pyridoclax 24 h, then ABT-737; Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A,B). Moreover, apoptosis was observed as soon as the cells were exposed to pyridoclax and ABT-737, arguing in favor of a BH3-mimetic activity.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of the combination of pyridoclax with ABT-737 on chemoresistant ovarian cancer cells IGROV1-R10 (top) and SKOV3 (bottom). Cells were concomitantly (A, E) or sequentially (B) exposed to 25 μM pyridoclax and 5 μM ABT-737, and cellular effects were assessed either in real-time (A, B, E) or after 24 h (C, D, F). (A, B, E) Real-time cellular activity assessed by impedancemetry (xCELLigence technology), after concomitant exposure (A, E) or sequential exposure (B; 24 h pyridoclax, then ABT-737). (C) Cellular morphology and DNA content histograms after a 24 h concomitant exposure. (D, F) PARP and caspase 3 cleavages after a 24 h concomitant exposure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Pyridoclax Induces ER Stress and Modifies Bcl-2 Family Expression, but Its Cytotoxic Effect Does Not Require These Events</h3><div class="NLM_p">Since numerous presumed Mcl-1 inhibitors have been demonstrated to exert their effect through an ER stress-mediated Noxa induction, we investigated whether pyridoclax was able to induce ER stress and subsequent BH3-only transcriptional activation. Our results showed that pyridoclax induced an increase of Mcl-1, Bim, and Noxa expression (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A), through a mechanism at least in part transcriptional that mimics the effect induced by the ER stress inducer thapsigargin (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). Indeed, Mcl-1 and Bim mRNA increased about 1.2-fold and Noxa mRNA about 3.5-fold after a 24 h exposure to pyridoclax as well as to thapsigargin. We also observed a time-dependent increase of Noxa protein expression from 2 to 24 h (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>C).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of pyridoclax on Bcl-2 family expression, ER stress, and association of these events with apoptosis in response to Bcl-x<sub>L</sub> targeting strategies. Cells were exposed to 25 μM pyridoclax, and Mcl-1, Bcl-x<sub>L</sub>, Bim, and Noxa expression were assessed at protein level after 24 h in response to pyridoclax (A) and at the mRNA level in response to pyridoclax and to the ER stress inducer thapsigargin (500 nM) (B). (C) Induction of Noxa expression by pyridoclax after 2, 4, 6, and 24 h exposure. (D) ER stress induction was assessed by the study of CHOP and HSP70 induction by western blot. (E) Immunoprecipitation of Bcl-x<sub>L</sub> and Mcl-1. Cells were exposed 24 h to ABT-737 and then 6 h to pyridoclax, and the binding of Bim, Noxa, Bax, and Bak to Bcl-x<sub>L</sub> and Mcl-1 was studied after immunoprecipitation (left panels). The expression of these proteins in whole lysate is presented on the right panel. (F) Bcl-x<sub>L</sub> and Noxa expression were silenced for 48 h using specific siRNA (siXL1 and siNOXA) and cells were then exposed to 25 μM pyridoclax. Cellular morphology and DNA content histogram (left panel), as well as PARP and caspase 3 cleavage (right panel), were studied after 24 h. G The effect of thapsigargin-induced ER stress on ABT-737 cytotoxicity was assessed by the study of cellular and nuclear morphology, DNA content histograms, trypan blue exclusion test, and caspase 3 cleavage after 24 h. CHOP and Noxa protein expression was studied by western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since it has been previously shown that ER stress could be responsible for such transcriptional activation of Bcl-2 family members, we assessed CHOP and HSP70 expression by western blot and showed that ER stress was strongly induced after a 24 h exposure to pyridoclax (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>D). However, it should be noticed that when pyridoclax is combined with siXL1, neither CHOP nor HSP70 appeared induced, suggesting that apoptosis occurred before ER stress. Moreover, as shown on Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, we observed apoptotic cell death as soon as 2 h after the beginning of the exposure, whereas Noxa induction is not strong yet (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>C).</div><div class="NLM_p">The immunoprecipitation experiments performed after 6 h showed that ABT-737 released Bax, Bak, and Bim from Bcl-x<sub>L</sub> to be resequestered by Mcl-1. Pyridoclax did not modify Bax and Bak sequestration by Bcl-x<sub>L</sub> but increased Bim binding to Bcl-x<sub>L</sub>. In contrast, it drastically decreased the amount of Bim bound to Mcl-1. Whole lysate observation showed that Noxa expression was induced, as previously observed, and immunoprecipitation showed that it was associated with Mcl-1 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>E). As expected, when ABT-737 and pyridoclax were associated, Bim was then released from both Bcl-x<sub>L</sub> and Mcl-1, in agreement with Bim/Mcl-1 BRET experiments evoked previously.</div><div class="NLM_p">In order to study whether Noxa induction is required for pyridoclax-induced Mcl-1 inactivation and subsequent cell death when Bcl-x<sub>L</sub> is inhibited (siXL1 or ABT-737), we silenced Noxa expression through interference RNA strategy (siNOXA). We showed that siNOXA was able to abrogate the pyridoclax-induced Noxa expression but was not able to protect IGROV1-R10 cells from apoptosis induced by the combination of pyridoclax/siXL1 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>F). Similar results were obtained with the combination pyridoclax/ABT-737 (data not shown).</div><div class="NLM_p">Finally, we used thapsigargin to induce ER stress and observed its effect on the response to a Bcl-x<sub>L</sub>-inhibiting strategy (siXL1, ABT-737). A 24 h exposure to thapsigargin induced ER stress as shown by CHOP induction, strongly induced Noxa expression, but only poorly sensitized cells to ABT-737 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>G) compared with pyridoclax. Indeed, whereas in response to the combination pyridoclax/ABT-737 cells were completely detached, presented nearly only condensed and fragmented nuclei (left panel), and showed a completely cleaved caspase3 (middle panel), they remained mainly attached and mainly presented normal nuclei in response to the combination thapsigargin/ABT-737. The number of viable cells (right panel) was not strongly affected, and caspase 3 remained globally uncleaved in this condition.</div><div class="NLM_p last">Therefore, it could be concluded that, although pyridoclax is able to induce ER stress, this event is not responsible for the observed apoptotic cell death when it is associated with Bcl-x<sub>L</sub> inhibiting strategies, thus clearly differentiating pyridoclax from numerous other presumed Mcl-1 inhibitors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">QSAR</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have demonstrated above that pyridoclax induces cell death through Mcl-1 inhibition (pro-apoptotic activity). In order to determine pyridoclax essential chemical functions for Mcl-1 inhibition property, we synthesized various derivatives presented in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Chemical Procedure To Synthesize MR29072 and Its Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>With identical ends when blue color (het)aryl boronic species were used and with different ends when purple, red, magenta, or green (het)aryl boronic species were used. Reagents and conditions: (a) NIS (1.1 equiv), CH<sub>3</sub>CN, rfx, 4 h; (b) PhPOCl<sub>2</sub>, 160 °C, 4 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), 1,4-dioxane, rfx, 24 h; (d) NaI (10 equiv), CH<sub>3</sub>COCl (1.5 equiv), CH<sub>3</sub>CN, 100 °C, 1 h, <i>C</i> = 0.25 M, microwave; (e) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), K<sub>3</sub>PO<sub>4</sub> (2.5 equiv), DME, rfx, 20 h; (f) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub> (5 equiv), 1,4-dioxane, rfx, 24 h.</p></p></figure><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Chemical Procedure To Synthesize MR30820<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), 1,4-dioxane, rfx, 4 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), K<sub>3</sub>PO<sub>4</sub> (2.5 equiv), DME/H<sub>2</sub>O, rfx, 20 h; (c) PhCH<sub>2</sub>P(O)(OEt)<sub>2</sub> (1 equiv), KOH (2 equiv), THF, rfx, 19 h.</p></p></figure><div class="NLM_p">Concerning the preparation of pyridoclax analogues, either they were synthesized using 2.5 equiv of corresponding (het)aryl boronic species in order to produce analogues with identical ends (pathway A, MR31321, MR31336, MR31322, MR31350, MR31361, MR30814, MR30846, MR30847, and MR30854) or they were prepared with two different (het)aryl boronic species in order to produce analogues with different ends (pathway B, MR31348 and MR31349; pathway C MR30849 and MR30850). The choice of the synthesis pathway was determined on the basis of the reactivity of different boronic species.</div><div class="NLM_p">In both cases, an iterative procedure as described for MR29072 was used. MR29071 was synthesized using the same procedure as described previously from the 5-bromo-2-iodo-3-(<i>E</i>)-styrylpyridine (<b>6</b>) and the 6-bromo-pyridin-3-yl boronic acid (<b>12</b>) to afford the intermediate dibromostyrylbipyridine (<b>13</b>) (pathway D).</div><div class="NLM_p">Another procedure was used to produce MR30820. First, we prepare in an excellent yield 5-bromo-2-(pyridin-3-yl)benzaldehyde (<b>19</b>) according to a SMC reaction from 2,5-dibromobenzaldehyde (<b>17</b>) and 3-pyridyl boronic acid (<b>18</b>). The selectivity of the reaction is due to the presence of the aldehyde function, which allows orientation of the coupling reaction only toward the formation of the C–C bond in the <i>ortho</i> position. Then, the SMC reaction between compound <b>19</b> and boronic acid <b>16</b> gave the desired aldehyde <b>20</b>. Finally, a Horner–Wadsworth–Emmons reaction was realized using aldehyde <b>20</b> in the presence of 1 equiv of diethyl benzylphosphonate and 2 equiv of potassium hydroxide in refluxing tetrahydrofuran during 19 h. We successfully obtained 2-(pyridin-3-yl)-5-(3-methyl-4-pyridin-3-ylphenyl)-(<i>E</i>)-styrylphenyl as MR30820 in 77% yield.</div><div class="NLM_p">We evaluated the ability of these analogues to sensitize IGROV1-R10 cells to siRNA-mediated Bcl-x<sub>L</sub> silencing (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The inhibition activities of derivative compounds were then compared with pyridoclax to evaluate the importance of individual pyridoclax chemical groups. We observed that some modifications did not affect the activity, whereas others decreased or abolished it completely.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structure–activity relationships. Various oligopyridines derivatives from pyridoclax were synthesized, and their activity was evaluated as previously described for pyridoclax, that is, after silencing of Bcl-x<sub>L</sub> in IGROV1-R10. The cells were transfected with siRNA for 48 h and then exposed for 24 h to pyridoclax derivatives. Cellular morphology and DNA content histograms are presented for each molecule. Molecules are classified considering the chemical function that has been modified compared with MR29072 (pyridoclax).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the middle of the molecule, pyridoclax has a bipyridine core substituted by a methyl and a styryl group in the 5 position. The styryl presence in the 5 position seems to be crucial for the pro-apoptotic activity: when styryl was replaced by hydrogen (MR29006<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>) or methyl (MR29004), we did not observe pro-apototic activity. When the styryl group was moved to the 4 position (MR30820), apoptotic activity was reduced, even if a similar sub-G1 fraction has been observed. Indeed, despite comparable proportions of sub-G1 fraction in DNA content histograms after exposure to pyridoclax and MR30820, both FS/FL3 biparametric histograms (size/DNA content) and cellular and nuclear morphologies showed that the extent of cell death was quite different. It was nearly complete after exposure to pyridoclax, whereas it was moderate after exposure to MR30820 (Supplementary Data 2, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). The methyl presence on the other middle ring seems necessary to the pro-apoptotic activity: the methyl absence (MR29071) abolished completely the activity.</div><div class="NLM_p">Terminal groups of pyridoclax are pyridines, each with nitrogen at the <i>meta</i> position of the junction link. The derivative MR30814, lacking the two N-terminal nitrogens, does not present good activity. From these data, we hypothesized that the pyridine nitrogens play a particular role in the pyridoclax activity. Because the docking studies proposed that one terminal nitrogen is situated in the proximity of Arg263, we synthesized derivatives with only one terminal pyridine and we also varied the nitrogen position in pyridines. Indeed, the absence of the nitrogen in just one terminal ring (MR31348 and MR31349) does not greatly affect the activity. In conclusion, pyridyl nitrogen on one terminal ring at least is necessary for good pro-apoptotic activity. We also observed that addition of a second nitrogen on the terminal ring (pyrimidine ring) in MR31361 or a switch of the nitrogen position (<i>meta</i> to <i>para</i>) in MR31350, decreased activity.</div><div class="NLM_p last">Finally terminal pyridyl or phenyl rings were replaced by a smaller one, thienyl ring. For those derivatives, we observed a lack of activity; only MR31336 presents a reduced activity due to introduction of the methyl substituents on the thienyl rings. Similarly to the data presented for MR30820, sub-G1 fraction was not, on its own, representative of the extent of cell death, and other parameters such as the intensity of PARP cleavage, cell detachment, or nuclear condensations and fragmentation should be taken into account, as shown in the table presented in Supplementary Data 3, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mcl-1 is frequently amplified in human cancers and has been designed as a high priority therapeutic target in oncology.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The cooperation between Bcl-2-like proteins and Mcl-1 to protect cancer cells has been well documented. In ovarian carcinoma, we clearly showed that Bcl-x<sub>L</sub> inhibition is highly cytotoxic provided that Mcl-1 is also inhibited.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, whereas great hopes are placed in the Bcl-x<sub>L</sub> or Bcl-2 inhibitors (ABT-263, ABT-199) that present some activity in hematological and solid cancers,<a onclick="showRef(event, 'ref8 ref13'); return false;" href="javascript:void(0);" class="ref ref8 ref13">(8, 13)</a> Mcl-1 inhibitors are dramatically lacking. The development of such Mcl-1 inhibiting molecules thus constitutes a major challenge for the success of Bcl-x<sub>L</sub> targeting strategies in numerous malignancies.</div><div class="NLM_p">The solved structures of pro-apoptotic/antiapoptotic complexes showed that the complex formation is ensured by a BH3 amphiphatic helix, which lies in the hydrophobic groove formed by BH1, BH2, and BH3 domains of the second partner. The mimicking of the BH3 amphiphatic helix could thus be realized by foldamers bearing substituents (key recognition motifs) able to interact with hydrophobic pocket of the targeted antiapoptotic protein. Systematically, the BH3 helix face in contact with the antiapoptotic groove consists of hydrophobic residues corresponding to the face of the α helix, that is, the positions <i>i</i>, <i>i</i> + 4, <i>i</i> + 7, and <i>i</i> + 11.</div><div class="NLM_p">This approach to design compounds distributing their substituents at the key interacting side chain positions of the BH3 helix mimetic, was already applied for example to search for a Bak mimetic.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Since these works, numerous abiotic foldamers with side chains mimicking peripheral functionalities of proteic α-helices have been published in the literature. For example, Hamilton et al. described a series of terphenyl scaffolds presenting 3,2′,2″ alkyl or aryl substituents on the three <i>ortho</i> positions of the phenyl rings in a spatial orientation that mimics the <i>i</i>, <i>i</i> + 3, or <i>i</i> + 4 and <i>i</i> + 7 residues on a native α helix.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Fluorescence polarization assays showed that less hydrophobic terphenyls present lower affinity, emphasizing the importance of hydrophobic interactions for the binding to the recognition cleft.<a onclick="showRef(event, 'ref54 ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57 ref58">(54-58)</a> From a predictive computational study, Che et al. have proposed that a pyridyl-based scaffold should be more flexible in the α-helix mimicking regions with respect to a phenyl scaffold and that it should be superior as a helical surface mimetic.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Subsequently, Hamilton and co-workers have synthesized terpyridyl scaffolds using sequential Bohlmann–Rahtz hetero annulation reactions with low yields. Recently, we have developed the Garlanding concept,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> which allows us to overcome the long and difficult synthesis of terpyridyl used by Hamilton and co-workers. This approach allows building of a long linear chain from one ring by the implementation of iterative SMC reactions between boronic species and dihalogenated compounds. It was applied to synthesize the oligopyridine family that is of interest as Mcl-1 inhibitors. Among these compounds, we were interested in MR29004, the pyridoclax inferior analogue, with a scaffold consisting of four pyridine rings substituted by methyl on the two central rings. We observed that methyl substituents can overlap helix side chains at the position <i>i</i> + 4 and <i>i</i> + 7 of an α helix. The comparative sequence analysis of the BH3 domain showed that the leucine residue in position <i>i</i> + 4 is fully conserved in all pro-apoptotic proteins. Next, pyridoclax was designed by replacing one methyl group of MR29004, by a more bulky hydrophobic substituent (a styryl), drawing inspiration from Noxa. Noxa, a selective Mcl-1 ligand, alone has a phenylalanine in position <i>i</i> + 7. Despite the introduction of a styryl in the inferior analogue, we predicted that pyridoclax has a conformation (twist angles) close to its inferior analogue and thus the substituents of pyridoclax can still mimic <i>i</i> + 4 and <i>i</i> + 7 α helix residues.</div><div class="NLM_p">Our docking studies have suggested that pro-apoptotic activity of pyridoclax can be due to direct pyridoclax/Mcl-1 interaction. The observed poses have been divided into two groups, the first group with pyridoclax positions relative 180° to positions of the second one. According to the docking poses (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), the styryl aromatic ring was situated in both groups in the same Mcl-1 cavity independently of scaffold orientation, and it stacked with Phe228. Docking studies have also shown that another type of pyridoclax/Mcl-1 interaction is present in the complex. One of the ending nitrogen rings was close to the Mcl-1 Arg263. This result is interesting according to previous structural studies. Indeed a solvent-exposed aspartic acid, conserved in all BH3-only proteins, is crucial for the BH3-only/antiapoptotic complex formation. This aspartic acid forms a salt bridge with an arginine, fully conserved among all the antiapoptotic proteins (Arg263 in human Mcl-1). Moreover, in the recently published X-ray structure of an Mcl-1 inhibitor (6-chloro-3-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1<i>H</i>-indole-2-carboxylic acid) complexed with hMcl-1, a hydrogen bond was established between the inhibitor carboxyl group and the nitrogen of Arg263.<a onclick="showRef(event, 'ref60 ref60'); return false;" href="javascript:void(0);" class="ref ref60 ref60">(60, 60)</a> So this predicted that electrostatic interaction could be important for the complex formation pyridoclax/Mcl-1.</div><div class="NLM_p">Thus, modeling studies suggested that the pyridoclax could have good chemical properties to interact with Mcl-1 protein.</div><div class="NLM_p">To study the capacity of pyridoclax to disrupt Bim/Mcl-1 in live cells, we used a method that allows us to monitor in-cell interactions between one transiently transfected luciferase tagged protein (Bim in this work) and a second, yellow fluorescent tagged protein (Mcl-1 in this work) by bioluminescence resonance energy transfer (BRET). This method provides robust and reliable signals. It allows direct study of the effects of oligopyridines added in the culture medium on intracellular interactions.</div><div class="NLM_p">Since it has been shown that Bcl-2 proteins change their conformation after insertion into the cell membranes, as reviewed in ref <a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">61</a>, BRET assay constitutes a pertinent assay to study protein–protein interaction between these proteins under native conditions compared with other screening assays performed using soluble fragments of the target protein. BRET assay, previously used to study the disruption of the interaction Bax/Bcl-x<sub>L</sub> by polyphenol derivatives,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> demonstrated the capacity of pyridoclax to dissociate Mcl-1 from Bim in whole living cells.</div><div class="NLM_p">We further investigated the ability of pyridoclax to sensitize cancers cells to Bcl-x<sub>L</sub> inhibition strategies. We previously demonstrated the dependence of ovarian cancer cells to both Bcl-x<sub>L</sub> and Mcl-1<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and the ability of Mcl-1 inhibition to sensitize chemoresistant ovarian cancer cells to Bcl-x<sub>L</sub> inhibiting strategies.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> These cell lines therefore constitute pertinent models for the screening of libraries of molecules with BH3-mimetic potential. In particular, the IGROV1-R10 cell line demonstrated strong sensitivity to the concomitant inhibition of Bcl-x<sub>L</sub> and Mcl-1, whereas the inhibition of these proteins separately does not induce cytotoxic effects.</div><div class="NLM_p">Here we showed that pyridoclax did not induce apoptosis as a single agent in IGROV1-R10 cells but presented a great ability to sensitize these cells to Bcl-x<sub>L</sub>-targeting siRNA, as well as to ABT-737. This was true in ovarian cancer cells, as well as in lung cancer and mesothelioma cells. Other Mcl-1 inhibitors have been shown to be able, as a single agent, to kill leukemia cells dependent on Mcl-1, particularly MIM1.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, in our study, the cell lines used were not sensitive to the siRNA-mediated inhibition of Mcl-1 alone, as presented previously.<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20, 22)</a> This observation is in agreement with the absence of effect of pyridoclax alone. In contrast, the exposure of the A2780 cell line (which is dependent on Mcl-1 for its survival) to pyridoclax as single agent led to massive cell death, as was also the case in response to Mcl-1 siRNA-mediated silencing.</div><div class="NLM_p">Interestingly, we also evaluated the association of pyridoclax with a Mcl-1-targeting siRNA (siMCL1), in order to evaluate the possible inhibition of Bcl-x<sub>L</sub> by pyridoclax. siRNA silencing of Mcl-1 does not lead to cytotoxicity in the presence of pyridoclax 50 μM (data not shown), whereas it would have been the case if pyridoclax could act as a Bcl-x<sub>L</sub> inhibitor. Moreover, it could be argued that if pyridoclax would be a pan-inhibitor, it should induce cell death as single agent, which is not the case. These elements suggest that pyridoclax presents a relative selectivity for Mcl-1.</div><div class="NLM_p">We used surface plasmon resonance (SPR) assays to demonstrate that pyridoclax was able to directly and selectively interact with Mcl-1 (versus Bcl-x<sub>L</sub>). The results show a direct interaction between His-Mcl-1 coated on the BIAcore sensor chip with pyridoclax used as an analyte with a dose-dependent binding and an affinity about <i>K</i><sub>D</sub> = 1.55 nM with 5000 RU of immobilized proteins. The same technology was used to verify that no interaction occurs with the antiapoptotic protein Bcl-x<sub>L</sub>. Moreover, using MR29004 as analyte in the same conditions, no interaction with Mcl-1 was recorded.</div><div class="NLM_p">Some BH3 mimetic molecules (ABT-737, HA14-1, Gossypol, 2-methoxy-Antimycin A3, S1) previously demonstrated either activity as a single agent or a sensitizing effect to ABT-737. However, it has been shown that only ABT-737 was able to inhibit Bcl-2<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (for review) and that the other molecules acted through an ER-stress mediated induction of Noxa (via ATF3 and ATF4 induction) and subsequent Mcl-1 inhibition.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> One of them (Gossypol) also appears able to inhibit proteasome activity that consequently induces ER stress.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Moreover, ABT-737 itself has been described to induce ER stress,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> even if the opposite has also been described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">Relationships between ER stress and Bcl-2 family are complex because ER stress can lead to BH3-only transcriptional activation,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and Bcl-2 family is known to modulate positively or negatively the unfolded protein response.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Noxa and Mcl-1 induction have been also observed in response to other ER stress inducers, thapsigargine<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and celestratol,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> the latter study also showing that this mechanism sensitizes cells to ABT-737.</div><div class="NLM_p">Here we also observed a strong induction of Noxa after a 24 h exposure to pyridoclax, as well as a moderate induction of Mcl-1 and Bim, both at mRNA and protein level. Similar events were observed in our cell lines in response to the ER stress inducer thapsigargin, suggesting that they are at least in part due to ER stress induction. Moreover, since surface plasmon resonance experiments (recently introduced in the manuscript in response to the reviewers) suggest that Mcl-1/pyridoclax is difficult to disrupt, it could also be hypothesized that pyridoclax binding to Mcl-1 leads to the stabilization of the protein itself, thus leading to its accumulation.</div><div class="NLM_p">However, we studied the possibility that the observed effect would be nonspecific, due to the activation of ER stress previously described in response to numerous other BH3-mimetic molecules.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> We observed that pyridoclax induced ER stress after 24 h. However, some elements argued in favor of an ER stress independent mechanism. Indeed, ER stress did not seem to occur when pyridoclax was combined with siXL1 or ABT-737, suggesting that rapid and massive apoptosis induced by these combinations did not allow the induction of ER stress. It could thus be hypothesized that ER stress that occurs in response to pyridoclax as a single agent cannot occur when it is combined with the inhibition of Bcl-x<sub>L</sub>, due to apoptosis induction. We also showed that the induction of Noxa was weak during the six first hours in response to pyridoclax alone and was quite absent when it was combined with siXL1 or ABT-737, arguing in favor of a Noxa independent mechanisms.</div><div class="NLM_p">This was verified by the use of a Noxa targeting siRNA. Noxa silencing did not affect the response to pyridoclax, thus demonstrating that ER stress mediated Noxa induction was not responsible for apoptotic cell death in response to pyridoclax/siXL1 or ABT-737 combination. In contrast, the activity of obatoclax (described as pan-inhibitor of Bcl-2 like proteins, including Mcl-1<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a>) is in part inhibited when Noxa expression is silenced by siRNA strategy.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Moreover, the use of the ER stress inducer thapsigargin and its combination with ABT-737 was drastically less efficient to induce cell death compared with the combination pyridoclax/ABT-737, despite the strong induction of Noxa, arguing in the same way.</div><div class="NLM_p">We also observed a decrease in Mcl-1 expression when pyridoclax was associated with a Bcl-x<sub>L</sub> targeting strategy, when a massive apoptotic cell death is observed. It is known that Mcl-1 could be degraded by caspases, thus explaining why, after a 24 h exposure, Mcl-1 appeared to be decreased. However, in both cell lines, pyridoclax strongly induced Mcl-1 expression, at least in part through transcriptional activation at least in part due to ER stress. When pyridoclax is associated with Bcl-x<sub>L</sub> inhibition (siRNA or ABT-737), this increase does not occur (neither ER stress) since the cells are rapidly orientated toward apoptosis. The level of Mcl-1 expression is thus comparable to the level observed in control cells when pyridoclax is combined with siXL1 and more clearly reduced when pyridoclax is combined with ABT-737 (apoptosis is in this case induced more quickly, and activated caspase 3 level appears to be more intense). The observed absence of Mcl-1 expression increase is thus probably the results of combined mechanisms, such as the absence of ER stress induction, the rapid orientation toward apoptosis, and Mcl-1 degradation by proteasome and caspases.</div><div class="NLM_p last">The QSAR studies allowed us to highlight the importance of individual pyridoclax chemical functions. The methyl and styryl hydrophobic motifs situated both at 5 position are necessary for the pro-apoptotic activity, and the docking results showed that these two groups anchor in the Mcl-1 hydrophobic pockets. The nitrogen present on terminal pyridines also plays an important role. The absence of the nitrogen on both terminal rings abolished the pyridoclax pro-apoptotic activity. Our simulations showed that the absence of nitrogen on the terminal ring does not influence the global conformation of the compound with respect to the pyridoclax. From this data, we hypothesized that nitrogen itself could be involved in the binding site recognition. Indeed, the docking studies showed that one of the ending pyridine nitrogens, in both orientations observed in docking, is situated in the proximity of Mcl-1 Arg263 and an electrostatic interaction could occur. Therefore, a series of derivatives with only one terminal pyridine and various nitrogen positions in the pyridine were synthesized and evaluated. In conclusion, only one N-terminal pyridine is necessary for the pro-apoptotic activity (with little preference for the pyridine next to the styryl substituted pyridine). Indeed, the docking studies proposed the two opposite orientations of pyridoclax, which match well with these experimental results.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we designed, synthesized, and identified new molecules among the oligopyridine family that could be efficiently used as Mcl-1 inhibitors, pyridoclax (MR29072) appearing as the lead compound of this family. We used SPR assays to demonstrate that pyridoclax was able to directly and selectively interact with Mcl-1. We also showed that pyridoclax induces ER-stress and subsequent Noxa expression, but that these events were not required for the observed sensitizing effect, thus differentiating this original molecule from most other Mcl-1 inhibitors. Although further <i>in vivo</i> preclinical studies are now required, our study demonstrated the potential interest of these innovative molecules to sensitize ovarian cancer cells to Bcl-x<sub>L</sub> targeting strategies. Considering the dramatic situation of patients with tumors resistant to conventional chemotherapy, this opens interesting perspectives concerning the use of pyridoclax and its derivatives in combination with Bcl-x<sub>L</sub> targeting molecules such as the ABT-737-derived orally available molecule navitoclax.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemical Synthesis</h3><div class="NLM_p">Commercial reagents were used as received without additional purification. Only new compounds are described. Melting points were determined on a Kofler heating bench. IR spectra were recorded on a PerkinElmer BX FT-IR spectrophotometer. The band positions are given in reciprocal centimeters (cm<sup>–1</sup>). <sup>1</sup>H NMR (400 MHz) and <sup>13</sup>C NMR (100 MHz) spectra were recorded on a JEOL Lambda 400 spectrometer. Chemical shifts are expressed in parts per million downfield from tetramethylsilane as an internal standard and coupling constants in hertz. Chemical shifts are reported in parts per million (ppm) relative to the solvent resonance. Chromatography was carried out on a column using flash silica gel 60 Merck (0.063–0.200 mm) as the stationary phase. The eluting solvent indicated for each purification was determined by thin layer chromatography (TLC) performed on 0.2 mm precoated plates of silica gel 60F-264 (Merck) and spots were visualized using an ultraviolet-light lamp. High resolution mass spectra were performed at 70 eV by electronic impact (HRMS/EI) or by positive or negative electrospray (HRMS/ESI) on a JEOL JMS GCMate spectrometer. Elemental analyses for new compounds were performed, and the data for C, H, and N were within ±0.4 of the theoretical values for all final compounds. Purities of samples subjected to biological testing were assessed using these two methods and shown to be ≥95%.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure To Synthesize MR29072 and Its Analogues with Identical Ends</h4><div class="NLM_p">To 5-bromo-2-hydroxypyridine (<b>1</b>; 5 g, 29 mmol) was added solid <i>N</i>-iodosuccinimide (7.1 g, 32 mmol) in acetonitrile (120 mL). The solution was stirred at reflux for 4 h and followed by TLC. The solution was cooled to room temperature, filtered, and washed with methanol. 5-Bromo-2-hydroxy-3-iodopyridine (<b>2</b>) was obtained as a pink solid (yield 83%).</div><div class="NLM_p">Compound <b>2</b> (9 g, 30 mmol) was dissolved in phenylphosphonic dichloride 90% (100 mL, 0.3 mol). The mixture was stirred and heated (160 °C) for 4 h and followed by TLC. At room temperature, it was introduced dropwise into a 1 L vial filled with water and cooled at 0 °C. The solution was neutralized by addition of NH<sub>4</sub>OH solution. The mixture was extracted in ethyl acetate. The product, 5-bromo-2-chloro-3-iodopyridine (<b>3</b>), was obtained as a white solid (yield 82%).</div><div class="NLM_p">To a reaction vessel (100 mL) in a nitrogen environment containing <b>3</b> (5 g, 15.7 mmol) were added <i>trans</i>-phenylvinylboronic acid (<b>4</b>; 2.7 g, 18 mmol), tetrakis(triphenylphosphine)palladium(0) (907 mg, 0.8 mmol), and sodium carbonate (4.2 g, 39 mmol) in 1,4-dioxane (100 mL). The mixture was stirred at reflux for 24 h followed by TLC. The product was cooled to room temperature and filtered on Celite. The solution was dried on MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by chromatography (<i>c</i>-hexane/ethyl acetate = 99:1, then 98:2) to afford 5-bromo-2-chloro-3-(<i>E</i>)-styrylpyridine (<b>5</b>) as a white solid (yield 93%). Mp: 104 °C. IR (KBr disc): 3036, 1627, 1530, 1494, 1447, 1389, 1152, 1116, 1063, 956, 897, 755, 719, 687, 491 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.30 (d, 1H, <i>J</i> = 1.9 Hz), 8.03 (d, 1H, <i>J</i> = 1.9 Hz), 7.52 (d, 2H <i>ortho</i> Ph, <i>J</i> = 7.8 Hz), 7.38 (dd, 2H <i>meta</i> Ph, <i>J</i> = 7.8 Hz), 7.32 (d, 1H <i>para</i> Ph, <i>J</i> = 7.8 Hz), 7.26 (d, 1H, CH═CH, <i>J</i> = 16.6 Hz), 7,04 (d, 1H, CH═CH, <i>J</i> = 16,6 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.5, 148.4, 136.6, 135.8, 134.5, 133.6, 129.0, 128.8 (2C Ph), 127.1 (2C Ph), 121.8, 119.3. LCMS(EI): 293[M + H<sup>+</sup>], 295[M<sup>+</sup> + 2], 297[M<sup>+</sup> + 4].</div><div class="NLM_p">To <b>5</b> (200 mg, 0.7 mmol) were added sodium iodide (1.05 g, 7 mmol), acetyl chloride (0.07 mL, 1 mmol), and acetonitrile (10 mL). The solution was stirred under microwave application for 1 h at 100 °C. At room temperature, the mixture was neutralized by a NaHCO<sub>3</sub> solution. After an extraction and a wash with sodium bisulfite solid/water, the organic layer was dried with MgSO<sub>4</sub>, filtered, and evaporated. The product was purified by chromatography (<i>c</i>-hexane/ethyl acetate = 98:2, then 95:5) to achieve 5-bromo-2-iodo-3-(<i>E</i>)-styrylpyridine <b>6</b> as white solid (yield 84%). Mp: 78 °C. IR (KBr disc): 3054, 3023, 1629, 1492, 1446, 1377, 1269, 1109, 1026, 952, 889, 751 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.29 (d, 1H, <i>J</i> = 1.96 Hz), 7.83 (d, 1H, <i>J</i> = 1.96 Hz), 7.52 (d, 2H <i>ortho</i> Ph, <i>J</i> = 7.8 Hz), 7.38 (dd, 2H <i>meta</i> Ph, <i>J</i> = 7.8 Hz), 7.32 (d, 1H <i>para</i> Ph, <i>J</i> = 7.8 Hz), 7.09 (d, 1H, CH═CH, <i>J</i> = 15.6 Hz), 6.94 (d, 1H, CH═CH, <i>J</i> = 15.6 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 149.64, 139.64, 135.87, 135.11 (CH═CH), 134.70 (CH═CH), 128.99, 128.89 (2C), 128.09, 127.09 (2C), 121.06, 120.78. LCMS(EI): 258[M + H<sup>+</sup>], 260[M<sup>+</sup> + 2].</div><div class="NLM_p">To a reaction vessel (100 mL) in a nitrogen atmosphere containing <b>6</b> (1.4 g, 3.6 mmol) were added 6-bromo-5-methylpyridin-3-ylboronic acid (<b>7</b>; 978 mg, 0.45 mmol), tetrakis(triphenylphosphine)palladium(0) (210 mg, 0.18 mmol), and potassium phosphate (2.1 g, 9 mmol) in 1,2-dimethoxyethane (30 mL). The mixture was stirred at reflux for 20 h, followed by TLC. At room temperature, the solution was extracted with ethyl acetate. The organic layer was dried on MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by chromatography (<i>c</i>-hexane/ethyl acetate = 95:5, then 9:1 and 8:2) and 5,6′-dibromo-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine (<b>8</b>; yield 86%) was obtained as white solid. Mp: 143 °C. IR (KBr disc): 3031, 1393, 1111, 1050, 968, 898, 740, 685, 499 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.65 (d, 1H, <i>J</i> = 1.9 Hz), 8,41 (d, 1H, <i>J</i> = 1.9 Hz), 8.17 (d, 1H, <i>J</i> = 1.9 Hz), 7.83 (d, 1H, <i>J</i> = 1.9 Hz), 7.42 (d, 2H, <i>J</i> = 7.8 Hz), 7.36 (dd, 2H, <i>J</i> = 7.8 Hz), 7.31 (d, 1H, <i>J</i> = 7.8 Hz), 7.12 (d, 1H, <i>J</i> = 16.6 Hz), 6,99 (d, 1H, <i>J</i> = 16.6 Hz), 2.46 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 151.4, 149.4, 147.8, 144.9, 139.6, 136.5, 136.0, 135.2, 134.0, 133.9, 133.3, 128.9 (2C), 128.8, 126.9 (2C), 123.4, 120.4, 22.0. LCMS(EI): 428 [M + H<sup>+</sup>], 430[M<sup>+</sup> + 2], 432[M<sup>+</sup> + 4].</div><div class="NLM_p">To a reaction vessel (100 mL) in a nitrogen atmosphere containing <b>8</b> (320 mg, 0.7 mmol) were added pyridin-3-yl boronic acid (156 mg, 1.7 mmol), tetrakis(triphenylphosphine)palladium(0) (78 mg, 0.07 mmol), and sodium carbonate (355 mg, 3.35 mmol) in 1,4-dioxane (20 mL). The mixture was stirred at reflux for 24 h, followed by TLC. At room temperature, the suspension was filtered on Celite, and the solution was extracted with ethyl acetate. The organic layer was dried on MgSO<sub>4</sub>, filtered, and evaporated. The product was purified by chromatography (<i>c</i>-hexane/ethyl acetate = 8:2, then 7:3 and 50:50) to achieve 5,6′-di(pyridin-3-yl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine as MR29072 or pyridoclax (yield 86%) as a white solid. Mp: 158 °C. IR (KBr): 2957, 1727, 1575, 1274, 1125, 1014, 967, 801, 770, 688 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.98 (d, <i>J</i> = 1.9 Hz, 1H), 8.91 (d, <i>J</i> = 1.9 Hz, 1H), 8.87 (m, 2H), 8.72 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.9 Hz, 2H), 8.68 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.9 Hz, 1H), 8.24 (d, <i>J</i> = 1.9 Hz, 1H), 8.00 (m, 3H), 7.48 (d, <i>J</i> = 7.8 Hz, 3H), 7.44 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.9 Hz, 1H), 7.36 (d, <i>J</i> = 7.8 Hz, 1H), 7.31 (d, <i>J</i> = 7.8 Hz, 1H), 7.28 (d, <i>J</i> = 16.6 Hz, 1H), 7.23 (d, <i>J</i> = 16.6 Hz, 1H), 2.51 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 155.3, 153.4, 149.9, 149.6, 149.2, 148.2, 148.0, 146.9, 139.8, 136.5, 136.3, 135.8, 134.4, 134.1, 133.1, 133.0, 132.9, 132.6, 132.0, 131.1, 128.8 (2C), 128.5, 126.8 (2C), 124.6, 123.8, 123.2, 20.0. LCMS (EI): <i>m</i>/<i>z</i> (%) [M + H]<sup>+</sup> theoretical 427.53; experimental 427.32. Anal.Calcd for C<sub>29</sub>H<sub>22</sub>N<sub>4</sub>: C, 81.67; H, 5.20; N, 13.14. Found: C, 81.65; H, 5.25; N, 13.23.</div><div id="sec6_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 3-Methyl-5-(3-(<i>E</i>)-styryl-5-(thiophen-2-yl)pyridin-2-yl)-2-(thiophen-2-yl)pyridine, MR31321</h5><div class="NLM_p last">The general procedure was followed using thiophen-2-yl boronic acid (445 mg, 3.48 mmol) and <b>8</b> (500 mg, 1.16 mmol) to yield the title compound (320 mg) as a yellow oil that crystallized (yield 63%). IR (KBr disc): 2922, 1638, 1618, 1451, 1437, 1222, 1150, 828, 701, 692 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.90 (d, 1H, <i>J</i> = 1.96 Hz), 8.73 (d, 1H, <i>J</i> = 1.96 Hz), 8.18 (d, 1H, <i>J</i> = 1.96 Hz), 7.95 (d, 1H, <i>J</i> = 1.96 Hz), 7.58 (d, 1H, <i>J</i> = 3.87 Hz), 7.49–7.46 (m, 4H), 7.43 (d, 1H, <i>J</i> = 3.87 Hz), 7.38–7.34 (dd, 2H, <i>J</i> = 7 Hz), 7.30 (m, 1H, <i>J</i> = 7 Hz), 7.20 (s, 2H, CH═CH), 7.19–7.17 (m, 2H), 2.68 (3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 152.85, 151.24, 147.70, 145.96, 145.06, 140.42, 140.12, 139.45, 136.71, 133.17, 132.82, 131.91, 131.29, 129.75, 129.59, 128.95, 128.57, 128.53, 128.03, 127.96, 127.54, 127.03, 126.47, 125.22, 124.74, 121.81, 21.77. LCMS(EI): 437 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 3-Methyl-5-(3-(<i>E</i>)-styryl-5-(thiophen-3-yl)pyridin-2-yl)-2-(thiophen-3-yl)pyridine, MR31322</h5><div class="NLM_p last">The general procedure was followed using thiophen-3-yl boronic acid (357 mg, 2.79 mmol) and <b>8</b> (400 g, 0.93 mmol) to yield the title compound (160 mg) as a brown oil (yield 49%). IR (KBr disc): 2943, 1648, 1389, 866, 759, 696, 615 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.89 (d, 1H, <i>J</i> = 1.92 Hz), 8.77 (d, 1H, <i>J</i> = 1.92 Hz), 8.21 (d, 1H, <i>J</i> = 1.92 Hz), 7.96 (1H, <i>J</i> = 1.92 Hz), 7.68–7.66 (dd, 2H, <i>J</i> = 2.92 Hz, <i>J</i> = 7.4 Hz), 7.57 (d, 1H, <i>J</i> = 7 Hz), 7.51 (d, 2H, <i>J</i> = 2.92 Hz), 7.47 (d, 2H, <i>J</i> = 7 Hz), 7.43–7.41 (dd, 2H, <i>J</i> = 2.92 Hz), 7.38–7.34 (dd, 2H, <i>J</i> = 7 Hz), 7.26–7.21 (m, 2H, CH═CH), 2.68 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 153.25, 152.67, 147.64, 146.56, 141.38, 139.75, 138.32, 136.60, 133.34, 132.37, 131.67, 131.63, 130.73, 130.53, 128.79 (3C), 128.30, 127.16, 126.81 (2C), 125.99, 125.30, 125.27, 125.12, 121.84, 26.86. LCMS(EI): 437 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 3-Methyl-2-(3-methylthiophen-2-yl)-5-(5-(3-methylthiophen-2-yl)-3-(<i>E</i>)-styrylpyridin-2-yl)pyridine, MR31336</h5><div class="NLM_p last">The general procedure was followed using 3-methylthiophen-2-yl boronic acid (401 mg, 2.82 mmol) and <b>8</b> (486 mg, 1.13 mmol) to yield the title compound (105 mg) as an orange oil (yield 20%). IR (KBr disc): 2943, 1648, 1389, 866, 759, 696, 615 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.89 (d, 1H, <i>J</i> = 1.92 Hz), 8.77 (d, 1H, <i>J</i> = 1.92 Hz), 8.21 (d, 1H, <i>J</i> = 1.92 Hz), 7.96 (1H, <i>J</i> = 1.92 Hz), 7.68–7.66 (dd, 2H, <i>J</i> = 2.92 Hz, <i>J</i> = 7.4 Hz), 7.57 (d, 1H, <i>J</i> = 7 Hz), 7.51 (d, 2H, <i>J</i> = 2.92 Hz), 7.47 (d, 2H, <i>J</i> = 7 Hz), 7.43–7.41 (dd, 2H, <i>J</i> = 2.92 Hz), 7.38–7.34 (dd, 2H, <i>J</i> = 7 Hz), 7.26–7.21 (m, 2H, CH═CH), 2.68 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 153.25, 152.67, 147.64, 146.56, 141.38, 139.75, 138.32, 136.60, 133.34, 132.37, 131.67, 131.63, 130.73, 130.53, 128.79 (3C), 128.30, 127.16, 126.81 (2C), 125.99, 125.30, 125.27, 125.12, 121.84, 26.86. LCMS(EI): 437 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2-(5-Methyl-6-(pyridin-4-yl)pyridin-3-yl)-5-(pyridin-4-yl)-3-(<i>E</i>)-styrylpyridine, MR31350</h5><div class="NLM_p last">The general procedure was followed using 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (500 mg, 2.44 mmol) and <b>8</b> (421 mg, 0.98 mmol) to yield the title compound (233 mg) as a pale yellow solid (yield 56%). Mp: 168–170 °C. IR (KBr disc): 2928, 2675, 2487, 1630, 1600, 1446, 1419, 1384, 1110, 1031, 963, 819, 766, 748, 680, 623 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.85 (d, 1H, <i>J</i> = 2.2 Hz), 8,80 (d, 1H, <i>J</i> = 1.9 Hz), 8.73–8.71 (dd, 2H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.5 Hz), 8.70–8.68 (dd, 2H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.5 Hz), 8.21 (d, 1H, <i>J</i> = 2.2 Hz), 7.97 (d, 1H, <i>J</i> = 1.9 Hz), 7.58–7.57 (dd, 2H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.5 Hz), 7.48–7.47 (dd, 2H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.5 Hz),7.41 (d, 2H, <i>J</i> = 6.8 Hz), 7.32–7.29 (m, 2H), 7.26–7.25 (m, 1H), 7.23–7.16 (m, 2H, CH═CH), 2.43 (s, 3H, CH<sub>3</sub>).<sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 155.78, 154.09, 150.69 (2C), 149.95, 148.06, 147.59, 146.84, 144.59, 140.04, 136.41, 134.42, 133.37, 132.67, 132.06, 131.10, 128.89 (2C), 128.65, 126.88 (2C), 124.67, 124.52, 123.76 (2C), 121.61 (2C), 121.40, 19.91. LCMS (EI): 427.37 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 5-(6-(5-Methyl-6-(pyrimidin-5-yl)pyridin-3-yl)-5-(<i>E</i>)-styrylpyridin-3-yl)pyrimidine, MR31361</h5><div class="NLM_p last">The general procedure was followed using pyrimidine-5-boronic acid (345 mg, 2.79 mmol) and <b>8</b> (400 mg, 0.93 mmol) to yield the title compound (200 mg) as a pale yellow solid (yield 50%). Mp: >250 °C. IR (KBr disc): 3036, 1557, 1454, 1408, 1128, 1015, 967, 893, 744, 725, 690,627 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.33 (s, 1H), 9.30 (s, 1H), 9.10 (s, 2H), 9.07 (s, 2H), 8.90 (d, 1H, <i>J</i> = 1.9 Hz), 8.88 (d, 1H <i>J</i> = 2.2 Hz), 8.25 (d, 1H, <i>J</i> = 2.2 Hz), 8.07 (d, 1H, <i>J</i> = 1.9 Hz), 7.48 (d, 2H, <i>J</i> = 7 Hz), 7.40–7.32 (m, 3H), 7.27 (d, 1H, <i>J</i> = 16 Hz, CH═CH), 7.22 (d, 1H, <i>J</i> = 16 Hz, CH═CH), 2.53 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 158.50, 158.05, 156.92 (2C), 155.03 (2C), 154.00, 152.28, 148.47, 146.55, 140.10, 136.17, 134.54, 133.83, 133.72, 132.65, 132.48, 131.66, 131.11, 129.75, 128.95 (2C), 128.83, 126.92 (2C), 124.13, 22.13. LCMS(EI): 429.58 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 5-Methyl-5′,6-biphenyl-3′-(<i>E</i>)-styryl-3,2′-bipyridine, MR30814</h5><div class="NLM_p last">The general procedure was followed using benzeneboronic acid (708 mg, 5.81 mmol) and <b>8</b> (1 g, 2.32 mmol) to yield the title compound (600 mg) as a white solid (yield 61%). Mp: 141 °C. IR (KBr): 3036, 3022, 2930, 2857, 2245, 1436, 1401, 1391, 1115, 852, 734, 672 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.88 (s, 1H), 8.83 (s, 1H), 8.23 (s, 1H), 7.99 (s, 1H, H4), 7.71 (d, <i>J</i> = 7.8 Hz, 2H), 7.63 (d, <i>J</i> = 7.8 Hz, 2H), 7.57–7.43 (m, 8H), 7.37–7.24 (m, 5H), 2.48 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 158.4, 153.1, 146.9, 146.2, 140.3, 139.7, 137.5, 136.8, 135.9, 133.3, 132.5 (2C), 131.7, 130.6, 129.3 (2C), 129.2 (2C), 128.8 (2C), 128.3 (2C), 128.2 (2C), 128.1, 127.2 (2C), 126.8 (2C), 125.4, 20.1. LCMS (ESI): 424.55; [M + H<sup>+</sup>] 425.27.</div></div><div id="sec6_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 5-(3,4-Dimethoxyphenyl)-2-(6-(3,4-dimethoxyphenyl)-5-methylpyridin-3-yl)-3 (<i>E</i>)-styrylpyridine, MR30846</h5><div class="NLM_p last">The general procedure was followed using 3,4-dimethoxyphenylboronic acid (293 mg, 1.85 mmol) and <b>8</b> (320 mg, (0.67 mmol) to yield the title compound (300 mg) as a yellow solid (yield 82%). Mp: 80 °C. IR (KBr): 3054, 3026, 2931, 2835, 1722, 1602, 1587, 1516, 1422, 1253, 1139, 1025, 693, 541 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.84 (s, 1H, H6), 8.80 (s, 1H), 8.17 (s, 1H), 7.98 (s,1H), 7.48 (d, <i>J</i> = 6.8 Hz, 2H), 7.36 (dd, <i>J</i> = 7.8, 7.1 Hz, 2H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.28 (d, <i>J</i> = 16.4 Hz, 1H, CH═CH), 7.27–7.21 (m, 4H), 7.18 (d, <i>J</i> = 15.9 Hz, 1H, CH═CH), 7.04 (d, <i>J</i> = 8.3 Hz, 1H), 6.98 (d, <i>J</i> = 8.3 Hz, 1H), 4.01 (s, 3H, CH<sub>3</sub>O-<i>meta</i>), 3,97 (s, 9H), 2,50 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 158, 152.7, 149.7, 149.6, 149.2, 148.8, 147.7, 147.1, 139.6, 136.8, 135.8, 133.5, 132.9, 132.4, 132.1, 131.6, 130.7, 130.3, 128.8, 128.4, 126.8, 125.5, 121.8, 119.7, 112.5, 111.7, 110.5 (2C), 110.3 (2C), 56.1, 56.0, 55.9, 55.8, 20.5. LCMS(ESI):545.64 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 5-(3,4,5-Trimethoxyphenyl)-6′-(3,4,5-trimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine, MR30847</h5><div class="NLM_p last">The general procedure was followed using 3,4,5-trimethoxyphenylboronic acid (392 mg, 1.85 mmol) and <b>8</b> (400 mg, 0.84 mmol) to yield the title compound (355 mg) as a yellow solid (yield 70%). Mp 100 °C. IR (KBr): 2995, 2931, 2833, 1723, 1584, 1508, 1451, 1418, 1343, 1238, 1125, 747 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.83 (s, 1H), 8.80 (s, 1H), 8.16 (s, 1H), 7.99 (s, 1H), 7.49 (d, <i>J</i> = 7.1 Hz, 2H), 7.35 (dd, <i>J</i> = 7.6, 6.8 Hz, 2H), 7.31 (d, <i>J</i> = 7.3 Hz, 1H), 7.28 (d, <i>J</i> = 15.6 Hz, 1H, CH═CH), 7,21 (d, <i>J</i> = 15.6 Hz, 1H, CH═CH), 6.86 (s, 2H), 6,84 (s, 2H), 3.99 (s, 6H, CH<sub>3</sub>O-<i>meta</i>), 3,93 (s, 3H, CH<sub>3</sub>O-<i>para</i>), 3,91 (s, 6H, CH<sub>3</sub>O-<i>meta</i>′), 3.82 (s, 3H, CH<sub>3</sub>O-<i>para</i>′), 2,50 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 158.4, 153.1, 146.9, 146.2, 140.3, 139.7, 137.5, 136.8, 135.9, 133.3, 132.5 (2C), 131.7, 130.6, 129.3 (2C), 129.2 (2C), 128.8 (2C), 128.3 (2C), 128.2 (2C), 128.1, 127.2 (2C), 126.8 (2C), 125.4, 56.1 (2C), 56.0 (2C), 55.8 (2C), 20.1. LCMS(EI): 605.69 [M + H<sup>+</sup>].</div></div><div id="sec6_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 6′,5-(Dicyanophenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine, MR30854</h5><div class="NLM_p last">The general procedure was followed using 4-cyanophenylboronic acid (63 mg, 0.43 mmol) and <b>8</b> (130 mg, 0.29 mmol) to yield the title compound (130 mg) as a yellow solid (yield 95%). Mp: 226 °C. IR (KBr): 3029, 2957, 2925, 2854, 2225, 1731, 1606, 1450, 1419, 1383, 1277, 838,747, 694 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.88 (d, <i>J</i> = 2.2 Hz), 8.85 (d, <i>J</i> = 2.2 Hz, 1H), 8.24 (d, <i>J</i> = 2.2 Hz, 1H), 8.04 (d, <i>J</i> = 2.2 Hz, 1H), 7.79 (dd, <i>J</i> = 8.3, 1.9 Hz, 4H), 7.74 (dd, <i>J</i> = 8.5, 2.0 Hz, 4H), 7.45 (d, <i>J</i> = 8.0 Hz, 2H), 7.35 (d, J=8.1 Hz, 2H), 7.31 (d, <i>J</i> = 7.3 Hz, 1H), 7.17 (d, <i>J</i> = 16.3 Hz, 2H, CH═CH), 2.49 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 156.5, 153.8, 148.0, 147.0, 144.6, 141.9, 140.0, 136.2(2C), 134.5, 134.4, 133.5, 133.2, 132.8, 132.4 (2C), 132.2, 131.1, 130.0 (2C), 129.0, 128.9, 128.0 (2C), 127.0 (2C), 124.7(2C), 118.8, 118.6, 112.5, 112.0, 20.5. LCMS(ESI): 475.55 [M + H<sup>+</sup>].</div></div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure To Synthesize Compounds of Formula <b>9</b></h4><div id="sec6_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 3-(6-Chloro-5-(<i>E</i>)-styrylpyridin-3-yl)pyridine</h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 5-bromo-2-chloro-3-(<i>E</i>)-styrylpyridine (<b>5</b>; 1.5 g, 5.08 mmol) were added pyridin-3-yl boronic acid (781 mg, 6.35 mmol), tetrakis(triphenylphosphine)palladium(0) (5% mol), and Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv) in 1,4-dioxane. The mixture was stirred at reflux for 24 h, followed by TLC. The product was cooled to room temperature and filtered on Celite. The solution was dried on MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by chromatography (<i>c</i>-hexane/ethyl acetate = 7:3) to afford the title compound (1.41 g) as a pale yellow solid (95% yield). Mp: 159 °C. IR (KBr disc): 3045, 3019, 2924, 2853, 1638, 1578, 1446, 1427, 1385, 1166, 1087, 1057, 1023, 951, 921, 804, 729, 714, 687 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.88 (d, 1H, <i>J</i> = 2.2 Hz), 8,71–8.69 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.76 Hz), 8.49 (d, 1H, <i>J</i> = 2.3 Hz), 8.14 (d, 1H, <i>J</i> = 2.3 Hz), 7.94–7.91 (m, 1H), 7.58 (d, 2H, <i>J</i> = 7.3 Hz), 7.40–7.26 (m, 5H), 7.13 (d, 1H, <i>J</i> = 16.4 Hz, CH═CH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 149.92, 149.70, 148.10, 146.09, 136.15, 136.10, 134.49, 133.99, 133.04, 132.91, 132.53, 132.30, 128.89 (2C), 127.06 (2C), 123.86, 122.72. LCMS(EI): 293.35 [M + H<sup>+</sup>], 295.34 [M<sup>+</sup> + 2].</div></div><div id="sec6_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2-Chloro-5-phenyl-3-(<i>E</i>)-styrylpyridine</h5><div class="NLM_p last">The general procedure was followed using phenyl boronic acid (929 mg, 7.62 mmol) and 5-bromo-2-chloro-3-(<i>E</i>)-styrylpyridine (<b>5</b>; 1.5 g, 5.08 mmol). The residue was purified by chromatography (<i>c</i>-hexane/ethyl acetate = 9:1) to yield the title compound (1.10 g) as a colorless oil (yield 74%). IR (KBr disc): 3058, 3033, 2924, 2850, 1630, 1601, 1580, 1546, 1494, 1448, 1417, 1407, 1390, 1322, 1222, 1210, 1162, 1116, 1085, 1054, 1008, 961, 903, 845, 762, 741, 696, 563 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.54 (d, 1H, <i>J</i> = 2.4 Hz), 8,07 (d, 1H, <i>J</i> = 2.4 Hz), 7.59–7.24 (m, 11H), 7.11 (d, 1H, <i>J</i> = 16 Hz, CH═CH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 146.3, 143.8, 136.4, 135.3, 135.2, 134.6, 133.4, 132.5, 129.3 (2C), 128.8, 128.7 (2C), 128, 127.5 (2C), 127.4, 126.4 (2C). LCMS(EI): 292.35 [M + H<sup>+</sup>], 294.34 [M<sup>+</sup> + 2].</div></div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure To Synthesize Compounds of Formula <b>10</b></h4><div id="sec6_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 3-(6-Iodo-5-(<i>E</i>)-styrylpyridin-3-yl)pyridine</h5><div class="NLM_p last">To a solution of 3-(6-chloro-5-(<i>E</i>)-styrylpyridin-3-yl)pyridine (1 g, 3.41 mmol) in acetonitrile at a concentration of 0.25 M, sodium iodide (10 equiv) and acetyl chloride (1.5 equiv) were added. The reaction mixture was heated under microwave irradiation at 100 °C for 60 min. It was carefully quenched with saturated NaHCO<sub>3</sub> aqueous solution until pH = 8. Product was extracted with ethyl acetate and washed with saturated NaHSO<sub>3</sub> aqueous solution. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue, a yellow solid (1.28 g, 98% yield), was subjected to <sup>1</sup>H NMR, and integrations of some characteristic signals permitted us to obtain the percentage of conversion. It was used in the successive reaction without further purification. Mp: 160 °C. IR (KBr disc): 3079, 3045, 3023, 2924, 1634, 1574, 1544, 1495, 1453, 1420, 1381, 1163, 1087, 1060, 1023, 959, 914, 805, 729, 712, 680 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.88 (d, 1H, <i>J</i> = 2.2 Hz), 8,71–8.69 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.76 Hz), 8.45 (d, 1H, <i>J</i> = 2.3 Hz), 7.94 (d, 1H, <i>J</i> = 2.3 Hz), 7.93–7.90 (m, 1H), 7.59 (d, 2H, <i>J</i> = 7.3 Hz), 7.46–7.35 (m, 4H), 7.28 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH), 7.09 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 149.1, 148, 144.8, 140.7, 135.4, 135.2, 134.1, 133.4, 133.2, 132.9, 128.7 (2C), 128, 127.4, 126.4 (2C), 124, 115.9. LCMS(EI): 385.11 [M + H<sup>+</sup>].</div></div><div id="sec6_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 2-Iodo-5-phenyl-3-(<i>E</i>)-styrylpyridine</h5><div class="NLM_p last">The general procedure was followed using 2-chloro-5-phenyl-3-(<i>E</i>)-styrylpyridine (1 g, 3.42 mmol). The residue, a yellow oil (1.01 g, 77% yield), was used in the successive reaction without further purification. IR (KBr disc): 3060, 3030, 2932, 1623, 1570, 1491, 1449, 1406, 1110, 1080, 1034, 1008, 959, 906, 761, 696 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.45 (d, 1H, <i>J</i> = 2.4 Hz), 7.95 (d, 1H, <i>J</i> = 2.4 Hz), 7.59–7.24 (m, 11H), 7.08 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 144.8, 140.7, 136.4, 135.4, 135.2, 133.4, 132.9, 129.3 (2C), 128.8, 128.7 (2C), 128, 127.5 (2C), 127.4, 126.4 (2C), 114.9. LCMS(EI): 384.18 [M + H<sup>+</sup>].</div></div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> General Procedure To Synthesize Compounds of Formula <b>11</b></h4><div id="sec6_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 2-Bromo-3-methyl-5-(5-(pyridine-3-yl)-3-(<i>E</i>)-styrylpyridin-2-yl)pyridine</h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 3-(6-iodo-5-(<i>E</i>)-styrylpyridin-3-yl)pyridine (120 mg, 0.31 mmol) was added 6-bromo-5-methylpyridin-3-yl boronic acid (100 mg, 0.46 mmmol), followed by tetrakis(triphenylphosphine)palladium(0) (5% mol) and aqueous K<sub>3</sub>PO<sub>4</sub> (2.5 equiv). The mixture was heated at 80 °C for 1 h and then under reflux until the complete consumption of aryl halide (TLC) (20 h). The reaction mixture was concentrated and extracted with ethyl acetate. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue was purified by chromatography on silica gel (cyclohexane/ethyl acetate, 5:5 to 3:7) to afford 130 mg of pure compound as a pale yellow solid (98% yield). Mp: 149 °C. IR (KBr disc): 3039, 1588, 1557, 1490, 1438, 1379, 1190, 1120, 1053, 1023, 970, 907, 804, 746, 708, 721, 686, 540 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.94 (d, 1H, <i>J</i> = 2 Hz), 8.81 (d, 1H, <i>J</i> = 2.2 Hz), 8.71–8.69 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.8 Hz), 8.48 (d, 1H, <i>J</i> = 2 Hz), 8.19 (d, 1H, <i>J</i> = 2.2 Hz), 7.99–7.96 (m, 1H), 7.90 (d, 1H, <i>J</i> = 2.4 Hz), 7.67–7.62 (m, 1H), 7.45–7.43 (m, 2H), 7.37–7.33 (m, 2H), 7.31–7.29 (m, 1H), 7.20 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH), 7.12 (d, 1H, <i>J</i> ═16 Hz, C<i>H</i>═CH), 2.47 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 152.61, 149.67, 148.22, 147.97, 146.97, 139.80, 136.26, 134.47, 134.40, 133.34, 132.71, 132.53, 132.13, 132.03, 131.95, 128.90 (2C), 128.66, 128.56, 128.43, 126.86, 124.37, 123.87, 22.12. LCMS(EI): 428.24 [M + H<sup>+</sup>], 430.29 [M<sup>+</sup> + 2].</div></div><div id="sec6_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 2-Bromo-3-methyl-5-(5-phenyl-3-(<i>E</i>)-styrylpyridin-2-yl)pyridine</h5><div class="NLM_p last">The general procedure was followed using 2-iodo-5-phenyl-3-(<i>E</i>)-styrylpyridine (170 mg, 0.44 mmol) and 6-bromo-5-methylpyridin-3-yl boronic acid (1.5 equiv, 142 mg, 0.66 mmol). The residue was purified by chromatography (cyclohexane/ethyl acetate, 8:2) to afford 182 mg of pure compound as a pale yellow solid (97% yield). Mp: 175 °C. IR (KBr disc): 3030, 2921, 2853, 1578, 1555, 1442, 1385, 1061, 970, 898, 760, 694 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.85 (d, 1H, <i>J</i> = 2.2 Hz), 8.50 (d, 1H, <i>J</i> = 2.2 Hz), 8.21 (d, 1H, <i>J</i> = 2.2 Hz), 7.93 (d, 1H, <i>J</i> = 2.2 Hz), 7.73–7.70 (m, 2H), 7.55–7,44 (m, 5H), 7.37–7.30 (m, 3H), 7.24 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH), 7.15 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH), 2.49 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 144.7, 143.8, 143.6, 142.5, 137.7, 136.4, 136, 135.3, 134.7, 133.7, 133.4, 132.9, 129.3 (2C), 129, 128.8, 128.7 (2C), 128, 127.5 (2C), 127.4, 126.4 (2C), 16.8. LCMS(EI): 427.20 [M + H<sup>+</sup>], 429.27 [M<sup>+</sup> + 2].</div></div><div id="sec6_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 2-(5-Methyl-6-(pyridin-3-yl)-pyridin-3-yl)-5-phenyl-3-(<i>E</i>)-styrylpyridine, MR31348</h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 2-bromo-3-methyl-5-(5-phenyl-3-(<i>E</i>)-styrylpyridin-2-yl) pyridine (650 mg, 1.52 mmol) were added pyridin-3-yl boronic acid (28àmg, 2.28 mmol), tetrakis(triphenylphosphine)palladium(0) (5% mol), and aqueous K<sub>3</sub>PO<sub>4</sub> (2.5 equiv) in 1,4-dioxane. The mixture was heated at 80 °C for 1 h and then under reflux until the complete consumption of aryl halide (TLC) (24 h). The reaction mixture was concentrated and extracted with ethyl acetate. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue was purified by chromatography on silica gel (cyclohexane/ethyl acetate, 5:5) to afford 310 mg of pure compound as a white solid (41% yield). Mp: 191 °C. IR (KBr disc): 2920, 2848, 1628, 1582, 1571, 1446, 1408, 1385, 1113, 1010, 760, 753, 692, 540 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.90 (d, 1H, <i>J</i> = 1.9 Hz), 8,88 (d, 1H, <i>J</i> = 2.2 Hz), 8.86 (d, 1H, <i>J</i> = 1.9 Hz), 8.68–8.67 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 4.8 Hz), 8.24 (d, 1H, <i>J</i> = 1.9 Hz), 8.03 (d, 1H, <i>J</i> = 1.7 Hz), 7.98–7.97 (m, 1H), 7.72 (d, 2H, <i>J</i> = 8.3 Hz), 7.57–7.53 (m, 2H),7.49–7.46 (m, 4H), 7.38–7.34 (m, 2H), 7.31–7.29 (m, 1H), 7.27 (d, 1H, <i>J</i> = 16.6 Hz), 7.22 (d, 1H, <i>J</i> = 16.6 Hz), 2.50 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 155.14, 152.55, 149.97, 149.22, 148.14, 147.23, 139.45, 137.29, 136.64, 136.60, 136.12, 135.66, 134.45, 132.69, 132.59, 131.71, 131.12, 129.22 (2C), 128.83 (2C), 128.39, 128.30, 127.23 (2C), 126.81 (2C), 125.06, 123.25, 20.03. LCMS(EI): 426.58 [M + H<sup>+</sup>].</div></div><div id="sec6_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 2-(5-Methyl-6-phenylpyridin-3-yl)-5-(pyridin-3-yl)-3-(<i>E</i>)-styrylpyridine, MR31349</h5><div class="NLM_p last">The general procedure was followed using 2-bromo-3-methyl-5-(5-(pyridine-3-yl)-3-styrylpyridin-2-yl) pyridine (250 mg, 0.58 mmol) and phenyl boronic acid (64 mg, 0.53 mmol). The residue was purified by chromatography on silica gel (cyclohexane/ethyl acetate, 5:5) to afford 200 mg of pure compound as a white–pale yellow solid (yield 81%). Mp: 159 °C. IR (KBr disc): 3052, 2924, 2855, 1598, 1552, 1495, 1454, 1423, 1378, 1010, 972, 912, 806, 745, 696, 686 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.90 (d, 1H, <i>J</i> = 1.9 Hz), 8,79 (d, 1H, <i>J</i> = 2.2 Hz), 8.75 (d, 1H, <i>J</i> = 2.2 Hz), 8.64–8.62 (dd, 1H, <i>J</i> = 1.2 Hz, <i>J</i> = 4.7 Hz), 8.15 (d, 1H, <i>J</i> = 2.2 Hz), 7.94–7.91 (m, 2H), 7.55 (d, 2H, <i>J</i> = 7 Hz), 7.44–7.33 (m, 6H),7.29–7.26 (m, 2H), 7.23–7.19 (m, 2H), 7.14 (d, 1H, <i>J</i> = 16 Hz, C<i>H</i>═CH), 2.42 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 158.44, 153.85, 149.46, 148.17, 147.51, 146.86, 139.90, 139.76, 136.43, 134.60, 133.41, 133.17, 132.97, 132.73, 132.58, 132.21, 131.97, 130.94, 129.08 (2C), 128.83 (2C), 128.49, 128.25 (2C), 126.88 (2C), 124.82, 123.91, 21.04. LCMS(EI): 426.42 [M + H<sup>+</sup>].</div></div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> General Procedure To Synthesize MR29072 Analogues with Different Ends</h4><div id="sec6_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 5-Bromo-6′-iodo-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine, <b>14</b></h5><div class="NLM_p last">To a solution of 5,6′-dibromo-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine, (<b>8</b>; 600 mg, 1.39 mmol) in acetonitrile at a concentration of 0.25 M, sodium iodide (10 equiv) and acetyl chloride (1.5 equiv) were added. The reaction mixture was heated under microwave irradiation at 100 °C for 60 min. It was carefully quenched with saturated NaHCO<sub>3</sub> aqueous solution until pH = 8. Product was extracted with ethyl acetate and washed with saturated NaHSO<sub>3</sub> aqueous solution. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue, a yellow solid (441 mg, 66% yield) was subjected to <sup>1</sup>H NMR and integrations of some characteristic signals permitted us to obtain the percentage of conversion. It was used in the successive reaction without further purification. Mp: 147 °C. IR (KBr): 3029, 1576, 1449, 1428, 1389, 1112, 1089, 968, 900, 686, 498 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.64 (d, <i>J</i> = 1.9 Hz, 1H), 8.38 (d, <i>J</i> = 1,9 Hz, 1H), 8.16 (d, <i>J</i> = 1.9 Hz, 1H), 7.73 (d, <i>J</i> = 1.9 Hz, 1H), 7.42 (d, <i>J</i> = 6.8 Hz, 2H), 7.35 (t, <i>J</i> = 7.8 Hz, 2H), 7.31 (d, <i>J</i> = 6.8 Hz, 1H), 7.11 (d, <i>J</i> = 16.6 Hz, 1H), 6.98 (d, <i>J</i> = 16.6 Hz, 1H), 2.46 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 151.4, 149.5, 148.1, 139.2, 137.5, 136.5, 135.9, 134, 133.9, 133.3, 128.9 (2C), 128.8, 126.9 (2C), 125.6, 123.4, 120.4, 26.2. LCMS (ESI): [M + H<sup>+</sup>] calcd 478.15; found 479.06.</div></div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> General Procedure for the Synthesis of Compounds <b>15</b></h4><div id="sec6_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 5-Bromo-6′-(3,4,5-trimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine</h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 5-bromo-6′-iodo-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine (<b>14</b>; 180 mg, 0.38 mmol) were added 3,4,5-trimethoxyphenylboronic acid (88 mg, 0.42 mmol), tetrakis(triphenylphosphine)palladium(0), and aqueous K<sub>3</sub>PO<sub>4</sub> in 1,2-dimethoxyethane. The mixture was heated at 80 °C for 1 h and then under reflux until the complete consumption of aryl halide (TLC) (24 h). The reaction mixture was concentrated and extracted with ethyl acetate. The organic layer was dried over MgSO<sub>4</sub> and concentrated. The residue was purified by chromatography on silica gel (<i>c</i>-hexane/ethyl acetate, 8:2) to afford 80 mg of pure compound as a yellow solid (94% yield). Mp 170 °C. IR (KBr): 3040, 2987, 2937, 2825, 1586, 1415, 1343, 1237, 1130, 1009, 770, 750, 696 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.73 (s, 1H), 8.69 (d, <i>J</i> = 2.2 Hz, 1H), 8.21 (s, 1H), 7.92 (s, 1H), 7.45 (d, <i>J</i> = 7.1 Hz, 2H), 7.35 (dd, <i>J</i> = 7.3, 6.8 Hz, 2H), 7.31 (d, <i>J</i> = 7.32 Hz, 1H), 7.17 (d, <i>J</i> = 7.6 Hz, 1H), 7.14 (s, 2H), 6.83 (d, <i>J</i> = 6.4 Hz, 1H), 3.98 (s, 9H, OCH<sub>3</sub>), 2.49 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 158.4, 152.9 (2C), 152.5, 149.3, 147.3, 139.5, 138.1, 136.4, 136.2, 135.5, 133.4, 133.3, 133.0, 130.7, 128.8 (2C), 128.6, 126.9 (2C), 123.8, 120.0, 106.3 (2C), 60.9, 56.1, 29.6, 20.2. LCMS(EI): 518.41 [M + H<sup>+</sup>], 520.42 [M<sup>+</sup> + 2].</div></div><div id="sec6_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 5-Bromo-6′-(3,4-dimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine</h5><div class="NLM_p last">The general procedure was followed using 2-bromo-3-methyl-5-(5-(pyridine-3-yl)-3-(<i>E</i>)-styrylpyridin-2-yl) pyridine (250 mg, 0.52 mmol) and of 3,4-dimethoxyphenylboronic acid (105 mg, 0.58 mmol). The residue was purified by chromatography on silica gel (<i>c</i>-hexane/ethyl acetate, 8:2 to 5:5) to afford 180 mg of pure compound as a yellow solid (yield 93%). Mp: 158 °C. IR (KBr): 3083, 2994, 2949, 2914, 2819, 1606, 1594, 1519, 1419, 1406, 1276, 1135, 1026, 968, 926, 759 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.73 (d, <i>J</i> = 1.9 Hz, 1H), 8.69 (d, <i>J</i> = 2.2 Hz, 1H), 8.20 (d, <i>J</i> = 2.2 Hz, 1H), 7.90 (d, <i>J</i> = 1.9 Hz, 1H), 7.45 (d, <i>J</i> = 7.3 Hz, 2H), 7.35 (dd, <i>J</i> = 7.6, 7.1 Hz, 2H), 7.31 (d, <i>J</i> = 7.4 Hz, 1H), 7.21–7.14 (m, 3H), 7.17 (d, <i>J</i> = 8.0 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 3.95 (s, 6H, OCH<sub>3</sub>), 2.49 (s, 3H, CH<sub>3</sub>).<sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 158.2, 152.5 (2C), 149.3, 149.0, 148.7, 147.5, 139.5, 136.6, 136.4, 133.3, 133.2, 132.6, 132.4, 130.7, 129.0, 128.7 (2C), 127.1, 123.9 (2C), 121.8, 112.3, 110.6, 74.2, 55.7, 20.3 (CH<sub>3</sub>). LCMS(EI): 488.39 [M + H<sup>+</sup>], 491.41 [M<sup>+</sup> + 2].</div></div><div id="sec6_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 5-(3,4-Dimethoxyphenyl)-6′-(3,4,5-trimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine, MR30849</h5><div class="NLM_p last">The general procedure was followed using 5-bromo-6′-(3,4,5-trimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine (280 mg, 0.54 mmol) and 3,4-dimethoxyphenylboronic acid (108 mg, 0.60 mmol). The residue was purified by chromatography on silica gel (<i>c</i>-hexane/ethyl acetate, 8:2 to 5:5) to afford 200 mg of pure compound as a yellow solid (yield 64%). Mp: 190 °C. IR (KBr): 3033, 2994, 2959, 2937, 2839, 1587, 1520, 1451, 1409, 1342, 1266, 1239, 1172, 1141, 1127, 1026, 750 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.84 (d, <i>J</i> = 2.2 Hz, 1H), 8.79 (d, <i>J</i> = 2.2 Hz, 1H), 8.17 (d, <i>J</i> = 2.2 Hz, 1H), 7.99 (d, <i>J</i> = 2.0 Hz, 1H), 7.48 (d, <i>J</i> = 7.3 Hz, 2H), 7.35 (dd, <i>J</i> = 7.8, 6.8 Hz, 2H), 7.30 (d, <i>J</i> = 7.1 Hz, 1H), 7.27 (d, <i>J</i> = 2.2 Hz, 1H), 7.27 (d, <i>J</i> = 16 Hz, 1H, <i>CH</i>═<i>CH</i>), 7.23 (d, <i>J</i> = 16.2 Hz, 1H, <i>CH</i>═<i>CH</i>), 7.19 (d, <i>J</i> = 2.2 Hz, 1H), 6.84 (s, 3H), 4.01 (s, 3H), 3.97 (s, 3H), 3.93 (s, 6H), 3.91 (s, 3H), 2.50 (s, 3H, <i>CH</i><sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 158.2, 157.0, 152.5, 149.6, 149.5, 147.6, 147.0, 139.7, 138.0, 136.8 (2C), 135.9, 135.8 (2C), 133.8, 132.5, 132.3, 131.7, 130.6, 130.3, 128.8 (2C), 128.3, 126.8 (2C), 125.5, 119.8, 111.7, 110.2, 106.3, 61.0, 56.3 (2C), 56.2, 56.0, 20.3. LCMS(EI): 575.67 [M + H<sup>+</sup>].</div></div><div id="sec6_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 5-(3,4,5-Trimethoxyphenyl)-6′-(3,4-dimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine, MR30850</h5><div class="NLM_p last">The general procedure was followed using 5-bromo-6′-(3,4-dimethoxyphenyl)-5′-methyl-3-(<i>E</i>)-styryl-2,3′-bipyridine (180 mg, 0.37 mmol) and 3,4,5-trimethoxyphenylboronic acid (86 mg, 0.41 mmol). The residue was purified by chromatography on silica gel (<i>c</i>-hexane/ethyl acetate, 8:2 to 5:5) to afford 140 mg of pure compound as a yellow solid (yield 66%). Mp: 174 °C. IR (KBr): 2999, 2967, 2932, 2838, 1582, 1514, 1450, 1419, 1242, 1146, 1124, 1024, 749 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.83 (d, <i>J</i> = 2.2 Hz, 1H), 8.80 (d, <i>J</i> = 2.2 Hz, 1H), 8.16 (d, <i>J</i> = 2.4 Hz, 1H), 7.98 (d, <i>J</i> = 1.7 Hz, 1H), 7.49 (d, <i>J</i> = 7.1 Hz, 2H), 7.36 (dd, <i>J</i> = 7,6, 7.1 Hz, 2H), 7.30 (d, <i>J</i> = 6.8 Hz, 1H), 7.21 (d, <i>J</i> = 17.8 Hz, 1H, <i>CH</i>═<i>CH</i>), 7.20 (d, <i>J</i> = 17.8 Hz, 1H, <i>CH</i>═<i>CH</i>), 7.20 (d, <i>J</i> = 8.3 Hz, 1H), 7.19 (d, <i>J</i> = 8.0 Hz, 1H), 6.98 (d, <i>J</i> = 8.3 Hz, 1H), 6.86 (s, 2H), 3.99 (s, 6H), 3.97 (s, 3H), 3.96 (s, 3H), 3.94 (s, 3H), 2.50 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 158.0, 153.8, 153.0, 149.0, 148.7, 147.5, 147.2, 139.9, 138.1, 136.6, 136.1, 133.6, 133.4, 132.8, 132.6, 132.5, 131.7, 131.0, 128.9 (2C), 128.5, 127.0 (2C), 125.2, 121.8, 112.1 (2C), 110.3 (2C), 104.2, 61.1, 56.4 (2C), 56.1, 55.9, 20.7. LCMS(EI): 575.67 [M + H<sup>+</sup>].</div></div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Procedure To Synthesize MR29071</h4><div id="sec6_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 5,6′-Dibromo-3-(<i>E</i>)-styryl-2,3′-bipyridine, <b>13</b></h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 5-bromo-2-iodo-3-(<i>E</i>)-styrylpyridine, (<b>6</b>; 780 mg, 2 mmol) were added 6-bromopyridin-3-yl boronic acid (<b>12</b>; 469 mg, 2.3 mmol), tetrakis(triphenylphosphine)palladium(0) (5% mol), and aqueous Na<sub>2</sub>CO<sub>3</sub> in 1,4-dioxane. Then the mixture was heated to 80 °C until the starting material was consumed (TLC). After cooling to room temperature, the mixture was filtered on Celite and washed with CH<sub>2</sub>Cl<sub>2</sub>. The aqueous layer was extracted with EtOAc. Combined organic layers were dried over MgSO<sub>4</sub>. Solvents were removed in vacuo, and crude product was purified by chromatography (<i>c</i>-hexane/ethyl acetate 97:3 to 95:5) affording product as a white solid (540 mg, 64% yield). Mp: 135 °C. IR (KBr): 3034, 1573, 1451, 1426, 1393, 1089, 971, 898, 831, 740, 684, 489 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8,66 (d, <i>J</i> = 1.9 Hz, 1H), 8.62 (d, <i>J</i> = 1.9 Hz, 1H), 8.17 (d, <i>J</i> = 1.9 Hz, 1H), 7.83 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.9 Hz, 1H), 7.6 (d, <i>J</i> = 7.8 Hz, 1H), 7.42 (d, <i>J</i> = 7.8 Hz, 2H), 7.36 (t, <i>J</i> = 7.8 Hz, 2H), 7.32 (d, <i>J</i> = 7.8 Hz, 1H), 7.12 (d, <i>J</i> = 16.6 Hz, 1H), 6.97 (d, <i>J</i> = 16.6 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 150.3, 149.7, 148.5, 141.3, 138.4, 135.6, 134.9, 133.1, 132.8, 132.4, 127.9 (2C), 127.8, 126.8, 125.9 (2C), 122.3, 119.5. LCMS (ESI) 415 [M + H<sup>+</sup>], 417 [M<sup>+</sup> + 2], 419 [M<sup>+</sup> + 4].</div></div><div id="sec6_1_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 5,6′-Di(pyridin-3-yl)-3-(<i>E</i>)-styryl-2,3′-bipyridine, MR29071</h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 5,6′-dibromo-3-(<i>E</i>)-styryl-2,3′-bipyridine (<b>13</b>; 0.250 mg, 0.6 mmol) were added 3-pyridyl boronic acid (185 mg, 1.5 mmol), tetrakis(triphenylphosphine)palladium(0) (10% mol), and aqueous Na<sub>2</sub>CO<sub>3</sub> in 1,4-dioxane. Then the mixture was heated to 80 °C until the starting material was consumed (TLC). After cooling to room temperature, the mixture was filtered on Celite and washed with CH<sub>2</sub>Cl<sub>2</sub>. The aqueous layer was extracted with EtOAc. Combined organic layers were dried over MgSO<sub>4</sub>. Solvents were removed in vacuo, and crude product was purified by chomatography (ethyl acetate to CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5) affording product as a white solid (180 mg, 73% yield). Mp: 224 °C. IR (KBr): 3027, 1585, 1451, 1415, 1011, 967, 809, 745, 704 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.29 (d, <i>J</i> = 1.9 Hz, 1H), 9.07 (d, <i>J</i> = 1.9 Hz, 1H), 8.98 (d, <i>J</i> = 1.9 Hz, 1H), 8.88 (d, <i>J</i> = 1.9 Hz, 1H), 8.72 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 1.9 Hz, 1H), 8.69 (dd, <i>J</i> = 4,8 Hz, <i>J</i> = 1.9 Hz, 1H), 8.41 (d, <i>J</i> = 7.8 Hz, 1H), 8,24 (d, <i>J</i> = 1.9 Hz, 1H), 8.18 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.9 Hz, 1H), 8,02 (d, <i>J</i> = 7.8 Hz, 1H), 7,92 (d, <i>J</i> = 7.8 Hz, 1H), 7.48 (d, <i>J</i> = 7.8 Hz, 2H), 7.46 (m, 2H), 7.36 (t, <i>J</i> = 7.8 Hz, 2H), 7,32 (d, <i>J</i> = 7.8 Hz, 1H), 7.25 (d, <i>J</i> = 16.6 Hz, 1H), 7.21 (d, <i>J</i> = 16.6 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.5, 153.4, 150.8, 150.1, 149.6, 148.3, 148.2, 146.9, 138.1, 136.3, 134.4 (2C), 134.3, 134.1, 133.1, 133.0, 132.9, 132.7, 132, 128.8 (2C), 128.5, 126.8 (2C), 124.7, 123.8, 123.6 120. LCMS(EI): 413.49 [M + H<sup>+</sup>].</div></div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Procedure To Synthesize MR30820</h4><div id="sec6_1_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 5-Bromo-2-(pyridin-3-yl)benzaldehyde, <b>19</b></h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 2,5-dibromobenzaldehyde (<b>17</b>; 2 g, 7.58 mmol) were added 3-pyridyl boronic acid <b>18</b> (1.16 g, 9.47 mmol), tetrakis(triphenylphosphine)palladium(0) (5% mol), and aqueous Na<sub>2</sub>CO<sub>3</sub> in 1,4-dioxane. Then the mixture was heated to 80 °C until the starting material was consumed (TLC). After cooling to room temperature, the mixture was filtered on Celite and washed with CH<sub>2</sub>Cl<sub>2</sub>. The aqueous layer was extracted with EtOAc. Combined organic layers were dried over MgSO<sub>4</sub>. Solvents were removed in vacuo, and crude product was purified by chomatography (<i>c</i>-hexane/ethyl acetate 9:1 to 5:5) affording product as a white solid (1.60 g, 80% yield). Mp 140 °C. IR (KBr): 3055, 2920, 2884, 1927, 1682, 1581, 1465, 1420, 1380, 1188, 1177, 1025, 888, 800, 714, 642, 559 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.90 (s, 1H, CHO), 8.72 (dd, <i>J</i> = 4.9, 2.0 Hz, 1H), 8.65 (s, 1H), 8.19 (d, <i>J</i> = 2.0 Hz, 1H), 7.81 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 7.70 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 7.44 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 7.32 (d, <i>J</i> = 7.8 Hz, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 189.7, 149.9 (2C), 149.7, 140.4, 137.0, 136.7, 134.9, 132.5, 131.2, 123.2, 123.1. MS (EI): <i>m</i>/<i>z</i> calcd 261.9868; found 261.9870.</div></div><div id="sec6_1_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 2-(Pyridin-3-yl)-5-(3-methyl-4-pyridin-3-ylphenyl)benzaldehyde, <b>20</b></h5><div class="NLM_p last">To a reaction vessel in a nitrogen atmosphere containing 5-bromo-2-(pyridin-3-yl)benzaldehyde (<b>19</b>; 100 mg, 0.38 mmol) were added 3-methyl-4-(pyridin-3-yl)phenyl boronic acid (<b>16</b>; 102 mg, 0.47 mmol), tetrakis(triphenylphosphine)palladium(0) (5% mol), and aqueous K<sub>3</sub>PO<sub>4</sub> in 1,2-dimethoxyethane. The mixture was then refluxed until the starting material was consumed (TLC). After cooling to room temperature, the mixture was filtered on Celite and washed with CH<sub>2</sub>Cl<sub>2</sub>. The aqueous layer was extracted with EtOAc. Combined organic layers were dried over MgSO<sub>4</sub>. The crude product was purified by chromatography (<i>c</i>-hexane/ethyl acetate 5:5 to EtOAc) affording the product as a white solid (130 mg, 97% yield). Mp 155 °C. IR (KBr): 3022, 2980, 2958, 2923, 2858, 1690, 1598, 1574, 1553, 1451, 1417, 1382, 1188, 1137, 1115, 1065, 1021, 999, 907, 874, 802, 763, 706, 678, 619, 565 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 10.07 (s, 1H, CHO), 8.75 (s, 2H), 8.68 (d, <i>J</i> = 7.3 Hz, 2H), 8.35 (d, <i>J</i> = 2.0 Hz, 1H), 7.98 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 7.79 (d, <i>J</i> = 7.8 Hz, 1H), 7.76 (d, <i>J</i> = 7.8 Hz, 1H), 7.65 (s, 1H), 7.61 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.49–7.44 (m, 2H), 7.37 (d, <i>J</i> = 7.4 Hz, 1H), 2.40 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 191.2, 150.0, 149.4, 149.3, 147.9, 141.1, 140.7, 139.0, 137.9, 137.3, 136.8, 136.5, 134.2, 132.2, 131.6, 130.6, 129.3, 126.8 (2C), 124.8 (2C), 123.3 (2C), 20.5 (CH<sub>3</sub>). LCMS(EI): 351.41 [M + H<sup>+</sup>].</div></div><div id="sec6_1_8_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 2-(Pyridin-3-yl)-5-(3-methyl-4-pyridin-3-ylphenyl)-(<i>E</i>)-styrylphenyl, MR30820</h5><div class="NLM_p last">To a stirred solution of diethyl benzylphosphonate (65 mg, 0.28 mmol) in tetrahydrofuran under nitrogen was added potassium hydroxide (32 mg, 0.57 mmol). After 30 min of stirring, 2-(pyridin-3-yl)-5-(3-methyl-4-pyridin-3-ylphenyl)benzaldehyde (100 mg, 0.28 mmol) was added. The mixture was stirred at room temperature for 1 h and then refluxed until the starting material was consumed (TLC). Water was added, and the mixture was extracted with EtOAc. Organic layer was washed with saturated aqueous solution of NaCl and dried over MgSO<sub>4</sub>. Solvents were removed in vacuo and crude product was purified by chromatography (<i>c</i>-hexane/ethyl acetate 5:5) affording product as a yellow solid (50 mg, 42% yield). Mp: 139 °C. IR (KBr): 3036, 3022, 2930, 2857, 2245, 1436, 1401, 1391, 1115, 852, 734, 672 cm<sup>–1</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.64 (s, 1H), 8.57 (bs, 3H), 7.92 (s, 1H), 7.64–7.62 (m, 2H), 7.56–7.51 (m, 3H), 7.34–7.27 (m, 4H), 7.26–7.17 (m, 3H), 7.16–7.13 (m, 2H), 7.00 (d, <i>J</i> = 16.5 Hz, 2H, CH═CH), 2.30 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 150.1, 149.8, 148.4, 148.1, 140.7, 140.3, 137.4, 137.1, 137.0, 136.5, 136.2, 136.1, 132.0, 131.9, 131.0, 130.7, 130.4, 129.3, 128.6 (2C), 128.5, 128.4, 128.2 (2C), 127.8, 126.6 (2C), 126.5, 124.8, 123.0, 20.5 (CH<sub>3</sub>). LCMS(EI): 425.54 [M + H<sup>+</sup>].</div></div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> X-ray Crystallography</h3><div class="NLM_p last">Single crystals of pyridoclax suitable for X-ray crystallographic analysis were obtained by slow evaporation from DMSO. Data for crystal structure analysis were collected at 100 K with a Bruker-Nonius Kappa CCD area detector diffractometer with graphite-monochromatized Kα radiation (λ = 0.71073 Å). The structure was solved using direct methods and refined by full-matrix least-squares analysis on F2. Program SHELXS-97<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> was used to solve structure and SHELXL-97<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> to refine structure. The refinement was based on <i>F</i><sup>2</sup> for all reflections, and all non-hydrogen atoms were refined anisotropically. Hydrogen atom positions were determined via difference Fourier maps and refined with isotropic atomic displacement parameters. Crystallographic data for pyridoclax have been deposited at the Cambridge Crystallographic Data Centre, CCDC No. 996607. Copies of this information may be obtained free of charge from the Director, CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (+44-1223-336408; E-mail: <a href="/cdn-cgi/l/email-protection#e58180958a968c91a586868186cb868488cb8486cb908e"><span class="__cf_email__" data-cfemail="85e1e0f5eaf6ecf1c5e6e6e1e6abe6e4e8abe4e6abf0ee">[email protected]</span></a> or <a href="http://www.ccdc.cam.ac.uk" class="extLink">http://www.ccdc.cam.ac.uk</a>).</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Molecular Modeling</h3><div class="NLM_p">The docking of pyridoclax and its derivatives into Mcl-1 target was carried out with the GOLD program (v5.0) using the default parameters.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> This program applies a genetic algorithm to explore conformational spaces and ligand binding modes. To evaluate the proposed ligand poses the ChemScore and Goldscore fitness functions were applied in the docking studies.</div><div class="NLM_p">For this docking study a tridimensional (3D) NMR structure of human Mcl-1 cocrystallized with BH3-only protein BID was used (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW">2KBW</a>;<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><a href="http://www.rcsb.org/" class="extLink">http://www.rcsb.org/</a>). The binding site in the Mcl-1 was defined as an 8 Å sphere on Bid helix present in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW">2KBW</a> crystal structure. The docking was carried out with a geometrically optimized pyridoclax 3D structure built using Discovery Studio,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> as well as with two MR29072 conformers extracted from X-ray data.</div><div class="NLM_p last">Molecular dynamics simulations were carried out on docking complexes between pyridoclax poses and MCL-1. All simulations were carried out using CHARMM version c29b2<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> with potential function parameter set 22 from Discovery Studio,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and each system was surrounded by a rectangular box of TIP3P water molecules<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> using CHARMmGUI solvator.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78, 79)</a> Force field parameters for the pyridoclax were generated using Discovery Studio program applying MMFF partial charges. Periodic boundary conditions were applied to the systems using the IMAGE algorithm. van der Waals interactions were truncated using a shift function with a cutoff distance of 12 Å and electrostatic ones using a force switching function, between 8 and 12 Å. The vacuum dielectric constant was used during all calculations. After an energy minimization of complexes, dynamics simulation of 1 ns were performed using Verlet algorithm using a 1 fs step. Systems were gradually heated to 300 K by 5 K jumps during 3 ps and then equilibrated during 25 ps. During the production phase (1 ns), 200 conformations were saved every 5 ps, and their energy was minimized with a root-mean-square gradient less than 0.001 kcal/(mol·Å<sup>2</sup>). The generated average structures from CHARMM were submitted to a quick energy minimization to optimize their geometry.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Cell Culture</h3><div class="NLM_p last">Human ovarian carcinoma OAW42 cell line was established from a human ovarian adenocarcinoma and was obtained from ECACC (Sigma-Aldrich, Saint Quentin Fallavier, France). It was grown in DMEM medium supplemented with 4500 mg/L glucose, 2 mM Glutamax, 1 mM sodium pyruvate, 10% fetal calf serum, 33 mM sodium bicarbonate (Gibco BRL, Lyon, France), and 20 IU/L recombinant human insulin (Lilly, Suresnes, France). Human ovarian carcinoma SKOV3 cell line was established from a human ovarian adenocarcinoma and was obtained from American Type Culture Collection (Manassas, VA, USA), as was the human malignant mesothelioma cell line NCI-H28 and the human lung carcinoma cell line A549. IGROV1 cell line was kindly provided by Dr. J. Bénard (Institut G. Roussy, Villejuif, France). These cell lines were grown in RPMI 1640 medium supplemented with 2 mM Glutamax, 25 mM HEPES, 10% fetal calf serum, and 33 mM sodium bicarbonate (Fisher Scientific, Illkirch, France). <i>In vitro</i> chemoresistant models of IGROV1 (IGROV1-R10) and OAW42 (OAW42-R) cell lines were obtained previously by mimicking a clinical protocol of cisplatin administration.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a> Cells were maintained at 37 °C in a 5% CO<sub>2</sub> humidified atmosphere and split twice a week by trypsinization.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Chemicals</h3><div class="NLM_p last">Oligopyridines were synthesized in our laboratory as described above and purified by chromatography, which was carried out on a column using flash silica gel 60 Merck (0.063–0.200 mm) as the stationary phase. ABT-737 was obtained from Selleckchem (Houston, TX, USA), and dimethyl sulfoxide (DMSO) was from Sigma-Aldrich (Saint-Quentin Fallavier, France). The compounds were commonly stored as stock solutions in DMSO at −20 °C.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Surface Plasmon Resonance Assays</h3><div class="NLM_p">All binding studies based on SPR technology were performed on BIAcore T200 optical biosensor instrument (GE Healthcare). Capture of His-Mcl-1 was performed on a nitrilotriacetic acid (NTA) sensorchip in HBS-P+ buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, and 0.05% surfactant P20; GE Healthcare). The Mcl-1 capture on Sensor Chip NTA was stabilized by covalent coupling of the ligand to the chip surface using amine coupling (as described by GE Healthcare in Laboratory Guideline 29-0057-17 AB). Briefly, NTA sensorchip is saturated with 0.5 mM NiCl<sub>2</sub>. Activation is performed with 7 min injection of NHS-EDC followed by ligand immobilization. All immobilization steps were performed at a flow rate of 10 μL/min with a final Mcl-1 concentration of 4 μg/mL. Total amount of immobilized Mcl-1 was 1000, 3500, or 5000 RU depending on experiments. Sensorchip surface deactivation is performed with 7 min injection of 1 M ethanolamine.</div><div class="NLM_p">Capture of His-Bcl-x<sub>L</sub> (same condition as His-Mcl-1) was performed on channel Fc1 that was used as a reference surface for nonspecific binding measurements.</div><div class="NLM_p last">Recombinant human Mcl-1 protein, fused to His-tag, and recombinant human Bcl-x<sub>L</sub>, His-tagged (DNA sequence encoding the human BCL2L1 isoform 1 (Met 1–Arg 212) fused with a polyhistidine tag at the C-terminus) were purchased from Creative BioMart (45–16 Ramsey Road, Shirley, NY 11967, USA). A low mass weight-single-cycle kinetics (LMW-SCK) analysis to determine association, dissociation, and affinity constants (<i>k</i><sub>a</sub>, <i>k</i><sub>d</sub>, and <i>K</i><sub>d</sub> respectively) was carried out by injecting different protein concentrations. Binding parameters were obtained by fitting the overlaid sensorgrams with the 1:1 Langmuir binding model of the BIAevaluation software version 1.0.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Treatments</h3><div class="NLM_p last">Exponentially growing cells were transfected by siRNA as described below, and after 48 h, cells were continuously exposed to oligopyridines (10, 25, or 50 μM) dissolved in DMSO (<0.1% of total volume) for 4–24 h.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> BRET Assay</h3><div class="NLM_p last">For donor saturating assays, Hela cells were seeded on 12-well plates and transfected with 200 ng/well of plasmid pRluc-BimL coding for BRET donor and an increasing quantity of BRET acceptor plasmids peYFP-Mcl-1 (or with pCMV-Mcl-1 as a control). Twenty-four hours after transfection, cells were trypsinized, reseeded into white flat bottom 96-well plates, and incubated for another day before measurements. A single donor/acceptor ratio (200/800) was used to carry out the drug treatment assay. After reseeding, cells were then subject to a 16 h pyridoclax treatment. Light emission at 485 and 530 nm was measured consecutively using the Mithras fluorescence–luminescence detector LB 940 (Berthold) after adding the luciferase substrate, coelenterazine H (Uptima), at a final concentration of 5 μM. BRET ratios were calculated as described.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div></div><div id="sec200" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Gene Silencing</h3><div class="NLM_p last">siRNAs were synthesized and annealed by Eurogentec (Liege, Belgium). Sequences were as follows: Bcl-x<sub>L</sub> siRNA antisense (siXL1), 5′-auuggugagucggaucgcatt-3′; Mcl-1 siRNA (siMCL1) 5′-gugccuuuguggcuaaacatt-3′; control siRNA (siCONT) 5′-gacguaaacggccacaagutt-3′. The control siRNA does not share any homology with any relevant human genes. Briefly, cells were seeded in 25 cm<sup>2</sup> flasks the day before to reach 30–50% confluency at the time of transfection. The transfection INTERFERin reagent (Polyplus Transfection, Strasbourg, France) was added to siRNA diluted in Opti-MEM reduced serum medium (Invitrogen, Cergy-Pontoise, France), and complex formation was allowed to proceed for 15 min at RT before application to cells. The final siRNA concentration in the flasks was 20 nM.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Real-Time Cellular Activity Assay</h3><div class="NLM_p last">Compound-mediated cytotoxicity was monitored using a real-time cell analyzer multiplate (RTCA MP) instrument, xCELLigence system (Roche Applied Science, Mannheim, Germany). This system monitors cellular events in real time measuring electrical impedance across interdigitated microelectrodes integrated on the bottom of tissue culture E-Plates View (Roche). The increase in the number and size of cells attached to the electrode sensors leads to increased impedance, from which derive the cell index values (CI) displayed in the plot. Thus, this index reflects changes in cell viability as described by ref <a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">83</a>. Briefly, 96-well E-Plates were seeded with 3 × 10<sup>3</sup> cells/well and placed onto the RTCA MP located inside a tissue culture incubator, where cells were left to grow for 24 h before treatment. Impedance was continuously measured until the end of the treatment. Standard deviations of well replicates were analyzed with the RTCA Software.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Apoptosis Assays</h3><div id="sec6_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Morphological Characterization of Apoptotic Cells by Nuclear Staining with DAPI</h4><div class="NLM_p last">After treatment, both detached and adherent cells were pooled after trypsinization, applied to a polylysine-coated glass slide by cytocentrifugation, and fixed with a solution of ethanol/chloroform/acetic acid (6:3:1). The preparations were then incubated for 15 min at room temperature with 1 μg/mL DAPI solution (Boehringer Mannheim-Roche, Mannheim, Germany), washed in distilled water, mounted under a coverslip in Mowiol (Calbiochem), and analyzed under a fluorescence microscope (BX51, Olympus, Rungis, France).</div></div><div id="sec6_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Cell Cycle Analysis by Flow Cytometry</h4><div class="NLM_p last">Adherent and floating cells were pooled, washed with 1× PBS, and fixed with ethanol. Before flow cytometry analysis, cells were centrifuged at 2000 rpm for 5 min and incubated for 30 min at 37 °C in PBS to allow the release of low-molecular weight DNA (characteristic of apoptotic cells). Cell pellets were stained with propidium iodide (PI) using the DNA Prep Coulter reagent kit (Beckman-Coulter, Villepinte France). Samples were thereafter analyzed using a Gallios flow cytometer (Beckman Coulter), and cell cycle distribution was determined using Kaluza acquisition software (Beckman Coulter).</div></div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Preparation of Cell Extracts and Western Blot Analysis</h3><div class="NLM_p last">Cells were rinsed with ice-cold PBS, suspended in a lysis buffer [RIPA: NaCl 150 mM, Tris (pH 8) 50 mM, Triton X100 1%, PMSF 4 mM, EDTA 5 mM, NaF 10 mM, NaPPi 10 mM, Na<sub>3</sub>OV<sub>4</sub> 1 mM, aprotinin 0.5 μL/mL, and 4.6 mL of ultrapure water] and incubated on ice for 30 min. Lysates were collected after centrifugation (13200<i>g</i>, 10 min, 4 °C), and protein concentrations were determined using the Bradford assay (Bio-Rad, Hercules, USA). Twenty micrograms of protein was separated by SDS–PAGE on a 4–12% gradient polyacrylamide gel (Invitrogen, Cergy-Pontoise, France) and transferred to Hybond-PVDF membranes (Amersham, Orsay, France). After blocking nonspecific binding sites for 1 h at RT by 5% (w/v) nonfat dry milk in TBS with 0.1% (v/v) Tween20 (T-TBS), the membranes were incubated overnight at 4 °C with the following rabbit monoclonal antibodies: PARP, caspase-3, and Bcl-x<sub>L</sub>, Bim (Cell Signaling Technology, Ozyme, Saint-Quentin-en-Yvelines, France), Mcl-1 (Santa Cruz, Le Perray-en-Yvelines, France), HSP-70, Noxa (Calbiochem, Fontenay-sous-Bois, France), and actin (Sigma-Aldrich, Saint-Quentin Fallavier, France). Membranes were then washed with T-TBS and incubated for 1 h with the appropriate horseradish peroxidase-conjugated anti-rabbit or anti-mouse (Amersham, Orsay, France) secondary antibodies. Revelation was done using a luminescent image analyzer (GE Healthcare, Orsay, France).</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Transmission Electron Microscopy</h3><div class="NLM_p last">Cells were fixed with 2.5% glutaraldehyde in PBS buffer, included in agar, rinsed in Sorensen’s buffer, postfixed in osmium tetroxide 1% in Sorensen’s buffer, deshydrated in ethanol, and embedded in EPON resin. Ultrathin sections were cut and stained with uranyl acetate and lead citrate and examined using a JEOL1011 transmission electron microscope.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/jm500672y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Pyridoclax disruption of BimL/Mcl-1 interaction as measured by BRET assay in MCF7 cells, extent of cell death after exposure to pyridoclax and MR30820, and indicators of cell death for molecules in combination with Bcl-x<sub>L</sub> targeting siRNA exposure to either Pyridoclax or MR30820 after silencing of Bcl-x<sub>L</sub>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500672y/suppl_file/jm500672y_si_001.pdf">jm500672y_si_001.pdf (448.91 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500672y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Sophie Voisin-Chiret</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d4a7bba4bcbdb1faa2bbbda7bdba94a1babdb7b5b1bafab2a6"><span class="__cf_email__" data-cfemail="02716d726a6b672c746d6b716b6c42776c6b6163676c2c6470">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Poulain</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ce0a2fce3f9e0ede5e2cceeedefe0e9ffffe9a2eafe"><span class="__cf_email__" data-cfemail="c4a8eab4abb1a8a5adaa84a6a5a7a8a1b7b7a1eaa2b6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Gloaguen</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Sopkova-de Oliveira Santos</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jade Fogha</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabien Gautier</span> - <span class="hlFld-Affiliation affiliation">Team 8, Nantes-Angers Centre for Cancer Research, UMR 892 Inserm 6299 CNRS, 44007 Nantes, France</span>; 
    <span class="hlFld-Affiliation affiliation">Institut de Cancérologie
de l’Ouest, Comprehensive Cancer
Center René Gauducheau, 44805 Nantes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcella De Giorgi</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grégory Burzicki</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Serge Perato</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cécile Pétigny-Lechartier</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Simonin-Le Jeune</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emilie Brotin</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Didier Goux</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, Centre de Microscopie Appliquée
à la Biologie, IBFA, SF4206 ICORE, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monique N’Diaye</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Lambert</span> - <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">CNRS (placed at the disposition of EA4656 by CNRS,
Délégation régionale Ile-de-France Est), 94532 Thiais cedex, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Hélène Louis</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, BioTICLA Unit (Biologie et Thérapies
Innovantes des Cancers Localement Agressifs), EA4656, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Comprehensive Cancer Center François Baclesse, 14076 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm, U1199 “Biologie et Thérapies Innovantes des Cancers localement Agressifs”, 14076 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laetitia Ligat</span> - <span class="hlFld-Affiliation affiliation">INSERM UMR1037-Plateforme
Protéomique-Pôle Technologique du Centre de Recherches
en Cancérologie de Toulouse, 2 avenue Hubert Curien, 31100 Toulouse, France</span>; 
    <span class="hlFld-Affiliation affiliation">Université
Toulouse III-Paul Sabatier, UMR1037 CRCT, 31000 Toulouse, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frédéric Lopez</span> - <span class="hlFld-Affiliation affiliation">INSERM UMR1037-Plateforme
Protéomique-Pôle Technologique du Centre de Recherches
en Cancérologie de Toulouse, 2 avenue Hubert Curien, 31100 Toulouse, France</span>; 
    <span class="hlFld-Affiliation affiliation">Université
Toulouse III-Paul Sabatier, UMR1037 CRCT, 31000 Toulouse, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Juin</span> - <span class="hlFld-Affiliation affiliation">Team 8, Nantes-Angers Centre for Cancer Research, UMR 892 Inserm 6299 CNRS, 44007 Nantes, France</span>; 
    <span class="hlFld-Affiliation affiliation">Institut de Cancérologie
de l’Ouest, Comprehensive Cancer
Center René Gauducheau, 44805 Nantes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronan Bureau</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvain Rault</span> - <span class="hlFld-Affiliation affiliation">Normandie Université, 14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN, CERMN
(Centre d’Etudes et de Recherche sur le Médicament de
Normandie) - FR CNRS INC3M, 14032 Caen, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d175e4235-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Edwige Abeilard and Siham Hedir (BioTICLA Unit, SF 4206 ICORE, University of Caen Low-Normandy), Maryline Duval (flow cytometry accommodation, SF 4206 ICORE, University of Caen Low-Normandy), Aurélien Lesnard (chemical library, CERMN and SF 4206 ICORE, University of Caen Low-Normandy), and Lorraine Chambry (chemical synthesis, CERMN and SF 4206 ICORE, University of Caen Low-Normandy) for their helpful technical support, Christophe Denoyelle and Pascal Gauduchon (BioTICLA Unit) for helpful discussions, and Khaled Meflah, head of the Comprehensive Cancer Center François Baclesse, for his constant support. This work was supported by the “Conseil Régional de Basse Normandie” (Emerging Project), by the French State and by the “Ligue Contre le Cancer” (Manche’s Comity). Acquisition of the xCELLigence real-time activity measurement system has been supported by European Community (FEDER) and Comprehensive Cancer Center F. Baclesse. K.S. was recipient of a doctoral fellowship from the ‘“Ligue Contre le Cancer”’ (Calvados’s committee). We acknowledge the CRIHAN (Centre of Ressources Informatiques de Haute Normandie) as well as the European Community (FEDER) for the molecular modeling software.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> Abbreviations</h2><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">CA</td><td class="NLM_def"><p class="first last">carboplatin</p></td></tr><tr><td class="NLM_term">CDDP</td><td class="NLM_def"><p class="first last">cisplatin [<i>cis</i>-diamino-dichloro-platinum(II)]</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribosyl) polymerase</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">immunoprecipitation</p></td></tr><tr><td class="NLM_term">SMC</td><td class="NLM_def"><p class="first last">Suzuki–Miyaura cross-coupling</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 83 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span> </span><span class="NLM_article-title">The Bcl-2 apoptotic switch in cancer development and therapy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fsj.onc.1210220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17322918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVKhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1324-1337&author=J.+M.+Adamsauthor=S.+Cory&title=The+Bcl-2+apoptotic+switch+in+cancer+development+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Bcl-2 apoptotic switch in cancer development and therapy</span></div><div class="casAuthors">Adams, J. M.; Cory, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1324-1337</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Impaired apoptosis is both crit. in cancer development and a major barrier to effective treatment.  In response to diverse intracellular damage signals, including those evoked by cancer therapy, the cell's decision to undergo apoptosis is detd. by interactions between three factions of the Bcl-2 protein family.  The damage signals are transduced by the diverse BH3-only' proteins, distinguished by the BH3 domain used to engage their pro-survival relatives: Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and A1.  This interaction ablates pro-survival function and allows activation of Bax and Bak, which commit the cell to apoptosis by permeabilizing the outer membrane of the mitochondrion.  Certain BH3-only proteins (e.g. Bim, Puma) can engage all the pro-survival proteins, but others (e.g. Bad, Noxa) engage only subsets.  Activation of Bax and Bak appears to require that the BH3-only proteins engage the multiple pro-survival proteins guarding Bax and Bak, rather than binding to the latter.  The balance between the pro-survival proteins and their BH3 ligands regulates tissue homeostasis, and either overexpression of a pro-survival family member or loss of a proapoptotic relative can be oncogenic.  Better understanding of the Bcl-2 family is clarifying its role in cancer development, revealing how conventional therapy works and stimulating the search for 'BH3 mimetics' as a novel class of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6J8GQArO2kbVg90H21EOLACvtfcHk0lgQVmdzxZc-3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVKhsL8%253D&md5=49704eaf2916ab06258320518065fdc0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210220%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DCory%26aufirst%3DS.%26atitle%3DThe%2520Bcl-2%2520apoptotic%2520switch%2520in%2520cancer%2520development%2520and%2520therapy%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1324%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Shamas-Din, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmbhatt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">BH3-only proteins: Orchestrators of apoptosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1813</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1813&publication_year=2011&pages=508-520&author=A.+Shamas-Dinauthor=H.+Brahmbhattauthor=B.+Leberauthor=D.+W.+Andrews&title=BH3-only+proteins%3A+Orchestrators+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShamas-Din%26aufirst%3DA.%26aulast%3DBrahmbhatt%26aufirst%3DH.%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DBH3-only%2520proteins%253A%2520Orchestrators%2520of%2520apoptosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1813%26spage%3D508%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Juin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geneste, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span> </span><span class="NLM_article-title">Decoding and unlocking the BCL-2 dependency of cancer cells</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnrc3538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23783119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1Ghur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=455-465&author=P.+Juinauthor=O.+Genesteauthor=F.+Gautierauthor=S.+Depilauthor=M.+Campone&title=Decoding+and+unlocking+the+BCL-2+dependency+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Decoding and unlocking the BCL-2 dependency of cancer cells</span></div><div class="casAuthors">Juin, Philippe; Geneste, Olivier; Gautier, Fabien; Depil, Stephane; Campone, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">455-465</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer cells are subject to many apoptotic stimuli that would kill them were it not for compensatory prosurvival alterations.  BCL-2-like (BCL-2L) proteins contribute to such aberrant behavior by engaging a network of interactions that is potent at promoting survival but that is also fragile: inhibition of a restricted no. of interactions may suffice to trigger cancer cell death.  Currently available and novel compds. that inhibit these interactions could be efficient therapeutic agents if this phenotype of BCL-2L dependence was better understood at a mol., cellular and systems level and if it could be diagnosed by relevant biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTFyJ_wwnZgLVg90H21EOLACvtfcHk0lgQVmdzxZc-3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1Ghur4%253D&md5=14ccf8c1e3a5fb1600110f6032e94b60</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc3538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3538%26sid%3Dliteratum%253Aachs%26aulast%3DJuin%26aufirst%3DP.%26aulast%3DGeneste%26aufirst%3DO.%26aulast%3DGautier%26aufirst%3DF.%26aulast%3DDepil%26aufirst%3DS.%26aulast%3DCampone%26aufirst%3DM.%26atitle%3DDecoding%2520and%2520unlocking%2520the%2520BCL-2%2520dependency%2520of%2520cancer%2520cells%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D455%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">De Giorgi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Targeting the BH3 domain of Bcl-2 family proteins. A brief history from natural products to foldamers as promising cancer therapeutic avenues</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.2174%2F0929867311320240003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23746270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=2964-2978&author=M.+De+Giorgiauthor=A.+S.+Voisin-Chiretauthor=S.+Rault&title=Targeting+the+BH3+domain+of+Bcl-2+family+proteins.+A+brief+history+from+natural+products+to+foldamers+as+promising+cancer+therapeutic+avenues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues</span></div><div class="casAuthors">De Giorgi, M.; Voisin-Chiret, A. S.; Rault, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2964-2978</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For many years the spotlight in drug discovery has been on a relatively small no. of validated therapeutic target classes, such as G-protein coupled receptors and enzymes such as protein kinases, with well characterized enzymic and cellular activities.  However, with recent progress in genomics and proteomics, protein-protein interactions (PPIs) provide new way of finding novel bioactive mols. acting on their interfaces.  This review addresses the current case studies and state of the art in the development of small chem. modulators controlling interactions of proteins that have pathol. implications in various human diseases and in particular in cancer.  The attention is focused on Bcl-2 family protein modulators ranging from natural products to synthetic ones with particular interest in foldamers as BH3 alpha helix mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0HaIzh5HnLVg90H21EOLACvtfcHk0lhbjRRV-WDRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygsLfL&md5=989bc5633fddf67dc966bee943d44dcd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867311320240003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320240003%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520BH3%2520domain%2520of%2520Bcl-2%2520family%2520proteins.%2520A%2520brief%2520history%2520from%2520natural%2520products%2520to%2520foldamers%2520as%2520promising%2520cancer%2520therapeutic%2520avenues%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D2964%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Zhang, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span> </span><span class="NLM_article-title">A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fcgt.2012.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23175245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslahtbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1-7&author=L.+N.+Zhangauthor=J.+Y.+Liauthor=W.+Xu&title=A+review+of+the+role+of+Puma%2C+Noxa+and+Bim+in+the+tumorigenesis%2C+therapy+and+drug+resistance+of+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia</span></div><div class="casAuthors">Zhang, L.-N.; Li, J.-Y.; Xu, W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in the Western countries.  The entire pathogenesis of CLL is not clear now, but defective regulation of apoptosis seems to be more important than uncontrolled cell proliferation in CLL.  There are two main pathways of apoptosis: the extrinsic pathway and the intrinsic pathway.  It is worth noting that the intrinsic pathway, rather than the extrinsic pathway, appears to be the key mediator of impaired apoptosis in CLL as a result of B-cell lymphoma 2 (Bcl-2) upregulation.  One subclass of pro-apoptotic members within the Bcl-2 family are Bcl-2 homol. 3 (BH3)-only proteins.  They can regulate directly and/or indirectly the remaining Bcl-2 proteins to endanger mitochondria and induce apoptosis.  We chose three mols. from the BH3-only family, Puma, Noxa and Bim, resp., which had shown an exciting antitumor potential in previous reports, to explore their characters and functions in tumorigenesis, therapy and drug resistance of CLL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp6Fsvkbz3TLVg90H21EOLACvtfcHk0lhbjRRV-WDRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslahtbjF&md5=1dc13a0accb59d2816d27acfac8186f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fcgt.2012.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcgt.2012.84%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BN.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DA%2520review%2520of%2520the%2520role%2520of%2520Puma%252C%2520Noxa%2520and%2520Bim%2520in%2520the%2520tumorigenesis%252C%2520therapy%2520and%2520drug%2520resistance%2520of%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2013%26volume%3D20%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwerth, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span> </span><span class="NLM_article-title">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+Wangauthor=M.+D.+Wendtauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+Bcl-2+family+proteins+induces+regression+of+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0lhYKZx58mCACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Varadarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsdale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, G. M.</span><span> </span><span class="NLM_article-title">Evaluation and critical assessment of putative MCL-1 inhibitors</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fcdd.2013.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23832116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1475-1484&author=S.+Varadarajanauthor=M.+Voglerauthor=M.+Butterworthauthor=D.+Dinsdaleauthor=L.+D.+Walenskyauthor=G.+M.+Cohen&title=Evaluation+and+critical+assessment+of+putative+MCL-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and critical assessment of putative MCL-1 inhibitors</span></div><div class="casAuthors">Varadarajan, S.; Vogler, M.; Butterworth, M.; Dinsdale, D.; Walensky, L. D.; Cohen, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1475-1484</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">High levels of BCL-2 family proteins are implicated in a failed/ineffective apoptotic program, often resulting in diseases, including cancer.  Owing to their potential as drug targets in cancer therapy, several inhibitors of BCL-2 family proteins have been developed.  These primarily target specific members of the BCL-2 family, particularly BCL-2 and BCL-XL but are ineffective against MCL-1.  Major efforts have been invested in developing inhibitors of MCL-1, which is commonly amplified in human tumors and assocd. with tumor relapse and chemoresistance.  In this report, the specificity of several BCL-2 family inhibitors (ABT-263, UCB-1350883, apogossypol and BH3I-1) was investigated and compared with putative MCL-1 inhibitors designed to exhibit improved or selective binding affinities for MCL-1 (TW-37, BI97C1, BI97C10, BI112D1, compds. 6 and 7, and MCL-1 inhibitor mol. (MIM-1)).  ABT-263, BI97C1, BI112D1, MIM-1 and TW-37 exhibited specificity in inducing apoptosis in a Bax/Bak- and caspase-9-dependent manner, whereas the other agents showed no killing activity, or little or no specificity.  Of these inhibitors, only ABT-263 and UCB-1350883 induced apoptosis in a BCL-2- or BCL-XL-dependent system.  In cells that depend on MCL-1 for survival, ABT-263 and TW-37 induced extensive apoptosis, suggesting that at high concns. these inhibitors have the propensity to inhibit MCL-1 in a cellular context.  TW-37 induced apoptosis, assessed by chromatin condensation, caspase processing and phosphatidylserine externalisation, in a BAK-dependent manner and in cells that require MCL-1 for survival.  TW-37-mediated apoptosis was also partly dependent on NOXA, suggesting that derivs. of TW-37, if engineered to exhibit better selectivity and efficacy at low nanomolar concns., may provide useful lead compds. for further synthetic programs.  Expanded medicinal chem. iteration, as performed for the ABT series, may likewise improve the potency and specificity of the evaluated MCL-1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb7rwc-6ii97Vg90H21EOLACvtfcHk0lhYKZx58mCACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7rK&md5=92e0298a09e4a4133f05b5945098a146</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2013.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2013.79%26sid%3Dliteratum%253Aachs%26aulast%3DVaradarajan%26aufirst%3DS.%26aulast%3DVogler%26aufirst%3DM.%26aulast%3DButterworth%26aufirst%3DM.%26aulast%3DDinsdale%26aufirst%3DD.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26atitle%3DEvaluation%2520and%2520critical%2520assessment%2520of%2520putative%2520MCL-1%2520inhibitors%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D1475%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velankar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmandam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlossman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2374</span><span class="NLM_x">–</span> <span class="NLM_lpage">2380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=2374-2380&author=D.+Chauhanauthor=M.+Velankarauthor=M.+Brahmandamauthor=T.+Hideshimaauthor=K.+Podarauthor=P.+Richardsonauthor=R.+Schlossmanauthor=I.+Ghobrialauthor=N.+Rajeauthor=N.+Munshiauthor=K.+C.+Anderson&title=A+novel+Bcl-2%2FBcl-X%28L%29%2FBcl-w+inhibitor+ABT-737+as+therapy+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DVelankar%26aufirst%3DM.%26aulast%3DBrahmandam%26aufirst%3DM.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DSchlossman%26aufirst%3DR.%26aulast%3DGhobrial%26aufirst%3DI.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DA%2520novel%2520Bcl-2%252FBcl-X%2528L%2529%252FBcl-w%2520inhibitor%2520ABT-737%2520as%2520therapy%2520in%2520multiple%2520myeloma%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D2374%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Del Gaizo Moore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Certo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novina, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span> </span><span class="NLM_article-title">Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=112-121&author=V.+Del+Gaizo+Mooreauthor=J.+R.+Brownauthor=M.+Certoauthor=T.+M.+Loveauthor=C.+D.+Novinaauthor=A.+Letai&title=Chronic+lymphocytic+leukemia+requires+BCL2+to+sequester+prodeath+BIM%2C+explaining+sensitivity+to+BCL2+antagonist+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BGaizo%2BMoore%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DCerto%26aufirst%3DM.%26aulast%3DLove%26aufirst%3DT.%2BM.%26aulast%3DNovina%26aufirst%3DC.%2BD.%26aulast%3DLetai%26aufirst%3DA.%26atitle%3DChronic%2520lymphocytic%2520leukemia%2520requires%2520BCL2%2520to%2520sequester%2520prodeath%2520BIM%252C%2520explaining%2520sensitivity%2520to%2520BCL2%2520antagonist%2520ABT-737%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D112%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kuroda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamitsuji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murotani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniwaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, T.</span><span> </span><span class="NLM_article-title">ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=18028486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2008&pages=181-190&author=J.+Kurodaauthor=S.+Kimuraauthor=M.+Andreeffauthor=E.+Ashiharaauthor=Y.+Kamitsujiauthor=A.+Yokotaauthor=E.+Kawataauthor=M.+Takeuchiauthor=R.+Tanakaauthor=Y.+Murotaniauthor=Y.+Matsumotoauthor=H.+Tanakaauthor=A.+Strasserauthor=M.+Taniwakiauthor=T.+Maekawa&title=ABT-737+is+a+useful+component+of+combinatory+chemotherapies+for+chronic+myeloid+leukaemias+with+diverse+drug-resistance+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-737 is useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms</span></div><div class="casAuthors">Kuroda, Junya; Kimura, Shinya; Andreeff, Michael; Ashihara, Eishi; Kamitsuji, Yuri; Yokota, Asumi; Kawata, Eri; Takeuchi, Miki; Tanaka, Ruriko; Murotani, Yoshihide; Matsumoto, Yosuke; Tanaka, Hideo; Strasser, Andreas; Taniwaki, Masafumi; Maekawa, Taira</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The effect of ABT-737, a BH3-mimicking inhibitor for anti-apoptotic Bcl-2 and Bcl-XL, but not Mcl-1, against Bcr-Abl-pos. (Bcr-Abl+) leukemic cells was examd.  ABT-737 potently induced apoptosis in Bcr-Abl+ chronic myeloid leukemia (CML) cell lines and primary CML samples in vitro and prolonged the survival of mice xenografted with BV173 cells, a CML cell line.  Higher expression of anti-apoptotic Bcl-2 proteins reduced cell killing by ABT-737 in each cell line, but there was no correlation between the sensitivities to ABT-737 and the specific expression patterns of Bcl-2 family proteins among cell lines.  Thus, the cell killing effect of ABT-737 must be detd. not only by the expression patterns of Bcl-2 family proteins but also by other mechanisms, such as high expression of Bcr-Abl, or a drug-efflux pump, in CML cells.  ABT-737 augmented the cell killing effect of imatinib in Bcr-Abl+ cells with diverse drug-resistance mechanisms unless leukemic cells harbored imatinib-insensitive Abl kinase domain mutations, such as T315I.  The combination of homoharringtonine that reduces Mcl-1 enhanced the killing by ABT-737 strongly in Bcr-Abl+ cells even with T315I mutation.  These results suggest that ABT-737 is a useful component of chemotherapies for CML with diverse drug-resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolOvUcIGyBvrVg90H21EOLACvtfcHk0lgVgWUDs7MPRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOntL8%253D&md5=1b891f8cd2abf62126cbe9ca258e5b33</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DAshihara%26aufirst%3DE.%26aulast%3DKamitsuji%26aufirst%3DY.%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DKawata%26aufirst%3DE.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DMurotani%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DTaniwaki%26aufirst%3DM.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3DABT-737%2520is%2520a%2520useful%2520component%2520of%2520combinatory%2520chemotherapies%2520for%2520chronic%2520myeloid%2520leukaemias%2520with%2520diverse%2520drug-resistance%2520mechanisms%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D140%26spage%3D181%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tagscherer, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macher-Goeppinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radlwimmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiestler, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, W.</span><span> </span><span class="NLM_article-title">Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6646-6656&author=K.+E.+Tagschererauthor=A.+Fasslauthor=B.+Camposauthor=M.+Farhadiauthor=A.+Kraemerauthor=B.+C.+Bockauthor=S.+Macher-Goeppingerauthor=B.+Radlwimmerauthor=O.+D.+Wiestlerauthor=C.+Herold-Mendeauthor=W.+Roth&title=Apoptosis-based+treatment+of+glioblastomas+with+ABT-737%2C+a+novel+small+molecule+inhibitor+of+Bcl-2+family+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTagscherer%26aufirst%3DK.%2BE.%26aulast%3DFassl%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DFarhadi%26aufirst%3DM.%26aulast%3DKraemer%26aufirst%3DA.%26aulast%3DBock%26aufirst%3DB.%2BC.%26aulast%3DMacher-Goeppinger%26aufirst%3DS.%26aulast%3DRadlwimmer%26aufirst%3DB.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DW.%26atitle%3DApoptosis-based%2520treatment%2520of%2520glioblastomas%2520with%2520ABT-737%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D6646%26epage%3D6656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan-Lappe, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarthy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span> </span><span class="NLM_article-title">Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1176-1183&author=S.+K.+Tahirauthor=X.+Yangauthor=M.+G.+Andersonauthor=S.+E.+Morgan-Lappeauthor=A.+V.+Sarthyauthor=J.+Chenauthor=R.+B.+Warnerauthor=S.+C.+Ngauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=C.+Tse&title=Influence+of+Bcl-2+family+members+on+the+cellular+response+of+small-cell+lung+cancer+cell+lines+to+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%2BE.%26aulast%3DSarthy%26aufirst%3DA.%2BV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DInfluence%2520of%2520Bcl-2%2520family%2520members%2520on%2520the%2520cellular%2520response%2520of%2520small-cell%2520lung%2520cancer%2520cell%2520lines%2520to%2520ABT-737%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D1176%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wesarg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffarth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiewrodt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesterfeld, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, M.</span><span> </span><span class="NLM_article-title">Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2Fijc.22977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17688235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlShtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=2387-2394&author=E.+Wesargauthor=S.+Hoffarthauthor=R.+Wiewrodtauthor=M.+Krollauthor=S.+Biesterfeldauthor=C.+Huberauthor=M.+Schuler&title=Targeting+BCL-2+family+proteins+to+overcome+drug+resistance+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer</span></div><div class="casAuthors">Wesarg, Emmanuelle; Hoffarth, Sandra; Wiewrodt, Rainer; Kroell, Monika; Biesterfeld, Stefan; Huber, Christoph; Schuler, Martin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2387-2394</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Cytotoxic chemotherapies are std. of care for patients suffering from advanced non-small cell lung cancer (NSCLC).  However, objective responses are only achieved in 20% of cases and long-term survival is rarely obsd.  Clin. applied anticancer drugs exert at least some of their activities by inducing apoptosis.  A crit. step in apoptotic signal transduction is the permeabilization of the mitochondrial outer membrane (MOM), which is regulated by the BCL-2 family of proteins.  Hence, therapeutic targeting of BCL-2 proteins is a promising approach to increase the drug-sensitivity of cancers.  To this end we have assessed the impact of conditional expression of the proapoptotic multidomain (BH1-2-3) protein BAK, which directly permeabilizes the MOM, and the BH3-mimetic ABT-737, which acts indirectly by derepressing BH1-2-3 proteins, on apoptosis and drug sensitivity of NSCLC cells.  Conditionally expressed BAK sensitized resistant NSCLC cells to drug-induced apoptosis.  In contrast, ABT-737 was ineffective in those NSCLC cells expressing high levels of the anti-apoptotic MCL-1 protein.  Tissue microarray anal. of tumor samples from 84 chemotherapy-naive NSCLC patients revealed MCL-1 expression in 56% of cases, thus supporting the relevance of this resistance factor in a clin. setting.  Enforced expression of the BH3-only protein NOXA, which targets MCL-1, overcame resistance to ABT-737.  Moreover, combining conditionally expressed BAK with ABT-737 enhanced apoptosis in NSCLC cells independently of their MCL-1 status.  In conclusion, the heterogeneity of apoptosis defects obsd. in drug-resistant NSCLC demands individually tailored mol. therapies.  Targeting the MOM permeabilizer BAK appears to have a broader apoptogenic activity than the BH3-only mimetic ABT-737.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPSGdartNqrVg90H21EOLACvtfcHk0lgo9nTAlMF-Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlShtb%252FO&md5=79d3c3a9eff2ea7875b1401f051167cb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fijc.22977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22977%26sid%3Dliteratum%253Aachs%26aulast%3DWesarg%26aufirst%3DE.%26aulast%3DHoffarth%26aufirst%3DS.%26aulast%3DWiewrodt%26aufirst%3DR.%26aulast%3DKroll%26aufirst%3DM.%26aulast%3DBiesterfeld%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DC.%26aulast%3DSchuler%26aufirst%3DM.%26atitle%3DTargeting%2520BCL-2%2520family%2520proteins%2520to%2520overcome%2520drug%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D2387%26epage%3D2394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2340</span><span class="NLM_x">–</span> <span class="NLM_lpage">2349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1158%2F1535-7163.MCT-11-0415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=21914853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2340-2349&author=J.+Chenauthor=S.+Jinauthor=V.+Abrahamauthor=X.+Huangauthor=B.+Liuauthor=M.+J.+Mittenauthor=P.+Nimmerauthor=X.+Linauthor=M.+Smithauthor=Y.+Shenauthor=A.+R.+Shoemakerauthor=S.+K.+Tahirauthor=H.+Zhangauthor=S.+L.+Acklerauthor=S.+H.+Rosenbergauthor=H.+Maeckerauthor=D.+Sampathauthor=J.+D.+Leversonauthor=C.+Tseauthor=S.+W.+Elmore&title=The+Bcl-2%2FBcl-X%28L%29%2FBcl-w+inhibitor%2C+navitoclax%2C+enhances+the+activity+of+chemotherapeutic+agents+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo</span></div><div class="casAuthors">Chen, Jun; Jin, Sha; Abraham, Vivek; Huang, Xiaoli; Liu, Bernard; Mitten, Michael J.; Nimmer, Paul; Lin, Xiaoyu; Smith, Morey; Shen, Yu; Shoemaker, Alexander R.; Tahir, Stephen K.; Zhang, Haichao; Ackler, Scott L.; Rosenberg, Saul H.; Maecker, Heather; Sampath, Deepak; Leverson, Joel D.; Tse, Chris; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2340-2349</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The ability of a cancer cell to avoid apoptosis is crucial to tumorigenesis and can also contribute to chemoresistance.  The Bcl-2 family of prosurvival proteins (Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and A1) plays a key role in these processes.  We previously reported the discovery of ABT-263 (navitoclax), a potent small-mol. inhibitor of Bcl-2, Bcl-XL, and Bcl-w.  While navitoclax exhibits single-agent activity in tumors dependent on Bcl-2 or Bcl-XL for survival, the expression of Mcl-1 has been shown to confer resistance to navitoclax, most notably in solid tumors.  Thus, therapeutic agents that can downregulate or neutralize Mcl-1 are predicted to synergize potently with navitoclax.  Here, we report the activity of navitoclax in combination with 19 clin. relevant agents across a panel of 46 human solid tumor cell lines.  Navitoclax broadly enhanced the activity of multiple therapeutic agents in vitro and enhanced efficacy of both docetaxel and erlotinib in xenograft models.  The ability of navitoclax to synergize with docetaxel or erlotinib corresponded to an altered sensitivity of the mitochondria toward navitoclax, which was assocd. with the downmodulation of Mcl-1 and/or upregulation of Bim.  These data provide a rationale to interrogate these combinations clin.  Mol Cancer Ther; 10(12); 2340-9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd9W2TOyfzbbVg90H21EOLACvtfcHk0li6XKad87t6Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurbL&md5=88acb30a86091f88c3db820e69c8baae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0415%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DMaecker%26aufirst%3DH.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DThe%2520Bcl-2%252FBcl-X%2528L%2529%252FBcl-w%2520inhibitor%252C%2520navitoclax%252C%2520enhances%2520the%2520activity%2520of%2520chemotherapeutic%2520agents%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther%26date%3D2011%26volume%3D10%26spage%3D2340%26epage%3D2349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=782-791&author=S.+Chenauthor=Y.+Daiauthor=H.+Haradaauthor=P.+Dentauthor=S.+Grant&title=Mcl-1+down-regulation+potentiates+ABT-737+lethality+by+cooperatively+inducing+Bak+activation+and+Bax+translocation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DDent%26aufirst%3DP.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DMcl-1%2520down-regulation%2520potentiates%2520ABT-737%2520lethality%2520by%2520cooperatively%2520inducing%2520Bak%2520activation%2520and%2520Bax%2520translocation%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D782%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contractor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samudio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruvolo, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soengas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruvolo, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiffar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCubrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.ccr.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17097560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=375-388&author=M.+Konoplevaauthor=R.+Contractorauthor=T.+Tsaoauthor=I.+Samudioauthor=P.+P.+Ruvoloauthor=S.+Kitadaauthor=X.+Dengauthor=D.+Zhaiauthor=Y.+X.+Shiauthor=T.+Sneedauthor=M.+Verhaegenauthor=M.+Soengasauthor=V.+R.+Ruvoloauthor=T.+McQueenauthor=W.+D.+Schoberauthor=J.+C.+Wattauthor=T.+Jiffarauthor=X.+Lingauthor=F.+C.+Mariniauthor=D.+Harrisauthor=M.+Dietrichauthor=Z.+Estrovauthor=J.+McCubreyauthor=W.+S.+Mayauthor=J.+C.+Reedauthor=M.+Andreeff&title=Mechanisms+of+apoptosis+sensitivity+and+resistance+to+the+BH3+mimetic+ABT-737+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia</span></div><div class="casAuthors">Konopleva, Marina; Contractor, Rooha; Tsao, Twee; Samudio, Ismael; Ruvolo, Peter P.; Kitada, Shinichi; Deng, Xingming; Zhai, Dayong; Shi, Yue-Xi; Sneed, Thomas; Verhaegen, Monique; Soengas, Maria; Ruvolo, Vivian R.; McQueen, Teresa; Schober, Wendy D.; Watt, Julie C.; Jiffar, Tilahun; Ling, Xiaoyang; Marini, Frank C.; Harris, David; Dietrich, Martin; Estrov, Zeev; McCubrey, James; May, W. Stratford; Reed, John C.; Andreeff, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-388</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">BCL-2 proteins are crit. for cell survival and are overexpressed in many tumors.  ABT-737 is a small-mol. BH3 mimetic that exhibits single-agent activity against lymphoma and small-cell lung cancer in preclin. studies.  We here report that ABT-737 effectively kills acute myeloid leukemia blast, progenitor, and stem cells without affecting normal hematopoietic cells.  ABT-737 induced the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway.  In cells with phosphorylated BCL-2 or increased MCL-1, ABT-737 was inactive.  Inhibition of BCL-2 phosphorylation and redn. of MCL-1 expression restored sensitivity to ABT-737.  These data suggest that ABT-737 could be a highly effective antileukemia agent when the mechanisms of resistance identified here are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDhsJzVCfTBbVg90H21EOLACvtfcHk0lgmf9ZE4q7Lpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nJ&md5=c2895bf6ccffe6a9f389dc6241666086</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DContractor%26aufirst%3DR.%26aulast%3DTsao%26aufirst%3DT.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DRuvolo%26aufirst%3DP.%2BP.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DY.%2BX.%26aulast%3DSneed%26aufirst%3DT.%26aulast%3DVerhaegen%26aufirst%3DM.%26aulast%3DSoengas%26aufirst%3DM.%26aulast%3DRuvolo%26aufirst%3DV.%2BR.%26aulast%3DMcQueen%26aufirst%3DT.%26aulast%3DSchober%26aufirst%3DW.%2BD.%26aulast%3DWatt%26aufirst%3DJ.%2BC.%26aulast%3DJiffar%26aufirst%3DT.%26aulast%3DLing%26aufirst%3DX.%26aulast%3DMarini%26aufirst%3DF.%2BC.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DDietrich%26aufirst%3DM.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DMcCubrey%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DW.%2BS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520apoptosis%2520sensitivity%2520and%2520resistance%2520to%2520the%2520BH3%2520mimetic%2520ABT-737%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D375%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Targeting multiple arms of the apoptotic regulatory machinery</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2908</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2908-2911&author=Y.+Daiauthor=S.+Grant&title=Targeting+multiple+arms+of+the+apoptotic+regulatory+machinery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DTargeting%2520multiple%2520arms%2520of%2520the%2520apoptotic%2520regulatory%2520machinery%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D2908%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0lgmf9ZE4q7Lpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Shigemasa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katoh, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohama, K.</span><span> </span><span class="NLM_article-title">Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1111%2Fj.1349-7006.2002.tb01289.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=12036450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A280%3ADC%252BD383ps12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2002&pages=542-550&author=K.+Shigemasaauthor=O.+Katohauthor=Y.+Shiroyamaauthor=S.+Miharaauthor=K.+Mukaiauthor=N.+Nagaiauthor=K.+Ohama&title=Increased+MCL-1+expression+is+associated+with+poor+prognosis+in+ovarian+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas</span></div><div class="casAuthors">Shigemasa Kazushi; Katoh Osamu; Shiroyama Yuko; Mihara Shoji; Mukai Keiji; Nagai Nobutaka; Ohama Koso</div><div class="citationInfo"><span class="NLM_cas:title">Japanese journal of cancer research : Gann</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-50</span>
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    </div><div class="casAbstract">To investigate the potential role of the BCL-2 gene family (BAX, BCL-2, MCL-1, and BCL-XL) in ovarian cancer development and progression, mRNA expression levels of these genes were measured using semi-quantitative PCR in epithelial ovarian tumor tissues and normal ovaries.  The immunohistochemical expression of MCL-1 in ovarian tumors was also examined.  The expression levels of BAX and MCL-1 mRNA were significantly higher in ovarian cancers and in adenomas than in normal ovaries (P < 0.05).  In contrast, the BCL-2 mRNA expression level in ovarian cancers was significantly lower than in ovarian adenomas and in normal ovaries (P < 0.05).  Expression of BCL-XL mRNA was no different between normal ovaries and ovarian tumors.  Log-rank testing showed that low BAX mRNA expression and high MCL-1 mRNA expression significantly correlate with poor survival for patients with stage III ovarian carcinomas (BAX, P = 0.05; MCL-1, P = 0.02).  Immunohistochemical analysis showed that diffuse-positive expression of MCL-1 protein in mucinous carcinomas was significantly higher than in mucinous low malignant potential (LMP) tumors (P = 0.03).  In ovarian cancer cases, diffuse-positive expression of MCL-1 protein significantly correlates with advanced clinical stage, high histologic grade, and poor survival (stage, P < 0.01; grade, P = 0.01; survival, P = 0.01).  These results suggest that increased MCL-1 expression may play an important role in replacing the functions of increased BAX and decreased BCL-2 in ovarian carcinoma cells, thereby promoting cell survival, and resulting in a poor prognosis for patients with ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaSlz5wkhgxxpyrDyM_m9cfW6udTcc2ebsm5xihOGax7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383ps12lsg%253D%253D&md5=dd0182a77e3fb21ad8d39e9e255f1715</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2002.tb01289.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2002.tb01289.x%26sid%3Dliteratum%253Aachs%26aulast%3DShigemasa%26aufirst%3DK.%26aulast%3DKatoh%26aufirst%3DO.%26aulast%3DShiroyama%26aufirst%3DY.%26aulast%3DMihara%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DK.%26aulast%3DNagai%26aufirst%3DN.%26aulast%3DOhama%26aufirst%3DK.%26atitle%3DIncreased%2520MCL-1%2520expression%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520ovarian%2520carcinomas%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D2002%26volume%3D93%26spage%3D542%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meryet-Figuiere, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duval, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villedieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy-Dudal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saison-Behmoaras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denoyelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=19634140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SqsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=885-895&author=E.+Brotinauthor=M.+Meryet-Figuiereauthor=K.+Simoninauthor=R.+E.+Duvalauthor=M.+Villedieuauthor=J.+Leroy-Dudalauthor=E.+Saison-Behmoarasauthor=P.+Gauduchonauthor=C.+Denoyelleauthor=L.+Poulain&title=Bcl-XL+and+MCL-1+constitute+pertinent+targets+in+ovarian+carcinoma+and+their+concomitant+inhibition+is+sufficient+to+induce+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis</span></div><div class="casAuthors">Brotin, Emilie; Meryet-Figuiere, Matthieu; Simonin, Karin; Duval, Raphael E.; Villedieu, Marie; Leroy-Dudal, Johanne; Saison-Behmoaras, Ester; Gauduchon, Pascal; Denoyelle, Christophe; Poulain, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-895</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In ovarian carcinomas, recurrence and acquired chemoresistance are the first leading causes of therapeutic failure and are responsible for the poor overall survival rate.  Cisplatin exposure of sensitive cells has been previously assocd. with a down-regulation of Bcl-XL expression and apoptosis, whereas recurrence was systematically obsd. when Bcl-XL expression was maintained.  Bcl-XL down-regulation could thus constitute an interesting chemosensitizing strategy.  We showed that a Bcl-XLtargeted RNA interference strategy efficiently sensitized chemoresistant ovarian carcinoma cells to cisplatin, but some of them were still able to re-proliferate.  Considering the possible cooperation between Bcl-XLand MCL-1, we investigated the possibility to avoid recurrence in vitro using a multi-targeted RNAi strategy directed against these two anti-apoptotic proteins.  We showed that their concomitant inhibition lead to massive apoptosis in absence of cisplatin, this multi-targeted RNAi approach being much more efficient than conventional chemotherapy.  We thus demonstrated that Bcl-XL and MCL-1 cooperate to constitute together a strong mol. "bolt", which elimination could be sufficient to allow chemoresistant ovarian carcinoma cells apoptosis.  Moreover, we demonstrated that in presence of a low concn. of cisplatin, the concomitant down-regulation of Bcl-XL and MCL-1 allowed a complete annihilation of tumor cells population thus avoiding subsequent recurrence in vitro in cell lines highly refractory to any type of conventional chemotherapy.  Therefore, Bcl-XL and MCL-1 targeted strategies could constitute an efficient therapeutic tool for the treatment of chemoresistant ovarian carcinoma, in assocn. with conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5MNifRb1ltrVg90H21EOLACvtfcHk0lhD8J7Bj6RwiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SqsLrI&md5=dca4ee5a00c3218da05d2536a6600555</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DMeryet-Figuiere%26aufirst%3DM.%26aulast%3DSimonin%26aufirst%3DK.%26aulast%3DDuval%26aufirst%3DR.%2BE.%26aulast%3DVilledieu%26aufirst%3DM.%26aulast%3DLeroy-Dudal%26aufirst%3DJ.%26aulast%3DSaison-Behmoaras%26aufirst%3DE.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DDenoyelle%26aufirst%3DC.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DBcl-XL%2520and%2520MCL-1%2520constitute%2520pertinent%2520targets%2520in%2520ovarian%2520carcinoma%2520and%2520their%2520concomitant%2520inhibition%2520is%2520sufficient%2520to%2520induce%2520apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D126%26spage%3D885%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Simonin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufort, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutoit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’diaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denoyelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3162</span><span class="NLM_x">–</span> <span class="NLM_lpage">3170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1158%2F1535-7163.MCT-09-0493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=19887550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3162-3170&author=K.+Simoninauthor=E.+Brotinauthor=S.+Dufortauthor=S.+Dutoitauthor=D.+Gouxauthor=M.+N%E2%80%99diayeauthor=C.+Denoyelleauthor=P.+Gauduchonauthor=L.+Poulain&title=Mcl-1+is+an+important+determinant+of+the+apoptotic+response+to+the+BH3-mimetic+molecule+HA14-1+in+cisplatin-resistant+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells</span></div><div class="casAuthors">Simonin, Karin; Brotin, Emilie; Dufort, Sandrine; Dutoit, Soizic; Goux, Didier; N'Diaye, Monique; Denoyelle, Christophe; Gauduchon, Pascal; Poulain, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3162-3170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chemoresistance of ovarian carcinoma has been assocd. previously to the absence of Bcl-xL expression downregulation in response to cisplatin.  Among BH3-mimetic mols. constituting promising anticancer agents able to inhibit the activity of antiapoptotic Bcl-2 family proteins, we evaluated the effect of one of them, HA14-1, on various ovarian carcinoma cell lines.  In response to HA14-1, the cisplatin-resistant IGROV1-R10 cell line underwent massive cell death, whereas other cell lines presented a partial response (IGROV1, SKOV3, and A2780) or did not respond to this mol. (OAW42 and OAW42-R).  However, the expression of HA14-1 targets (Bcl-2 and Bcl-xL) did not correlate to these different responses.  In contrast, cell death was assocd. with the disappearance of Mcl-1 after exposure to HA14-1.  We showed that, in the HA14-1 nonresponsive cell lines (SKOV3 and OAW42), small interfering RNA-mediated Mcl-1 downregulation allowed HA14-1-induced massive apoptosis in the absence of chemotherapy.  Furthermore, cisplatin-induced Mcl-1 downregulation was also able to sensitize highly chemoresistant SKOV3 cells to HA14-1.  Taken together, these results show that Bcl-xL and Mcl-1 are able to cooperate to protect ovarian carcinoma cells against oncogenic stress or chemotherapy-induced apoptosis and suggest that the development of multitargeted strategies directed against these two antiapoptotic proteins may constitute a major challenge for the therapeutic care of chemoresistant ovarian carcinomas.  BH3-mimetic compds. represent promising tools for this purpose either on their own (direct or indirect pan-inhibitors) or in combination with new drugs aiming to inactivate Mcl-1. [Mol Cancer Ther 2009;8(11):3162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruERdWJYwjbLVg90H21EOLACvtfcHk0lispRtsVCJ9AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zO&md5=cbf890e939ec33abc700a8893ff49853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0493%26sid%3Dliteratum%253Aachs%26aulast%3DSimonin%26aufirst%3DK.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DDufort%26aufirst%3DS.%26aulast%3DDutoit%26aufirst%3DS.%26aulast%3DGoux%26aufirst%3DD.%26aulast%3DN%25E2%2580%2599diaye%26aufirst%3DM.%26aulast%3DDenoyelle%26aufirst%3DC.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DMcl-1%2520is%2520an%2520important%2520determinant%2520of%2520the%2520apoptotic%2520response%2520to%2520the%2520BH3-mimetic%2520molecule%2520HA14-1%2520in%2520cisplatin-resistant%2520ovarian%2520carcinoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D3162%26epage%3D3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Simonin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’diaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lheureux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loussouarn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutoit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giffard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanc-Fournier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=492-508&author=K.+Simoninauthor=M.+N%E2%80%99diayeauthor=S.+Lheureuxauthor=C.+Loussouarnauthor=S.+Dutoitauthor=M.+Briandauthor=F.+Giffardauthor=E.+Brotinauthor=C.+Blanc-Fournierauthor=L.+Poulain&title=Platinum+compounds+sensitize+ovarian+carcinoma+cells+to+ABT-737+by+modulation+of+the+Mcl-1%2FNoxa+axis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimonin%26aufirst%3DK.%26aulast%3DN%25E2%2580%2599diaye%26aufirst%3DM.%26aulast%3DLheureux%26aufirst%3DS.%26aulast%3DLoussouarn%26aufirst%3DC.%26aulast%3DDutoit%26aufirst%3DS.%26aulast%3DBriand%26aufirst%3DM.%26aulast%3DGiffard%26aufirst%3DF.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DBlanc-Fournier%26aufirst%3DC.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DPlatinum%2520compounds%2520sensitize%2520ovarian%2520carcinoma%2520cells%2520to%2520ABT-737%2520by%2520modulation%2520of%2520the%2520Mcl-1%252FNoxa%2520axis%26jtitle%3DApoptosis%26date%3D2013%26volume%3D18%26spage%3D492%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raychaudhuri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barretina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc Henry, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinchback, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haery, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prensner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liefeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yecies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signoretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demichelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladanyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraway, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">True, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomeroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span> </span><span class="NLM_article-title">The landscape of somatic copy-number alteration across human cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnature08822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=20164920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=899-905&author=R.+Beroukhimauthor=C.+H.+Mermelauthor=D.+Porterauthor=G.+Weiauthor=S.+Raychaudhuriauthor=J.+Donovanauthor=J.+Barretinaauthor=J.+S.+Boehmauthor=J.+Dobsonauthor=M.+Urashimaauthor=K.+T.+Mc+Henryauthor=R.+M.+Pinchbackauthor=A.+H.+Ligonauthor=Y.+J.+Choauthor=L.+Haeryauthor=H.+Greulichauthor=M.+Reichauthor=W.+Wincklerauthor=M.+S.+Lawrenceauthor=B.+A.+Weirauthor=K.+E.+Tanakaauthor=D.+Y.+Chiangauthor=A.+J.+Bassauthor=A.+Looauthor=C.+Hoffmanauthor=J.+Prensnerauthor=T.+Liefeldauthor=Q.+Gaoauthor=D.+Yeciesauthor=S.+Signorettiauthor=E.+Maherauthor=F.+J.+Kayeauthor=H.+Sasakiauthor=J.+E.+Tepperauthor=J.+A.+Fletcherauthor=J.+Taberneroauthor=J.+Baselgaauthor=M.+S.+Tsaoauthor=F.+Demichelisauthor=M.+A.+Rubinauthor=P.+A.+Janneauthor=M.+J.+Dalyauthor=C.+Nuceraauthor=R.+L.+Levineauthor=B.+L.+Ebertauthor=S.+Gabrielauthor=A.+K.+Rustgiauthor=C.+R.+Antonescuauthor=M.+Ladanyiauthor=A.+Letaiauthor=L.+A.+Garrawayauthor=M.+Lodaauthor=D.+G.+Beerauthor=L.+D.+Trueauthor=A.+Okamotoauthor=S.+L.+Pomeroyauthor=S.+Singerauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=G.+Getzauthor=W.+R.+Sellersauthor=M.+Meyerson&title=The+landscape+of+somatic+copy-number+alteration+across+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The landscape of somatic copy-number alteration across human cancers</span></div><div class="casAuthors">Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers.  Here we present high-resoln. analyses of somatic copy-no. alterations (SCNAs) from 3131 cancer specimens, belonging largely to 26 histol. types.  We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions.  Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-κB pathway.  We show that cancer cells contg. amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival.  Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYRlqR0wXLVg90H21EOLACvtfcHk0ljCH_hxKy_SPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D&md5=be6d81f5449cba96dfb4659106f706b0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature08822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08822%26sid%3Dliteratum%253Aachs%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DMermel%26aufirst%3DC.%2BH.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DBarretina%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DDobson%26aufirst%3DJ.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DMc%2BHenry%26aufirst%3DK.%2BT.%26aulast%3DPinchback%26aufirst%3DR.%2BM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26aulast%3DHaery%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DWinckler%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%2BE.%26aulast%3DChiang%26aufirst%3DD.%2BY.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DC.%26aulast%3DPrensner%26aufirst%3DJ.%26aulast%3DLiefeld%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYecies%26aufirst%3DD.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DMaher%26aufirst%3DE.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DTepper%26aufirst%3DJ.%2BE.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DNucera%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DThe%2520landscape%2520of%2520somatic%2520copy-number%2520alteration%2520across%2520human%2520cancers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D899%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan-Lappe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakula, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernetti, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">‘Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3972</span><span class="NLM_x">–</span> <span class="NLM_lpage">3979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3972-3979&author=X.+Linauthor=S.+Morgan-Lappeauthor=X.+Huangauthor=L.+Liauthor=D.+M.+Zakulaauthor=L.+A.+Vernettiauthor=S.+W.+Fesikauthor=Y.+Shen&title=%E2%80%98Seed%E2%80%99+analysis+of+off-target+siRNAs+reveals+an+essential+role+of+Mcl-1+in+resistance+to+the+small-molecule+Bcl-2%2FBcl-XL+inhibitor+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZakula%26aufirst%3DD.%2BM.%26aulast%3DVernetti%26aufirst%3DL.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26atitle%3D%25E2%2580%2598Seed%25E2%2580%2599%2520analysis%2520of%2520off-target%2520siRNAs%2520reveals%2520an%2520essential%2520role%2520of%2520Mcl-1%2520in%2520resistance%2520to%2520the%2520small-molecule%2520Bcl-2%252FBcl-XL%2520inhibitor%2520ABT-737%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D3972%26epage%3D3979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lucas, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohana-Kumaran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weninger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. D.</span><span> </span><span class="NLM_article-title">Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1158%2F1078-0432.CCR-11-1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=22173547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=783-795&author=K.+M.+Lucasauthor=N.+Mohana-Kumaranauthor=D.+Lauauthor=X.+D.+Zhangauthor=P.+Herseyauthor=D.+C.+Huangauthor=W.+Weningerauthor=N.+K.+Haassauthor=J.+D.+Allen&title=Modulation+of+NOXA+and+MCL-1+as+a+strategy+for+sensitizing+melanoma+cells+to+the+BH3-mimetic+ABT-737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737</span></div><div class="casAuthors">Lucas, Keryn M.; Mohana-Kumaran, Nethia; Lau, Diana; Zhang, Xu Dong; Hersey, Peter; Huang, David C.; Weninger, Wolfgang; Haass, Nikolas K.; Allen, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">783-795</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Drug resistance in melanoma is commonly attributed to ineffective apoptotic pathways.  Inhibiting antiapoptotic BCL-2 and its relatives is an attractive strategy for sensitizing lymphoid malignancies to drugs but it has been largely unsuccessful for melanoma and other solid tumors.  ABT-737, a small-mol. BH3-mimetic, selectively inhibits BCL-2, BCL-XL, and BCL-w and shows promise for treating leukemia, lymphoma, and small-cell lung cancer.  Melanoma cells are insensitive to ABT-737, but MCL-1 inhibition reportedly increases the sensitivity of other tumors to the compd.  Exptl. Design: The efficacy of MCL-1 and BFL-1 inhibition for sensitizing melanoma cells to ABT-737 was investigated by short hairpin RNA-mediated knockdown or overexpression of their antagonist NOXA in two-dimensional cell culture, a three-dimensional organotypic spheroid model, and an in vivo model.  RESULTS:MCL-1 downregulation or NOXA overexpression strongly sensitized melanoma cells to ABT-737 in vitro.  NOXA-inducing cytotoxic drugs also strongly sensitized melanomas to ABT-737 but, surprisingly, not vice versa.  The drugs most suitable are not necessarily those normally used to treat melanoma.  Resistance to ABT-737 occurred quickly in three-dimensional melanoma spheroids through reduced NOXA expression, although expts. with both xenografts and three-dimensional spheroids suggest that penetration of ABT-737 into tumor masses may be the principal limitation, which may be obviated through use of more diffusible BH3-mimetics.  CONCLUSION: Sensitization of tumors to BH3-mimetics by cytotoxic drugs that induce NOXA is a therapeutic strategy worth exploring for the treatment of melanoma and other solid cancers.  Clin Cancer Res; 18(3); 783-95.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0cpQgRwax7Vg90H21EOLACvtfcHk0ljCH_hxKy_SPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOktbY%253D&md5=908c621dd5e5665271e4c9020f29d0a9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1166%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DK.%2BM.%26aulast%3DMohana-Kumaran%26aufirst%3DN.%26aulast%3DLau%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%2BD.%26aulast%3DHersey%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DWeninger%26aufirst%3DW.%26aulast%3DHaass%26aufirst%3DN.%2BK.%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26atitle%3DModulation%2520of%2520NOXA%2520and%2520MCL-1%2520as%2520a%2520strategy%2520for%2520sensitizing%2520melanoma%2520cells%2520to%2520the%2520BH3-mimetic%2520ABT-737%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D783%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Russo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spagnuolo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, G. L.</span><span> </span><span class="NLM_article-title">ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=927-936&author=M.+Russoauthor=C.+Spagnuoloauthor=S.+Volpeauthor=I.+Tedescoauthor=S.+Bilottoauthor=G.+L.+Russo&title=ABT-737+resistance+in+B-cells+isolated+from+chronic+lymphocytic+leukemia+patients+and+leukemia+cell+lines+is+overcome+by+the+pleiotropic+kinase+inhibitor+quercetin+through+Mcl-1+down-regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DSpagnuolo%26aufirst%3DC.%26aulast%3DVolpe%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DI.%26aulast%3DBilotto%26aufirst%3DS.%26aulast%3DRusso%26aufirst%3DG.%2BL.%26atitle%3DABT-737%2520resistance%2520in%2520B-cells%2520isolated%2520from%2520chronic%2520lymphocytic%2520leukemia%2520patients%2520and%2520leukemia%2520cell%2520lines%2520is%2520overcome%2520by%2520the%2520pleiotropic%2520kinase%2520inhibitor%2520quercetin%2520through%2520Mcl-1%2520down-regulation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D927%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jebahi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villedieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petigny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeilard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giffard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guercio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lheureux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-x-targeting strategies, provided that Bim expression is induced</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.canlet.2014.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=24576622" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2014&pages=212-224&author=A.+Jebahiauthor=M.+Villedieuauthor=C.+Petignyauthor=E.+Brotinauthor=M.+H.+Louisauthor=E.+Abeilardauthor=F.+Giffardauthor=M.+Guercioauthor=M.+Briandauthor=P.+Gauduchonauthor=S.+Lheureuxauthor=L.+Poulain&title=PI3K%2FmTOR+dual+inhibitor+NVP-BEZ235+decreases+Mcl-1+expression+and+sensitizes+ovarian+carcinoma+cells+to+Bcl-x-targeting+strategies%2C+provided+that+Bim+expression+is+induced"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DJebahi%26aufirst%3DA.%26aulast%3DVilledieu%26aufirst%3DM.%26aulast%3DPetigny%26aufirst%3DC.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DLouis%26aufirst%3DM.%2BH.%26aulast%3DAbeilard%26aufirst%3DE.%26aulast%3DGiffard%26aufirst%3DF.%26aulast%3DGuercio%26aufirst%3DM.%26aulast%3DBriand%26aufirst%3DM.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DLheureux%26aufirst%3DS.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DPI3K%252FmTOR%2520dual%2520inhibitor%2520NVP-BEZ235%2520decreases%2520Mcl-1%2520expression%2520and%2520sensitizes%2520ovarian%2520carcinoma%2520cells%2520to%2520Bcl-x-targeting%2520strategies%252C%2520provided%2520that%2520Bim%2520expression%2520is%2520induced%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D347%26spage%3D212%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, M. G.</span><span> </span><span class="NLM_article-title">Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=4738-4744&author=C.+L.+Dayauthor=L.+Chenauthor=S.+J.+Richardsonauthor=P.+J.+Harrisonauthor=D.+C.+Huangauthor=M.+G.+Hinds&title=Solution+structure+of+prosurvival+Mcl-1+and+characterization+of+its+binding+by+proapoptotic+BH3-only+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DHarrison%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26atitle%3DSolution%2520structure%2520of%2520prosurvival%2520Mcl-1%2520and%2520characterization%2520of%2520its%2520binding%2520by%2520proapoptotic%2520BH3-only%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D4738%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Quinn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azab, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyesanya, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curiel, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dmitriev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedvat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, P. B.</span><span> </span><span class="NLM_article-title">Targeting Mcl-1 for the therapy of cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1517%2F13543784.2011.609167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=21851287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGgur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1397-1411&author=B.+A.+Quinnauthor=R.+Dashauthor=B.+Azabauthor=S.+Sarkarauthor=S.+K.+Dasauthor=S.+Kumarauthor=R.+A.+Oyesanyaauthor=S.+Dasguptaauthor=P.+Dentauthor=S.+Grantauthor=M.+Rahmaniauthor=D.+T.+Curielauthor=I.+Dmitrievauthor=M.+Hedvatauthor=J.+Weiauthor=B.+Wuauthor=J.+L.+Stebbinsauthor=J.+C.+Reedauthor=M.+Pellecchiaauthor=D.+Sarkarauthor=P.+B.+Fisher&title=Targeting+Mcl-1+for+the+therapy+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mcl-1 for the therapy of cancer</span></div><div class="casAuthors">Quinn, Bridget A.; Dash, Rupesh; Azab, Belal; Sarkar, Siddik; Das, Swadesh K.; Kumar, Sachin; Oyesanya, Regina A.; Dasgupta, Santanu; Dent, Paul; Grant, Steven; Rahmani, Mohamed; Curiel, David T.; Dmitriev, Igor; Hedvat, Michael; Wei, Jun; Wu, Bainan; Stebbins, John L.; Reed, John C.; Pellecchia, Maurizio; Sarkar, Devanand; Fisher, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1397-1411</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Human cancers are genetically and epigenetically heterogeneous and have the capacity to commandeer a variety of cellular processes to aid in their survival, growth and resistance to therapy.  One strategy is to overexpress proteins that suppress apoptosis, such as the Bcl-2 family protein Mcl-1.  The Mcl-1 protein plays a pivotal role in protecting cells from apoptosis and is overexpressed in a variety of human cancers.Areas covered:Targeting Mcl-1 for extinction in these cancers, using genetic and pharmacol. approaches, represents a potentially effectual means of developing new efficacious cancer therapeutics.  Here we review the multiple strategies that have been employed in targeting this fundamental protein, as well as the significant potential these targeting agents provide in not only suppressing cancer growth, but also in reversing resistance to conventional cancer treatments.Expert opinion:We discuss the potential issues that arise in targeting Mcl-1 and other Bcl-2 anti-apoptotic proteins, as well problems with acquired resistance.  The application of combinatorial approaches that involve inhibiting Mcl-1 and manipulation of addnl. signaling pathways to enhance therapeutic outcomes is also highlighted.  The ability to specifically inhibit key genetic/epigenetic elements and biochem. pathways that maintain the tumor state represent a viable approach for developing rationally based, effective cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeNFpz1mcESrVg90H21EOLACvtfcHk0lj9wnL8X08Drw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGgur3N&md5=7e2e0ab1cedb25a32b8e97a935238013</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.609167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.609167%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DB.%2BA.%26aulast%3DDash%26aufirst%3DR.%26aulast%3DAzab%26aufirst%3DB.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DOyesanya%26aufirst%3DR.%2BA.%26aulast%3DDasgupta%26aufirst%3DS.%26aulast%3DDent%26aufirst%3DP.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DRahmani%26aufirst%3DM.%26aulast%3DCuriel%26aufirst%3DD.%2BT.%26aulast%3DDmitriev%26aufirst%3DI.%26aulast%3DHedvat%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DPellecchia%26aufirst%3DM.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26atitle%3DTargeting%2520Mcl-1%2520for%2520the%2520therapy%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1397%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Billard, C.</span><span> </span><span class="NLM_article-title">Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2032</span><span class="NLM_x">–</span> <span class="NLM_lpage">2038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2032-2038&author=C.+Billard&title=Design+of+novel+BH3+mimetics+for+the+treatment+of+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBillard%26aufirst%3DC.%26atitle%3DDesign%2520of%2520novel%2520BH3%2520mimetics%2520for%2520the%2520treatment%2520of%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26spage%3D2032%26epage%3D2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puthalakath, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=341-355&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=M.+F.+van+Delftauthor=E.+M.+Michalakauthor=M.+J.+Boyleauthor=S.+N.+Willisauthor=H.+Puthalakathauthor=P.+Bouilletauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=A+novel+BH3+ligand+that+selectively+targets+Mcl-1+reveals+that+apoptosis+can+proceed+without+Mcl-1+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DMichalak%26aufirst%3DE.%2BM.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520BH3%2520ligand%2520that%2520selectively%2520targets%2520Mcl-1%2520reveals%2520that%2520apoptosis%2520can%2520proceed%2520without%2520Mcl-1%2520degradation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D341%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Stewart, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fire, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnchembio.391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=20562877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXns1Gis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=595-601&author=M.+L.+Stewartauthor=E.+Fireauthor=A.+E.+Keatingauthor=L.+D.+Walensky&title=The+MCL-1+BH3+helix+is+an+exclusive+MCL-1+inhibitor+and+apoptosis+sensitizer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer</span></div><div class="casAuthors">Stewart, Michelle L.; Fire, Emiko; Keating, Amy E.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">595-601</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of selective inhibitors for discrete anti-apoptotic BCL-2 family proteins implicated in pathol. cell survival remains a formidable but pressing challenge.  Such precisely tailored compds. would serve as mol. probes and targeted therapies to study and treat human diseases driven by specific anti-apoptotic blockades.  In particular, MCL-1 has emerged as a major resistance factor in human cancer.  By screening a library of stabilized alpha-helix of BCL-2 domains (SAHBs), we detd. that the MCL-1 BH3 helix is itself a potent and exclusive MCL-1 inhibitor.  X-ray crystallog. and mutagenesis studies defined key binding and specificity determinants, including the capacity to harness the hydrocarbon staple to optimize affinity while preserving selectivity.  MCL-1 SAHB directly targets MCL-1, neutralizes its inhibitory interaction with pro-apoptotic BAK and sensitizes cancer cells to caspase-dependent apoptosis.  By leveraging nature's soln. to ligand selectivity, we generated an MCL-1-specific agent that defines the structural and functional features of targeted MCL-1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKSZxSkketOLVg90H21EOLACvtfcHk0lgcNShAuinbzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXns1Gis7c%253D&md5=4cc80db931dac5360d650ac9c45334ea</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.391%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DM.%2BL.%26aulast%3DFire%26aufirst%3DE.%26aulast%3DKeating%26aufirst%3DA.%2BE.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DThe%2520MCL-1%2520BH3%2520helix%2520is%2520an%2520exclusive%2520MCL-1%2520inhibitor%2520and%2520apoptosis%2520sensitizer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D595%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span> </span><span class="NLM_article-title">S1, a novel pan-BH3 mimetic, induces apoptosis in Mcl-1-overexpressing cells through Bak</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1254%2Fjphs.12103FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=22814102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlagtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=330-340&author=T.+Songauthor=X.+Changauthor=Z.+Zhangauthor=Y.+Liuauthor=X.+Shen&title=S1%2C+a+novel+pan-BH3+mimetic%2C+induces+apoptosis+in+Mcl-1-overexpressing+cells+through+Bak"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">S1, a novel Pan-BH3 mimetic, induces apoptosis in Mcl-1-overexpressing cells through Bak</span></div><div class="casAuthors">Song, Ting; Chang, Xilong; Zhang, Zhichao; Liu, Yubo; Shen, Xiaoyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">330-340</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Mcl-1, an anti-apoptotic Bcl-2 homolog that has a structurally divergent BH3-binding pocket, non-redundant action model, and unique characteristic of short life confers complete resistance to the BH3 mimetic ABT-737.  Herein, we used S1, previously identified as a Mcl-1/Bcl-2 dual inhibitor and a pure BH3 mimetic, to explore the mechanism of Mcl-1's action and supply a strategy to challenge Mcl-1's protection.  Apoptosis assay in SMMC-7721, HCT116, and K562 cells demonstrated that S1 can effectively challenge Mcl-1's anti-apoptotic effect.  Notably, we discovered an unexpected dynamic change of Mcl-1 that directly correlates with resistance or commitment to apoptosis induced by both ABT-737 and S1.  Co-immunopptn. assays demonstrated that Mcl-1 increase results from Bim trafficking from Bcl-2 to Mcl-1, while subsequent Bak released by S1 dets. Mcl-1 decrease and full-blown apoptosis.  Further expts. using Bak shRNA testified that Bak accounts for S1-induced apoptosis and Mcl-1 decrease.  Consistently, Bax-deficient DU145 cells are sensitive to S1, whereas Bak-mutant MKN-28 cells are significantly more resistant.  The in vitro model could be extended to an in vivo mouse xenograft model in which Mcl-1 confers resistance by increased protein level, and the release of Bak could serve as a biomarker of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTk7MtIp1CY7Vg90H21EOLACvtfcHk0lgcNShAuinbzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlagtbvO&md5=4715e90a31166ee255d00018b6f0ecf8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1254%2Fjphs.12103FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.12103FP%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DS1%252C%2520a%2520novel%2520pan-BH3%2520mimetic%252C%2520induces%2520apoptosis%2520in%2520Mcl-1-overexpressing%2520cells%2520through%2520Bak%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D119%26spage%3D330%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H.</span><span> </span><span class="NLM_article-title">Design and application of a rigid quinazolone scaffold based on two-face Bim alpha-helix mimicking</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=711-718&author=Z.+Zhangauthor=X.+Liangauthor=X.+Liauthor=T.+Songauthor=Q.+Chenauthor=H.+Sheng&title=Design+and+application+of+a+rigid+quinazolone+scaffold+based+on+two-face+Bim+alpha-helix+mimicking"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DSheng%26aufirst%3DH.%26atitle%3DDesign%2520and%2520application%2520of%2520a%2520rigid%2520quinazolone%2520scaffold%2520based%2520on%2520two-face%2520Bim%2520alpha-helix%2520mimicking%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D711%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Doi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manieri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnegowda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awwad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daughdrill, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. G.</span><span> </span><span class="NLM_article-title">Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">10224</span><span class="NLM_x">–</span> <span class="NLM_lpage">10235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=10224-10235&author=K.+Doiauthor=R.+Liauthor=S.+S.+Sungauthor=H.+Wuauthor=Y.+Liuauthor=W.+Manieriauthor=G.+Krishnegowdaauthor=A.+Awwadauthor=A.+Deweyauthor=X.+Liuauthor=S.+Aminauthor=C.+Chengauthor=Y.+Qinauthor=E.+Schonbrunnauthor=G.+Daughdrillauthor=T.+P.+Loughranauthor=S.+Sebtiauthor=H.+G.+Wang&title=Discovery+of+marinopyrrole+A+%28maritoclax%29+as+a+selective+Mcl-1+antagonist+that+overcomes+ABT-737+resistance+by+binding+to+and+targeting+Mcl-1+for+proteasomal+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoi%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DManieri%26aufirst%3DW.%26aulast%3DKrishnegowda%26aufirst%3DG.%26aulast%3DAwwad%26aufirst%3DA.%26aulast%3DDewey%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DDaughdrill%26aufirst%3DG.%26aulast%3DLoughran%26aufirst%3DT.%2BP.%26aulast%3DSebti%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%2BG.%26atitle%3DDiscovery%2520of%2520marinopyrrole%2520A%2520%2528maritoclax%2529%2520as%2520a%2520selective%2520Mcl-1%2520antagonist%2520that%2520overcomes%2520ABT-737%2520resistance%2520by%2520binding%2520to%2520and%2520targeting%2520Mcl-1%2520for%2520proteasomal%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D10224%26epage%3D10235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Cohen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavathiotis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruekner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opferman, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.chembiol.2012.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=22999885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2rsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1175-1186&author=N.+A.+Cohenauthor=M.+L.+Stewartauthor=E.+Gavathiotisauthor=J.+L.+Tepperauthor=S.+R.+Brueknerauthor=B.+Kossauthor=J.+T.+Opfermanauthor=L.+D.+Walensky&title=A+competitive+stapled+peptide+screen+identifies+a+selective+small+molecule+that+overcomes+MCL-1-dependent+leukemia+cell+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Competitive Stapled Peptide Screen Identifies a Selective Small Molecule that Overcomes MCL-1-Dependent Leukemia Cell Survival</span></div><div class="casAuthors">Cohen, Nicole A.; Stewart, Michelle L.; Gavathiotis, Evripidis; Tepper, Jared L.; Bruekner, Susanne R.; Koss, Brian; Opferman, Joseph T.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1175-1186</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cancer cells hijack BCL-2 family survival proteins to suppress the death effectors and thereby enforce an immortal state.  This is accomplished biochem. by an antiapoptotic surface groove that neutralizes the proapoptotic BH3 α helix of death proteins.  Antiapoptotic MCL-1 in particular has emerged as a ubiquitous resistance factor in cancer.  Although targeting the BCL-2 antiapoptotic subclass effectively restores the death pathway in BCL-2-dependent cancer, the development of mols. tailored to the binding specificity of MCL-1 has lagged.  We previously discovered that a hydrocarbon-stapled MCL-1 BH3 helix is an exquisitely selective MCL-1 antagonist.  By deploying this unique reagent in a competitive screen, we identified an MCL-1 inhibitor mol. that selectively targets the BH3-binding groove of MCL-1, neutralizes its biochem. lock-hold on apoptosis, and induces caspase activation and leukemia cell death in the specific context of MCL-1 dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Lokm8RYN5rVg90H21EOLACvtfcHk0lgcNShAuinbzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2rsL7M&md5=5306c2b2c2ff29a70ecfc83674f07423</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DN.%2BA.%26aulast%3DStewart%26aufirst%3DM.%2BL.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DTepper%26aufirst%3DJ.%2BL.%26aulast%3DBruekner%26aufirst%3DS.%2BR.%26aulast%3DKoss%26aufirst%3DB.%26aulast%3DOpferman%26aufirst%3DJ.%2BT.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DA%2520competitive%2520stapled%2520peptide%2520screen%2520identifies%2520a%2520selective%2520small%2520molecule%2520that%2520overcomes%2520MCL-1-dependent%2520leukemia%2520cell%2520survival%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1175%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Friberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301448p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=15-30&author=A.+Fribergauthor=D.+Vigilauthor=B.+Zhaoauthor=R.+N.+Danielsauthor=J.+P.+Burkeauthor=P.+M.+Garcia-Barrantesauthor=D.+Camperauthor=B.+A.+Chauderauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Discovery+of+potent+myeloid+cell+leukemia+1+%28Mcl-1%29+inhibitors+using+fragment-based+methods+and+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design</span></div><div class="casAuthors">Friberg, Anders; Vigil, Dominico; Zhao, Bin; Daniels, R. Nathan; Burke, Jason P.; Garcia-Barrantes, Pedro M.; Camper, DeMarco; Chauder, Brian A.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-30</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis.  Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design.  NMR-based screening of a large fragment library identified two chem. distinct hit series that bind to different sites on Mcl-1.  Members of the two fragment classes were merged together to produce lead compds. that bind to Mcl-1 with a dissocn. const. of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2.  Structures of merged compds. when complexed to Mcl-1 were obtained by x-ray crystallog. and provide detailed information about the mol. recognition of small-mol. ligands binding Mcl-1.  The compds. represent starting points for the discovery of clin. useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-bJGKKNPbErVg90H21EOLACvtfcHk0ljVP8DCjLFSkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J&md5=74e72c3d56cdff85d263bd974319b2db</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm301448p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301448p%26sid%3Dliteratum%253Aachs%26aulast%3DFriberg%26aufirst%3DA.%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520myeloid%2520cell%2520leukemia%25201%2520%2528Mcl-1%2529%2520inhibitors%2520using%2520fragment-based%2520methods%2520and%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D15%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swann, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1484</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1484-1488&author=A.+M.+Petrosauthor=S.+L.+Swannauthor=D.+Songauthor=K.+Swingerauthor=C.+Parkauthor=H.+Zhangauthor=M.+D.+Wendtauthor=A.+R.+Kunzerauthor=A.+J.+Souersauthor=C.+Sun&title=Fragment-based+discovery+of+potent+inhibitors+of+the+anti-apoptotic+MCL-1+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DSwann%26aufirst%3DS.%2BL.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DSwinger%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DSun%26aufirst%3DC.%26atitle%3DFragment-based%2520discovery%2520of%2520potent%2520inhibitors%2520of%2520the%2520anti-apoptotic%2520MCL-1%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1484%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Abulwerdi, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mady, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cierpicki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span> </span><span class="NLM_article-title">3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: Structure-based design, synthesis, SAR, and biological evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4111</span><span class="NLM_x">–</span> <span class="NLM_lpage">4133</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500010b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4111-4133&author=F.+A.+Abulwerdiauthor=C.+Liaoauthor=A.+S.+Madyauthor=J.+Gavinauthor=C.+Shenauthor=T.+Cierpickiauthor=J.+A.+Stuckeyauthor=H.+D.+Showalterauthor=Z.+Nikolovska-Coleska&title=3-Substituted-N-%284-hydroxynaphthalen-1-yl%29arylsulfonamides+as+a+novel+class+of+selective+Mcl-1+inhibitors%3A+Structure-based+design%2C+synthesis%2C+SAR%2C+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm500010b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500010b%26sid%3Dliteratum%253Aachs%26aulast%3DAbulwerdi%26aufirst%3DF.%2BA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DMady%26aufirst%3DA.%2BS.%26aulast%3DGavin%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DCierpicki%26aufirst%3DT.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26atitle%3D3-Substituted-N-%25284-hydroxynaphthalen-1-yl%2529arylsulfonamides%2520as%2520a%2520novel%2520class%2520of%2520selective%2520Mcl-1%2520inhibitors%253A%2520Structure-based%2520design%252C%2520synthesis%252C%2520SAR%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4111%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebaoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohier, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oulyadi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Structural characterizations of oligopyridyl foldamers, α-helix mimetics</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200424a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=429-439&author=J.+Sopkova-de+Oliveira+Santosauthor=A.+S.+Voisin-Chiretauthor=G.+Burzickiauthor=L.+Sebaounauthor=M.+Sebbanauthor=J.+F.+Lohierauthor=R.+Legayauthor=H.+Oulyadiauthor=R.+Bureauauthor=S.+Rault&title=Structural+characterizations+of+oligopyridyl+foldamers%2C+%CE%B1-helix+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci200424a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200424a%26sid%3Dliteratum%253Aachs%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DSebaoun%26aufirst%3DL.%26aulast%3DSebban%26aufirst%3DM.%26aulast%3DLohier%26aufirst%3DJ.%2BF.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DOulyadi%26aufirst%3DH.%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DStructural%2520characterizations%2520of%2520oligopyridyl%2520foldamers%252C%2520%25CE%25B1-helix%2520mimetics%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D429%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oulyadi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Conformation control of abiotic alpha-helical foldamers</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2671</span><span class="NLM_x">–</span> <span class="NLM_lpage">2680</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci400365y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCgtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=2671-2680&author=S.+Peratoauthor=J.+Foghaauthor=M.+Sebbanauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=H.+Oulyadiauthor=S.+Rault&title=Conformation+control+of+abiotic+alpha-helical+foldamers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation Control of Abiotic α-Helical Foldamers</span></div><div class="casAuthors">Perato, Serge; Fogha, Jade; Sebban, Muriel; Voisin-Chiret, Anne Sophie; Sopkova-de Oliveira Santos, Jana; Oulyadi, Hassan; Rault, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2671-2680</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim to find new protein-protein inhibitors, a three part methodol. was applied to oligophenylpyridines.  Theor. ring twist angle predictions have been validated by X-ray diffraction and mol. dynamics simulations with NMR constraints.  Careful choice of substituent and nitrogen positions in oligophenylpyridyl foldamer units opens the way to conformational control of the side chain distribution of this α-helix mimic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUAi6DuH3NfbVg90H21EOLACvtfcHk0lg_CGnEjywFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCgtbzI&md5=308b27550aabe4eda5c2ca2a1677a995</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci400365y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400365y%26sid%3Dliteratum%253Aachs%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DFogha%26aufirst%3DJ.%26aulast%3DSebban%26aufirst%3DM.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DOulyadi%26aufirst%3DH.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DConformation%2520control%2520of%2520abiotic%2520alpha-helical%2520foldamers%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D2671%26epage%3D2680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bouillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">An efficient two-step total synthesis of the quaterpyridine nemertelline</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">10178</span><span class="NLM_x">–</span> <span class="NLM_lpage">10180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034805b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1WqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=10178-10180&author=A.+Bouillonauthor=A.+S.+Voisinauthor=A.+Robicauthor=J.+C.+Lancelotauthor=V.+Collotauthor=S.+Rault&title=An+efficient+two-step+total+synthesis+of+the+quaterpyridine+nemertelline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Two-Step Total Synthesis of the Quaterpyridine Nemertelline</span></div><div class="casAuthors">Bouillon, Alexandre; Voisin, Anne Sophie; Robic, Audrey; Lancelot, Jean-Charles; Collot, Valerie; Rault, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10178-10180</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Regioselective and univocal Suzuki cross-coupling reactions performed on halopyridinyl boronic acids provide a flexible and versatile route to a multigram scale synthesis of 2,2'-dichloro-3,4'-bipyridine (I), which allows couplings with excess pyridin-3-yl boronic acid to give a new and efficient two-step rapid synthesis of nemertelline (II), the quaterpyridine neurotoxin isolated from a Hoplonemertine sea worm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptG0gXaWBmibVg90H21EOLACvtfcHk0lg_CGnEjywFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1WqtLg%253D&md5=7dc54cce7e04a6f3da9b24877c4490dc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo034805b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034805b%26sid%3Dliteratum%253Aachs%26aulast%3DBouillon%26aufirst%3DA.%26aulast%3DVoisin%26aufirst%3DA.%2BS.%26aulast%3DRobic%26aufirst%3DA.%26aulast%3DLancelot%26aufirst%3DJ.%2BC.%26aulast%3DCollot%26aufirst%3DV.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DAn%2520efficient%2520two-step%2520total%2520synthesis%2520of%2520the%2520quaterpyridine%2520nemertelline%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D10178%26epage%3D10180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of dihalo bi- and terpyridines by regioselective Suzuki-Miyaura cross-coupling reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">5413</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=5413-5417&author=G.+Burzickiauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santoauthor=S.+Rault&title=Synthesis+of+dihalo+bi-+and+terpyridines+by+regioselective+Suzuki-Miyaura+cross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSanto%26aufirst%3DJ.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520dihalo%2520bi-%2520and%2520terpyridines%2520by%2520regioselective%2520Suzuki-Miyaura%2520cross-coupling%2520reactions%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D5413%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of New [2,3′:6′,3″]Terpyridines Using Iterative Cross-Coupling Reactions</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2804</span><span class="NLM_x">–</span> <span class="NLM_lpage">2810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2804-2810&author=G.+Burzickiauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=S.+Rault&title=Synthesis+of+New+%5B2%2C3%E2%80%B2%3A6%E2%80%B2%2C3%E2%80%B3%5DTerpyridines+Using+Iterative+Cross-Coupling+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520New%2520%255B2%252C3%25E2%2580%25B2%253A6%25E2%2580%25B2%252C3%25E2%2580%25B3%255DTerpyridines%2520Using%2520Iterative%2520Cross-Coupling%2520Reactions%26jtitle%3DSynthesis%26date%3D2010%26volume%3D16%26spage%3D2804%26epage%3D2810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Using halo (het) arylboronic species to achieve synthesis of foldamers as protein–protein interaction disruptors</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=2467-2478&author=A.+S.+Voisin-Chiretauthor=S.+Rault&title=Using+halo+%28het%29+arylboronic+species+to+achieve+synthesis+of+foldamers+as+protein%E2%80%93protein+interaction+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DUsing%2520halo%2520%2528het%2529%2520arylboronic%2520species%2520to%2520achieve%2520synthesis%2520of%2520foldamers%2520as%2520protein%25E2%2580%2593protein%2520interaction%2520disruptors%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2012%26volume%3D84%26spage%3D2467%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Célant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kashef, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">A general synthesis of halo-oligopyridines. The Garlanding concept</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=605-612&author=A.+S.+Voisin-Chiretauthor=A.+Bouillonauthor=G.+Burzickiauthor=M.+C%C3%A9lantauthor=R.+Legayauthor=H.+El-Kashefauthor=S.+Rault&title=A+general+synthesis+of+halo-oligopyridines.+The+Garlanding+concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DBouillon%26aufirst%3DA.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DC%25C3%25A9lant%26aufirst%3DM.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DEl-Kashef%26aufirst%3DH.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DA%2520general%2520synthesis%2520of%2520halo-oligopyridines.%2520The%2520Garlanding%2520concept%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D605%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moldoveanu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprules, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matta-Camacho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansur-Azzam, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, K.</span><span> </span><span class="NLM_article-title">Apoptotic regulation by MCL-1 through heterodimerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">19615</span><span class="NLM_x">–</span> <span class="NLM_lpage">19624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=19615-19624&author=Q.+Liuauthor=T.+Moldoveanuauthor=T.+Sprulesauthor=E.+Matta-Camachoauthor=N.+Mansur-Azzamauthor=K.+Gehring&title=Apoptotic+regulation+by+MCL-1+through+heterodimerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMoldoveanu%26aufirst%3DT.%26aulast%3DSprules%26aufirst%3DT.%26aulast%3DMatta-Camacho%26aufirst%3DE.%26aulast%3DMansur-Azzam%26aufirst%3DN.%26aulast%3DGehring%26aufirst%3DK.%26atitle%3DApoptotic%2520regulation%2520by%2520MCL-1%2520through%2520heterodimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D19615%26epage%3D19624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Friberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301448p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=15-30&author=A.+Fribergauthor=D.+Vigilauthor=B.+Zhaoauthor=R.+N.+Danielsauthor=J.+P.+Burkeauthor=P.+M.+Garcia-Barrantesauthor=D.+Camperauthor=B.+A.+Chauderauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Discovery+of+potent+myeloid+cell+leukemia+1+%28Mcl-1%29+inhibitors+using+fragment-based+methods+and+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design</span></div><div class="casAuthors">Friberg, Anders; Vigil, Dominico; Zhao, Bin; Daniels, R. Nathan; Burke, Jason P.; Garcia-Barrantes, Pedro M.; Camper, DeMarco; Chauder, Brian A.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-30</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis.  Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design.  NMR-based screening of a large fragment library identified two chem. distinct hit series that bind to different sites on Mcl-1.  Members of the two fragment classes were merged together to produce lead compds. that bind to Mcl-1 with a dissocn. const. of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2.  Structures of merged compds. when complexed to Mcl-1 were obtained by x-ray crystallog. and provide detailed information about the mol. recognition of small-mol. ligands binding Mcl-1.  The compds. represent starting points for the discovery of clin. useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-bJGKKNPbErVg90H21EOLACvtfcHk0lhHyNGUnqbrVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J&md5=74e72c3d56cdff85d263bd974319b2db</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm301448p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301448p%26sid%3Dliteratum%253Aachs%26aulast%3DFriberg%26aufirst%3DA.%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520myeloid%2520cell%2520leukemia%25201%2520%2528Mcl-1%2529%2520inhibitors%2520using%2520fragment-based%2520methods%2520and%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D15%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oulyadi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of new linear poly(phenylpyridyl) chains</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1910</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=1910-1917&author=S.+Peratoauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=R.+Legayauthor=H.+Oulyadiauthor=S.+Rault&title=Synthesis+of+new+linear+poly%28phenylpyridyl%29+chains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DOulyadi%26aufirst%3DH.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520new%2520linear%2520poly%2528phenylpyridyl%2529%2520chains%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D1910%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of new phenylpyridyl scaffolds using the Garlanding approach</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8000</span><span class="NLM_x">–</span> <span class="NLM_lpage">8005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=8000-8005&author=A.+S.+Voisin-Chiretauthor=M.+Muragliaauthor=G.+Burzickiauthor=S.+Peratoauthor=F.+Corboauthor=J.+Sopkova-de+Oliveira+Santosauthor=C.+Franchiniauthor=S.+Rault&title=Synthesis+of+new+phenylpyridyl+scaffolds+using+the+Garlanding+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DMuraglia%26aufirst%3DM.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DCorbo%26aufirst%3DF.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DFranchini%26aufirst%3DC.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520new%2520phenylpyridyl%2520scaffolds%2520using%2520the%2520Garlanding%2520approach%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D8000%26epage%3D8005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">De Giorgi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Design and synthesis of thienylpyridyl garlands as non-peptidic alpha helix mimetics and potential protein-protein interactions disruptors</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6147</span><span class="NLM_x">–</span> <span class="NLM_lpage">6154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=6147-6154&author=M.+De+Giorgiauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=F.+Corboauthor=C.+Franchiniauthor=S.+Rault&title=Design+and+synthesis+of+thienylpyridyl+garlands+as+non-peptidic+alpha+helix+mimetics+and+potential+protein-protein+interactions+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DCorbo%26aufirst%3DF.%26aulast%3DFranchini%26aufirst%3DC.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thienylpyridyl%2520garlands%2520as%2520non-peptidic%2520alpha%2520helix%2520mimetics%2520and%2520potential%2520protein-protein%2520interactions%2520disruptors%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D6147%26epage%3D6154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Légalité, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span> </span><span class="NLM_article-title">Focus on Microwaves Assisted Halogen-halogen Reaction Conditions on 2-Halopyridines</span> <span class="citation_source-journal">Curr. Microwave Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.2174%2F22133356114019990003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWksb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=75-80&author=S.+Peratoauthor=M.+De+Giorgiauthor=G.+Burzickiauthor=F.+L%C3%A9galit%C3%A9author=S.+Raultauthor=A.+S.+Voisin-Chiret&title=Focus+on+Microwaves+Assisted+Halogen-halogen+Reaction+Conditions+on+2-Halopyridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Focus on microwave assisted halogen-halogen exchange reaction conditions on 2-halopyridines</span></div><div class="casAuthors">Perato, Serge; De Giorgi, Marcella; Burzicki, Gregory; Legalite, Florent; Rault, Sylvain; Voisin-Chiret, Anne Sophie</div><div class="citationInfo"><span class="NLM_cas:title">Current Microwave Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-80</span>CODEN:
                <span class="NLM_cas:coden">CMCUB9</span>;
        ISSN:<span class="NLM_cas:issn">2213-3364</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This paper describes an optimized microwave irradn.-assisted methodol. for halogen-halogen exchange reactions on various substituted pyridines.  The protocol provides an efficient and simple methodol. to improve the reactivity of some positions on the pyridine ring towards metallocatalyzed reactions.  Influence of various substituents were explored and limiting factors of reaction highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQvqn3-8_bQrVg90H21EOLACvtfcHk0lhTFbMXy7-c1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWksb7K&md5=78bc74eff780b647dc3fa7905ab87670</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2174%2F22133356114019990003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F22133356114019990003%26sid%3Dliteratum%253Aachs%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DL%25C3%25A9galit%25C3%25A9%26aufirst%3DF.%26aulast%3DRault%26aufirst%3DS.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26atitle%3DFocus%2520on%2520Microwaves%2520Assisted%2520Halogen-halogen%2520Reaction%2520Conditions%2520on%25202-Halopyridines%26jtitle%3DCurr.%2520Microwave%2520Chem.%26date%3D2014%26volume%3D1%26spage%3D75%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlan, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberstadt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuker, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minn, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1126%2Fscience.275.5302.983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=9020082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK2sXht1CqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=983-986&author=M.+Sattlerauthor=H.+Liangauthor=D.+Nettesheimauthor=R.+P.+Meadowsauthor=J.+E.+Harlanauthor=M.+Eberstadtauthor=H.+S.+Yoonauthor=S.+B.+Shukerauthor=B.+S.+Changauthor=A.+J.+Minnauthor=C.+B.+Thompsonauthor=S.+W.+Fesik&title=Structure+of+Bcl-xL-Bak+peptide+complex%3A+recognition+between+regulators+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis</span></div><div class="casAuthors">Sattler, Michael; Liang, Heng; Nettesheim, David; Meadows, Robert P.; Harlan, John E.; Eberstadt, Matthias; Yoon, Ho Sup; Shuker, Suzanne B.; Chang, Brian S.; Minn, Andy J.; Thompson, Craig B.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5302</span>),
    <span class="NLM_cas:pages">983-986</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Heterodimerization between members of the Bcl-2 family of proteins is a key event in the regulation of programmed cell death.  The mol. basis for heterodimer formation was investigated by detn. of the soln. structure of a complex between the survival protein Bcl-xL and the death-promoting region of the Bcl-2-related protein Bak.  The structure and binding affinities of mutant Bak peptides indicate that the Bak peptide adopts an amphipathic α helix that interacts with Bcl-xL through hydrophobic and electrostatic interactions.  Mutations in full-length Bak that disrupt either type of interaction inhibit the ability of Bak to heterodimerize with Bcl-xL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCI9cZE3QkJ7Vg90H21EOLACvtfcHk0lhTFbMXy7-c1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1CqtL8%253D&md5=352e09341d74c0b0531a0ebf08230efb</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5302.983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5302.983%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DHarlan%26aufirst%3DJ.%2BE.%26aulast%3DEberstadt%26aufirst%3DM.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DChang%26aufirst%3DB.%2BS.%26aulast%3DMinn%26aufirst%3DA.%2BJ.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructure%2520of%2520Bcl-xL-Bak%2520peptide%2520complex%253A%2520recognition%2520between%2520regulators%2520of%2520apoptosis%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D983%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutzki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=278-281&author=J.+T.+Ernstauthor=O.+Kutzkiauthor=A.+K.+Debnathauthor=S.+Jiangauthor=H.+Luauthor=A.+D.+Hamilton&title=Design+of+a+protein+surface+antagonist+based+on+alpha-helix+mimicry%3A+inhibition+of+gp41+assembly+and+viral+fusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DKutzki%26aufirst%3DO.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DDesign%2520of%2520a%2520protein%2520surface%2520antagonist%2520based%2520on%2520alpha-helix%2520mimicry%253A%2520inhibition%2520of%2520gp41%2520assembly%2520and%2520viral%2520fusion%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D278%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Kutzki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orner, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">11838</span><span class="NLM_x">–</span> <span class="NLM_lpage">11839</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja026861k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=11838-11839&author=O.+Kutzkiauthor=H.+S.+Parkauthor=J.+T.+Ernstauthor=B.+P.+Ornerauthor=H.+Yinauthor=A.+D.+Hamilton&title=Development+of+a+potent+Bcl-x%28L%29+antagonist+based+on+alpha-helix+mimicry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja026861k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja026861k%26sid%3Dliteratum%253Aachs%26aulast%3DKutzki%26aufirst%3DO.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DOrner%26aufirst%3DB.%2BP.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520potent%2520Bcl-x%2528L%2529%2520antagonist%2520based%2520on%2520alpha-helix%2520mimicry%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D11838%26epage%3D11839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Orner, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Toward proteomimetics: Terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helix</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">5382</span><span class="NLM_x">–</span> <span class="NLM_lpage">5383</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0025548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=5382-5383&author=B.+P.+Ornerauthor=J.+T.+Ernstauthor=A.+D.+Hamilton&title=Toward+proteomimetics%3A+Terphenyl+derivatives+as+structural+and+functional+mimics+of+extended+regions+of+an+alpha-helix"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja0025548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0025548%26sid%3Dliteratum%253Aachs%26aulast%3DOrner%26aufirst%3DB.%2BP.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DToward%2520proteomimetics%253A%2520Terphenyl%2520derivatives%2520as%2520structural%2520and%2520functional%2520mimics%2520of%2520extended%2520regions%2520of%2520an%2520alpha-helix%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D5382%26epage%3D5383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Saraogi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">alpha-Helix mimetics as inhibitors of protein-protein interactions</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1414</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1042%2FBST0361414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=19021566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCgsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=1414-1417&author=I.+Saraogiauthor=A.+D.+Hamilton&title=alpha-Helix+mimetics+as+inhibitors+of+protein-protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">α-Helix mimetics as inhibitors of protein-protein interactions</span></div><div class="casAuthors">Saraogi, Ishu; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1414-1417</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The inhibition of protein-protein interactions using small mols. is a viable approach for the treatment of a range of pathol. conditions that result from a malfunctioning of these interactions.  Our strategy for the design of such agents involves the mimicry of side-chain residues on one face of the α-helix; these residues frequently play a key role in mediating protein-protein interactions.  The first-generation terphenyl scaffold, with a 3,2',2''-substitution pattern, is able to successfully mimic key helix residues and disrupt therapeutically relevant interactions, including the Bcl-XL-Bak and the p53-hDM2 (human double minute 2) interactions that are implicated in cancer.  The second- and third-generation scaffolds have resulted in greater synthetic accessibility and more drug-like character in these mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNfqRdM67vrVg90H21EOLACvtfcHk0lhTFbMXy7-c1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCgsb3P&md5=0cc8778ddb2529e3b1188291f7ab074d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2FBST0361414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0361414%26sid%3Dliteratum%253Aachs%26aulast%3DSaraogi%26aufirst%3DI.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3Dalpha-Helix%2520mimetics%2520as%2520inhibitors%2520of%2520protein-protein%2520interactions%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2008%26volume%3D36%26spage%3D1414%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutzki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orner, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Terphenyl-Based Bak BH3 α-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">10191</span><span class="NLM_x">–</span> <span class="NLM_lpage">10196</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja050122x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=10191-10196&author=H.+Yinauthor=G.+I.+Leeauthor=K.+A.+Sedeyauthor=O.+Kutzkiauthor=H.+S.+Parkauthor=B.+P.+Ornerauthor=J.+T.+Ernstauthor=H.+G.+Wangauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Terphenyl-Based+Bak+BH3+%CE%B1-helical+proteomimetics+as+low-molecular-weight+antagonists+of+Bcl-xL"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fja050122x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja050122x%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DG.%2BI.%26aulast%3DSedey%26aufirst%3DK.%2BA.%26aulast%3DKutzki%26aufirst%3DO.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DOrner%26aufirst%3DB.%2BP.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DH.%2BG.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DTerphenyl-Based%2520Bak%2520BH3%2520%25CE%25B1-helical%2520proteomimetics%2520as%2520low-molecular-weight%2520antagonists%2520of%2520Bcl-xL%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D10191%26epage%3D10196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">Development of small molecules designed to modulate protein-protein interactions</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1007%2Fs10822-006-9040-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=16622794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVGru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=109-130&author=Y.+Cheauthor=B.+R.+Brooksauthor=G.+R.+Marshall&title=Development+of+small+molecules+designed+to+modulate+protein-protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development of small molecules designed to modulate protein-protein interactions</span></div><div class="casAuthors">Che, Ye; Brooks, Bernard R.; Marshall, Garland R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-130</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions are ubiquitous, essential to almost all known biol. processes, and offer attractive opportunities for therapeutic intervention.  Developing small mols. that modulate protein-protein interactions is challenging, owing to the large size of protein-complex interface, the lack of well-defined binding pockets, etc.  We describe a general approach based on the privileged-structure hypothesis, that any org. templates capable of mimicking surfaces of protein-recognition motifs are potential privileged scaffolds as protein-complex antagonists, to address the challenges inherent in the discovery of small-mol. inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFX3Hyurwum7Vg90H21EOLACvtfcHk0ljAOJTSv95hfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVGru70%253D&md5=62c15674695b88bb25335363a991bdc1</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs10822-006-9040-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-006-9040-8%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DY.%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DDevelopment%2520of%2520small%2520molecules%2520designed%2520to%2520modulate%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2006%26volume%3D20%26spage%3D109%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Frank, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldkamp, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelz, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangamudi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camper, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossanese, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9242</span><span class="NLM_x">–</span> <span class="NLM_lpage">9250</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401333u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9242-9250&author=A.+O.+Frankauthor=M.+D.+Feldkampauthor=J.+P.+Kennedyauthor=A.+G.+Watersonauthor=N.+F.+Pelzauthor=J.+D.+Patroneauthor=B.+Vangamudiauthor=D.+V.+Camperauthor=O.+W.+Rossaneseauthor=W.+J.+Chazinauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+replication+protein+a+protein-protein+interactions+using+a+fragment-linking+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions Using a Fragment-Linking Approach</span></div><div class="casAuthors">Frank, Andreas O.; Feldkamp, Michael D.; Kennedy, J. Phillip; Waterson, Alex G.; Pelz, Nicholas F.; Patrone, James D.; Vangamudi, Bhavatarini; Camper, DeMarco V.; Rossanese, Olivia W.; Chazin, Walter J.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9242-9250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Replication protein A (RPA), the major eukaryotic single-stranded DNA (ssDNA)-binding protein, is involved in nearly all cellular DNA transactions.  The RPA N-terminal domain (RPA70N) is a recruitment site for proteins involved in DNA-damage response and repair.  Selective inhibition of these protein-protein interactions has the potential to inhibit the DNA-damage response and to sensitize cancer cells to DNA-damaging agents without affecting other functions of RPA.  To discover a potent, selective inhibitor of the RPA70N protein-protein interactions to test this hypothesis, we used NMR spectroscopy to identify fragment hits that bind to two adjacent sites in the basic cleft of RPA70N.  High-resoln. X-ray crystal structures of RPA70N-ligand complexes revealed how these fragments bind to RPA and guided the design of linked compds. that simultaneously occupy both sites.  We have synthesized linked mols. that bind to RPA70N with submicromolar affinity and minimal disruption of RPA's interaction with ssDNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgZEDSY6TA3rVg90H21EOLACvtfcHk0ljAOJTSv95hfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL&md5=ee3a60f76302dcb30fec7d88a1a386c5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm401333u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401333u%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DFeldkamp%26aufirst%3DM.%2BD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DPelz%26aufirst%3DN.%2BF.%26aulast%3DPatrone%26aufirst%3DJ.%2BD.%26aulast%3DVangamudi%26aufirst%3DB.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520replication%2520protein%2520a%2520protein-protein%2520interactions%2520using%2520a%2520fragment-linking%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9242%26epage%3D9250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Shamas-Din, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">Mechanisms of action of Bcl-2 family proteins</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_elocation-id">a008714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1101%2Fcshperspect.a008714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23545417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVKltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&author=A.+Shamas-Dinauthor=J.+Kaleauthor=B.+Leberauthor=D.+W.+Andrews&title=Mechanisms+of+action+of+Bcl-2+family+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of Bcl-2 family proteins</span></div><div class="casAuthors">Shamas-Din, Aisha; Kale, Justin; Leber, Brian; Andrews, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">a008714/1-a008714/21</span>CODEN:
                <span class="NLM_cas:coden">CSHPEU</span>;
        ISSN:<span class="NLM_cas:issn">1943-0264</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The Bcl-2 family of proteins controls a crit. step in commitment to apoptosis by regulating permeabilization of the mitochondrial outer membrane (MOM).  The family is divided into three classes: multiregion proapoptotic proteins that directly permeabilize the MOM; BH3 proteins that directly or indirectly activate the pore-forming class members; and the anti-apoptotic proteins that inhibit this process at several steps.  Different exptl. approaches have led to several models, each proposed to explain the interactions between Bcl-2 family proteins.  The discovery that many of these interactions occur at or in membranes as well as in the cytoplasm, and are governed by the concns. and relative binding affinities of the proteins, provides a new basis for rationalizing these models.  Furthermore, these dynamic interactions cause conformational changes in the Bcl-2 proteins that modulate their apoptotic function, providing addnl. potential modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO2OO_FgbxvbVg90H21EOLACvtfcHk0ljBuZLLKqlPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVKltb8%253D&md5=2f1ac863d45aa71d76b116c288eacae5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a008714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a008714%26sid%3Dliteratum%253Aachs%26aulast%3DShamas-Din%26aufirst%3DA.%26aulast%3DKale%26aufirst%3DJ.%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DMechanisms%2520of%2520action%2520of%2520Bcl-2%2520family%2520proteins%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2013%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Vo, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gree, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=286-293&author=D.+D.+Voauthor=F.+Gautierauthor=P.+Juinauthor=R.+Gree&title=Structure-activity+relationship+of+selected+polyphenol+derivatives+as+inhibitors+of+Bax%2FBcl-xL+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVo%26aufirst%3DD.%2BD.%26aulast%3DGautier%26aufirst%3DF.%26aulast%3DJuin%26aufirst%3DP.%26aulast%3DGree%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520of%2520selected%2520polyphenol%2520derivatives%2520as%2520inhibitors%2520of%2520Bax%252FBcl-xL%2520interaction%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Albershardt, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerni, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderquist, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletnev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, A.</span><span> </span><span class="NLM_article-title">Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">24882</span><span class="NLM_x">–</span> <span class="NLM_lpage">24895</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=24882-24895&author=T.+C.+Albershardtauthor=B.+L.+Salerniauthor=R.+S.+Soderquistauthor=D.+J.+Batesauthor=A.+A.+Pletnevauthor=A.+F.+Kisselevauthor=A.+Eastman&title=Multiple+BH3+mimetics+antagonize+antiapoptotic+MCL1+protein+by+inducing+the+endoplasmic+reticulum+stress+response+and+up-regulating+BH3-only+protein+NOXA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlbershardt%26aufirst%3DT.%2BC.%26aulast%3DSalerni%26aufirst%3DB.%2BL.%26aulast%3DSoderquist%26aufirst%3DR.%2BS.%26aulast%3DBates%26aufirst%3DD.%2BJ.%26aulast%3DPletnev%26aufirst%3DA.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DEastman%26aufirst%3DA.%26atitle%3DMultiple%2520BH3%2520mimetics%2520antagonize%2520antiapoptotic%2520MCL1%2520protein%2520by%2520inducing%2520the%2520endoplasmic%2520reticulum%2520stress%2520response%2520and%2520up-regulating%2520BH3-only%2520protein%2520NOXA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D24882%26epage%3D24895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Risberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodstad, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, Y.</span><span> </span><span class="NLM_article-title">Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_elocation-id">e24012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=K.+Risbergauthor=O.+Fodstadauthor=Y.+Andersson&title=Synergistic+anticancer+effects+of+the+9.2.27PE+immunotoxin+and+ABT-737+in+melanoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisberg%26aufirst%3DK.%26aulast%3DFodstad%26aufirst%3DO.%26aulast%3DAndersson%26aufirst%3DY.%26atitle%3DSynergistic%2520anticancer%2520effects%2520of%2520the%25209.2.27PE%2520immunotoxin%2520and%2520ABT-737%2520in%2520melanoma%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Rodriguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rivera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetz, C.</span><span> </span><span class="NLM_article-title">Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1813</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1813&publication_year=2011&pages=564-574&author=D.+Rodriguezauthor=D.+Rojas-Riveraauthor=C.+Hetz&title=Integrating+stress+signals+at+the+endoplasmic+reticulum%3A+The+BCL-2+protein+family+rheostat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DD.%26aulast%3DRojas-Rivera%26aufirst%3DD.%26aulast%3DHetz%26aufirst%3DC.%26atitle%3DIntegrating%2520stress%2520signals%2520at%2520the%2520endoplasmic%2520reticulum%253A%2520The%2520BCL-2%2520protein%2520family%2520rheostat%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1813%26spage%3D564%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Rodriguez, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisbona, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rivera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubillos-Ruiz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armisen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriquez, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irrazabal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Billault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimentel-Muinos, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetz, C.</span><span> </span><span class="NLM_article-title">BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1alpha</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2322</span><span class="NLM_x">–</span> <span class="NLM_lpage">2335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2322-2335&author=D.+A.+Rodriguezauthor=S.+Zamoranoauthor=F.+Lisbonaauthor=D.+Rojas-Riveraauthor=H.+Urraauthor=J.+R.+Cubillos-Ruizauthor=R.+Armisenauthor=D.+R.+Henriquezauthor=E.+H.+Chengauthor=M.+Letekauthor=T.+Vaisarauthor=T.+Irrazabalauthor=C.+Gonzalez-Billaultauthor=A.+Letaiauthor=F.+X.+Pimentel-Muinosauthor=G.+Kroemerauthor=C.+Hetz&title=BH3-only+proteins+are+part+of+a+regulatory+network+that+control+the+sustained+signalling+of+the+unfolded+protein+response+sensor+IRE1alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DD.%2BA.%26aulast%3DZamorano%26aufirst%3DS.%26aulast%3DLisbona%26aufirst%3DF.%26aulast%3DRojas-Rivera%26aufirst%3DD.%26aulast%3DUrra%26aufirst%3DH.%26aulast%3DCubillos-Ruiz%26aufirst%3DJ.%2BR.%26aulast%3DArmisen%26aufirst%3DR.%26aulast%3DHenriquez%26aufirst%3DD.%2BR.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DLetek%26aufirst%3DM.%26aulast%3DVaisar%26aufirst%3DT.%26aulast%3DIrrazabal%26aufirst%3DT.%26aulast%3DGonzalez-Billault%26aufirst%3DC.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DPimentel-Muinos%26aufirst%3DF.%2BX.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DHetz%26aufirst%3DC.%26atitle%3DBH3-only%2520proteins%2520are%2520part%2520of%2520a%2520regulatory%2520network%2520that%2520control%2520the%2520sustained%2520signalling%2520of%2520the%2520unfolded%2520protein%2520response%2520sensor%2520IRE1alpha%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2322%26epage%3D2335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Jiang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery-Kiejda, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deBock, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. D.</span><span> </span><span class="NLM_article-title">Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6708</span><span class="NLM_x">–</span> <span class="NLM_lpage">6717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=6708-6717&author=C.+C.+Jiangauthor=K.+Lucasauthor=K.+A.+Avery-Kiejdaauthor=M.+Wadeauthor=C.+E.+deBockauthor=R.+F.+Thorneauthor=J.+Allenauthor=P.+Herseyauthor=X.+D.+Zhang&title=Up-regulation+of+Mcl-1+is+critical+for+survival+of+human+melanoma+cells+upon+endoplasmic+reticulum+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.%2BC.%26aulast%3DLucas%26aufirst%3DK.%26aulast%3DAvery-Kiejda%26aufirst%3DK.%2BA.%26aulast%3DWade%26aufirst%3DM.%26aulast%3DdeBock%26aufirst%3DC.%2BE.%26aulast%3DThorne%26aufirst%3DR.%2BF.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DHersey%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%2BD.%26atitle%3DUp-regulation%2520of%2520Mcl-1%2520is%2520critical%2520for%2520survival%2520of%2520human%2520melanoma%2520cells%2520upon%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D6708%26epage%3D6717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">e52333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=H.+Zhuauthor=W.+Yangauthor=L.+J.+Heauthor=W.+J.+Dingauthor=L.+Zhengauthor=S.+D.+Liaoauthor=P.+Huangauthor=W.+Luauthor=Q.+J.+Heauthor=B.+Yang&title=Upregulating+Noxa+by+ER+stress%2C+celastrol+exerts+synergistic+anti-cancer+activity+in+combination+with+ABT-737+in+human+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DL.%2BJ.%26aulast%3DDing%26aufirst%3DW.%2BJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DS.%2BD.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DQ.%2BJ.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DUpregulating%2520Noxa%2520by%2520ER%2520stress%252C%2520celastrol%2520exerts%2520synergistic%2520anti-cancer%2520activity%2520in%2520combination%2520with%2520ABT-737%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serfass, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy Madiraju, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viallet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acoca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purisima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegmans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauparlant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. C.</span><span> </span><span class="NLM_article-title">Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">19512</span><span class="NLM_x">–</span> <span class="NLM_lpage">19517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1073%2Fpnas.0709443104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=18040043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19512-19517&author=M.+Nguyenauthor=R.+C.+Marcellusauthor=A.+Roulstonauthor=M.+Watsonauthor=L.+Serfassauthor=S.+R.+Murthy+Madirajuauthor=D.+Gouletauthor=J.+Vialletauthor=L.+Belecauthor=X.+Billotauthor=S.+Acocaauthor=E.+Purisimaauthor=A.+Wiegmansauthor=L.+Cluseauthor=R.+W.+Johnstoneauthor=P.+Beauparlantauthor=G.+C.+Shore&title=Small+molecule+obatoclax+%28GX15-070%29+antagonizes+MCL-1+and+overcomes+MCL-1-mediated+resistance+to+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis</span></div><div class="casAuthors">Nguyen, Mai; Marcellus, Richard C.; Roulston, Anne; Watson, Mark; Serfass, Lucile; Madiraju, S. R. Murthy; Goulet, Daniel; Viallet, Jean; Belec, Laurent; Billot, Xavier; Acoca, Stephane; Purisima, Enrico; Wiegmans, Adrian; Cluse, Leonie; Johnstone, Ricky W.; Beauparlant, Pierre; Shore, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19512-19517</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elevated expression of members of the BCL-2 pro-survival family of proteins can confer resistance to apoptosis in cancer cells.  Small mol. obatoclax (GX15-070), which is predicted to occupy a hydrophobic pocket within the BH3 binding groove of BCL-2, antagonizes these members and induces apoptosis, dependent on BAX and BAK.  Reconstitution in yeast confirmed that obatoclax acts on the pathway and overcomes BCL-2-, BCL-XL-, BCL-w-, and MCL-1-mediated resistance to BAX or BAK.  The compd. potently interfered with the direct interaction between MCL-1 and BAK in intact mitochondrial outer membrane and inhibited the assocn. between MCL-1 and BAK in intact cells.  MCL-1 has been shown to confer resistance to the BCL-2/BCL-XL/BCL-w-selective antagonist ABT-737 and to the proteasome inhibitor bortezomib.  In both cases, this resistance was overcome by obatoclax.  These findings support a rational clin. development opportunity for the compd. in cancer indications or treatments where MCL-1 contributes to resistance to cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrngkiYbISvrbVg90H21EOLACvtfcHk0lgeBSijGmI1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVOgsA%253D%253D&md5=e502d448c92c39cca482744b8c8ab7b1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709443104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709443104%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DMarcellus%26aufirst%3DR.%2BC.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DSerfass%26aufirst%3DL.%26aulast%3DMurthy%2BMadiraju%26aufirst%3DS.%2BR.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DViallet%26aufirst%3DJ.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DAcoca%26aufirst%3DS.%26aulast%3DPurisima%26aufirst%3DE.%26aulast%3DWiegmans%26aufirst%3DA.%26aulast%3DCluse%26aufirst%3DL.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DBeauparlant%26aufirst%3DP.%26aulast%3DShore%26aufirst%3DG.%2BC.%26atitle%3DSmall%2520molecule%2520obatoclax%2520%2528GX15-070%2529%2520antagonizes%2520MCL-1%2520and%2520overcomes%2520MCL-1-mediated%2520resistance%2520to%2520apoptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19512%26epage%3D19517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamed, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruickshanks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span> </span><span class="NLM_article-title">Obatoclax and lapatinib interact to induce toxic autophagy through NOXA</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=527-540&author=Y.+Tangauthor=H.+A.+Hamedauthor=N.+Cruickshanksauthor=P.+B.+Fisherauthor=S.+Grantauthor=P.+Dent&title=Obatoclax+and+lapatinib+interact+to+induce+toxic+autophagy+through+NOXA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHamed%26aufirst%3DH.%2BA.%26aulast%3DCruickshanks%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DDent%26aufirst%3DP.%26atitle%3DObatoclax%2520and%2520lapatinib%2520interact%2520to%2520induce%2520toxic%2520autophagy%2520through%2520NOXA%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D527%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">Phase Annealing in SHELX-90: Direct Methods for Larger Structures</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">A46</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A46&publication_year=1990&pages=467-473&author=G.+M.+Sheldrick&title=Phase+Annealing+in+SHELX-90%3A+Direct+Methods+for+Larger+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DPhase%2520Annealing%2520in%2520SHELX-90%253A%2520Direct%2520Methods%2520for%2520Larger%2520Structures%26jtitle%3DActa%2520Crystallogr.%26date%3D1990%26volume%3DA46%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">A64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lgeBSijGmI1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=7823319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor+sites+using+a+genetic+algorithm+with+a+description+of+desolvation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Understanding the principles whereby macromol. biol. receptors can recognize small mol. substrates or inhibitors is the subject of a major effort.  This is of paramount importance in rational drug design where the receptor structure is known (the "docking" problem).  Current theor. approaches utilize models of the steric and electrostatic interaction of bound ligands and recently conformational flexibility has been incorporated.  The authors report results based on software using a genetic algorithm that uses an evolutionary strategy in exploring the full conformational flexibility of the ligand with partial flexibility of the protein, and which satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Results are reported on five test systems showing excellent agreement with exptl. data.  The design of the algorithm offers insight into the mol. recognition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Xcn7nQyVRLVg90H21EOLACvtfcHk0lgeBSijGmI1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D&md5=bf45edafb986a73c7c1d0ac55e070f28</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor%2520sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgEtevwzTgx5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span>Discovery Studio, version 3.0.0.10321; <span class="NLM_publisher-name">Accelrys Software Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discovery+Studio%2C+version+3.0.0.10321%3B+Accelrys+Software+Inc.%3A+San+Diego%2C+CA%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26pub%3DAccelrys%2520Software%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruccoleri, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olafson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">States, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2Fjcc.54004021110.1002%2Fjcc.540040211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaL3sXit1aiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=187-217&author=B.+R.+Brooksauthor=R.+E.+Bruccoleriauthor=B.+D.+Olafsonauthor=D.+J.+Statesauthor=S.+Swaminathanauthor=M.+Karplus&title=CHARMM%3A+A+Program+for+Macromolecular+Energy%2C+Minimization%2C+and+Dynamics+Calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">CHARMM:  a program for macromolecular energy, minimization, and dynamics calculations</span></div><div class="casAuthors">Brooks, Bernard R.; Bruccoleri, Robert E.; Olafson, Barry D.; States, David J.; Swaminathan, S.; Karplus, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-217</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    </div><div class="casAbstract">CHARMM (Chem. at HARvard Macromol. Mechanics) is a highly flexible computer program which uses empirical energy functions to model macromol. systems.  The program can read or model build structures, energy minimize them by first- or second-deriv. techniques, perform a normal mode or mol. dynamics simulation, and analyze the structural, equil., and dynamic properties detd. in these calcns.  The operations that CHARMM can perform are described, and some implementation details are given.  A set of parameters for the empirical energy function and a sample run are included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBSFuoT3w87LVg90H21EOLACvtfcHk0lgEtevwzTgx5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXit1aiu7w%253D&md5=bd639b4299ac9934f4497c1a9fe750d2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2Fjcc.54004021110.1002%2Fjcc.540040211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.54004021110.1002%252Fjcc.540040211%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBruccoleri%26aufirst%3DR.%2BE.%26aulast%3DOlafson%26aufirst%3DB.%2BD.%26aulast%3DStates%26aufirst%3DD.%2BJ.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCHARMM%253A%2520A%2520Program%2520for%2520Macromolecular%2520Energy%252C%2520Minimization%252C%2520and%2520Dynamics%2520Calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1983%26volume%3D4%26spage%3D187%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madura, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. L.</span><span> </span><span class="NLM_article-title">Comparison of simple potential functions for simulating liquid water</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1063%2F1.445869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1983&pages=926-935&author=W.+L.+Jorgensenauthor=J.+Chandrasekharauthor=J.+D.+Maduraauthor=R.+W.+Impeyauthor=M.+L.+Klein&title=Comparison+of+simple+potential+functions+for+simulating+liquid+water"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of simple potential functions for simulating liquid water</span></div><div class="casAuthors">Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.; Impey, Roger W.; Klein, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">926-35</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">Classical Monte Carlo simulations were carried out for liq. H2O in the NPT ensemble at 25° and 1 atm using 6 of the simpler intermol. potential functions for the dimer.  Comparisons were made with exptl. thermodn. and structural data including the neutron diffraction results of Thiessen and Narten (1982).  The computed densities and potential energies agree with expt. except for the original Bernal-Fowler model, which yields an 18% overest. of the d. and poor structural results.  The discrepancy may be due to the correction terms needed in processing the neutron data or to an effect uniformly neglected in the computations.  Comparisons were made for the self-diffusion coeffs. obtained from mol. dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4QUFMvwYFrVg90H21EOLACvtfcHk0lgEtevwzTgx5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D&md5=a1161334e381746be8c9b15a5e56f704</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1063%2F1.445869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.445869%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DImpey%26aufirst%3DR.%2BW.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26atitle%3DComparison%2520of%2520simple%2520potential%2520functions%2520for%2520simulating%2520liquid%2520water%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1983%26volume%3D79%26spage%3D926%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Jo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, W.</span><span> </span><span class="NLM_article-title">CHARMM-GUI: A web-based graphical user interface for CHARMM</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2Fjcc.20945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=18351591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVKksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1859-1865&author=S.+Joauthor=T.+Kimauthor=V.+G.+Iyerauthor=W.+Im&title=CHARMM-GUI%3A+A+web-based+graphical+user+interface+for+CHARMM"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">CHARMM-GUI: a web-based graphical user interface for CHARMM</span></div><div class="casAuthors">Jo, Sunhwan; Kim, Taehoon; Iyer, Vidyashankara G.; Im, Wonpil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1859-1865</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">CHARMM is an academic research program used widely for macromol. mechanics and dynamics with versatile anal. and manipulation tools of at. coordinates and dynamics trajectories.  CHARMM-GUI, http://www.charmm-gui.org, has been developed to provide a web-based graphical user interface to generate various input files and mol. systems to facilitate and standardize the usage of common and advanced simulation techniques in CHARMM.  The web environment provides an ideal platform to build and validate a mol. model system in an interactive fashion such that, if a problem is found through visual inspection, one can go back to the previous setup and regenerate the whole system again.  In this article, we describe the currently available functional modules of CHARMM-GUI Input Generator that form a basis for the advanced simulation techniques.  Future directions of the CHARMM-GUI development project are also discussed briefly together with other features in the CHARMM-GUI website, such as Archive and Movie Gallery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gpU-1N3WOLVg90H21EOLACvtfcHk0ljDPS3k111lNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVKksbc%253D&md5=112a3dd61d792b040f9f716b32220d7e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20945%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DIyer%26aufirst%3DV.%2BG.%26aulast%3DIm%26aufirst%3DW.%26atitle%3DCHARMM-GUI%253A%2520A%2520web-based%2520graphical%2520user%2520interface%2520for%2520CHARMM%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2008%26volume%3D29%26spage%3D1859%26epage%3D1865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span>CHARMM-GUI.<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CHARMM-GUI.+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Poulain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duigou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deslandes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sichel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staedel, C.</span><span> </span><span class="NLM_article-title">Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2F%28SICI%291097-0215%2819981109%2978%3A4%3C454%3A%3AAID-IJC11%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=9797134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK1cXnsVShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=454-463&author=L.+Poulainauthor=H.+Lincetauthor=F.+Duigouauthor=E.+Deslandesauthor=F.+Sichelauthor=P.+Gauduchonauthor=C.+Staedel&title=Acquisition+of+chemoresistance+in+a+human+ovarian+carcinoma+cell+is+linked+to+a+defect+in+cell+cycle+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control</span></div><div class="casAuthors">Poulain, Laurent; Lincet, Hubert; Duigou, Franmoise; Deslandes, Edwige; Sichel, Francois; Gauduchon, Pascal; Staedeli, Cathy</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">454-463</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Chemoresistance is a major concern in cancer eradication; it involves various mechanisms, including defects in the apoptosis program induced by anticancer drugs.  In order to further explore the mechanisms underlying the development of chemoresistance in ovarian carcinoma after cisplatin treatment, we established an in vitro model, mimicking a clin. protocol of administration of cisplatin.  Therefore, IGROVI ovarian carcinoma cells were exposed for 2 h to the drug and allowed to recover for several weeks; this way of exposure was reiterated with escalating doses.  We followed changes in cytotoxicity of the drug, cell cycle kinetics and long-term survival of cells after cisplatin treatment, and found that resistance to cisplatin was not assocd. with altered apoptosis pathway, since both cisplatin sensitive and resistant cells underwent apoptosis in a similar way.  Acquisition of resistance to cisplatin was assocd. with the ability of the treated cells to progress through the cell cycle beyond the G1/S checkpoint; although most cells died by apoptosis, a few surviving cells proliferated and recolonized the cultures.  Compared to sensitive cells, the chemoresistant variants were able to override the G1S checkpoint whatever the dose, and the recurrent cells recolonized the cultures much faster.  Anal. of alterations in gene expression suggests that the defect in cell cycle regulation could take place at the level of the cdk inhibitor p21CIPI/WAFI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXebK_Xo1LmLVg90H21EOLACvtfcHk0ljDPS3k111lNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsVShtbg%253D&md5=b717c616e231b5b127177bbe0da8f9ce</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819981109%2978%3A4%3C454%3A%3AAID-IJC11%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819981109%252978%253A4%253C454%253A%253AAID-IJC11%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DPoulain%26aufirst%3DL.%26aulast%3DLincet%26aufirst%3DH.%26aulast%3DDuigou%26aufirst%3DF.%26aulast%3DDeslandes%26aufirst%3DE.%26aulast%3DSichel%26aufirst%3DF.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DStaedel%26aufirst%3DC.%26atitle%3DAcquisition%2520of%2520chemoresistance%2520in%2520a%2520human%2520ovarian%2520carcinoma%2520cell%2520is%2520linked%2520to%2520a%2520defect%2520in%2520cell%2520cycle%2520control%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1998%26volume%3D78%26spage%3D454%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Villedieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutoit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duigou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staedel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.ygyno.2006.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17275076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVemsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=31-44&author=M.+Villedieuauthor=M.+H.+Louisauthor=S.+Dutoitauthor=E.+Brotinauthor=H.+Lincetauthor=F.+Duigouauthor=C.+Staedelauthor=P.+Gauduchonauthor=L.+Poulain&title=Absence+of+Bcl-xL+down-regulation+in+response+to+cisplatin+is+associated+with+chemoresistance+in+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells</span></div><div class="casAuthors">Villedieu, M.; Louis, M.-H.; Dutoit, S.; Brotin, E.; Lincet, H.; Duigou, F.; Staedel, C.; Gauduchon, P.; Poulain, L.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-44</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recurrence and subsequent acquired chemoresistance to platinum-based treatments constitute major hurdles to ovarian carcinoma therapy.  Our objective was to examine the involvement of Bcl-xL anti-apoptotic protein in resistance to cisplatin.  We described the effect of cisplatin on cell cycle and apoptosis induction in sensitive (IGROV1 and OAW42) and resistant (IGROV1-R10 and SKOV3) ovarian carcinoma cell lines.  We correlated it with Bcl-xL mRNA and protein expression after exposure to cisplatin.  We then used bcl-xS gene transfer to impede Bcl-xL activity.  Our study showed that Bcl-xL basal expression was high in both sensitive and resistant cell lines, as well as in all the studied ovarian tumor samples.  Thus, Bcl-xL basal expression could not allow to predict sensitivity.  Wondering whether variation of Bcl-xL level in response to cisplatin could be a better determinant of sensitivity, we investigated the expression of this protein in the cell lines after treatment.  Cisplatin-induced down-regulation of Bcl-xL was strictly assocd. with apoptosis and absence of recurrence in vitro.  Conversely, the maintenance of Bcl-xL expression in response to cisplatin appeared as a sine qua non condition to escape to treatment.  To try to sensitize SKOV3 cells by impeding anti-apoptotic activity of Bcl-xL, we transfected bcl-x S gene in these cells.  Bcl-xS exogenous expression was only slightly cytotoxic on its own, but highly sensitized SKOV3 resistant cells to cisplatin-induced apoptosis, and delayed recurrence.  This work thus provides one more argument to put Bcl-xL forward as a pertinent target of inhibition to overcome chemoresistance of epithelial ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8kPhvixR8qLVg90H21EOLACvtfcHk0ljDPS3k111lNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVemsbg%253D&md5=2d69f78bd609ba4b49143dfe83e8d3d2</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2006.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2006.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DVilledieu%26aufirst%3DM.%26aulast%3DLouis%26aufirst%3DM.%2BH.%26aulast%3DDutoit%26aufirst%3DS.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DLincet%26aufirst%3DH.%26aulast%3DDuigou%26aufirst%3DF.%26aulast%3DStaedel%26aufirst%3DC.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DAbsence%2520of%2520Bcl-xL%2520down-regulation%2520in%2520response%2520to%2520cisplatin%2520is%2520associated%2520with%2520chemoresistance%2520in%2520ovarian%2520carcinoma%2520cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2007%26volume%3D105%26spage%3D31%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Terrillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayoub, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taulan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jockers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1210%2Fme.2002-0222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=12554793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=677-691&author=S.+Terrillonauthor=T.+Durrouxauthor=B.+Mouillacauthor=A.+Breitauthor=M.+A.+Ayoubauthor=M.+Taulanauthor=R.+Jockersauthor=C.+Barberisauthor=M.+Bouvier&title=Oxytocin+and+vasopressin+V1a+and+V2+receptors+form+constitutive+homo-+and+heterodimers+during+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis</span></div><div class="casAuthors">Terrillon, Sonia; Durroux, Thierry; Mouillac, Bernard; Breit, Andreas; Ayoub, Mohammed A.; Taulan, Magali; Jockers, Ralf; Barberis, Claude; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">677-691</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">G protein-coupled receptor (GPCR) oligomerization is a growing concept that has emerged from several studies suggesting that GPCRs can form both homo- and heterodimers.  Using both co-immunopptn. and bioluminescence resonance energy transfer (BRET) approaches, we established that the vasopressin V1a, V2, and the oxytocin receptors exist as homo- and heterodimers in transfected human embryonic kidney 293T cells.  Each receptor protomer had a similar propensity to form homo- and heterodimers, indicating that their relative expression levels may det. the homo-/heterodimer ratio.  The finding that immature forms of the receptor can be immunopptd. as homo- and heterodimers and the detection by BRET of such oligomer in endoplasmic reticulum-enriched fractions suggest that the oligomerization processes take place early during biosynthesis.  Treatment with agonists or antagonists did not modify the BRET among any of the vasopressin and oxytocin receptor pairs studied, indicating that the dimerization state of the receptors is not regulated by ligand binding once they have reached the cell surface.  Taken together, these results strongly support the notion that GPCR dimerization is a constitutive process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpffNYKIGDTibVg90H21EOLACvtfcHk0lgRlCYtzF70-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCksro%253D&md5=cc0bb2c4aa80353db10ad75c36388d2a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0222%26sid%3Dliteratum%253Aachs%26aulast%3DTerrillon%26aufirst%3DS.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBreit%26aufirst%3DA.%26aulast%3DAyoub%26aufirst%3DM.%2BA.%26aulast%3DTaulan%26aufirst%3DM.%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520vasopressin%2520V1a%2520and%2520V2%2520receptors%2520form%2520constitutive%2520homo-%2520and%2520heterodimers%2520during%2520biosynthesis%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D677%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Ke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abassi, Y. A.</span><span> </span><span class="NLM_article-title">The xCELLigence system for real-time and label-free monitoring of cell viability</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">740</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1007%2F978-1-61779-108-6_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=21468966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFylur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=740&publication_year=2011&pages=33-43&author=N.+Keauthor=X.+Wangauthor=X.+Xuauthor=Y.+A.+Abassi&title=The+xCELLigence+system+for+real-time+and+label-free+monitoring+of+cell+viability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The xCELLigence system for real-time and label-free monitoring of cell viability</span></div><div class="casAuthors">Ke, Ning; Wang, Xiaobo; Xu, Xiao; Abassi, Yama A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">740</span>
        (<span class="NLM_cas:issue">Mammalian Cell Viability</span>),
    <span class="NLM_cas:pages">33-43</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We describe here the use of the xCELLigence system for label-free and real-time monitoring of cell-viability.  The xCELLigence system uses specially designed microtiter plates contg. interdigitated gold microelectrodes to noninvasively monitor the viability of cultured cells using elec. impedance as the readout.  The continuous monitoring of cell viability by the xCELLigence system makes it possible to distinguish between different perturbations of cell viability, such as senescence, cell toxicity (cell death), and reduced proliferation (cell cycle arrest).  In addn., the time resoln. of the xCELLigence system allows for the detn. of optimal time points to perform std. cell viability assays as well as other end-point assays to understand the mode of action.  We have used the WST-1 assay (end-point viability readout), the cell index detn. (continuous monitoring of viability by xCELLigence), and the DNA fragmentation assay (end-point apoptosis assay) to systematically examine cytotoxic effects triggered by two cytotoxic compds. with different cell-killing kinetics.  Good correlation was obsd. for viability readouts between WST-1 and cell index.  The significance of time resoln. by xCELLigence readout is exemplified by its ability to pinpoint the optimal time points for conducting end point viability and apoptosis assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQt28H9IqMbVg90H21EOLACvtfcHk0lgRlCYtzF70-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFylur7F&md5=3d6527ec0ce4efe6fb59de6fb352c5ab</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-108-6_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-108-6_6%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DAbassi%26aufirst%3DY.%2BA.%26atitle%3DThe%2520xCELLigence%2520system%2520for%2520real-time%2520and%2520label-free%2520monitoring%2520of%2520cell%2520viability%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D740%26spage%3D33%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Camille Denis, Jana Sopková-de Oliveira Santos, Ronan Bureau, <span class="NLM_string-name hlFld-ContribAuthor">Anne Sophie Voisin-Chiret</span>. </span><span class="cited-content_cbyCitation_article-title">Hot-Spots of Mcl-1 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 928-943. <a href="https://doi.org/10.1021/acs.jmedchem.9b00983" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00983%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHot-Spots%252Bof%252BMcl-1%252BProtein%26aulast%3DDenis%26aufirst%3DCamille%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D21062019%26date%3D16102019%26date%3D03102019%26volume%3D63%26issue%3D3%26spage%3D928%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nuno M. M. Moura, Inês F.
A. Mariz, José A. S. Cavaleiro, Artur M. S. Silva, Carlos Lodeiro, José M.
G. Martinho, Ermelinda M. S. Maçôas, <span class="NLM_string-name hlFld-ContribAuthor">Maria G. P. M. S. Neves</span>. </span><span class="cited-content_cbyCitation_article-title">Porphyrin-Oligopyridine Triads: Synthesis and Optical Properties. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (9)
                                     , 5282-5287. <a href="https://doi.org/10.1021/acs.joc.8b00208" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00208%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPorphyrin-Oligopyridine%252BTriads%25253A%252BSynthesis%252Band%252BOptical%252BProperties%26aulast%3DMoura%26aufirst%3DNuno%2BM.%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23012018%26date%3D25042018%26date%3D12042018%26volume%3D83%26issue%3D9%26spage%3D5282%26epage%3D5287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jade  Fogha</span>, <span class="hlFld-ContribAuthor ">Bogdan  Marekha</span>, <span class="hlFld-ContribAuthor ">Marcella  De Giorgi</span>, <span class="hlFld-ContribAuthor ">Anne Sophie  Voisin-Chiret</span>, <span class="hlFld-ContribAuthor ">Sylvain  Rault</span>, <span class="hlFld-ContribAuthor ">Ronan  Bureau</span>, and <span class="hlFld-ContribAuthor ">Jana  Sopkova-de Oliveira Santos</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward Understanding Mcl-1 Promiscuous and Specific Binding Mode. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (11)
                                     , 2885-2895. <a href="https://doi.org/10.1021/acs.jcim.7b00396" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DToward%252BUnderstanding%252BMcl-1%252BPromiscuous%252Band%252BSpecific%252BBinding%252BMode%26aulast%3DFogha%26aufirst%3DJade%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28062017%26date%3D27102017%26date%3D27112017%26date%3D10102017%26volume%3D57%26issue%3D11%26spage%3D2885%26epage%3D2895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy L.  Yap</span>, <span class="hlFld-ContribAuthor ">Lijia  Chen</span>, <span class="hlFld-ContribAuthor ">Maryanna E.  Lanning</span>, and <span class="hlFld-ContribAuthor ">Steven  Fletcher</span>  . </span><span class="cited-content_cbyCitation_article-title">Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (3)
                                     , 821-838. <a href="https://doi.org/10.1021/acs.jmedchem.5b01888" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01888%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExpanding%252Bthe%252BCancer%252BArsenal%252Bwith%252BTargeted%252BTherapies%25253A%252BDisarmament%252Bof%252Bthe%252BAntiapoptotic%252BBcl-2%252BProteins%252Bby%252BSmall%252BMolecules%26aulast%3DYap%26aufirst%3DJeremy%2BL.%26date%3D2017%26date%3D2016%26date%3D2015%26date%3D06122015%26date%3D13122016%26date%3D09022017%26date%3D17102016%26volume%3D60%26issue%3D3%26spage%3D821%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Mamane</span>, <span class="hlFld-ContribAuthor ">P.  Peluso</span>, <span class="hlFld-ContribAuthor ">E.  Aubert</span>, <span class="hlFld-ContribAuthor ">S.  Cossu</span>, and <span class="hlFld-ContribAuthor ">P.  Pale</span>  . </span><span class="cited-content_cbyCitation_article-title">Chiral Hexahalogenated 4,4′-Bipyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (11)
                                     , 4576-4587. <a href="https://doi.org/10.1021/acs.joc.6b00413" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00413%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DChiral%252BHexahalogenated%252B4%25252C4%2525E2%252580%2525B2-Bipyridines%26aulast%3DMamane%26aufirst%3DV.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25022016%26date%3D17052016%26date%3D03062016%26date%3D05052016%26volume%3D81%26issue%3D11%26spage%3D4576%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haolan  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Hudie  Wei</span>, <span class="hlFld-ContribAuthor ">Yongheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MCL-1 in cancer: current status and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01079-1" title="DOI URL">https://doi.org/10.1186/s13045-021-01079-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01079-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01079-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DTargeting%252BMCL-1%252Bin%252Bcancer%25253A%252Bcurrent%252Bstatus%252Band%252Bperspectives%26aulast%3DWang%26aufirst%3DHaolan%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xi  Gu</span>, <span class="hlFld-ContribAuthor ">Churen  Meng</span>, <span class="hlFld-ContribAuthor ">Di  Zhou</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Computational investigation of 4,5-diphenyl-1H-pyrrole-3-carboxylic acid derivatives as B-cell lymphoma-extra large (Bcl-xL) inhibitors by using 3D-QSAR, molecular docking, and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (3)
                                     , 1005-1018. <a href="https://doi.org/10.1007/s11224-020-01631-8" title="DOI URL">https://doi.org/10.1007/s11224-020-01631-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-020-01631-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-020-01631-8%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DComputational%252Binvestigation%252Bof%252B4%25252C5-diphenyl-1H-pyrrole-3-carboxylic%252Bacid%252Bderivatives%252Bas%252BB-cell%252Blymphoma-extra%252Blarge%252B%252528Bcl-xL%252529%252Binhibitors%252Bby%252Busing%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DZhang%26aufirst%3DHeng%26date%3D2021%26date%3D2020%26volume%3D32%26issue%3D3%26spage%3D1005%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arvind  Negi</span>, <span class="hlFld-ContribAuthor ">Paul V.  Murphy</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Mcl-1 inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 113038. <a href="https://doi.org/10.1016/j.ejmech.2020.113038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BMcl-1%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DNegi%26aufirst%3DArvind%26date%3D2021%26volume%3D210%26spage%3D113038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinlan A. F.  Cook</span>, <span class="hlFld-ContribAuthor ">Antoine  Gombert</span>, <span class="hlFld-ContribAuthor ">Janette  McKnight</span>, <span class="hlFld-ContribAuthor ">Loïc R. E.  Pantaine</span>, <span class="hlFld-ContribAuthor ">Michael C.  Willis</span>. </span><span class="cited-content_cbyCitation_article-title">The 2‐Pyridyl Problem: Challenging Nucleophiles in Cross‐Coupling Arylations. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.1002/ange.202010631" title="DOI URL">https://doi.org/10.1002/ange.202010631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202010631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202010631%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DThe%252B2%2525E2%252580%252590Pyridyl%252BProblem%25253A%252BChallenging%252BNucleophiles%252Bin%252BCross%2525E2%252580%252590Coupling%252BArylations%26aulast%3DCook%26aufirst%3DXinlan%2BA.%2BF.%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinlan A. F.  Cook</span>, <span class="hlFld-ContribAuthor ">Antoine  Gombert</span>, <span class="hlFld-ContribAuthor ">Janette  McKnight</span>, <span class="hlFld-ContribAuthor ">Loïc R. E.  Pantaine</span>, <span class="hlFld-ContribAuthor ">Michael C.  Willis</span>. </span><span class="cited-content_cbyCitation_article-title">The 2‐Pyridyl Problem: Challenging Nucleophiles in Cross‐Coupling Arylations. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.1002/anie.202010631" title="DOI URL">https://doi.org/10.1002/anie.202010631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202010631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202010631%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThe%252B2%2525E2%252580%252590Pyridyl%252BProblem%25253A%252BChallenging%252BNucleophiles%252Bin%252BCross%2525E2%252580%252590Coupling%252BArylations%26aulast%3DCook%26aufirst%3DXinlan%2BA.%2BF.%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew H.  Wei</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Roberts</span>, <span class="hlFld-ContribAuthor ">Andrew  Spencer</span>, <span class="hlFld-ContribAuthor ">Aaron Seth  Rosenberg</span>, <span class="hlFld-ContribAuthor ">David  Siegel</span>, <span class="hlFld-ContribAuthor ">Roland B.  Walter</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Paul  Hughes</span>, <span class="hlFld-ContribAuthor ">Zach  McIver</span>, <span class="hlFld-ContribAuthor ">Khalid  Mezzi</span>, <span class="hlFld-ContribAuthor ">Phuong Khanh  Morrow</span>, <span class="hlFld-ContribAuthor ">Anthony  Stein</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MCL-1 in hematologic malignancies: Rationale and progress. </span><span class="cited-content_cbyCitation_journal-name">Blood Reviews</span><span> <strong>2020,</strong> <em>44 </em>, 100672. <a href="https://doi.org/10.1016/j.blre.2020.100672" title="DOI URL">https://doi.org/10.1016/j.blre.2020.100672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.blre.2020.100672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.blre.2020.100672%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Reviews%26atitle%3DTargeting%252BMCL-1%252Bin%252Bhematologic%252Bmalignancies%25253A%252BRationale%252Band%252Bprogress%26aulast%3DWei%26aufirst%3DAndrew%2BH.%26date%3D2020%26volume%3D44%26spage%3D100672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiko  Murai</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Ebara</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Ohashi</span>, <span class="hlFld-ContribAuthor ">Tohru  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Nomura</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Araki</span>, . </span><span class="cited-content_cbyCitation_article-title">Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , e0240718. <a href="https://doi.org/10.1371/journal.pone.0240718" title="DOI URL">https://doi.org/10.1371/journal.pone.0240718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0240718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0240718%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSynergistic%252Bapoptotic%252Beffects%252Bin%252Bcancer%252Bcells%252Bby%252Bthe%252Bcombination%252Bof%252BCLK%252Band%252BBcl-2%252Bfamily%252Binhibitors%26aulast%3DMurai%26aufirst%3DAiko%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3De0240718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Bourafai-Aziez</span>, <span class="hlFld-ContribAuthor ">M.  Sebban</span>, <span class="hlFld-ContribAuthor ">M.  Benabderrahmane</span>, <span class="hlFld-ContribAuthor ">B.  Marekha</span>, <span class="hlFld-ContribAuthor ">C.  Denis</span>, <span class="hlFld-ContribAuthor ">H.  Paysant</span>, <span class="hlFld-ContribAuthor ">L. B.  Weiswald</span>, <span class="hlFld-ContribAuthor ">L.  Carlier</span>, <span class="hlFld-ContribAuthor ">R.  Bureau</span>, <span class="hlFld-ContribAuthor ">G.  Coadou</span>, <span class="hlFld-ContribAuthor ">D.  Ravault</span>, <span class="hlFld-ContribAuthor ">A. S.  Voisin-Chiret</span>, <span class="hlFld-ContribAuthor ">J.  Sopková-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">H.  Oulyadi</span>. </span><span class="cited-content_cbyCitation_article-title">Binding mode of Pyridoclax to myeloid cell leukemia-1 (Mcl-1) revealed by nuclear magnetic resonance spectroscopy, docking and molecular dynamics approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (14)
                                     , 4162-4178. <a href="https://doi.org/10.1080/07391102.2019.1680434" title="DOI URL">https://doi.org/10.1080/07391102.2019.1680434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1680434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1680434%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DBinding%252Bmode%252Bof%252BPyridoclax%252Bto%252Bmyeloid%252Bcell%252Bleukemia-1%252B%252528Mcl-1%252529%252Brevealed%252Bby%252Bnuclear%252Bmagnetic%252Bresonance%252Bspectroscopy%25252C%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bapproaches%26aulast%3DBourafai-Aziez%26aufirst%3DA.%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D14%26spage%3D4162%26epage%3D4178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.C.  Groo</span>, <span class="hlFld-ContribAuthor ">S.  Hedir</span>, <span class="hlFld-ContribAuthor ">M.  Since</span>, <span class="hlFld-ContribAuthor ">E.  Brotin</span>, <span class="hlFld-ContribAuthor ">L.-B.  Weiswald</span>, <span class="hlFld-ContribAuthor ">H.  Paysant</span>, <span class="hlFld-ContribAuthor ">G.  Nee</span>, <span class="hlFld-ContribAuthor ">M.  Coolzaet</span>, <span class="hlFld-ContribAuthor ">D.  Goux</span>, <span class="hlFld-ContribAuthor ">R.  Delépée</span>, <span class="hlFld-ContribAuthor ">T.  Freret</span>, <span class="hlFld-ContribAuthor ">L.  Poulain</span>, <span class="hlFld-ContribAuthor ">A.S.  Voisin-Chiret</span>, <span class="hlFld-ContribAuthor ">A.  Malzert-Fréon</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2020,</strong> <em>587 </em>, 119655. <a href="https://doi.org/10.1016/j.ijpharm.2020.119655" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2020.119655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2020.119655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2020.119655%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DPyridoclax-loaded%252Bnanoemulsion%252Bfor%252Benhanced%252Banticancer%252Beffect%252Bon%252Bovarian%252Bcancer%26aulast%3DGroo%26aufirst%3DA.C.%26date%3D2020%26volume%3D587%26spage%3D119655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damien  Hédou</span>, <span class="hlFld-ContribAuthor ">Anne Sophie  Voisin‐Chiret</span>. </span><span class="cited-content_cbyCitation_article-title">Br vs. TsO Chemoselective Suzuki–Miyaura Cross‐Coupling Reaction on Nicotinaldehyde Moiety for the Preparation of 2,3,5‐Trisubstituted Pyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (24)
                                     , 3640-3649. <a href="https://doi.org/10.1002/ejoc.202000417" title="DOI URL">https://doi.org/10.1002/ejoc.202000417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000417%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBr%252Bvs.%252BTsO%252BChemoselective%252BSuzuki%2525E2%252580%252593Miyaura%252BCross%2525E2%252580%252590Coupling%252BReaction%252Bon%252BNicotinaldehyde%252BMoiety%252Bfor%252Bthe%252BPreparation%252Bof%252B2%25252C3%25252C5%2525E2%252580%252590Trisubstituted%252BPyridines%26aulast%3DH%25C3%25A9dou%26aufirst%3DDamien%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D24%26spage%3D3640%26epage%3D3649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lulu  Liu</span>, <span class="hlFld-ContribAuthor ">Renshuai  Liu</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112142. <a href="https://doi.org/10.1016/j.ejmech.2020.112142" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112142%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Btyrosine%252Bderivatives%252Bas%252BMcl-1%252Binhibitors%26aulast%3DLiu%26aufirst%3DLulu%26date%3D2020%26volume%3D191%26spage%3D112142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Domenico  Iacopetta</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Véronique  Vie</span>, <span class="hlFld-ContribAuthor ">Gilles  Paboeuf</span>, <span class="hlFld-ContribAuthor ">Didier  Hennequin</span>, <span class="hlFld-ContribAuthor ">Serge  Perato</span>, <span class="hlFld-ContribAuthor ">Marcella  De Giorgi</span>, <span class="hlFld-ContribAuthor ">Maria Stefania  Sinicropi</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova‐De Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Anne‐Sophie  Voisin‐Chiret</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert‐Freon</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , 136-154. <a href="https://doi.org/10.1002/cmdc.201900542" title="DOI URL">https://doi.org/10.1002/cmdc.201900542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900542%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Bof%252BPyridoclax%252BAnalogues%25253A%252BInsight%252Binto%252BTheir%252BDruggability%252Bby%252BInvestigating%252BTheir%252BPhysicochemical%252BProperties%252Band%252BInteractions%252Bwith%252BMembranes%26aulast%3DDe%2BPascale%26aufirst%3DMartina%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D1%26spage%3D136%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aarti  Anantram</span>, <span class="hlFld-ContribAuthor ">Mariam  Degani</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cancer's Achilles’ heel: role of BCL-2 inhibitors in cellular senescence and apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (17)
                                     , 2287-2312. <a href="https://doi.org/10.4155/fmc-2018-0366" title="DOI URL">https://doi.org/10.4155/fmc-2018-0366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0366%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bcancer%252527s%252BAchilles%2525E2%252580%252599%252Bheel%25253A%252Brole%252Bof%252BBCL-2%252Binhibitors%252Bin%252Bcellular%252Bsenescence%252Band%252Bapoptosis%26aulast%3DAnantram%26aufirst%3DAarti%26date%3D2019%26volume%3D11%26issue%3D17%26spage%3D2287%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Willy  Smeralda</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Anne-Sophie  Voisin-Chiret</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Freon</span>. </span><span class="cited-content_cbyCitation_article-title">Microplate assay for lipophilicity determination using intrinsic fluorescence of drugs: Application to a promising anticancer lead, pyridoclax. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2019,</strong> <em>131 </em>, 75-83. <a href="https://doi.org/10.1016/j.ejps.2019.02.010" title="DOI URL">https://doi.org/10.1016/j.ejps.2019.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2019.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2019.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMicroplate%252Bassay%252Bfor%252Blipophilicity%252Bdetermination%252Busing%252Bintrinsic%252Bfluorescence%252Bof%252Bdrugs%25253A%252BApplication%252Bto%252Ba%252Bpromising%252Banticancer%252Blead%25252C%252Bpyridoclax%26aulast%3DSmeralda%26aufirst%3DWilly%26date%3D2019%26volume%3D131%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siham  Hedir</span>, <span class="hlFld-ContribAuthor ">Marcella  De Giorgi</span>, <span class="hlFld-ContribAuthor ">Jade  Fogha</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Louis-Bastien  Weiswald</span>, <span class="hlFld-ContribAuthor ">Emilie  Brotin</span>, <span class="hlFld-ContribAuthor ">Bogdan  Marekha</span>, <span class="hlFld-ContribAuthor ">Christophe  Denoyelle</span>, <span class="hlFld-ContribAuthor ">Camille  Denis</span>, <span class="hlFld-ContribAuthor ">Peggy  Suzanne</span>, <span class="hlFld-ContribAuthor ">Fabien  Gautier</span>, <span class="hlFld-ContribAuthor ">Philippe  Juin</span>, <span class="hlFld-ContribAuthor ">Laetitia  Ligat</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lopez</span>, <span class="hlFld-ContribAuthor ">Ludovic  Carlier</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Ronan  Bureau</span>, <span class="hlFld-ContribAuthor ">Sylvain  Rault</span>, <span class="hlFld-ContribAuthor ">Laurent  Poulain</span>, <span class="hlFld-ContribAuthor ">Jana Sopková-de  Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Anne Sophie  Voisin-Chiret</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>159 </em>, 357-380. <a href="https://doi.org/10.1016/j.ejmech.2018.10.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-guided%252Bdesign%252Bof%252Bpyridoclax%252Bderivatives%252Bbased%252Bon%252BNoxa%252B%25252F%252BMcl-1%252Binteraction%252Bmode%26aulast%3DHedir%26aufirst%3DSiham%26date%3D2018%26volume%3D159%26spage%3D357%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Laure  Bonnefond</span>, <span class="hlFld-ContribAuthor ">Romane  Florent</span>, <span class="hlFld-ContribAuthor ">Sophie  Lenoir</span>, <span class="hlFld-ContribAuthor ">Bernard  Lambert</span>, <span class="hlFld-ContribAuthor ">Edwige  Abeilard</span>, <span class="hlFld-ContribAuthor ">Florence  Giffard</span>, <span class="hlFld-ContribAuthor ">Marie-Hélène  Louis</span>, <span class="hlFld-ContribAuthor ">Nicolas  Elie</span>, <span class="hlFld-ContribAuthor ">Mélanie  Briand</span>, <span class="hlFld-ContribAuthor ">Denis  Vivien</span>, <span class="hlFld-ContribAuthor ">Laurent  Poulain</span>, <span class="hlFld-ContribAuthor ">Pascal  Gauduchon</span>, <span class="hlFld-ContribAuthor ">Monique  N’Diaye</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of store-operated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to anti-BclxL strategies through Mcl-1 down-regulation. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (74)
                                     , 33896-33911. <a href="https://doi.org/10.18632/oncotarget.26084" title="DOI URL">https://doi.org/10.18632/oncotarget.26084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.26084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.26084%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252Bstore-operated%252Bchannels%252Bby%252Bcarboxyamidotriazole%252Bsensitizes%252Bovarian%252Bcarcinoma%252Bcells%252Bto%252Banti-BclxL%252Bstrategies%252Bthrough%252BMcl-1%252Bdown-regulation%26aulast%3DBonnefond%26aufirst%3DMarie-Laure%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D74%26spage%3D33896%26epage%3D33911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangsen  Xu</span>, <span class="hlFld-ContribAuthor ">Tingting  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5548-5556. <a href="https://doi.org/10.1016/j.bmc.2017.08.024" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.08.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.08.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1-Phenyl-1H-indole%252Bderivatives%252Bas%252Ba%252Bnew%252Bclass%252Bof%252BBcl-2%25252FMcl-1%252Bdual%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bpreliminary%252Bbiological%252Bevaluation%26aulast%3DXu%26aufirst%3DGuangsen%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5548%26epage%3D5556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hajer  Ziouziou</span>, <span class="hlFld-ContribAuthor ">Claudia  Andrieu</span>, <span class="hlFld-ContribAuthor ">Erik  Laurini</span>, <span class="hlFld-ContribAuthor ">Sara  Karaki</span>, <span class="hlFld-ContribAuthor ">Maurizio  Fermeglia</span>, <span class="hlFld-ContribAuthor ">Ridha  Oueslati</span>, <span class="hlFld-ContribAuthor ">David  Taieb</span>, <span class="hlFld-ContribAuthor ">Michel  Camplo</span>, <span class="hlFld-ContribAuthor ">Olivier  Siri</span>, <span class="hlFld-ContribAuthor ">Sabrina  Pricl</span>, <span class="hlFld-ContribAuthor ">Maria  Katsogiannou</span>, <span class="hlFld-ContribAuthor ">Palma  Rocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (44)
                                     , 77317-77329. <a href="https://doi.org/10.18632/oncotarget.20469" title="DOI URL">https://doi.org/10.18632/oncotarget.20469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.20469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.20469%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DTargeting%252BHsp27%25252FeIF4E%252Binteraction%252Bwith%252Bphenazine%252Bcompound%25253A%252Ba%252Bpromising%252Balternative%252Bfor%252Bcastration-resistant%252Bprostate%252Bcancer%252Btreatment%26aulast%3DZiouziou%26aufirst%3DHajer%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D44%26spage%3D77317%26epage%3D77329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Zheng-kui  Jiang</span>, <span class="hlFld-ContribAuthor ">Yan-qiu  Zhao</span>, <span class="hlFld-ContribAuthor ">Feng-feng  Ping</span>. </span><span class="cited-content_cbyCitation_article-title">Geraniin suppresses ovarian cancer growth through inhibition of NF-κB activation and downregulation of Mcl-1 expression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biochemical and Molecular Toxicology</span><span> <strong>2017,</strong> <em>31 </em>
                                    (9)
                                     , e21929. <a href="https://doi.org/10.1002/jbt.21929" title="DOI URL">https://doi.org/10.1002/jbt.21929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jbt.21929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjbt.21929%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biochemical%2520and%2520Molecular%2520Toxicology%26atitle%3DGeraniin%252Bsuppresses%252Bovarian%252Bcancer%252Bgrowth%252Bthrough%252Binhibition%252Bof%252BNF-%2525CE%2525BAB%252Bactivation%252Band%252Bdownregulation%252Bof%252BMcl-1%252Bexpression%26aulast%3DWang%26aufirst%3DXue%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D9%26spage%3De21929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthieu  Meryet-Figuière</span>, <span class="hlFld-ContribAuthor ">Charlotte  Lecerf</span>, <span class="hlFld-ContribAuthor ">Emilie  Varin</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Coll</span>, <span class="hlFld-ContribAuthor ">Marie-Hélène  Louis</span>, <span class="hlFld-ContribAuthor ">Soizic  Dutoit</span>, <span class="hlFld-ContribAuthor ">Florence  Giffard</span>, <span class="hlFld-ContribAuthor ">Cécile  Blanc-Fournier</span>, <span class="hlFld-ContribAuthor ">Siham  Hedir</span>, <span class="hlFld-ContribAuthor ">Nicolas  Vigneron</span>, <span class="hlFld-ContribAuthor ">Emilie  Brotin</span>, <span class="hlFld-ContribAuthor ">Laurent  Pelletier</span>, <span class="hlFld-ContribAuthor ">Véronique  Josserand</span>, <span class="hlFld-ContribAuthor ">Christophe  Denoyelle</span>, <span class="hlFld-ContribAuthor ">Laurent  Poulain</span>. </span><span class="cited-content_cbyCitation_article-title">Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route. </span><span class="cited-content_cbyCitation_journal-name">Oncology Reports</span><span> <strong>2017,</strong> <em>38 </em>
                                    (4)
                                     , 1949-1958. <a href="https://doi.org/10.3892/or.2017.5882" title="DOI URL">https://doi.org/10.3892/or.2017.5882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/or.2017.5882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2For.2017.5882%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Reports%26atitle%3DAtelocollagen-mediated%252Bin%252Bvivo%252BsiRNA%252Btransfection%252Bin%252Bovarian%252Bcarcinoma%252Bis%252Binfluenced%252Bby%252Btumor%252Bsite%25252C%252BsiRNA%252Btarget%252Band%252Badministration%252Broute%26aulast%3DMeryet-Figui%25C3%25A8re%26aufirst%3DMatthieu%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D1949%26epage%3D1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Pasco</span>, <span class="hlFld-ContribAuthor ">C.  Dolain</span>, <span class="hlFld-ContribAuthor ">G.  Guichard</span>. </span><span class="cited-content_cbyCitation_article-title">Foldamers in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 89-125. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12565-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12565-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12565-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12565-X%26sid%3Dliteratum%253Aachs%26atitle%3DFoldamers%252Bin%252BMedicinal%252BChemistry%26aulast%3DPasco%26aufirst%3DM.%26date%3D2017%26spage%3D89%26epage%3D125%26pub%3DElsevier%26atitle%3DComprehensive%252BSupramolecular%252BChemistry%252BII%26date%3D2017%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.-C.  Groo</span>, <span class="hlFld-ContribAuthor ">M.  De Pascale</span>, <span class="hlFld-ContribAuthor ">A.-S.  Voisin-Chiret</span>, <span class="hlFld-ContribAuthor ">S.  Corvaisier</span>, <span class="hlFld-ContribAuthor ">M.  Since</span>, <span class="hlFld-ContribAuthor ">A.  Malzert-Fréon</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of 2 strategies to enhance pyridoclax solubility: Nanoemulsion delivery system versus salt synthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>97 </em>, 218-226. <a href="https://doi.org/10.1016/j.ejps.2016.11.025" title="DOI URL">https://doi.org/10.1016/j.ejps.2016.11.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2016.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2016.11.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DComparison%252Bof%252B2%252Bstrategies%252Bto%252Benhance%252Bpyridoclax%252Bsolubility%25253A%252BNanoemulsion%252Bdelivery%252Bsystem%252Bversus%252Bsalt%252Bsynthesis%26aulast%3DGroo%26aufirst%3DA.-C.%26date%3D2017%26volume%3D97%26spage%3D218%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cécile  Pétigny-Lechartier</span>, <span class="hlFld-ContribAuthor ">Charlène  Duboc</span>, <span class="hlFld-ContribAuthor ">Abdelghani  Jebahi</span>, <span class="hlFld-ContribAuthor ">Marie-Hélène  Louis</span>, <span class="hlFld-ContribAuthor ">Edwige  Abeilard</span>, <span class="hlFld-ContribAuthor ">Christophe  Denoyelle</span>, <span class="hlFld-ContribAuthor ">Pascal  Gauduchon</span>, <span class="hlFld-ContribAuthor ">Laurent  Poulain</span>, <span class="hlFld-ContribAuthor ">Marie  Villedieu</span>. </span><span class="cited-content_cbyCitation_article-title">The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     , 102-115. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0342" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0342%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DThe%252BmTORC1%25252F2%252BInhibitor%252BAZD8055%252BStrengthens%252Bthe%252BEfficiency%252Bof%252Bthe%252BMEK%252BInhibitor%252BTrametinib%252Bto%252BReduce%252Bthe%252BMcl-1%25252F%25255BBim%252Band%252BPuma%25255D%252Bratio%252Band%252Bto%252BSensitize%252BOvarian%252BCarcinoma%252BCells%252Bto%252BABT-737%26aulast%3DP%25C3%25A9tigny-Lechartier%26aufirst%3DC%25C3%25A9cile%26date%3D2017%26date%3D2016%26volume%3D16%26issue%3D1%26spage%3D102%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y  Fernández-Marrero</span>, <span class="hlFld-ContribAuthor ">S  Spinner</span>, <span class="hlFld-ContribAuthor ">T  Kaufmann</span>, <span class="hlFld-ContribAuthor ">P J  Jost</span>. </span><span class="cited-content_cbyCitation_article-title">Survival control of malignant lymphocytes by anti-apoptotic MCL-1. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2016,</strong> <em>30 </em>
                                    (11)
                                     , 2152-2159. <a href="https://doi.org/10.1038/leu.2016.213" title="DOI URL">https://doi.org/10.1038/leu.2016.213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/leu.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fleu.2016.213%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DSurvival%252Bcontrol%252Bof%252Bmalignant%252Blymphocytes%252Bby%252Banti-apoptotic%252BMCL-1%26aulast%3DFern%25C3%25A1ndez-Marrero%26aufirst%3DY%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D11%26spage%3D2152%26epage%3D2159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew M.  Beekman</span>, <span class="hlFld-ContribAuthor ">Lesley A.  Howell</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule and Peptide Inhibitors of the Pro-Survival Protein Mcl-1. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 802-813. <a href="https://doi.org/10.1002/cmdc.201500497" title="DOI URL">https://doi.org/10.1002/cmdc.201500497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500497%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSmall-Molecule%252Band%252BPeptide%252BInhibitors%252Bof%252Bthe%252BPro-Survival%252BProtein%252BMcl-1%26aulast%3DBeekman%26aufirst%3DAndrew%2BM.%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D8%26spage%3D802%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Jewginski</span>, <span class="hlFld-ContribAuthor ">Lucile  Fischer</span>, <span class="hlFld-ContribAuthor ">Cinzia  Colombo</span>, <span class="hlFld-ContribAuthor ">Ivan  Huc</span>, <span class="hlFld-ContribAuthor ">Cameron D.  Mackereth</span>. </span><span class="cited-content_cbyCitation_article-title">Solution Observation of Dimerization and Helix Handedness Induction in a Human Carbonic Anhydrase-Helical Aromatic Amide Foldamer Complex. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2016,</strong> <em>17 </em>
                                    (8)
                                     , 727-736. <a href="https://doi.org/10.1002/cbic.201500619" title="DOI URL">https://doi.org/10.1002/cbic.201500619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201500619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201500619%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DSolution%252BObservation%252Bof%252BDimerization%252Band%252BHelix%252BHandedness%252BInduction%252Bin%252Ba%252BHuman%252BCarbonic%252BAnhydrase-Helical%252BAromatic%252BAmide%252BFoldamer%252BComplex%26aulast%3DJewginski%26aufirst%3DMichal%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D8%26spage%3D727%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Chen</span>, <span class="hlFld-ContribAuthor ">P. T.  Wilder</span>, <span class="hlFld-ContribAuthor ">B.  Drennen</span>, <span class="hlFld-ContribAuthor ">J.  Tran</span>, <span class="hlFld-ContribAuthor ">B. M.  Roth</span>, <span class="hlFld-ContribAuthor ">K.  Chesko</span>, <span class="hlFld-ContribAuthor ">P.  Shapiro</span>, <span class="hlFld-ContribAuthor ">S.  Fletcher</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of 3-carboxy-substituted 1,2,3,4-tetrahydroquinolines as inhibitors of myeloid cell leukemia-1 (Mcl-1). </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (24)
                                     , 5505-5510. <a href="https://doi.org/10.1039/C5OB02063H" title="DOI URL">https://doi.org/10.1039/C5OB02063H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02063H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02063H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252B3-carboxy-substituted%252B1%25252C2%25252C3%25252C4-tetrahydroquinolines%252Bas%252Binhibitors%252Bof%252Bmyeloid%252Bcell%252Bleukemia-1%252B%252528Mcl-1%252529%26aulast%3DChen%26aufirst%3DL.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D24%26spage%3D5505%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Computational modeling of pyridoclax. (A) ORTEP representation of MR29004 and pyridoclax MR29072 X-ray structures (left) and superposition of a polyalanyl α helix (in blue) and X-ray structure (in purple) of MR29004 and pyridoclax MR29072 (right). (B) Representative docking poses of pyridoclax in hMcl-1 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW">2KBW</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>). (C) The minimized average complex from MR29072/hMcl-1 dynamic study. The protein is presented in gray as surface (left) and as ribbon (right) and pyridoclax as stick.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Procedure To Synthesize MR29072 (Pyridoclax)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS (1.1 equiv), CH<sub>3</sub>CN, rfx, 4 h; (b) PhPOCl<sub>2</sub>, 160 °C, 4 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), 1,4-dioxane, rfx, 24 h; (d) NaI (10 equiv), CH<sub>3</sub>COCl (1.5 equiv), CH<sub>3</sub>CN, 100 °C, 1 h, <i>C</i> = 0.25 M, microwave; (e) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), K<sub>3</sub>PO<sub>4</sub> (2.5 equiv), DME, rfx, 20 h; (f) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub> (5 equiv), 1,4-dioxane, rfx, 24 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Real-time binding of pyridoclax and MR29004 on immobilized His fusion proteins. (A) Low mass weight-single cycle kinetics analysis was simultaneously performed on immobilized His fusion Mcl-1 (5000 RU) and His fusion Bcl-x<sub>L</sub> (5000 RU) with five injections of analyte at 1, 2, 4, 8, and 16 nM. Analyte injections lasted for 120 s each and were separated by 10 s dissociation phases. An extended dissociation period of 10 min followed the last injection. The pyridoclax sensorgram recorded for Mcl-1 was fitted globally to a 1:1 interaction (black curves). (B) Low mass weight-single cycle kinetics analysis was simultaneously performed on immobilized His fusion Mcl-1 (3500 RU) and His fusion Bcl-x<sub>L</sub> (3500 RU) with five injections of analytes (pyridoclax and MR29004) at 70, 140, 280, 560, and 1120 nM. Analyte injections lasted for 120 s each and were separated by 10 s dissociation phases. An extended dissociation period of 10 min followed the last injection. The MR29004 sensorgram was not fitted. Each sensorgram represents a differential response where response on an empty reference channel (A) or Bcl-x<sub>L</sub>-coated reference channel (B) has been subtracted and is expressed in RU as a function of time in seconds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of pyridoclax in whole living cells using BRET assay. (A) Donor saturation assay. Saturation curves were measured in Hela cells transiently cotransfected with increasing acceptor/donor (peYFP-Mcl-1/pRluc-BimL) ratio as described in <a class="ref internalNav" href="#sec6" aria-label="Experimental Procedures">Experimental Procedures</a> and untreated or treated with pyridoclax. (B) Effect of pyridoclax treatment on a single ratio acceptor/donor (yielding 50% of the maximal BRET signal) after a 16 h exposure at 50 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of pyridoclax on IGROV1-R10 ovarian cancer cells, alone or associated with a Bcl-x<sub>L</sub> targeting siRNA (siXL1). Cells were transfected with 10 nM siRNA for 48 h before a 24 h (A, B, C, D) or 2, 4, or 6 h (E) exposure to 25 μM pyridoclax. (A) Cellular morphology, DNA content histograms, and annexin V/propidium iodide biparametric histograms. (B) Trypan blue exclusion assay. (C) Bcl-x<sub>L</sub> expression and PARP and caspase 3 cleavage assessed by western blot. (D) Nuclear morphology studied after DAPI staining (top) and cellular morphology studied by electron microscopy. (E) Short time effects of the combination pyridoclax/siXL1 (assessed 2, 4, and 6 h after the beginning of the exposure to pyridoclax). Cellular morphology and DNA content histograms (left panel) and PARP and caspase 3 cleavage assessed by western blot (right panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of pyridoclax alone or combined with a Bcl-x<sub>L</sub> targeting siRNA (siXL1) on ovarian, lung, and mesothelial cancer cell lines. Cells were transfected with 10 nM siRNA for 48 h before a 24 h exposure to 25 μM pyridoclax. Cell detachment and sub-G1 proportion on DNA histograms were assessed by the observation of cellular morphology and by flow cytometry, respectively, in ovarian carcinoma cells (A) and lung or mesothelioma cancer cells (B). (C) expression of Bcl-x<sub>L</sub> and Mcl-1 in a panel of ovarian cancer cell lines. Note the strong ratio of Mcl-1/Bcl-x<sub>L</sub> expression in A2780 cells. (D and E) Effects of Mcl-1-targeting siRNA (siMCL1) and pyridoclax, respectively, on apoptotic cell death in Mcl-1-dependent ovarian cancer cell line A2780.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of the combination of pyridoclax with ABT-737 on chemoresistant ovarian cancer cells IGROV1-R10 (top) and SKOV3 (bottom). Cells were concomitantly (A, E) or sequentially (B) exposed to 25 μM pyridoclax and 5 μM ABT-737, and cellular effects were assessed either in real-time (A, B, E) or after 24 h (C, D, F). (A, B, E) Real-time cellular activity assessed by impedancemetry (xCELLigence technology), after concomitant exposure (A, E) or sequential exposure (B; 24 h pyridoclax, then ABT-737). (C) Cellular morphology and DNA content histograms after a 24 h concomitant exposure. (D, F) PARP and caspase 3 cleavages after a 24 h concomitant exposure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of pyridoclax on Bcl-2 family expression, ER stress, and association of these events with apoptosis in response to Bcl-x<sub>L</sub> targeting strategies. Cells were exposed to 25 μM pyridoclax, and Mcl-1, Bcl-x<sub>L</sub>, Bim, and Noxa expression were assessed at protein level after 24 h in response to pyridoclax (A) and at the mRNA level in response to pyridoclax and to the ER stress inducer thapsigargin (500 nM) (B). (C) Induction of Noxa expression by pyridoclax after 2, 4, 6, and 24 h exposure. (D) ER stress induction was assessed by the study of CHOP and HSP70 induction by western blot. (E) Immunoprecipitation of Bcl-x<sub>L</sub> and Mcl-1. Cells were exposed 24 h to ABT-737 and then 6 h to pyridoclax, and the binding of Bim, Noxa, Bax, and Bak to Bcl-x<sub>L</sub> and Mcl-1 was studied after immunoprecipitation (left panels). The expression of these proteins in whole lysate is presented on the right panel. (F) Bcl-x<sub>L</sub> and Noxa expression were silenced for 48 h using specific siRNA (siXL1 and siNOXA) and cells were then exposed to 25 μM pyridoclax. Cellular morphology and DNA content histogram (left panel), as well as PARP and caspase 3 cleavage (right panel), were studied after 24 h. G The effect of thapsigargin-induced ER stress on ABT-737 cytotoxicity was assessed by the study of cellular and nuclear morphology, DNA content histograms, trypan blue exclusion test, and caspase 3 cleavage after 24 h. CHOP and Noxa protein expression was studied by western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Chemical Procedure To Synthesize MR29072 and Its Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>With identical ends when blue color (het)aryl boronic species were used and with different ends when purple, red, magenta, or green (het)aryl boronic species were used. Reagents and conditions: (a) NIS (1.1 equiv), CH<sub>3</sub>CN, rfx, 4 h; (b) PhPOCl<sub>2</sub>, 160 °C, 4 h; (c) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), 1,4-dioxane, rfx, 24 h; (d) NaI (10 equiv), CH<sub>3</sub>COCl (1.5 equiv), CH<sub>3</sub>CN, 100 °C, 1 h, <i>C</i> = 0.25 M, microwave; (e) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), K<sub>3</sub>PO<sub>4</sub> (2.5 equiv), DME, rfx, 20 h; (f) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub> (5 equiv), 1,4-dioxane, rfx, 24 h.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Chemical Procedure To Synthesize MR30820<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), Na<sub>2</sub>CO<sub>3</sub> (2.5 equiv), 1,4-dioxane, rfx, 4 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), K<sub>3</sub>PO<sub>4</sub> (2.5 equiv), DME/H<sub>2</sub>O, rfx, 20 h; (c) PhCH<sub>2</sub>P(O)(OEt)<sub>2</sub> (1 equiv), KOH (2 equiv), THF, rfx, 19 h.</p></p></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/medium/jm-2014-00672y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structure–activity relationships. Various oligopyridines derivatives from pyridoclax were synthesized, and their activity was evaluated as previously described for pyridoclax, that is, after silencing of Bcl-x<sub>L</sub> in IGROV1-R10. The cells were transfected with siRNA for 48 h and then exposed for 24 h to pyridoclax derivatives. Cellular morphology and DNA content histograms are presented for each molecule. Molecules are classified considering the chemical function that has been modified compared with MR29072 (pyridoclax).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm500672y/20150220/images/large/jm-2014-00672y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500672y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 83 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span> </span><span class="NLM_article-title">The Bcl-2 apoptotic switch in cancer development and therapy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fsj.onc.1210220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17322918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVKhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1324-1337&author=J.+M.+Adamsauthor=S.+Cory&title=The+Bcl-2+apoptotic+switch+in+cancer+development+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Bcl-2 apoptotic switch in cancer development and therapy</span></div><div class="casAuthors">Adams, J. M.; Cory, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1324-1337</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Impaired apoptosis is both crit. in cancer development and a major barrier to effective treatment.  In response to diverse intracellular damage signals, including those evoked by cancer therapy, the cell's decision to undergo apoptosis is detd. by interactions between three factions of the Bcl-2 protein family.  The damage signals are transduced by the diverse BH3-only' proteins, distinguished by the BH3 domain used to engage their pro-survival relatives: Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and A1.  This interaction ablates pro-survival function and allows activation of Bax and Bak, which commit the cell to apoptosis by permeabilizing the outer membrane of the mitochondrion.  Certain BH3-only proteins (e.g. Bim, Puma) can engage all the pro-survival proteins, but others (e.g. Bad, Noxa) engage only subsets.  Activation of Bax and Bak appears to require that the BH3-only proteins engage the multiple pro-survival proteins guarding Bax and Bak, rather than binding to the latter.  The balance between the pro-survival proteins and their BH3 ligands regulates tissue homeostasis, and either overexpression of a pro-survival family member or loss of a proapoptotic relative can be oncogenic.  Better understanding of the Bcl-2 family is clarifying its role in cancer development, revealing how conventional therapy works and stimulating the search for 'BH3 mimetics' as a novel class of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6J8GQArO2kbVg90H21EOLACvtfcHk0lhJq5L1-rlsgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVKhsL8%253D&md5=49704eaf2916ab06258320518065fdc0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210220%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DCory%26aufirst%3DS.%26atitle%3DThe%2520Bcl-2%2520apoptotic%2520switch%2520in%2520cancer%2520development%2520and%2520therapy%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1324%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Shamas-Din, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmbhatt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">BH3-only proteins: Orchestrators of apoptosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1813</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1813&publication_year=2011&pages=508-520&author=A.+Shamas-Dinauthor=H.+Brahmbhattauthor=B.+Leberauthor=D.+W.+Andrews&title=BH3-only+proteins%3A+Orchestrators+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShamas-Din%26aufirst%3DA.%26aulast%3DBrahmbhatt%26aufirst%3DH.%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DBH3-only%2520proteins%253A%2520Orchestrators%2520of%2520apoptosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1813%26spage%3D508%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Juin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geneste, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span> </span><span class="NLM_article-title">Decoding and unlocking the BCL-2 dependency of cancer cells</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnrc3538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23783119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1Ghur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=455-465&author=P.+Juinauthor=O.+Genesteauthor=F.+Gautierauthor=S.+Depilauthor=M.+Campone&title=Decoding+and+unlocking+the+BCL-2+dependency+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Decoding and unlocking the BCL-2 dependency of cancer cells</span></div><div class="casAuthors">Juin, Philippe; Geneste, Olivier; Gautier, Fabien; Depil, Stephane; Campone, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">455-465</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer cells are subject to many apoptotic stimuli that would kill them were it not for compensatory prosurvival alterations.  BCL-2-like (BCL-2L) proteins contribute to such aberrant behavior by engaging a network of interactions that is potent at promoting survival but that is also fragile: inhibition of a restricted no. of interactions may suffice to trigger cancer cell death.  Currently available and novel compds. that inhibit these interactions could be efficient therapeutic agents if this phenotype of BCL-2L dependence was better understood at a mol., cellular and systems level and if it could be diagnosed by relevant biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTFyJ_wwnZgLVg90H21EOLACvtfcHk0lhJq5L1-rlsgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1Ghur4%253D&md5=14ccf8c1e3a5fb1600110f6032e94b60</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc3538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3538%26sid%3Dliteratum%253Aachs%26aulast%3DJuin%26aufirst%3DP.%26aulast%3DGeneste%26aufirst%3DO.%26aulast%3DGautier%26aufirst%3DF.%26aulast%3DDepil%26aufirst%3DS.%26aulast%3DCampone%26aufirst%3DM.%26atitle%3DDecoding%2520and%2520unlocking%2520the%2520BCL-2%2520dependency%2520of%2520cancer%2520cells%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D455%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">De Giorgi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Targeting the BH3 domain of Bcl-2 family proteins. A brief history from natural products to foldamers as promising cancer therapeutic avenues</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.2174%2F0929867311320240003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23746270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=2964-2978&author=M.+De+Giorgiauthor=A.+S.+Voisin-Chiretauthor=S.+Rault&title=Targeting+the+BH3+domain+of+Bcl-2+family+proteins.+A+brief+history+from+natural+products+to+foldamers+as+promising+cancer+therapeutic+avenues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues</span></div><div class="casAuthors">De Giorgi, M.; Voisin-Chiret, A. S.; Rault, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2964-2978</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For many years the spotlight in drug discovery has been on a relatively small no. of validated therapeutic target classes, such as G-protein coupled receptors and enzymes such as protein kinases, with well characterized enzymic and cellular activities.  However, with recent progress in genomics and proteomics, protein-protein interactions (PPIs) provide new way of finding novel bioactive mols. acting on their interfaces.  This review addresses the current case studies and state of the art in the development of small chem. modulators controlling interactions of proteins that have pathol. implications in various human diseases and in particular in cancer.  The attention is focused on Bcl-2 family protein modulators ranging from natural products to synthetic ones with particular interest in foldamers as BH3 alpha helix mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0HaIzh5HnLVg90H21EOLACvtfcHk0lg-y5WkVJZiFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygsLfL&md5=989bc5633fddf67dc966bee943d44dcd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867311320240003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320240003%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DTargeting%2520the%2520BH3%2520domain%2520of%2520Bcl-2%2520family%2520proteins.%2520A%2520brief%2520history%2520from%2520natural%2520products%2520to%2520foldamers%2520as%2520promising%2520cancer%2520therapeutic%2520avenues%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D2964%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Zhang, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span> </span><span class="NLM_article-title">A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fcgt.2012.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23175245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslahtbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1-7&author=L.+N.+Zhangauthor=J.+Y.+Liauthor=W.+Xu&title=A+review+of+the+role+of+Puma%2C+Noxa+and+Bim+in+the+tumorigenesis%2C+therapy+and+drug+resistance+of+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia</span></div><div class="casAuthors">Zhang, L.-N.; Li, J.-Y.; Xu, W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in the Western countries.  The entire pathogenesis of CLL is not clear now, but defective regulation of apoptosis seems to be more important than uncontrolled cell proliferation in CLL.  There are two main pathways of apoptosis: the extrinsic pathway and the intrinsic pathway.  It is worth noting that the intrinsic pathway, rather than the extrinsic pathway, appears to be the key mediator of impaired apoptosis in CLL as a result of B-cell lymphoma 2 (Bcl-2) upregulation.  One subclass of pro-apoptotic members within the Bcl-2 family are Bcl-2 homol. 3 (BH3)-only proteins.  They can regulate directly and/or indirectly the remaining Bcl-2 proteins to endanger mitochondria and induce apoptosis.  We chose three mols. from the BH3-only family, Puma, Noxa and Bim, resp., which had shown an exciting antitumor potential in previous reports, to explore their characters and functions in tumorigenesis, therapy and drug resistance of CLL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp6Fsvkbz3TLVg90H21EOLACvtfcHk0lg-y5WkVJZiFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslahtbjF&md5=1dc13a0accb59d2816d27acfac8186f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fcgt.2012.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcgt.2012.84%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BN.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DA%2520review%2520of%2520the%2520role%2520of%2520Puma%252C%2520Noxa%2520and%2520Bim%2520in%2520the%2520tumorigenesis%252C%2520therapy%2520and%2520drug%2520resistance%2520of%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2013%26volume%3D20%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwerth, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span> </span><span class="NLM_article-title">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+Wangauthor=M.+D.+Wendtauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+Bcl-2+family+proteins+induces+regression+of+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0lg-y5WkVJZiFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Varadarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsdale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, G. M.</span><span> </span><span class="NLM_article-title">Evaluation and critical assessment of putative MCL-1 inhibitors</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fcdd.2013.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23832116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1475-1484&author=S.+Varadarajanauthor=M.+Voglerauthor=M.+Butterworthauthor=D.+Dinsdaleauthor=L.+D.+Walenskyauthor=G.+M.+Cohen&title=Evaluation+and+critical+assessment+of+putative+MCL-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and critical assessment of putative MCL-1 inhibitors</span></div><div class="casAuthors">Varadarajan, S.; Vogler, M.; Butterworth, M.; Dinsdale, D.; Walensky, L. D.; Cohen, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1475-1484</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">High levels of BCL-2 family proteins are implicated in a failed/ineffective apoptotic program, often resulting in diseases, including cancer.  Owing to their potential as drug targets in cancer therapy, several inhibitors of BCL-2 family proteins have been developed.  These primarily target specific members of the BCL-2 family, particularly BCL-2 and BCL-XL but are ineffective against MCL-1.  Major efforts have been invested in developing inhibitors of MCL-1, which is commonly amplified in human tumors and assocd. with tumor relapse and chemoresistance.  In this report, the specificity of several BCL-2 family inhibitors (ABT-263, UCB-1350883, apogossypol and BH3I-1) was investigated and compared with putative MCL-1 inhibitors designed to exhibit improved or selective binding affinities for MCL-1 (TW-37, BI97C1, BI97C10, BI112D1, compds. 6 and 7, and MCL-1 inhibitor mol. (MIM-1)).  ABT-263, BI97C1, BI112D1, MIM-1 and TW-37 exhibited specificity in inducing apoptosis in a Bax/Bak- and caspase-9-dependent manner, whereas the other agents showed no killing activity, or little or no specificity.  Of these inhibitors, only ABT-263 and UCB-1350883 induced apoptosis in a BCL-2- or BCL-XL-dependent system.  In cells that depend on MCL-1 for survival, ABT-263 and TW-37 induced extensive apoptosis, suggesting that at high concns. these inhibitors have the propensity to inhibit MCL-1 in a cellular context.  TW-37 induced apoptosis, assessed by chromatin condensation, caspase processing and phosphatidylserine externalisation, in a BAK-dependent manner and in cells that require MCL-1 for survival.  TW-37-mediated apoptosis was also partly dependent on NOXA, suggesting that derivs. of TW-37, if engineered to exhibit better selectivity and efficacy at low nanomolar concns., may provide useful lead compds. for further synthetic programs.  Expanded medicinal chem. iteration, as performed for the ABT series, may likewise improve the potency and specificity of the evaluated MCL-1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb7rwc-6ii97Vg90H21EOLACvtfcHk0liG8p2FBdHkEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7rK&md5=92e0298a09e4a4133f05b5945098a146</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2013.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2013.79%26sid%3Dliteratum%253Aachs%26aulast%3DVaradarajan%26aufirst%3DS.%26aulast%3DVogler%26aufirst%3DM.%26aulast%3DButterworth%26aufirst%3DM.%26aulast%3DDinsdale%26aufirst%3DD.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26atitle%3DEvaluation%2520and%2520critical%2520assessment%2520of%2520putative%2520MCL-1%2520inhibitors%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D1475%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velankar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmandam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlossman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2374</span><span class="NLM_x">–</span> <span class="NLM_lpage">2380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=2374-2380&author=D.+Chauhanauthor=M.+Velankarauthor=M.+Brahmandamauthor=T.+Hideshimaauthor=K.+Podarauthor=P.+Richardsonauthor=R.+Schlossmanauthor=I.+Ghobrialauthor=N.+Rajeauthor=N.+Munshiauthor=K.+C.+Anderson&title=A+novel+Bcl-2%2FBcl-X%28L%29%2FBcl-w+inhibitor+ABT-737+as+therapy+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DVelankar%26aufirst%3DM.%26aulast%3DBrahmandam%26aufirst%3DM.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DSchlossman%26aufirst%3DR.%26aulast%3DGhobrial%26aufirst%3DI.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DA%2520novel%2520Bcl-2%252FBcl-X%2528L%2529%252FBcl-w%2520inhibitor%2520ABT-737%2520as%2520therapy%2520in%2520multiple%2520myeloma%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D2374%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Del Gaizo Moore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Certo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novina, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span> </span><span class="NLM_article-title">Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=112-121&author=V.+Del+Gaizo+Mooreauthor=J.+R.+Brownauthor=M.+Certoauthor=T.+M.+Loveauthor=C.+D.+Novinaauthor=A.+Letai&title=Chronic+lymphocytic+leukemia+requires+BCL2+to+sequester+prodeath+BIM%2C+explaining+sensitivity+to+BCL2+antagonist+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BGaizo%2BMoore%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DCerto%26aufirst%3DM.%26aulast%3DLove%26aufirst%3DT.%2BM.%26aulast%3DNovina%26aufirst%3DC.%2BD.%26aulast%3DLetai%26aufirst%3DA.%26atitle%3DChronic%2520lymphocytic%2520leukemia%2520requires%2520BCL2%2520to%2520sequester%2520prodeath%2520BIM%252C%2520explaining%2520sensitivity%2520to%2520BCL2%2520antagonist%2520ABT-737%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D112%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kuroda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamitsuji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murotani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniwaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, T.</span><span> </span><span class="NLM_article-title">ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=18028486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2008&pages=181-190&author=J.+Kurodaauthor=S.+Kimuraauthor=M.+Andreeffauthor=E.+Ashiharaauthor=Y.+Kamitsujiauthor=A.+Yokotaauthor=E.+Kawataauthor=M.+Takeuchiauthor=R.+Tanakaauthor=Y.+Murotaniauthor=Y.+Matsumotoauthor=H.+Tanakaauthor=A.+Strasserauthor=M.+Taniwakiauthor=T.+Maekawa&title=ABT-737+is+a+useful+component+of+combinatory+chemotherapies+for+chronic+myeloid+leukaemias+with+diverse+drug-resistance+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-737 is useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms</span></div><div class="casAuthors">Kuroda, Junya; Kimura, Shinya; Andreeff, Michael; Ashihara, Eishi; Kamitsuji, Yuri; Yokota, Asumi; Kawata, Eri; Takeuchi, Miki; Tanaka, Ruriko; Murotani, Yoshihide; Matsumoto, Yosuke; Tanaka, Hideo; Strasser, Andreas; Taniwaki, Masafumi; Maekawa, Taira</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The effect of ABT-737, a BH3-mimicking inhibitor for anti-apoptotic Bcl-2 and Bcl-XL, but not Mcl-1, against Bcr-Abl-pos. (Bcr-Abl+) leukemic cells was examd.  ABT-737 potently induced apoptosis in Bcr-Abl+ chronic myeloid leukemia (CML) cell lines and primary CML samples in vitro and prolonged the survival of mice xenografted with BV173 cells, a CML cell line.  Higher expression of anti-apoptotic Bcl-2 proteins reduced cell killing by ABT-737 in each cell line, but there was no correlation between the sensitivities to ABT-737 and the specific expression patterns of Bcl-2 family proteins among cell lines.  Thus, the cell killing effect of ABT-737 must be detd. not only by the expression patterns of Bcl-2 family proteins but also by other mechanisms, such as high expression of Bcr-Abl, or a drug-efflux pump, in CML cells.  ABT-737 augmented the cell killing effect of imatinib in Bcr-Abl+ cells with diverse drug-resistance mechanisms unless leukemic cells harbored imatinib-insensitive Abl kinase domain mutations, such as T315I.  The combination of homoharringtonine that reduces Mcl-1 enhanced the killing by ABT-737 strongly in Bcr-Abl+ cells even with T315I mutation.  These results suggest that ABT-737 is a useful component of chemotherapies for CML with diverse drug-resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolOvUcIGyBvrVg90H21EOLACvtfcHk0liG8p2FBdHkEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOntL8%253D&md5=1b891f8cd2abf62126cbe9ca258e5b33</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DAshihara%26aufirst%3DE.%26aulast%3DKamitsuji%26aufirst%3DY.%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DKawata%26aufirst%3DE.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DMurotani%26aufirst%3DY.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DTaniwaki%26aufirst%3DM.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3DABT-737%2520is%2520a%2520useful%2520component%2520of%2520combinatory%2520chemotherapies%2520for%2520chronic%2520myeloid%2520leukaemias%2520with%2520diverse%2520drug-resistance%2520mechanisms%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D140%26spage%3D181%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tagscherer, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macher-Goeppinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radlwimmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiestler, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, W.</span><span> </span><span class="NLM_article-title">Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6646-6656&author=K.+E.+Tagschererauthor=A.+Fasslauthor=B.+Camposauthor=M.+Farhadiauthor=A.+Kraemerauthor=B.+C.+Bockauthor=S.+Macher-Goeppingerauthor=B.+Radlwimmerauthor=O.+D.+Wiestlerauthor=C.+Herold-Mendeauthor=W.+Roth&title=Apoptosis-based+treatment+of+glioblastomas+with+ABT-737%2C+a+novel+small+molecule+inhibitor+of+Bcl-2+family+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTagscherer%26aufirst%3DK.%2BE.%26aulast%3DFassl%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DFarhadi%26aufirst%3DM.%26aulast%3DKraemer%26aufirst%3DA.%26aulast%3DBock%26aufirst%3DB.%2BC.%26aulast%3DMacher-Goeppinger%26aufirst%3DS.%26aulast%3DRadlwimmer%26aufirst%3DB.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DW.%26atitle%3DApoptosis-based%2520treatment%2520of%2520glioblastomas%2520with%2520ABT-737%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D6646%26epage%3D6656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan-Lappe, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarthy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span> </span><span class="NLM_article-title">Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1176-1183&author=S.+K.+Tahirauthor=X.+Yangauthor=M.+G.+Andersonauthor=S.+E.+Morgan-Lappeauthor=A.+V.+Sarthyauthor=J.+Chenauthor=R.+B.+Warnerauthor=S.+C.+Ngauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=C.+Tse&title=Influence+of+Bcl-2+family+members+on+the+cellular+response+of+small-cell+lung+cancer+cell+lines+to+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%2BE.%26aulast%3DSarthy%26aufirst%3DA.%2BV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DInfluence%2520of%2520Bcl-2%2520family%2520members%2520on%2520the%2520cellular%2520response%2520of%2520small-cell%2520lung%2520cancer%2520cell%2520lines%2520to%2520ABT-737%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D1176%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wesarg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffarth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiewrodt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesterfeld, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, M.</span><span> </span><span class="NLM_article-title">Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2Fijc.22977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17688235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlShtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=2387-2394&author=E.+Wesargauthor=S.+Hoffarthauthor=R.+Wiewrodtauthor=M.+Krollauthor=S.+Biesterfeldauthor=C.+Huberauthor=M.+Schuler&title=Targeting+BCL-2+family+proteins+to+overcome+drug+resistance+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer</span></div><div class="casAuthors">Wesarg, Emmanuelle; Hoffarth, Sandra; Wiewrodt, Rainer; Kroell, Monika; Biesterfeld, Stefan; Huber, Christoph; Schuler, Martin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2387-2394</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Cytotoxic chemotherapies are std. of care for patients suffering from advanced non-small cell lung cancer (NSCLC).  However, objective responses are only achieved in 20% of cases and long-term survival is rarely obsd.  Clin. applied anticancer drugs exert at least some of their activities by inducing apoptosis.  A crit. step in apoptotic signal transduction is the permeabilization of the mitochondrial outer membrane (MOM), which is regulated by the BCL-2 family of proteins.  Hence, therapeutic targeting of BCL-2 proteins is a promising approach to increase the drug-sensitivity of cancers.  To this end we have assessed the impact of conditional expression of the proapoptotic multidomain (BH1-2-3) protein BAK, which directly permeabilizes the MOM, and the BH3-mimetic ABT-737, which acts indirectly by derepressing BH1-2-3 proteins, on apoptosis and drug sensitivity of NSCLC cells.  Conditionally expressed BAK sensitized resistant NSCLC cells to drug-induced apoptosis.  In contrast, ABT-737 was ineffective in those NSCLC cells expressing high levels of the anti-apoptotic MCL-1 protein.  Tissue microarray anal. of tumor samples from 84 chemotherapy-naive NSCLC patients revealed MCL-1 expression in 56% of cases, thus supporting the relevance of this resistance factor in a clin. setting.  Enforced expression of the BH3-only protein NOXA, which targets MCL-1, overcame resistance to ABT-737.  Moreover, combining conditionally expressed BAK with ABT-737 enhanced apoptosis in NSCLC cells independently of their MCL-1 status.  In conclusion, the heterogeneity of apoptosis defects obsd. in drug-resistant NSCLC demands individually tailored mol. therapies.  Targeting the MOM permeabilizer BAK appears to have a broader apoptogenic activity than the BH3-only mimetic ABT-737.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPSGdartNqrVg90H21EOLACvtfcHk0lgviWzRpIURFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlShtb%252FO&md5=79d3c3a9eff2ea7875b1401f051167cb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fijc.22977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22977%26sid%3Dliteratum%253Aachs%26aulast%3DWesarg%26aufirst%3DE.%26aulast%3DHoffarth%26aufirst%3DS.%26aulast%3DWiewrodt%26aufirst%3DR.%26aulast%3DKroll%26aufirst%3DM.%26aulast%3DBiesterfeld%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DC.%26aulast%3DSchuler%26aufirst%3DM.%26atitle%3DTargeting%2520BCL-2%2520family%2520proteins%2520to%2520overcome%2520drug%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D2387%26epage%3D2394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2340</span><span class="NLM_x">–</span> <span class="NLM_lpage">2349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1158%2F1535-7163.MCT-11-0415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=21914853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2340-2349&author=J.+Chenauthor=S.+Jinauthor=V.+Abrahamauthor=X.+Huangauthor=B.+Liuauthor=M.+J.+Mittenauthor=P.+Nimmerauthor=X.+Linauthor=M.+Smithauthor=Y.+Shenauthor=A.+R.+Shoemakerauthor=S.+K.+Tahirauthor=H.+Zhangauthor=S.+L.+Acklerauthor=S.+H.+Rosenbergauthor=H.+Maeckerauthor=D.+Sampathauthor=J.+D.+Leversonauthor=C.+Tseauthor=S.+W.+Elmore&title=The+Bcl-2%2FBcl-X%28L%29%2FBcl-w+inhibitor%2C+navitoclax%2C+enhances+the+activity+of+chemotherapeutic+agents+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo</span></div><div class="casAuthors">Chen, Jun; Jin, Sha; Abraham, Vivek; Huang, Xiaoli; Liu, Bernard; Mitten, Michael J.; Nimmer, Paul; Lin, Xiaoyu; Smith, Morey; Shen, Yu; Shoemaker, Alexander R.; Tahir, Stephen K.; Zhang, Haichao; Ackler, Scott L.; Rosenberg, Saul H.; Maecker, Heather; Sampath, Deepak; Leverson, Joel D.; Tse, Chris; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2340-2349</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The ability of a cancer cell to avoid apoptosis is crucial to tumorigenesis and can also contribute to chemoresistance.  The Bcl-2 family of prosurvival proteins (Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and A1) plays a key role in these processes.  We previously reported the discovery of ABT-263 (navitoclax), a potent small-mol. inhibitor of Bcl-2, Bcl-XL, and Bcl-w.  While navitoclax exhibits single-agent activity in tumors dependent on Bcl-2 or Bcl-XL for survival, the expression of Mcl-1 has been shown to confer resistance to navitoclax, most notably in solid tumors.  Thus, therapeutic agents that can downregulate or neutralize Mcl-1 are predicted to synergize potently with navitoclax.  Here, we report the activity of navitoclax in combination with 19 clin. relevant agents across a panel of 46 human solid tumor cell lines.  Navitoclax broadly enhanced the activity of multiple therapeutic agents in vitro and enhanced efficacy of both docetaxel and erlotinib in xenograft models.  The ability of navitoclax to synergize with docetaxel or erlotinib corresponded to an altered sensitivity of the mitochondria toward navitoclax, which was assocd. with the downmodulation of Mcl-1 and/or upregulation of Bim.  These data provide a rationale to interrogate these combinations clin.  Mol Cancer Ther; 10(12); 2340-9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd9W2TOyfzbbVg90H21EOLACvtfcHk0lgviWzRpIURFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurbL&md5=88acb30a86091f88c3db820e69c8baae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0415%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DMaecker%26aufirst%3DH.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DThe%2520Bcl-2%252FBcl-X%2528L%2529%252FBcl-w%2520inhibitor%252C%2520navitoclax%252C%2520enhances%2520the%2520activity%2520of%2520chemotherapeutic%2520agents%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther%26date%3D2011%26volume%3D10%26spage%3D2340%26epage%3D2349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=782-791&author=S.+Chenauthor=Y.+Daiauthor=H.+Haradaauthor=P.+Dentauthor=S.+Grant&title=Mcl-1+down-regulation+potentiates+ABT-737+lethality+by+cooperatively+inducing+Bak+activation+and+Bax+translocation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DDent%26aufirst%3DP.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DMcl-1%2520down-regulation%2520potentiates%2520ABT-737%2520lethality%2520by%2520cooperatively%2520inducing%2520Bak%2520activation%2520and%2520Bax%2520translocation%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D782%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contractor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samudio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruvolo, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhaegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soengas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruvolo, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiffar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCubrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.ccr.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17097560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=375-388&author=M.+Konoplevaauthor=R.+Contractorauthor=T.+Tsaoauthor=I.+Samudioauthor=P.+P.+Ruvoloauthor=S.+Kitadaauthor=X.+Dengauthor=D.+Zhaiauthor=Y.+X.+Shiauthor=T.+Sneedauthor=M.+Verhaegenauthor=M.+Soengasauthor=V.+R.+Ruvoloauthor=T.+McQueenauthor=W.+D.+Schoberauthor=J.+C.+Wattauthor=T.+Jiffarauthor=X.+Lingauthor=F.+C.+Mariniauthor=D.+Harrisauthor=M.+Dietrichauthor=Z.+Estrovauthor=J.+McCubreyauthor=W.+S.+Mayauthor=J.+C.+Reedauthor=M.+Andreeff&title=Mechanisms+of+apoptosis+sensitivity+and+resistance+to+the+BH3+mimetic+ABT-737+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia</span></div><div class="casAuthors">Konopleva, Marina; Contractor, Rooha; Tsao, Twee; Samudio, Ismael; Ruvolo, Peter P.; Kitada, Shinichi; Deng, Xingming; Zhai, Dayong; Shi, Yue-Xi; Sneed, Thomas; Verhaegen, Monique; Soengas, Maria; Ruvolo, Vivian R.; McQueen, Teresa; Schober, Wendy D.; Watt, Julie C.; Jiffar, Tilahun; Ling, Xiaoyang; Marini, Frank C.; Harris, David; Dietrich, Martin; Estrov, Zeev; McCubrey, James; May, W. Stratford; Reed, John C.; Andreeff, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-388</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">BCL-2 proteins are crit. for cell survival and are overexpressed in many tumors.  ABT-737 is a small-mol. BH3 mimetic that exhibits single-agent activity against lymphoma and small-cell lung cancer in preclin. studies.  We here report that ABT-737 effectively kills acute myeloid leukemia blast, progenitor, and stem cells without affecting normal hematopoietic cells.  ABT-737 induced the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway.  In cells with phosphorylated BCL-2 or increased MCL-1, ABT-737 was inactive.  Inhibition of BCL-2 phosphorylation and redn. of MCL-1 expression restored sensitivity to ABT-737.  These data suggest that ABT-737 could be a highly effective antileukemia agent when the mechanisms of resistance identified here are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDhsJzVCfTBbVg90H21EOLACvtfcHk0lha01GUB03MeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nJ&md5=c2895bf6ccffe6a9f389dc6241666086</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DContractor%26aufirst%3DR.%26aulast%3DTsao%26aufirst%3DT.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DRuvolo%26aufirst%3DP.%2BP.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DY.%2BX.%26aulast%3DSneed%26aufirst%3DT.%26aulast%3DVerhaegen%26aufirst%3DM.%26aulast%3DSoengas%26aufirst%3DM.%26aulast%3DRuvolo%26aufirst%3DV.%2BR.%26aulast%3DMcQueen%26aufirst%3DT.%26aulast%3DSchober%26aufirst%3DW.%2BD.%26aulast%3DWatt%26aufirst%3DJ.%2BC.%26aulast%3DJiffar%26aufirst%3DT.%26aulast%3DLing%26aufirst%3DX.%26aulast%3DMarini%26aufirst%3DF.%2BC.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DDietrich%26aufirst%3DM.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DMcCubrey%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DW.%2BS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520apoptosis%2520sensitivity%2520and%2520resistance%2520to%2520the%2520BH3%2520mimetic%2520ABT-737%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D375%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Targeting multiple arms of the apoptotic regulatory machinery</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2908</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2908-2911&author=Y.+Daiauthor=S.+Grant&title=Targeting+multiple+arms+of+the+apoptotic+regulatory+machinery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DTargeting%2520multiple%2520arms%2520of%2520the%2520apoptotic%2520regulatory%2520machinery%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D2908%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0lha01GUB03MeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Shigemasa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katoh, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohama, K.</span><span> </span><span class="NLM_article-title">Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas</span> <span class="citation_source-journal">Jpn. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1111%2Fj.1349-7006.2002.tb01289.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=12036450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A280%3ADC%252BD383ps12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2002&pages=542-550&author=K.+Shigemasaauthor=O.+Katohauthor=Y.+Shiroyamaauthor=S.+Miharaauthor=K.+Mukaiauthor=N.+Nagaiauthor=K.+Ohama&title=Increased+MCL-1+expression+is+associated+with+poor+prognosis+in+ovarian+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas</span></div><div class="casAuthors">Shigemasa Kazushi; Katoh Osamu; Shiroyama Yuko; Mihara Shoji; Mukai Keiji; Nagai Nobutaka; Ohama Koso</div><div class="citationInfo"><span class="NLM_cas:title">Japanese journal of cancer research : Gann</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-50</span>
        ISSN:<span class="NLM_cas:issn">0910-5050</span>.
    </div><div class="casAbstract">To investigate the potential role of the BCL-2 gene family (BAX, BCL-2, MCL-1, and BCL-XL) in ovarian cancer development and progression, mRNA expression levels of these genes were measured using semi-quantitative PCR in epithelial ovarian tumor tissues and normal ovaries.  The immunohistochemical expression of MCL-1 in ovarian tumors was also examined.  The expression levels of BAX and MCL-1 mRNA were significantly higher in ovarian cancers and in adenomas than in normal ovaries (P < 0.05).  In contrast, the BCL-2 mRNA expression level in ovarian cancers was significantly lower than in ovarian adenomas and in normal ovaries (P < 0.05).  Expression of BCL-XL mRNA was no different between normal ovaries and ovarian tumors.  Log-rank testing showed that low BAX mRNA expression and high MCL-1 mRNA expression significantly correlate with poor survival for patients with stage III ovarian carcinomas (BAX, P = 0.05; MCL-1, P = 0.02).  Immunohistochemical analysis showed that diffuse-positive expression of MCL-1 protein in mucinous carcinomas was significantly higher than in mucinous low malignant potential (LMP) tumors (P = 0.03).  In ovarian cancer cases, diffuse-positive expression of MCL-1 protein significantly correlates with advanced clinical stage, high histologic grade, and poor survival (stage, P < 0.01; grade, P = 0.01; survival, P = 0.01).  These results suggest that increased MCL-1 expression may play an important role in replacing the functions of increased BAX and decreased BCL-2 in ovarian carcinoma cells, thereby promoting cell survival, and resulting in a poor prognosis for patients with ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaSlz5wkhgxxpyrDyM_m9cfW6udTcc2eb8QzWSKO_0crntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383ps12lsg%253D%253D&md5=dd0182a77e3fb21ad8d39e9e255f1715</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2002.tb01289.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2002.tb01289.x%26sid%3Dliteratum%253Aachs%26aulast%3DShigemasa%26aufirst%3DK.%26aulast%3DKatoh%26aufirst%3DO.%26aulast%3DShiroyama%26aufirst%3DY.%26aulast%3DMihara%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DK.%26aulast%3DNagai%26aufirst%3DN.%26aulast%3DOhama%26aufirst%3DK.%26atitle%3DIncreased%2520MCL-1%2520expression%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520ovarian%2520carcinomas%26jtitle%3DJpn.%2520J.%2520Cancer%2520Res.%26date%3D2002%26volume%3D93%26spage%3D542%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meryet-Figuiere, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duval, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villedieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy-Dudal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saison-Behmoaras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denoyelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=19634140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SqsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=885-895&author=E.+Brotinauthor=M.+Meryet-Figuiereauthor=K.+Simoninauthor=R.+E.+Duvalauthor=M.+Villedieuauthor=J.+Leroy-Dudalauthor=E.+Saison-Behmoarasauthor=P.+Gauduchonauthor=C.+Denoyelleauthor=L.+Poulain&title=Bcl-XL+and+MCL-1+constitute+pertinent+targets+in+ovarian+carcinoma+and+their+concomitant+inhibition+is+sufficient+to+induce+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis</span></div><div class="casAuthors">Brotin, Emilie; Meryet-Figuiere, Matthieu; Simonin, Karin; Duval, Raphael E.; Villedieu, Marie; Leroy-Dudal, Johanne; Saison-Behmoaras, Ester; Gauduchon, Pascal; Denoyelle, Christophe; Poulain, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">885-895</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In ovarian carcinomas, recurrence and acquired chemoresistance are the first leading causes of therapeutic failure and are responsible for the poor overall survival rate.  Cisplatin exposure of sensitive cells has been previously assocd. with a down-regulation of Bcl-XL expression and apoptosis, whereas recurrence was systematically obsd. when Bcl-XL expression was maintained.  Bcl-XL down-regulation could thus constitute an interesting chemosensitizing strategy.  We showed that a Bcl-XLtargeted RNA interference strategy efficiently sensitized chemoresistant ovarian carcinoma cells to cisplatin, but some of them were still able to re-proliferate.  Considering the possible cooperation between Bcl-XLand MCL-1, we investigated the possibility to avoid recurrence in vitro using a multi-targeted RNAi strategy directed against these two anti-apoptotic proteins.  We showed that their concomitant inhibition lead to massive apoptosis in absence of cisplatin, this multi-targeted RNAi approach being much more efficient than conventional chemotherapy.  We thus demonstrated that Bcl-XL and MCL-1 cooperate to constitute together a strong mol. "bolt", which elimination could be sufficient to allow chemoresistant ovarian carcinoma cells apoptosis.  Moreover, we demonstrated that in presence of a low concn. of cisplatin, the concomitant down-regulation of Bcl-XL and MCL-1 allowed a complete annihilation of tumor cells population thus avoiding subsequent recurrence in vitro in cell lines highly refractory to any type of conventional chemotherapy.  Therefore, Bcl-XL and MCL-1 targeted strategies could constitute an efficient therapeutic tool for the treatment of chemoresistant ovarian carcinoma, in assocn. with conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5MNifRb1ltrVg90H21EOLACvtfcHk0liiiMl3XyhV_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SqsLrI&md5=dca4ee5a00c3218da05d2536a6600555</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DMeryet-Figuiere%26aufirst%3DM.%26aulast%3DSimonin%26aufirst%3DK.%26aulast%3DDuval%26aufirst%3DR.%2BE.%26aulast%3DVilledieu%26aufirst%3DM.%26aulast%3DLeroy-Dudal%26aufirst%3DJ.%26aulast%3DSaison-Behmoaras%26aufirst%3DE.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DDenoyelle%26aufirst%3DC.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DBcl-XL%2520and%2520MCL-1%2520constitute%2520pertinent%2520targets%2520in%2520ovarian%2520carcinoma%2520and%2520their%2520concomitant%2520inhibition%2520is%2520sufficient%2520to%2520induce%2520apoptosis%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D126%26spage%3D885%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Simonin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufort, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutoit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’diaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denoyelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3162</span><span class="NLM_x">–</span> <span class="NLM_lpage">3170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1158%2F1535-7163.MCT-09-0493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=19887550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3162-3170&author=K.+Simoninauthor=E.+Brotinauthor=S.+Dufortauthor=S.+Dutoitauthor=D.+Gouxauthor=M.+N%E2%80%99diayeauthor=C.+Denoyelleauthor=P.+Gauduchonauthor=L.+Poulain&title=Mcl-1+is+an+important+determinant+of+the+apoptotic+response+to+the+BH3-mimetic+molecule+HA14-1+in+cisplatin-resistant+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells</span></div><div class="casAuthors">Simonin, Karin; Brotin, Emilie; Dufort, Sandrine; Dutoit, Soizic; Goux, Didier; N'Diaye, Monique; Denoyelle, Christophe; Gauduchon, Pascal; Poulain, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3162-3170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chemoresistance of ovarian carcinoma has been assocd. previously to the absence of Bcl-xL expression downregulation in response to cisplatin.  Among BH3-mimetic mols. constituting promising anticancer agents able to inhibit the activity of antiapoptotic Bcl-2 family proteins, we evaluated the effect of one of them, HA14-1, on various ovarian carcinoma cell lines.  In response to HA14-1, the cisplatin-resistant IGROV1-R10 cell line underwent massive cell death, whereas other cell lines presented a partial response (IGROV1, SKOV3, and A2780) or did not respond to this mol. (OAW42 and OAW42-R).  However, the expression of HA14-1 targets (Bcl-2 and Bcl-xL) did not correlate to these different responses.  In contrast, cell death was assocd. with the disappearance of Mcl-1 after exposure to HA14-1.  We showed that, in the HA14-1 nonresponsive cell lines (SKOV3 and OAW42), small interfering RNA-mediated Mcl-1 downregulation allowed HA14-1-induced massive apoptosis in the absence of chemotherapy.  Furthermore, cisplatin-induced Mcl-1 downregulation was also able to sensitize highly chemoresistant SKOV3 cells to HA14-1.  Taken together, these results show that Bcl-xL and Mcl-1 are able to cooperate to protect ovarian carcinoma cells against oncogenic stress or chemotherapy-induced apoptosis and suggest that the development of multitargeted strategies directed against these two antiapoptotic proteins may constitute a major challenge for the therapeutic care of chemoresistant ovarian carcinomas.  BH3-mimetic compds. represent promising tools for this purpose either on their own (direct or indirect pan-inhibitors) or in combination with new drugs aiming to inactivate Mcl-1. [Mol Cancer Ther 2009;8(11):3162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruERdWJYwjbLVg90H21EOLACvtfcHk0liiiMl3XyhV_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zO&md5=cbf890e939ec33abc700a8893ff49853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0493%26sid%3Dliteratum%253Aachs%26aulast%3DSimonin%26aufirst%3DK.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DDufort%26aufirst%3DS.%26aulast%3DDutoit%26aufirst%3DS.%26aulast%3DGoux%26aufirst%3DD.%26aulast%3DN%25E2%2580%2599diaye%26aufirst%3DM.%26aulast%3DDenoyelle%26aufirst%3DC.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DMcl-1%2520is%2520an%2520important%2520determinant%2520of%2520the%2520apoptotic%2520response%2520to%2520the%2520BH3-mimetic%2520molecule%2520HA14-1%2520in%2520cisplatin-resistant%2520ovarian%2520carcinoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D3162%26epage%3D3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Simonin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’diaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lheureux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loussouarn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutoit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giffard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanc-Fournier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=492-508&author=K.+Simoninauthor=M.+N%E2%80%99diayeauthor=S.+Lheureuxauthor=C.+Loussouarnauthor=S.+Dutoitauthor=M.+Briandauthor=F.+Giffardauthor=E.+Brotinauthor=C.+Blanc-Fournierauthor=L.+Poulain&title=Platinum+compounds+sensitize+ovarian+carcinoma+cells+to+ABT-737+by+modulation+of+the+Mcl-1%2FNoxa+axis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimonin%26aufirst%3DK.%26aulast%3DN%25E2%2580%2599diaye%26aufirst%3DM.%26aulast%3DLheureux%26aufirst%3DS.%26aulast%3DLoussouarn%26aufirst%3DC.%26aulast%3DDutoit%26aufirst%3DS.%26aulast%3DBriand%26aufirst%3DM.%26aulast%3DGiffard%26aufirst%3DF.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DBlanc-Fournier%26aufirst%3DC.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DPlatinum%2520compounds%2520sensitize%2520ovarian%2520carcinoma%2520cells%2520to%2520ABT-737%2520by%2520modulation%2520of%2520the%2520Mcl-1%252FNoxa%2520axis%26jtitle%3DApoptosis%26date%3D2013%26volume%3D18%26spage%3D492%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raychaudhuri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barretina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc Henry, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinchback, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haery, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prensner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liefeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yecies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signoretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demichelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladanyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraway, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">True, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomeroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span> </span><span class="NLM_article-title">The landscape of somatic copy-number alteration across human cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnature08822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=20164920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=899-905&author=R.+Beroukhimauthor=C.+H.+Mermelauthor=D.+Porterauthor=G.+Weiauthor=S.+Raychaudhuriauthor=J.+Donovanauthor=J.+Barretinaauthor=J.+S.+Boehmauthor=J.+Dobsonauthor=M.+Urashimaauthor=K.+T.+Mc+Henryauthor=R.+M.+Pinchbackauthor=A.+H.+Ligonauthor=Y.+J.+Choauthor=L.+Haeryauthor=H.+Greulichauthor=M.+Reichauthor=W.+Wincklerauthor=M.+S.+Lawrenceauthor=B.+A.+Weirauthor=K.+E.+Tanakaauthor=D.+Y.+Chiangauthor=A.+J.+Bassauthor=A.+Looauthor=C.+Hoffmanauthor=J.+Prensnerauthor=T.+Liefeldauthor=Q.+Gaoauthor=D.+Yeciesauthor=S.+Signorettiauthor=E.+Maherauthor=F.+J.+Kayeauthor=H.+Sasakiauthor=J.+E.+Tepperauthor=J.+A.+Fletcherauthor=J.+Taberneroauthor=J.+Baselgaauthor=M.+S.+Tsaoauthor=F.+Demichelisauthor=M.+A.+Rubinauthor=P.+A.+Janneauthor=M.+J.+Dalyauthor=C.+Nuceraauthor=R.+L.+Levineauthor=B.+L.+Ebertauthor=S.+Gabrielauthor=A.+K.+Rustgiauthor=C.+R.+Antonescuauthor=M.+Ladanyiauthor=A.+Letaiauthor=L.+A.+Garrawayauthor=M.+Lodaauthor=D.+G.+Beerauthor=L.+D.+Trueauthor=A.+Okamotoauthor=S.+L.+Pomeroyauthor=S.+Singerauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=G.+Getzauthor=W.+R.+Sellersauthor=M.+Meyerson&title=The+landscape+of+somatic+copy-number+alteration+across+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The landscape of somatic copy-number alteration across human cancers</span></div><div class="casAuthors">Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers.  Here we present high-resoln. analyses of somatic copy-no. alterations (SCNAs) from 3131 cancer specimens, belonging largely to 26 histol. types.  We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions.  Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-κB pathway.  We show that cancer cells contg. amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival.  Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYRlqR0wXLVg90H21EOLACvtfcHk0liOkz_5THDcEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D&md5=be6d81f5449cba96dfb4659106f706b0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature08822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08822%26sid%3Dliteratum%253Aachs%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DMermel%26aufirst%3DC.%2BH.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DBarretina%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DDobson%26aufirst%3DJ.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DMc%2BHenry%26aufirst%3DK.%2BT.%26aulast%3DPinchback%26aufirst%3DR.%2BM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26aulast%3DHaery%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DWinckler%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%2BE.%26aulast%3DChiang%26aufirst%3DD.%2BY.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DC.%26aulast%3DPrensner%26aufirst%3DJ.%26aulast%3DLiefeld%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYecies%26aufirst%3DD.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DMaher%26aufirst%3DE.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DTepper%26aufirst%3DJ.%2BE.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DNucera%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DThe%2520landscape%2520of%2520somatic%2520copy-number%2520alteration%2520across%2520human%2520cancers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D899%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan-Lappe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakula, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernetti, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span> </span><span class="NLM_article-title">‘Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3972</span><span class="NLM_x">–</span> <span class="NLM_lpage">3979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3972-3979&author=X.+Linauthor=S.+Morgan-Lappeauthor=X.+Huangauthor=L.+Liauthor=D.+M.+Zakulaauthor=L.+A.+Vernettiauthor=S.+W.+Fesikauthor=Y.+Shen&title=%E2%80%98Seed%E2%80%99+analysis+of+off-target+siRNAs+reveals+an+essential+role+of+Mcl-1+in+resistance+to+the+small-molecule+Bcl-2%2FBcl-XL+inhibitor+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZakula%26aufirst%3DD.%2BM.%26aulast%3DVernetti%26aufirst%3DL.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26atitle%3D%25E2%2580%2598Seed%25E2%2580%2599%2520analysis%2520of%2520off-target%2520siRNAs%2520reveals%2520an%2520essential%2520role%2520of%2520Mcl-1%2520in%2520resistance%2520to%2520the%2520small-molecule%2520Bcl-2%252FBcl-XL%2520inhibitor%2520ABT-737%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D3972%26epage%3D3979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lucas, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohana-Kumaran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weninger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. D.</span><span> </span><span class="NLM_article-title">Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1158%2F1078-0432.CCR-11-1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=22173547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=783-795&author=K.+M.+Lucasauthor=N.+Mohana-Kumaranauthor=D.+Lauauthor=X.+D.+Zhangauthor=P.+Herseyauthor=D.+C.+Huangauthor=W.+Weningerauthor=N.+K.+Haassauthor=J.+D.+Allen&title=Modulation+of+NOXA+and+MCL-1+as+a+strategy+for+sensitizing+melanoma+cells+to+the+BH3-mimetic+ABT-737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737</span></div><div class="casAuthors">Lucas, Keryn M.; Mohana-Kumaran, Nethia; Lau, Diana; Zhang, Xu Dong; Hersey, Peter; Huang, David C.; Weninger, Wolfgang; Haass, Nikolas K.; Allen, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">783-795</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Drug resistance in melanoma is commonly attributed to ineffective apoptotic pathways.  Inhibiting antiapoptotic BCL-2 and its relatives is an attractive strategy for sensitizing lymphoid malignancies to drugs but it has been largely unsuccessful for melanoma and other solid tumors.  ABT-737, a small-mol. BH3-mimetic, selectively inhibits BCL-2, BCL-XL, and BCL-w and shows promise for treating leukemia, lymphoma, and small-cell lung cancer.  Melanoma cells are insensitive to ABT-737, but MCL-1 inhibition reportedly increases the sensitivity of other tumors to the compd.  Exptl. Design: The efficacy of MCL-1 and BFL-1 inhibition for sensitizing melanoma cells to ABT-737 was investigated by short hairpin RNA-mediated knockdown or overexpression of their antagonist NOXA in two-dimensional cell culture, a three-dimensional organotypic spheroid model, and an in vivo model.  RESULTS:MCL-1 downregulation or NOXA overexpression strongly sensitized melanoma cells to ABT-737 in vitro.  NOXA-inducing cytotoxic drugs also strongly sensitized melanomas to ABT-737 but, surprisingly, not vice versa.  The drugs most suitable are not necessarily those normally used to treat melanoma.  Resistance to ABT-737 occurred quickly in three-dimensional melanoma spheroids through reduced NOXA expression, although expts. with both xenografts and three-dimensional spheroids suggest that penetration of ABT-737 into tumor masses may be the principal limitation, which may be obviated through use of more diffusible BH3-mimetics.  CONCLUSION: Sensitization of tumors to BH3-mimetics by cytotoxic drugs that induce NOXA is a therapeutic strategy worth exploring for the treatment of melanoma and other solid cancers.  Clin Cancer Res; 18(3); 783-95.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0cpQgRwax7Vg90H21EOLACvtfcHk0lgT-ohtD8EETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOktbY%253D&md5=908c621dd5e5665271e4c9020f29d0a9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1166%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DK.%2BM.%26aulast%3DMohana-Kumaran%26aufirst%3DN.%26aulast%3DLau%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%2BD.%26aulast%3DHersey%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DWeninger%26aufirst%3DW.%26aulast%3DHaass%26aufirst%3DN.%2BK.%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26atitle%3DModulation%2520of%2520NOXA%2520and%2520MCL-1%2520as%2520a%2520strategy%2520for%2520sensitizing%2520melanoma%2520cells%2520to%2520the%2520BH3-mimetic%2520ABT-737%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D783%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Russo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spagnuolo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, G. L.</span><span> </span><span class="NLM_article-title">ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=927-936&author=M.+Russoauthor=C.+Spagnuoloauthor=S.+Volpeauthor=I.+Tedescoauthor=S.+Bilottoauthor=G.+L.+Russo&title=ABT-737+resistance+in+B-cells+isolated+from+chronic+lymphocytic+leukemia+patients+and+leukemia+cell+lines+is+overcome+by+the+pleiotropic+kinase+inhibitor+quercetin+through+Mcl-1+down-regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DSpagnuolo%26aufirst%3DC.%26aulast%3DVolpe%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DI.%26aulast%3DBilotto%26aufirst%3DS.%26aulast%3DRusso%26aufirst%3DG.%2BL.%26atitle%3DABT-737%2520resistance%2520in%2520B-cells%2520isolated%2520from%2520chronic%2520lymphocytic%2520leukemia%2520patients%2520and%2520leukemia%2520cell%2520lines%2520is%2520overcome%2520by%2520the%2520pleiotropic%2520kinase%2520inhibitor%2520quercetin%2520through%2520Mcl-1%2520down-regulation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D927%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jebahi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villedieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petigny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeilard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giffard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guercio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lheureux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-x-targeting strategies, provided that Bim expression is induced</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.canlet.2014.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=24576622" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2014&pages=212-224&author=A.+Jebahiauthor=M.+Villedieuauthor=C.+Petignyauthor=E.+Brotinauthor=M.+H.+Louisauthor=E.+Abeilardauthor=F.+Giffardauthor=M.+Guercioauthor=M.+Briandauthor=P.+Gauduchonauthor=S.+Lheureuxauthor=L.+Poulain&title=PI3K%2FmTOR+dual+inhibitor+NVP-BEZ235+decreases+Mcl-1+expression+and+sensitizes+ovarian+carcinoma+cells+to+Bcl-x-targeting+strategies%2C+provided+that+Bim+expression+is+induced"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DJebahi%26aufirst%3DA.%26aulast%3DVilledieu%26aufirst%3DM.%26aulast%3DPetigny%26aufirst%3DC.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DLouis%26aufirst%3DM.%2BH.%26aulast%3DAbeilard%26aufirst%3DE.%26aulast%3DGiffard%26aufirst%3DF.%26aulast%3DGuercio%26aufirst%3DM.%26aulast%3DBriand%26aufirst%3DM.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DLheureux%26aufirst%3DS.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DPI3K%252FmTOR%2520dual%2520inhibitor%2520NVP-BEZ235%2520decreases%2520Mcl-1%2520expression%2520and%2520sensitizes%2520ovarian%2520carcinoma%2520cells%2520to%2520Bcl-x-targeting%2520strategies%252C%2520provided%2520that%2520Bim%2520expression%2520is%2520induced%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D347%26spage%3D212%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, M. G.</span><span> </span><span class="NLM_article-title">Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=4738-4744&author=C.+L.+Dayauthor=L.+Chenauthor=S.+J.+Richardsonauthor=P.+J.+Harrisonauthor=D.+C.+Huangauthor=M.+G.+Hinds&title=Solution+structure+of+prosurvival+Mcl-1+and+characterization+of+its+binding+by+proapoptotic+BH3-only+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DHarrison%26aufirst%3DP.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26atitle%3DSolution%2520structure%2520of%2520prosurvival%2520Mcl-1%2520and%2520characterization%2520of%2520its%2520binding%2520by%2520proapoptotic%2520BH3-only%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D4738%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Quinn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azab, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyesanya, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curiel, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dmitriev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedvat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, P. B.</span><span> </span><span class="NLM_article-title">Targeting Mcl-1 for the therapy of cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1517%2F13543784.2011.609167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=21851287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGgur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1397-1411&author=B.+A.+Quinnauthor=R.+Dashauthor=B.+Azabauthor=S.+Sarkarauthor=S.+K.+Dasauthor=S.+Kumarauthor=R.+A.+Oyesanyaauthor=S.+Dasguptaauthor=P.+Dentauthor=S.+Grantauthor=M.+Rahmaniauthor=D.+T.+Curielauthor=I.+Dmitrievauthor=M.+Hedvatauthor=J.+Weiauthor=B.+Wuauthor=J.+L.+Stebbinsauthor=J.+C.+Reedauthor=M.+Pellecchiaauthor=D.+Sarkarauthor=P.+B.+Fisher&title=Targeting+Mcl-1+for+the+therapy+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mcl-1 for the therapy of cancer</span></div><div class="casAuthors">Quinn, Bridget A.; Dash, Rupesh; Azab, Belal; Sarkar, Siddik; Das, Swadesh K.; Kumar, Sachin; Oyesanya, Regina A.; Dasgupta, Santanu; Dent, Paul; Grant, Steven; Rahmani, Mohamed; Curiel, David T.; Dmitriev, Igor; Hedvat, Michael; Wei, Jun; Wu, Bainan; Stebbins, John L.; Reed, John C.; Pellecchia, Maurizio; Sarkar, Devanand; Fisher, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1397-1411</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Human cancers are genetically and epigenetically heterogeneous and have the capacity to commandeer a variety of cellular processes to aid in their survival, growth and resistance to therapy.  One strategy is to overexpress proteins that suppress apoptosis, such as the Bcl-2 family protein Mcl-1.  The Mcl-1 protein plays a pivotal role in protecting cells from apoptosis and is overexpressed in a variety of human cancers.Areas covered:Targeting Mcl-1 for extinction in these cancers, using genetic and pharmacol. approaches, represents a potentially effectual means of developing new efficacious cancer therapeutics.  Here we review the multiple strategies that have been employed in targeting this fundamental protein, as well as the significant potential these targeting agents provide in not only suppressing cancer growth, but also in reversing resistance to conventional cancer treatments.Expert opinion:We discuss the potential issues that arise in targeting Mcl-1 and other Bcl-2 anti-apoptotic proteins, as well problems with acquired resistance.  The application of combinatorial approaches that involve inhibiting Mcl-1 and manipulation of addnl. signaling pathways to enhance therapeutic outcomes is also highlighted.  The ability to specifically inhibit key genetic/epigenetic elements and biochem. pathways that maintain the tumor state represent a viable approach for developing rationally based, effective cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeNFpz1mcESrVg90H21EOLACvtfcHk0lgT-ohtD8EETQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGgur3N&md5=7e2e0ab1cedb25a32b8e97a935238013</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.609167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.609167%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DB.%2BA.%26aulast%3DDash%26aufirst%3DR.%26aulast%3DAzab%26aufirst%3DB.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DOyesanya%26aufirst%3DR.%2BA.%26aulast%3DDasgupta%26aufirst%3DS.%26aulast%3DDent%26aufirst%3DP.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DRahmani%26aufirst%3DM.%26aulast%3DCuriel%26aufirst%3DD.%2BT.%26aulast%3DDmitriev%26aufirst%3DI.%26aulast%3DHedvat%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DPellecchia%26aufirst%3DM.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26atitle%3DTargeting%2520Mcl-1%2520for%2520the%2520therapy%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1397%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Billard, C.</span><span> </span><span class="NLM_article-title">Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2032</span><span class="NLM_x">–</span> <span class="NLM_lpage">2038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2032-2038&author=C.+Billard&title=Design+of+novel+BH3+mimetics+for+the+treatment+of+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBillard%26aufirst%3DC.%26atitle%3DDesign%2520of%2520novel%2520BH3%2520mimetics%2520for%2520the%2520treatment%2520of%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26spage%3D2032%26epage%3D2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puthalakath, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=341-355&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=M.+F.+van+Delftauthor=E.+M.+Michalakauthor=M.+J.+Boyleauthor=S.+N.+Willisauthor=H.+Puthalakathauthor=P.+Bouilletauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=A+novel+BH3+ligand+that+selectively+targets+Mcl-1+reveals+that+apoptosis+can+proceed+without+Mcl-1+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DMichalak%26aufirst%3DE.%2BM.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520BH3%2520ligand%2520that%2520selectively%2520targets%2520Mcl-1%2520reveals%2520that%2520apoptosis%2520can%2520proceed%2520without%2520Mcl-1%2520degradation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D341%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Stewart, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fire, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1038%2Fnchembio.391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=20562877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXns1Gis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=595-601&author=M.+L.+Stewartauthor=E.+Fireauthor=A.+E.+Keatingauthor=L.+D.+Walensky&title=The+MCL-1+BH3+helix+is+an+exclusive+MCL-1+inhibitor+and+apoptosis+sensitizer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer</span></div><div class="casAuthors">Stewart, Michelle L.; Fire, Emiko; Keating, Amy E.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">595-601</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of selective inhibitors for discrete anti-apoptotic BCL-2 family proteins implicated in pathol. cell survival remains a formidable but pressing challenge.  Such precisely tailored compds. would serve as mol. probes and targeted therapies to study and treat human diseases driven by specific anti-apoptotic blockades.  In particular, MCL-1 has emerged as a major resistance factor in human cancer.  By screening a library of stabilized alpha-helix of BCL-2 domains (SAHBs), we detd. that the MCL-1 BH3 helix is itself a potent and exclusive MCL-1 inhibitor.  X-ray crystallog. and mutagenesis studies defined key binding and specificity determinants, including the capacity to harness the hydrocarbon staple to optimize affinity while preserving selectivity.  MCL-1 SAHB directly targets MCL-1, neutralizes its inhibitory interaction with pro-apoptotic BAK and sensitizes cancer cells to caspase-dependent apoptosis.  By leveraging nature's soln. to ligand selectivity, we generated an MCL-1-specific agent that defines the structural and functional features of targeted MCL-1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKSZxSkketOLVg90H21EOLACvtfcHk0ljzciWsdXWLXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXns1Gis7c%253D&md5=4cc80db931dac5360d650ac9c45334ea</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.391%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DM.%2BL.%26aulast%3DFire%26aufirst%3DE.%26aulast%3DKeating%26aufirst%3DA.%2BE.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DThe%2520MCL-1%2520BH3%2520helix%2520is%2520an%2520exclusive%2520MCL-1%2520inhibitor%2520and%2520apoptosis%2520sensitizer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D595%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span> </span><span class="NLM_article-title">S1, a novel pan-BH3 mimetic, induces apoptosis in Mcl-1-overexpressing cells through Bak</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1254%2Fjphs.12103FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=22814102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlagtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=330-340&author=T.+Songauthor=X.+Changauthor=Z.+Zhangauthor=Y.+Liuauthor=X.+Shen&title=S1%2C+a+novel+pan-BH3+mimetic%2C+induces+apoptosis+in+Mcl-1-overexpressing+cells+through+Bak"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">S1, a novel Pan-BH3 mimetic, induces apoptosis in Mcl-1-overexpressing cells through Bak</span></div><div class="casAuthors">Song, Ting; Chang, Xilong; Zhang, Zhichao; Liu, Yubo; Shen, Xiaoyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">330-340</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Mcl-1, an anti-apoptotic Bcl-2 homolog that has a structurally divergent BH3-binding pocket, non-redundant action model, and unique characteristic of short life confers complete resistance to the BH3 mimetic ABT-737.  Herein, we used S1, previously identified as a Mcl-1/Bcl-2 dual inhibitor and a pure BH3 mimetic, to explore the mechanism of Mcl-1's action and supply a strategy to challenge Mcl-1's protection.  Apoptosis assay in SMMC-7721, HCT116, and K562 cells demonstrated that S1 can effectively challenge Mcl-1's anti-apoptotic effect.  Notably, we discovered an unexpected dynamic change of Mcl-1 that directly correlates with resistance or commitment to apoptosis induced by both ABT-737 and S1.  Co-immunopptn. assays demonstrated that Mcl-1 increase results from Bim trafficking from Bcl-2 to Mcl-1, while subsequent Bak released by S1 dets. Mcl-1 decrease and full-blown apoptosis.  Further expts. using Bak shRNA testified that Bak accounts for S1-induced apoptosis and Mcl-1 decrease.  Consistently, Bax-deficient DU145 cells are sensitive to S1, whereas Bak-mutant MKN-28 cells are significantly more resistant.  The in vitro model could be extended to an in vivo mouse xenograft model in which Mcl-1 confers resistance by increased protein level, and the release of Bak could serve as a biomarker of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTk7MtIp1CY7Vg90H21EOLACvtfcHk0ljzciWsdXWLXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlagtbvO&md5=4715e90a31166ee255d00018b6f0ecf8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1254%2Fjphs.12103FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.12103FP%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DS1%252C%2520a%2520novel%2520pan-BH3%2520mimetic%252C%2520induces%2520apoptosis%2520in%2520Mcl-1-overexpressing%2520cells%2520through%2520Bak%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D119%26spage%3D330%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H.</span><span> </span><span class="NLM_article-title">Design and application of a rigid quinazolone scaffold based on two-face Bim alpha-helix mimicking</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=711-718&author=Z.+Zhangauthor=X.+Liangauthor=X.+Liauthor=T.+Songauthor=Q.+Chenauthor=H.+Sheng&title=Design+and+application+of+a+rigid+quinazolone+scaffold+based+on+two-face+Bim+alpha-helix+mimicking"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DSheng%26aufirst%3DH.%26atitle%3DDesign%2520and%2520application%2520of%2520a%2520rigid%2520quinazolone%2520scaffold%2520based%2520on%2520two-face%2520Bim%2520alpha-helix%2520mimicking%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D711%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Doi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manieri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnegowda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awwad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daughdrill, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. G.</span><span> </span><span class="NLM_article-title">Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">10224</span><span class="NLM_x">–</span> <span class="NLM_lpage">10235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=10224-10235&author=K.+Doiauthor=R.+Liauthor=S.+S.+Sungauthor=H.+Wuauthor=Y.+Liuauthor=W.+Manieriauthor=G.+Krishnegowdaauthor=A.+Awwadauthor=A.+Deweyauthor=X.+Liuauthor=S.+Aminauthor=C.+Chengauthor=Y.+Qinauthor=E.+Schonbrunnauthor=G.+Daughdrillauthor=T.+P.+Loughranauthor=S.+Sebtiauthor=H.+G.+Wang&title=Discovery+of+marinopyrrole+A+%28maritoclax%29+as+a+selective+Mcl-1+antagonist+that+overcomes+ABT-737+resistance+by+binding+to+and+targeting+Mcl-1+for+proteasomal+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoi%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DManieri%26aufirst%3DW.%26aulast%3DKrishnegowda%26aufirst%3DG.%26aulast%3DAwwad%26aufirst%3DA.%26aulast%3DDewey%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DDaughdrill%26aufirst%3DG.%26aulast%3DLoughran%26aufirst%3DT.%2BP.%26aulast%3DSebti%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%2BG.%26atitle%3DDiscovery%2520of%2520marinopyrrole%2520A%2520%2528maritoclax%2529%2520as%2520a%2520selective%2520Mcl-1%2520antagonist%2520that%2520overcomes%2520ABT-737%2520resistance%2520by%2520binding%2520to%2520and%2520targeting%2520Mcl-1%2520for%2520proteasomal%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D10224%26epage%3D10235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Cohen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavathiotis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruekner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opferman, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.chembiol.2012.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=22999885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2rsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1175-1186&author=N.+A.+Cohenauthor=M.+L.+Stewartauthor=E.+Gavathiotisauthor=J.+L.+Tepperauthor=S.+R.+Brueknerauthor=B.+Kossauthor=J.+T.+Opfermanauthor=L.+D.+Walensky&title=A+competitive+stapled+peptide+screen+identifies+a+selective+small+molecule+that+overcomes+MCL-1-dependent+leukemia+cell+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Competitive Stapled Peptide Screen Identifies a Selective Small Molecule that Overcomes MCL-1-Dependent Leukemia Cell Survival</span></div><div class="casAuthors">Cohen, Nicole A.; Stewart, Michelle L.; Gavathiotis, Evripidis; Tepper, Jared L.; Bruekner, Susanne R.; Koss, Brian; Opferman, Joseph T.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1175-1186</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cancer cells hijack BCL-2 family survival proteins to suppress the death effectors and thereby enforce an immortal state.  This is accomplished biochem. by an antiapoptotic surface groove that neutralizes the proapoptotic BH3 α helix of death proteins.  Antiapoptotic MCL-1 in particular has emerged as a ubiquitous resistance factor in cancer.  Although targeting the BCL-2 antiapoptotic subclass effectively restores the death pathway in BCL-2-dependent cancer, the development of mols. tailored to the binding specificity of MCL-1 has lagged.  We previously discovered that a hydrocarbon-stapled MCL-1 BH3 helix is an exquisitely selective MCL-1 antagonist.  By deploying this unique reagent in a competitive screen, we identified an MCL-1 inhibitor mol. that selectively targets the BH3-binding groove of MCL-1, neutralizes its biochem. lock-hold on apoptosis, and induces caspase activation and leukemia cell death in the specific context of MCL-1 dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Lokm8RYN5rVg90H21EOLACvtfcHk0lhf1_iqmiKoPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2rsL7M&md5=5306c2b2c2ff29a70ecfc83674f07423</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DN.%2BA.%26aulast%3DStewart%26aufirst%3DM.%2BL.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DTepper%26aufirst%3DJ.%2BL.%26aulast%3DBruekner%26aufirst%3DS.%2BR.%26aulast%3DKoss%26aufirst%3DB.%26aulast%3DOpferman%26aufirst%3DJ.%2BT.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DA%2520competitive%2520stapled%2520peptide%2520screen%2520identifies%2520a%2520selective%2520small%2520molecule%2520that%2520overcomes%2520MCL-1-dependent%2520leukemia%2520cell%2520survival%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1175%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Friberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301448p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=15-30&author=A.+Fribergauthor=D.+Vigilauthor=B.+Zhaoauthor=R.+N.+Danielsauthor=J.+P.+Burkeauthor=P.+M.+Garcia-Barrantesauthor=D.+Camperauthor=B.+A.+Chauderauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Discovery+of+potent+myeloid+cell+leukemia+1+%28Mcl-1%29+inhibitors+using+fragment-based+methods+and+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design</span></div><div class="casAuthors">Friberg, Anders; Vigil, Dominico; Zhao, Bin; Daniels, R. Nathan; Burke, Jason P.; Garcia-Barrantes, Pedro M.; Camper, DeMarco; Chauder, Brian A.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-30</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis.  Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design.  NMR-based screening of a large fragment library identified two chem. distinct hit series that bind to different sites on Mcl-1.  Members of the two fragment classes were merged together to produce lead compds. that bind to Mcl-1 with a dissocn. const. of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2.  Structures of merged compds. when complexed to Mcl-1 were obtained by x-ray crystallog. and provide detailed information about the mol. recognition of small-mol. ligands binding Mcl-1.  The compds. represent starting points for the discovery of clin. useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-bJGKKNPbErVg90H21EOLACvtfcHk0lhf1_iqmiKoPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J&md5=74e72c3d56cdff85d263bd974319b2db</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm301448p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301448p%26sid%3Dliteratum%253Aachs%26aulast%3DFriberg%26aufirst%3DA.%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520myeloid%2520cell%2520leukemia%25201%2520%2528Mcl-1%2529%2520inhibitors%2520using%2520fragment-based%2520methods%2520and%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D15%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swann, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1484</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1484-1488&author=A.+M.+Petrosauthor=S.+L.+Swannauthor=D.+Songauthor=K.+Swingerauthor=C.+Parkauthor=H.+Zhangauthor=M.+D.+Wendtauthor=A.+R.+Kunzerauthor=A.+J.+Souersauthor=C.+Sun&title=Fragment-based+discovery+of+potent+inhibitors+of+the+anti-apoptotic+MCL-1+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DSwann%26aufirst%3DS.%2BL.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DSwinger%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DSun%26aufirst%3DC.%26atitle%3DFragment-based%2520discovery%2520of%2520potent%2520inhibitors%2520of%2520the%2520anti-apoptotic%2520MCL-1%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1484%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Abulwerdi, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mady, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cierpicki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span> </span><span class="NLM_article-title">3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: Structure-based design, synthesis, SAR, and biological evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4111</span><span class="NLM_x">–</span> <span class="NLM_lpage">4133</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500010b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4111-4133&author=F.+A.+Abulwerdiauthor=C.+Liaoauthor=A.+S.+Madyauthor=J.+Gavinauthor=C.+Shenauthor=T.+Cierpickiauthor=J.+A.+Stuckeyauthor=H.+D.+Showalterauthor=Z.+Nikolovska-Coleska&title=3-Substituted-N-%284-hydroxynaphthalen-1-yl%29arylsulfonamides+as+a+novel+class+of+selective+Mcl-1+inhibitors%3A+Structure-based+design%2C+synthesis%2C+SAR%2C+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm500010b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500010b%26sid%3Dliteratum%253Aachs%26aulast%3DAbulwerdi%26aufirst%3DF.%2BA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DMady%26aufirst%3DA.%2BS.%26aulast%3DGavin%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DCierpicki%26aufirst%3DT.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26atitle%3D3-Substituted-N-%25284-hydroxynaphthalen-1-yl%2529arylsulfonamides%2520as%2520a%2520novel%2520class%2520of%2520selective%2520Mcl-1%2520inhibitors%253A%2520Structure-based%2520design%252C%2520synthesis%252C%2520SAR%252C%2520and%2520biological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4111%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebaoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohier, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oulyadi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bureau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Structural characterizations of oligopyridyl foldamers, α-helix mimetics</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200424a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=429-439&author=J.+Sopkova-de+Oliveira+Santosauthor=A.+S.+Voisin-Chiretauthor=G.+Burzickiauthor=L.+Sebaounauthor=M.+Sebbanauthor=J.+F.+Lohierauthor=R.+Legayauthor=H.+Oulyadiauthor=R.+Bureauauthor=S.+Rault&title=Structural+characterizations+of+oligopyridyl+foldamers%2C+%CE%B1-helix+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci200424a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200424a%26sid%3Dliteratum%253Aachs%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DSebaoun%26aufirst%3DL.%26aulast%3DSebban%26aufirst%3DM.%26aulast%3DLohier%26aufirst%3DJ.%2BF.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DOulyadi%26aufirst%3DH.%26aulast%3DBureau%26aufirst%3DR.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DStructural%2520characterizations%2520of%2520oligopyridyl%2520foldamers%252C%2520%25CE%25B1-helix%2520mimetics%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D429%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oulyadi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Conformation control of abiotic alpha-helical foldamers</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2671</span><span class="NLM_x">–</span> <span class="NLM_lpage">2680</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci400365y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCgtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=2671-2680&author=S.+Peratoauthor=J.+Foghaauthor=M.+Sebbanauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=H.+Oulyadiauthor=S.+Rault&title=Conformation+control+of+abiotic+alpha-helical+foldamers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation Control of Abiotic α-Helical Foldamers</span></div><div class="casAuthors">Perato, Serge; Fogha, Jade; Sebban, Muriel; Voisin-Chiret, Anne Sophie; Sopkova-de Oliveira Santos, Jana; Oulyadi, Hassan; Rault, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2671-2680</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim to find new protein-protein inhibitors, a three part methodol. was applied to oligophenylpyridines.  Theor. ring twist angle predictions have been validated by X-ray diffraction and mol. dynamics simulations with NMR constraints.  Careful choice of substituent and nitrogen positions in oligophenylpyridyl foldamer units opens the way to conformational control of the side chain distribution of this α-helix mimic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUAi6DuH3NfbVg90H21EOLACvtfcHk0lh6m6D8eOaHgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCgtbzI&md5=308b27550aabe4eda5c2ca2a1677a995</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci400365y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400365y%26sid%3Dliteratum%253Aachs%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DFogha%26aufirst%3DJ.%26aulast%3DSebban%26aufirst%3DM.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DOulyadi%26aufirst%3DH.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DConformation%2520control%2520of%2520abiotic%2520alpha-helical%2520foldamers%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D2671%26epage%3D2680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bouillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">An efficient two-step total synthesis of the quaterpyridine nemertelline</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">10178</span><span class="NLM_x">–</span> <span class="NLM_lpage">10180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034805b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1WqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=10178-10180&author=A.+Bouillonauthor=A.+S.+Voisinauthor=A.+Robicauthor=J.+C.+Lancelotauthor=V.+Collotauthor=S.+Rault&title=An+efficient+two-step+total+synthesis+of+the+quaterpyridine+nemertelline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Two-Step Total Synthesis of the Quaterpyridine Nemertelline</span></div><div class="casAuthors">Bouillon, Alexandre; Voisin, Anne Sophie; Robic, Audrey; Lancelot, Jean-Charles; Collot, Valerie; Rault, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10178-10180</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Regioselective and univocal Suzuki cross-coupling reactions performed on halopyridinyl boronic acids provide a flexible and versatile route to a multigram scale synthesis of 2,2'-dichloro-3,4'-bipyridine (I), which allows couplings with excess pyridin-3-yl boronic acid to give a new and efficient two-step rapid synthesis of nemertelline (II), the quaterpyridine neurotoxin isolated from a Hoplonemertine sea worm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptG0gXaWBmibVg90H21EOLACvtfcHk0lh6m6D8eOaHgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1WqtLg%253D&md5=7dc54cce7e04a6f3da9b24877c4490dc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo034805b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034805b%26sid%3Dliteratum%253Aachs%26aulast%3DBouillon%26aufirst%3DA.%26aulast%3DVoisin%26aufirst%3DA.%2BS.%26aulast%3DRobic%26aufirst%3DA.%26aulast%3DLancelot%26aufirst%3DJ.%2BC.%26aulast%3DCollot%26aufirst%3DV.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DAn%2520efficient%2520two-step%2520total%2520synthesis%2520of%2520the%2520quaterpyridine%2520nemertelline%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D10178%26epage%3D10180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of dihalo bi- and terpyridines by regioselective Suzuki-Miyaura cross-coupling reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">5413</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=5413-5417&author=G.+Burzickiauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santoauthor=S.+Rault&title=Synthesis+of+dihalo+bi-+and+terpyridines+by+regioselective+Suzuki-Miyaura+cross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSanto%26aufirst%3DJ.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520dihalo%2520bi-%2520and%2520terpyridines%2520by%2520regioselective%2520Suzuki-Miyaura%2520cross-coupling%2520reactions%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D5413%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of New [2,3′:6′,3″]Terpyridines Using Iterative Cross-Coupling Reactions</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2804</span><span class="NLM_x">–</span> <span class="NLM_lpage">2810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2804-2810&author=G.+Burzickiauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=S.+Rault&title=Synthesis+of+New+%5B2%2C3%E2%80%B2%3A6%E2%80%B2%2C3%E2%80%B3%5DTerpyridines+Using+Iterative+Cross-Coupling+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520New%2520%255B2%252C3%25E2%2580%25B2%253A6%25E2%2580%25B2%252C3%25E2%2580%25B3%255DTerpyridines%2520Using%2520Iterative%2520Cross-Coupling%2520Reactions%26jtitle%3DSynthesis%26date%3D2010%26volume%3D16%26spage%3D2804%26epage%3D2810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Using halo (het) arylboronic species to achieve synthesis of foldamers as protein–protein interaction disruptors</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=2467-2478&author=A.+S.+Voisin-Chiretauthor=S.+Rault&title=Using+halo+%28het%29+arylboronic+species+to+achieve+synthesis+of+foldamers+as+protein%E2%80%93protein+interaction+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DUsing%2520halo%2520%2528het%2529%2520arylboronic%2520species%2520to%2520achieve%2520synthesis%2520of%2520foldamers%2520as%2520protein%25E2%2580%2593protein%2520interaction%2520disruptors%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2012%26volume%3D84%26spage%3D2467%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Célant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kashef, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">A general synthesis of halo-oligopyridines. The Garlanding concept</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=605-612&author=A.+S.+Voisin-Chiretauthor=A.+Bouillonauthor=G.+Burzickiauthor=M.+C%C3%A9lantauthor=R.+Legayauthor=H.+El-Kashefauthor=S.+Rault&title=A+general+synthesis+of+halo-oligopyridines.+The+Garlanding+concept"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DBouillon%26aufirst%3DA.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DC%25C3%25A9lant%26aufirst%3DM.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DEl-Kashef%26aufirst%3DH.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DA%2520general%2520synthesis%2520of%2520halo-oligopyridines.%2520The%2520Garlanding%2520concept%26jtitle%3DTetrahedron%26date%3D2009%26volume%3D65%26spage%3D605%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moldoveanu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprules, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matta-Camacho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansur-Azzam, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, K.</span><span> </span><span class="NLM_article-title">Apoptotic regulation by MCL-1 through heterodimerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">19615</span><span class="NLM_x">–</span> <span class="NLM_lpage">19624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=19615-19624&author=Q.+Liuauthor=T.+Moldoveanuauthor=T.+Sprulesauthor=E.+Matta-Camachoauthor=N.+Mansur-Azzamauthor=K.+Gehring&title=Apoptotic+regulation+by+MCL-1+through+heterodimerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMoldoveanu%26aufirst%3DT.%26aulast%3DSprules%26aufirst%3DT.%26aulast%3DMatta-Camacho%26aufirst%3DE.%26aulast%3DMansur-Azzam%26aufirst%3DN.%26aulast%3DGehring%26aufirst%3DK.%26atitle%3DApoptotic%2520regulation%2520by%2520MCL-1%2520through%2520heterodimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D19615%26epage%3D19624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Friberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301448p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=15-30&author=A.+Fribergauthor=D.+Vigilauthor=B.+Zhaoauthor=R.+N.+Danielsauthor=J.+P.+Burkeauthor=P.+M.+Garcia-Barrantesauthor=D.+Camperauthor=B.+A.+Chauderauthor=T.+Leeauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=Discovery+of+potent+myeloid+cell+leukemia+1+%28Mcl-1%29+inhibitors+using+fragment-based+methods+and+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design</span></div><div class="casAuthors">Friberg, Anders; Vigil, Dominico; Zhao, Bin; Daniels, R. Nathan; Burke, Jason P.; Garcia-Barrantes, Pedro M.; Camper, DeMarco; Chauder, Brian A.; Lee, Taekyu; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-30</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Myeloid cell leukemia 1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis.  Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design.  NMR-based screening of a large fragment library identified two chem. distinct hit series that bind to different sites on Mcl-1.  Members of the two fragment classes were merged together to produce lead compds. that bind to Mcl-1 with a dissocn. const. of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2.  Structures of merged compds. when complexed to Mcl-1 were obtained by x-ray crystallog. and provide detailed information about the mol. recognition of small-mol. ligands binding Mcl-1.  The compds. represent starting points for the discovery of clin. useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-bJGKKNPbErVg90H21EOLACvtfcHk0liTjMdM6FNJAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjur3J&md5=74e72c3d56cdff85d263bd974319b2db</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm301448p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301448p%26sid%3Dliteratum%253Aachs%26aulast%3DFriberg%26aufirst%3DA.%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520myeloid%2520cell%2520leukemia%25201%2520%2528Mcl-1%2529%2520inhibitors%2520using%2520fragment-based%2520methods%2520and%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D15%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oulyadi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of new linear poly(phenylpyridyl) chains</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1910</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=1910-1917&author=S.+Peratoauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=R.+Legayauthor=H.+Oulyadiauthor=S.+Rault&title=Synthesis+of+new+linear+poly%28phenylpyridyl%29+chains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DOulyadi%26aufirst%3DH.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520new%2520linear%2520poly%2528phenylpyridyl%2529%2520chains%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D1910%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Synthesis of new phenylpyridyl scaffolds using the Garlanding approach</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8000</span><span class="NLM_x">–</span> <span class="NLM_lpage">8005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=8000-8005&author=A.+S.+Voisin-Chiretauthor=M.+Muragliaauthor=G.+Burzickiauthor=S.+Peratoauthor=F.+Corboauthor=J.+Sopkova-de+Oliveira+Santosauthor=C.+Franchiniauthor=S.+Rault&title=Synthesis+of+new+phenylpyridyl+scaffolds+using+the+Garlanding+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DMuraglia%26aufirst%3DM.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DCorbo%26aufirst%3DF.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DFranchini%26aufirst%3DC.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520new%2520phenylpyridyl%2520scaffolds%2520using%2520the%2520Garlanding%2520approach%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D8000%26epage%3D8005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">De Giorgi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span> </span><span class="NLM_article-title">Design and synthesis of thienylpyridyl garlands as non-peptidic alpha helix mimetics and potential protein-protein interactions disruptors</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6147</span><span class="NLM_x">–</span> <span class="NLM_lpage">6154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=6147-6154&author=M.+De+Giorgiauthor=A.+S.+Voisin-Chiretauthor=J.+Sopkova-de+Oliveira+Santosauthor=F.+Corboauthor=C.+Franchiniauthor=S.+Rault&title=Design+and+synthesis+of+thienylpyridyl+garlands+as+non-peptidic+alpha+helix+mimetics+and+potential+protein-protein+interactions+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DCorbo%26aufirst%3DF.%26aulast%3DFranchini%26aufirst%3DC.%26aulast%3DRault%26aufirst%3DS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thienylpyridyl%2520garlands%2520as%2520non-peptidic%2520alpha%2520helix%2520mimetics%2520and%2520potential%2520protein-protein%2520interactions%2520disruptors%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D6147%26epage%3D6154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Perato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giorgi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzicki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Légalité, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voisin-Chiret, A. S.</span><span> </span><span class="NLM_article-title">Focus on Microwaves Assisted Halogen-halogen Reaction Conditions on 2-Halopyridines</span> <span class="citation_source-journal">Curr. Microwave Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.2174%2F22133356114019990003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWksb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=75-80&author=S.+Peratoauthor=M.+De+Giorgiauthor=G.+Burzickiauthor=F.+L%C3%A9galit%C3%A9author=S.+Raultauthor=A.+S.+Voisin-Chiret&title=Focus+on+Microwaves+Assisted+Halogen-halogen+Reaction+Conditions+on+2-Halopyridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Focus on microwave assisted halogen-halogen exchange reaction conditions on 2-halopyridines</span></div><div class="casAuthors">Perato, Serge; De Giorgi, Marcella; Burzicki, Gregory; Legalite, Florent; Rault, Sylvain; Voisin-Chiret, Anne Sophie</div><div class="citationInfo"><span class="NLM_cas:title">Current Microwave Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-80</span>CODEN:
                <span class="NLM_cas:coden">CMCUB9</span>;
        ISSN:<span class="NLM_cas:issn">2213-3364</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This paper describes an optimized microwave irradn.-assisted methodol. for halogen-halogen exchange reactions on various substituted pyridines.  The protocol provides an efficient and simple methodol. to improve the reactivity of some positions on the pyridine ring towards metallocatalyzed reactions.  Influence of various substituents were explored and limiting factors of reaction highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQvqn3-8_bQrVg90H21EOLACvtfcHk0ljojH9rPbwHZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWksb7K&md5=78bc74eff780b647dc3fa7905ab87670</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2174%2F22133356114019990003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F22133356114019990003%26sid%3Dliteratum%253Aachs%26aulast%3DPerato%26aufirst%3DS.%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DBurzicki%26aufirst%3DG.%26aulast%3DL%25C3%25A9galit%25C3%25A9%26aufirst%3DF.%26aulast%3DRault%26aufirst%3DS.%26aulast%3DVoisin-Chiret%26aufirst%3DA.%2BS.%26atitle%3DFocus%2520on%2520Microwaves%2520Assisted%2520Halogen-halogen%2520Reaction%2520Conditions%2520on%25202-Halopyridines%26jtitle%3DCurr.%2520Microwave%2520Chem.%26date%3D2014%26volume%3D1%26spage%3D75%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlan, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberstadt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuker, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minn, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1126%2Fscience.275.5302.983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=9020082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK2sXht1CqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=983-986&author=M.+Sattlerauthor=H.+Liangauthor=D.+Nettesheimauthor=R.+P.+Meadowsauthor=J.+E.+Harlanauthor=M.+Eberstadtauthor=H.+S.+Yoonauthor=S.+B.+Shukerauthor=B.+S.+Changauthor=A.+J.+Minnauthor=C.+B.+Thompsonauthor=S.+W.+Fesik&title=Structure+of+Bcl-xL-Bak+peptide+complex%3A+recognition+between+regulators+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis</span></div><div class="casAuthors">Sattler, Michael; Liang, Heng; Nettesheim, David; Meadows, Robert P.; Harlan, John E.; Eberstadt, Matthias; Yoon, Ho Sup; Shuker, Suzanne B.; Chang, Brian S.; Minn, Andy J.; Thompson, Craig B.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5302</span>),
    <span class="NLM_cas:pages">983-986</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Heterodimerization between members of the Bcl-2 family of proteins is a key event in the regulation of programmed cell death.  The mol. basis for heterodimer formation was investigated by detn. of the soln. structure of a complex between the survival protein Bcl-xL and the death-promoting region of the Bcl-2-related protein Bak.  The structure and binding affinities of mutant Bak peptides indicate that the Bak peptide adopts an amphipathic α helix that interacts with Bcl-xL through hydrophobic and electrostatic interactions.  Mutations in full-length Bak that disrupt either type of interaction inhibit the ability of Bak to heterodimerize with Bcl-xL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCI9cZE3QkJ7Vg90H21EOLACvtfcHk0ljojH9rPbwHZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1CqtL8%253D&md5=352e09341d74c0b0531a0ebf08230efb</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5302.983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5302.983%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DHarlan%26aufirst%3DJ.%2BE.%26aulast%3DEberstadt%26aufirst%3DM.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DChang%26aufirst%3DB.%2BS.%26aulast%3DMinn%26aufirst%3DA.%2BJ.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructure%2520of%2520Bcl-xL-Bak%2520peptide%2520complex%253A%2520recognition%2520between%2520regulators%2520of%2520apoptosis%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D983%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutzki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=278-281&author=J.+T.+Ernstauthor=O.+Kutzkiauthor=A.+K.+Debnathauthor=S.+Jiangauthor=H.+Luauthor=A.+D.+Hamilton&title=Design+of+a+protein+surface+antagonist+based+on+alpha-helix+mimicry%3A+inhibition+of+gp41+assembly+and+viral+fusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DKutzki%26aufirst%3DO.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DDesign%2520of%2520a%2520protein%2520surface%2520antagonist%2520based%2520on%2520alpha-helix%2520mimicry%253A%2520inhibition%2520of%2520gp41%2520assembly%2520and%2520viral%2520fusion%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D278%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Kutzki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orner, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">11838</span><span class="NLM_x">–</span> <span class="NLM_lpage">11839</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja026861k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=11838-11839&author=O.+Kutzkiauthor=H.+S.+Parkauthor=J.+T.+Ernstauthor=B.+P.+Ornerauthor=H.+Yinauthor=A.+D.+Hamilton&title=Development+of+a+potent+Bcl-x%28L%29+antagonist+based+on+alpha-helix+mimicry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja026861k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja026861k%26sid%3Dliteratum%253Aachs%26aulast%3DKutzki%26aufirst%3DO.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DOrner%26aufirst%3DB.%2BP.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520potent%2520Bcl-x%2528L%2529%2520antagonist%2520based%2520on%2520alpha-helix%2520mimicry%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D11838%26epage%3D11839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Orner, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Toward proteomimetics: Terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helix</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">5382</span><span class="NLM_x">–</span> <span class="NLM_lpage">5383</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0025548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=5382-5383&author=B.+P.+Ornerauthor=J.+T.+Ernstauthor=A.+D.+Hamilton&title=Toward+proteomimetics%3A+Terphenyl+derivatives+as+structural+and+functional+mimics+of+extended+regions+of+an+alpha-helix"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja0025548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0025548%26sid%3Dliteratum%253Aachs%26aulast%3DOrner%26aufirst%3DB.%2BP.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DToward%2520proteomimetics%253A%2520Terphenyl%2520derivatives%2520as%2520structural%2520and%2520functional%2520mimics%2520of%2520extended%2520regions%2520of%2520an%2520alpha-helix%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D5382%26epage%3D5383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Saraogi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">alpha-Helix mimetics as inhibitors of protein-protein interactions</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1414</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1042%2FBST0361414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=19021566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCgsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=1414-1417&author=I.+Saraogiauthor=A.+D.+Hamilton&title=alpha-Helix+mimetics+as+inhibitors+of+protein-protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">α-Helix mimetics as inhibitors of protein-protein interactions</span></div><div class="casAuthors">Saraogi, Ishu; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1414-1417</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The inhibition of protein-protein interactions using small mols. is a viable approach for the treatment of a range of pathol. conditions that result from a malfunctioning of these interactions.  Our strategy for the design of such agents involves the mimicry of side-chain residues on one face of the α-helix; these residues frequently play a key role in mediating protein-protein interactions.  The first-generation terphenyl scaffold, with a 3,2',2''-substitution pattern, is able to successfully mimic key helix residues and disrupt therapeutically relevant interactions, including the Bcl-XL-Bak and the p53-hDM2 (human double minute 2) interactions that are implicated in cancer.  The second- and third-generation scaffolds have resulted in greater synthetic accessibility and more drug-like character in these mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNfqRdM67vrVg90H21EOLACvtfcHk0li6-7LM7BFjeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCgsb3P&md5=0cc8778ddb2529e3b1188291f7ab074d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2FBST0361414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0361414%26sid%3Dliteratum%253Aachs%26aulast%3DSaraogi%26aufirst%3DI.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3Dalpha-Helix%2520mimetics%2520as%2520inhibitors%2520of%2520protein-protein%2520interactions%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2008%26volume%3D36%26spage%3D1414%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutzki, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orner, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Terphenyl-Based Bak BH3 α-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">10191</span><span class="NLM_x">–</span> <span class="NLM_lpage">10196</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja050122x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=10191-10196&author=H.+Yinauthor=G.+I.+Leeauthor=K.+A.+Sedeyauthor=O.+Kutzkiauthor=H.+S.+Parkauthor=B.+P.+Ornerauthor=J.+T.+Ernstauthor=H.+G.+Wangauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Terphenyl-Based+Bak+BH3+%CE%B1-helical+proteomimetics+as+low-molecular-weight+antagonists+of+Bcl-xL"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fja050122x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja050122x%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DG.%2BI.%26aulast%3DSedey%26aufirst%3DK.%2BA.%26aulast%3DKutzki%26aufirst%3DO.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DOrner%26aufirst%3DB.%2BP.%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DH.%2BG.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DTerphenyl-Based%2520Bak%2520BH3%2520%25CE%25B1-helical%2520proteomimetics%2520as%2520low-molecular-weight%2520antagonists%2520of%2520Bcl-xL%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D10191%26epage%3D10196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">Development of small molecules designed to modulate protein-protein interactions</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1007%2Fs10822-006-9040-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=16622794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVGru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=109-130&author=Y.+Cheauthor=B.+R.+Brooksauthor=G.+R.+Marshall&title=Development+of+small+molecules+designed+to+modulate+protein-protein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development of small molecules designed to modulate protein-protein interactions</span></div><div class="casAuthors">Che, Ye; Brooks, Bernard R.; Marshall, Garland R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-130</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions are ubiquitous, essential to almost all known biol. processes, and offer attractive opportunities for therapeutic intervention.  Developing small mols. that modulate protein-protein interactions is challenging, owing to the large size of protein-complex interface, the lack of well-defined binding pockets, etc.  We describe a general approach based on the privileged-structure hypothesis, that any org. templates capable of mimicking surfaces of protein-recognition motifs are potential privileged scaffolds as protein-complex antagonists, to address the challenges inherent in the discovery of small-mol. inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFX3Hyurwum7Vg90H21EOLACvtfcHk0li6-7LM7BFjeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVGru70%253D&md5=62c15674695b88bb25335363a991bdc1</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs10822-006-9040-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-006-9040-8%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DY.%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DDevelopment%2520of%2520small%2520molecules%2520designed%2520to%2520modulate%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2006%26volume%3D20%26spage%3D109%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Frank, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldkamp, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelz, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangamudi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camper, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossanese, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9242</span><span class="NLM_x">–</span> <span class="NLM_lpage">9250</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401333u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9242-9250&author=A.+O.+Frankauthor=M.+D.+Feldkampauthor=J.+P.+Kennedyauthor=A.+G.+Watersonauthor=N.+F.+Pelzauthor=J.+D.+Patroneauthor=B.+Vangamudiauthor=D.+V.+Camperauthor=O.+W.+Rossaneseauthor=W.+J.+Chazinauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+replication+protein+a+protein-protein+interactions+using+a+fragment-linking+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Replication Protein A Protein-Protein Interactions Using a Fragment-Linking Approach</span></div><div class="casAuthors">Frank, Andreas O.; Feldkamp, Michael D.; Kennedy, J. Phillip; Waterson, Alex G.; Pelz, Nicholas F.; Patrone, James D.; Vangamudi, Bhavatarini; Camper, DeMarco V.; Rossanese, Olivia W.; Chazin, Walter J.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9242-9250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Replication protein A (RPA), the major eukaryotic single-stranded DNA (ssDNA)-binding protein, is involved in nearly all cellular DNA transactions.  The RPA N-terminal domain (RPA70N) is a recruitment site for proteins involved in DNA-damage response and repair.  Selective inhibition of these protein-protein interactions has the potential to inhibit the DNA-damage response and to sensitize cancer cells to DNA-damaging agents without affecting other functions of RPA.  To discover a potent, selective inhibitor of the RPA70N protein-protein interactions to test this hypothesis, we used NMR spectroscopy to identify fragment hits that bind to two adjacent sites in the basic cleft of RPA70N.  High-resoln. X-ray crystal structures of RPA70N-ligand complexes revealed how these fragments bind to RPA and guided the design of linked compds. that simultaneously occupy both sites.  We have synthesized linked mols. that bind to RPA70N with submicromolar affinity and minimal disruption of RPA's interaction with ssDNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgZEDSY6TA3rVg90H21EOLACvtfcHk0lhe_Pek0i77dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrzL&md5=ee3a60f76302dcb30fec7d88a1a386c5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm401333u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401333u%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DFeldkamp%26aufirst%3DM.%2BD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DPelz%26aufirst%3DN.%2BF.%26aulast%3DPatrone%26aufirst%3DJ.%2BD.%26aulast%3DVangamudi%26aufirst%3DB.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520replication%2520protein%2520a%2520protein-protein%2520interactions%2520using%2520a%2520fragment-linking%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9242%26epage%3D9250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Shamas-Din, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">Mechanisms of action of Bcl-2 family proteins</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_elocation-id">a008714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1101%2Fcshperspect.a008714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=23545417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVKltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&author=A.+Shamas-Dinauthor=J.+Kaleauthor=B.+Leberauthor=D.+W.+Andrews&title=Mechanisms+of+action+of+Bcl-2+family+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of Bcl-2 family proteins</span></div><div class="casAuthors">Shamas-Din, Aisha; Kale, Justin; Leber, Brian; Andrews, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">a008714/1-a008714/21</span>CODEN:
                <span class="NLM_cas:coden">CSHPEU</span>;
        ISSN:<span class="NLM_cas:issn">1943-0264</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The Bcl-2 family of proteins controls a crit. step in commitment to apoptosis by regulating permeabilization of the mitochondrial outer membrane (MOM).  The family is divided into three classes: multiregion proapoptotic proteins that directly permeabilize the MOM; BH3 proteins that directly or indirectly activate the pore-forming class members; and the anti-apoptotic proteins that inhibit this process at several steps.  Different exptl. approaches have led to several models, each proposed to explain the interactions between Bcl-2 family proteins.  The discovery that many of these interactions occur at or in membranes as well as in the cytoplasm, and are governed by the concns. and relative binding affinities of the proteins, provides a new basis for rationalizing these models.  Furthermore, these dynamic interactions cause conformational changes in the Bcl-2 proteins that modulate their apoptotic function, providing addnl. potential modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO2OO_FgbxvbVg90H21EOLACvtfcHk0lhe_Pek0i77dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVKltb8%253D&md5=2f1ac863d45aa71d76b116c288eacae5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a008714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a008714%26sid%3Dliteratum%253Aachs%26aulast%3DShamas-Din%26aufirst%3DA.%26aulast%3DKale%26aufirst%3DJ.%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DMechanisms%2520of%2520action%2520of%2520Bcl-2%2520family%2520proteins%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2013%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Vo, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gree, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=286-293&author=D.+D.+Voauthor=F.+Gautierauthor=P.+Juinauthor=R.+Gree&title=Structure-activity+relationship+of+selected+polyphenol+derivatives+as+inhibitors+of+Bax%2FBcl-xL+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVo%26aufirst%3DD.%2BD.%26aulast%3DGautier%26aufirst%3DF.%26aulast%3DJuin%26aufirst%3DP.%26aulast%3DGree%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520of%2520selected%2520polyphenol%2520derivatives%2520as%2520inhibitors%2520of%2520Bax%252FBcl-xL%2520interaction%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Albershardt, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerni, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderquist, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletnev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, A.</span><span> </span><span class="NLM_article-title">Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">24882</span><span class="NLM_x">–</span> <span class="NLM_lpage">24895</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=24882-24895&author=T.+C.+Albershardtauthor=B.+L.+Salerniauthor=R.+S.+Soderquistauthor=D.+J.+Batesauthor=A.+A.+Pletnevauthor=A.+F.+Kisselevauthor=A.+Eastman&title=Multiple+BH3+mimetics+antagonize+antiapoptotic+MCL1+protein+by+inducing+the+endoplasmic+reticulum+stress+response+and+up-regulating+BH3-only+protein+NOXA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlbershardt%26aufirst%3DT.%2BC.%26aulast%3DSalerni%26aufirst%3DB.%2BL.%26aulast%3DSoderquist%26aufirst%3DR.%2BS.%26aulast%3DBates%26aufirst%3DD.%2BJ.%26aulast%3DPletnev%26aufirst%3DA.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DEastman%26aufirst%3DA.%26atitle%3DMultiple%2520BH3%2520mimetics%2520antagonize%2520antiapoptotic%2520MCL1%2520protein%2520by%2520inducing%2520the%2520endoplasmic%2520reticulum%2520stress%2520response%2520and%2520up-regulating%2520BH3-only%2520protein%2520NOXA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D24882%26epage%3D24895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Risberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodstad, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, Y.</span><span> </span><span class="NLM_article-title">Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_elocation-id">e24012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=K.+Risbergauthor=O.+Fodstadauthor=Y.+Andersson&title=Synergistic+anticancer+effects+of+the+9.2.27PE+immunotoxin+and+ABT-737+in+melanoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisberg%26aufirst%3DK.%26aulast%3DFodstad%26aufirst%3DO.%26aulast%3DAndersson%26aufirst%3DY.%26atitle%3DSynergistic%2520anticancer%2520effects%2520of%2520the%25209.2.27PE%2520immunotoxin%2520and%2520ABT-737%2520in%2520melanoma%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Rodriguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rivera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetz, C.</span><span> </span><span class="NLM_article-title">Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1813</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1813&publication_year=2011&pages=564-574&author=D.+Rodriguezauthor=D.+Rojas-Riveraauthor=C.+Hetz&title=Integrating+stress+signals+at+the+endoplasmic+reticulum%3A+The+BCL-2+protein+family+rheostat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DD.%26aulast%3DRojas-Rivera%26aufirst%3DD.%26aulast%3DHetz%26aufirst%3DC.%26atitle%3DIntegrating%2520stress%2520signals%2520at%2520the%2520endoplasmic%2520reticulum%253A%2520The%2520BCL-2%2520protein%2520family%2520rheostat%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1813%26spage%3D564%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Rodriguez, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisbona, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rivera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubillos-Ruiz, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armisen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriquez, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irrazabal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Billault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimentel-Muinos, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetz, C.</span><span> </span><span class="NLM_article-title">BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1alpha</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2322</span><span class="NLM_x">–</span> <span class="NLM_lpage">2335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2322-2335&author=D.+A.+Rodriguezauthor=S.+Zamoranoauthor=F.+Lisbonaauthor=D.+Rojas-Riveraauthor=H.+Urraauthor=J.+R.+Cubillos-Ruizauthor=R.+Armisenauthor=D.+R.+Henriquezauthor=E.+H.+Chengauthor=M.+Letekauthor=T.+Vaisarauthor=T.+Irrazabalauthor=C.+Gonzalez-Billaultauthor=A.+Letaiauthor=F.+X.+Pimentel-Muinosauthor=G.+Kroemerauthor=C.+Hetz&title=BH3-only+proteins+are+part+of+a+regulatory+network+that+control+the+sustained+signalling+of+the+unfolded+protein+response+sensor+IRE1alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DD.%2BA.%26aulast%3DZamorano%26aufirst%3DS.%26aulast%3DLisbona%26aufirst%3DF.%26aulast%3DRojas-Rivera%26aufirst%3DD.%26aulast%3DUrra%26aufirst%3DH.%26aulast%3DCubillos-Ruiz%26aufirst%3DJ.%2BR.%26aulast%3DArmisen%26aufirst%3DR.%26aulast%3DHenriquez%26aufirst%3DD.%2BR.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DLetek%26aufirst%3DM.%26aulast%3DVaisar%26aufirst%3DT.%26aulast%3DIrrazabal%26aufirst%3DT.%26aulast%3DGonzalez-Billault%26aufirst%3DC.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DPimentel-Muinos%26aufirst%3DF.%2BX.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DHetz%26aufirst%3DC.%26atitle%3DBH3-only%2520proteins%2520are%2520part%2520of%2520a%2520regulatory%2520network%2520that%2520control%2520the%2520sustained%2520signalling%2520of%2520the%2520unfolded%2520protein%2520response%2520sensor%2520IRE1alpha%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2322%26epage%3D2335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Jiang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery-Kiejda, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deBock, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. D.</span><span> </span><span class="NLM_article-title">Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6708</span><span class="NLM_x">–</span> <span class="NLM_lpage">6717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=6708-6717&author=C.+C.+Jiangauthor=K.+Lucasauthor=K.+A.+Avery-Kiejdaauthor=M.+Wadeauthor=C.+E.+deBockauthor=R.+F.+Thorneauthor=J.+Allenauthor=P.+Herseyauthor=X.+D.+Zhang&title=Up-regulation+of+Mcl-1+is+critical+for+survival+of+human+melanoma+cells+upon+endoplasmic+reticulum+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.%2BC.%26aulast%3DLucas%26aufirst%3DK.%26aulast%3DAvery-Kiejda%26aufirst%3DK.%2BA.%26aulast%3DWade%26aufirst%3DM.%26aulast%3DdeBock%26aufirst%3DC.%2BE.%26aulast%3DThorne%26aufirst%3DR.%2BF.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DHersey%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%2BD.%26atitle%3DUp-regulation%2520of%2520Mcl-1%2520is%2520critical%2520for%2520survival%2520of%2520human%2520melanoma%2520cells%2520upon%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D6708%26epage%3D6717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">e52333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=H.+Zhuauthor=W.+Yangauthor=L.+J.+Heauthor=W.+J.+Dingauthor=L.+Zhengauthor=S.+D.+Liaoauthor=P.+Huangauthor=W.+Luauthor=Q.+J.+Heauthor=B.+Yang&title=Upregulating+Noxa+by+ER+stress%2C+celastrol+exerts+synergistic+anti-cancer+activity+in+combination+with+ABT-737+in+human+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DL.%2BJ.%26aulast%3DDing%26aufirst%3DW.%2BJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DS.%2BD.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DQ.%2BJ.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DUpregulating%2520Noxa%2520by%2520ER%2520stress%252C%2520celastrol%2520exerts%2520synergistic%2520anti-cancer%2520activity%2520in%2520combination%2520with%2520ABT-737%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serfass, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy Madiraju, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viallet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acoca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purisima, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegmans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauparlant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. C.</span><span> </span><span class="NLM_article-title">Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">19512</span><span class="NLM_x">–</span> <span class="NLM_lpage">19517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1073%2Fpnas.0709443104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=18040043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19512-19517&author=M.+Nguyenauthor=R.+C.+Marcellusauthor=A.+Roulstonauthor=M.+Watsonauthor=L.+Serfassauthor=S.+R.+Murthy+Madirajuauthor=D.+Gouletauthor=J.+Vialletauthor=L.+Belecauthor=X.+Billotauthor=S.+Acocaauthor=E.+Purisimaauthor=A.+Wiegmansauthor=L.+Cluseauthor=R.+W.+Johnstoneauthor=P.+Beauparlantauthor=G.+C.+Shore&title=Small+molecule+obatoclax+%28GX15-070%29+antagonizes+MCL-1+and+overcomes+MCL-1-mediated+resistance+to+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis</span></div><div class="casAuthors">Nguyen, Mai; Marcellus, Richard C.; Roulston, Anne; Watson, Mark; Serfass, Lucile; Madiraju, S. R. Murthy; Goulet, Daniel; Viallet, Jean; Belec, Laurent; Billot, Xavier; Acoca, Stephane; Purisima, Enrico; Wiegmans, Adrian; Cluse, Leonie; Johnstone, Ricky W.; Beauparlant, Pierre; Shore, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19512-19517</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elevated expression of members of the BCL-2 pro-survival family of proteins can confer resistance to apoptosis in cancer cells.  Small mol. obatoclax (GX15-070), which is predicted to occupy a hydrophobic pocket within the BH3 binding groove of BCL-2, antagonizes these members and induces apoptosis, dependent on BAX and BAK.  Reconstitution in yeast confirmed that obatoclax acts on the pathway and overcomes BCL-2-, BCL-XL-, BCL-w-, and MCL-1-mediated resistance to BAX or BAK.  The compd. potently interfered with the direct interaction between MCL-1 and BAK in intact mitochondrial outer membrane and inhibited the assocn. between MCL-1 and BAK in intact cells.  MCL-1 has been shown to confer resistance to the BCL-2/BCL-XL/BCL-w-selective antagonist ABT-737 and to the proteasome inhibitor bortezomib.  In both cases, this resistance was overcome by obatoclax.  These findings support a rational clin. development opportunity for the compd. in cancer indications or treatments where MCL-1 contributes to resistance to cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrngkiYbISvrbVg90H21EOLACvtfcHk0lj0JOBZ0a4NDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVOgsA%253D%253D&md5=e502d448c92c39cca482744b8c8ab7b1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709443104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709443104%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DMarcellus%26aufirst%3DR.%2BC.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DSerfass%26aufirst%3DL.%26aulast%3DMurthy%2BMadiraju%26aufirst%3DS.%2BR.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DViallet%26aufirst%3DJ.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DAcoca%26aufirst%3DS.%26aulast%3DPurisima%26aufirst%3DE.%26aulast%3DWiegmans%26aufirst%3DA.%26aulast%3DCluse%26aufirst%3DL.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DBeauparlant%26aufirst%3DP.%26aulast%3DShore%26aufirst%3DG.%2BC.%26atitle%3DSmall%2520molecule%2520obatoclax%2520%2528GX15-070%2529%2520antagonizes%2520MCL-1%2520and%2520overcomes%2520MCL-1-mediated%2520resistance%2520to%2520apoptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19512%26epage%3D19517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamed, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruickshanks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, P.</span><span> </span><span class="NLM_article-title">Obatoclax and lapatinib interact to induce toxic autophagy through NOXA</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=527-540&author=Y.+Tangauthor=H.+A.+Hamedauthor=N.+Cruickshanksauthor=P.+B.+Fisherauthor=S.+Grantauthor=P.+Dent&title=Obatoclax+and+lapatinib+interact+to+induce+toxic+autophagy+through+NOXA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DHamed%26aufirst%3DH.%2BA.%26aulast%3DCruickshanks%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DDent%26aufirst%3DP.%26atitle%3DObatoclax%2520and%2520lapatinib%2520interact%2520to%2520induce%2520toxic%2520autophagy%2520through%2520NOXA%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D527%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">Phase Annealing in SHELX-90: Direct Methods for Larger Structures</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">A46</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A46&publication_year=1990&pages=467-473&author=G.+M.+Sheldrick&title=Phase+Annealing+in+SHELX-90%3A+Direct+Methods+for+Larger+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DPhase%2520Annealing%2520in%2520SHELX-90%253A%2520Direct%2520Methods%2520for%2520Larger%2520Structures%26jtitle%3DActa%2520Crystallogr.%26date%3D1990%26volume%3DA46%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">A64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lgbsQMNFnUJnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=7823319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor+sites+using+a+genetic+algorithm+with+a+description+of+desolvation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Understanding the principles whereby macromol. biol. receptors can recognize small mol. substrates or inhibitors is the subject of a major effort.  This is of paramount importance in rational drug design where the receptor structure is known (the "docking" problem).  Current theor. approaches utilize models of the steric and electrostatic interaction of bound ligands and recently conformational flexibility has been incorporated.  The authors report results based on software using a genetic algorithm that uses an evolutionary strategy in exploring the full conformational flexibility of the ligand with partial flexibility of the protein, and which satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Results are reported on five test systems showing excellent agreement with exptl. data.  The design of the algorithm offers insight into the mol. recognition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Xcn7nQyVRLVg90H21EOLACvtfcHk0lgbsQMNFnUJnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D&md5=bf45edafb986a73c7c1d0ac55e070f28</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor%2520sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgbsQMNFnUJnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span>Discovery Studio, version 3.0.0.10321; <span class="NLM_publisher-name">Accelrys Software Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Discovery+Studio%2C+version+3.0.0.10321%3B+Accelrys+Software+Inc.%3A+San+Diego%2C+CA%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26pub%3DAccelrys%2520Software%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Brooks, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruccoleri, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olafson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">States, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karplus, M.</span><span> </span><span class="NLM_article-title">CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2Fjcc.54004021110.1002%2Fjcc.540040211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaL3sXit1aiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1983&pages=187-217&author=B.+R.+Brooksauthor=R.+E.+Bruccoleriauthor=B.+D.+Olafsonauthor=D.+J.+Statesauthor=S.+Swaminathanauthor=M.+Karplus&title=CHARMM%3A+A+Program+for+Macromolecular+Energy%2C+Minimization%2C+and+Dynamics+Calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">CHARMM:  a program for macromolecular energy, minimization, and dynamics calculations</span></div><div class="casAuthors">Brooks, Bernard R.; Bruccoleri, Robert E.; Olafson, Barry D.; States, David J.; Swaminathan, S.; Karplus, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-217</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    </div><div class="casAbstract">CHARMM (Chem. at HARvard Macromol. Mechanics) is a highly flexible computer program which uses empirical energy functions to model macromol. systems.  The program can read or model build structures, energy minimize them by first- or second-deriv. techniques, perform a normal mode or mol. dynamics simulation, and analyze the structural, equil., and dynamic properties detd. in these calcns.  The operations that CHARMM can perform are described, and some implementation details are given.  A set of parameters for the empirical energy function and a sample run are included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBSFuoT3w87LVg90H21EOLACvtfcHk0lgmSyaVL_Gd1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXit1aiu7w%253D&md5=bd639b4299ac9934f4497c1a9fe750d2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2Fjcc.54004021110.1002%2Fjcc.540040211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.54004021110.1002%252Fjcc.540040211%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26aulast%3DBruccoleri%26aufirst%3DR.%2BE.%26aulast%3DOlafson%26aufirst%3DB.%2BD.%26aulast%3DStates%26aufirst%3DD.%2BJ.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DKarplus%26aufirst%3DM.%26atitle%3DCHARMM%253A%2520A%2520Program%2520for%2520Macromolecular%2520Energy%252C%2520Minimization%252C%2520and%2520Dynamics%2520Calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1983%26volume%3D4%26spage%3D187%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madura, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. L.</span><span> </span><span class="NLM_article-title">Comparison of simple potential functions for simulating liquid water</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1063%2F1.445869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1983&pages=926-935&author=W.+L.+Jorgensenauthor=J.+Chandrasekharauthor=J.+D.+Maduraauthor=R.+W.+Impeyauthor=M.+L.+Klein&title=Comparison+of+simple+potential+functions+for+simulating+liquid+water"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of simple potential functions for simulating liquid water</span></div><div class="casAuthors">Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.; Impey, Roger W.; Klein, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">926-35</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">Classical Monte Carlo simulations were carried out for liq. H2O in the NPT ensemble at 25° and 1 atm using 6 of the simpler intermol. potential functions for the dimer.  Comparisons were made with exptl. thermodn. and structural data including the neutron diffraction results of Thiessen and Narten (1982).  The computed densities and potential energies agree with expt. except for the original Bernal-Fowler model, which yields an 18% overest. of the d. and poor structural results.  The discrepancy may be due to the correction terms needed in processing the neutron data or to an effect uniformly neglected in the computations.  Comparisons were made for the self-diffusion coeffs. obtained from mol. dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4QUFMvwYFrVg90H21EOLACvtfcHk0lgmSyaVL_Gd1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D&md5=a1161334e381746be8c9b15a5e56f704</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1063%2F1.445869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.445869%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DImpey%26aufirst%3DR.%2BW.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26atitle%3DComparison%2520of%2520simple%2520potential%2520functions%2520for%2520simulating%2520liquid%2520water%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1983%26volume%3D79%26spage%3D926%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Jo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, W.</span><span> </span><span class="NLM_article-title">CHARMM-GUI: A web-based graphical user interface for CHARMM</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2Fjcc.20945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=18351591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVKksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1859-1865&author=S.+Joauthor=T.+Kimauthor=V.+G.+Iyerauthor=W.+Im&title=CHARMM-GUI%3A+A+web-based+graphical+user+interface+for+CHARMM"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">CHARMM-GUI: a web-based graphical user interface for CHARMM</span></div><div class="casAuthors">Jo, Sunhwan; Kim, Taehoon; Iyer, Vidyashankara G.; Im, Wonpil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1859-1865</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">CHARMM is an academic research program used widely for macromol. mechanics and dynamics with versatile anal. and manipulation tools of at. coordinates and dynamics trajectories.  CHARMM-GUI, http://www.charmm-gui.org, has been developed to provide a web-based graphical user interface to generate various input files and mol. systems to facilitate and standardize the usage of common and advanced simulation techniques in CHARMM.  The web environment provides an ideal platform to build and validate a mol. model system in an interactive fashion such that, if a problem is found through visual inspection, one can go back to the previous setup and regenerate the whole system again.  In this article, we describe the currently available functional modules of CHARMM-GUI Input Generator that form a basis for the advanced simulation techniques.  Future directions of the CHARMM-GUI development project are also discussed briefly together with other features in the CHARMM-GUI website, such as Archive and Movie Gallery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gpU-1N3WOLVg90H21EOLACvtfcHk0lgmSyaVL_Gd1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVKksbc%253D&md5=112a3dd61d792b040f9f716b32220d7e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20945%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DIyer%26aufirst%3DV.%2BG.%26aulast%3DIm%26aufirst%3DW.%26atitle%3DCHARMM-GUI%253A%2520A%2520web-based%2520graphical%2520user%2520interface%2520for%2520CHARMM%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2008%26volume%3D29%26spage%3D1859%26epage%3D1865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span>CHARMM-GUI.<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CHARMM-GUI.+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Poulain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duigou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deslandes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sichel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staedel, C.</span><span> </span><span class="NLM_article-title">Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1002%2F%28SICI%291097-0215%2819981109%2978%3A4%3C454%3A%3AAID-IJC11%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=9797134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADyaK1cXnsVShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=454-463&author=L.+Poulainauthor=H.+Lincetauthor=F.+Duigouauthor=E.+Deslandesauthor=F.+Sichelauthor=P.+Gauduchonauthor=C.+Staedel&title=Acquisition+of+chemoresistance+in+a+human+ovarian+carcinoma+cell+is+linked+to+a+defect+in+cell+cycle+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control</span></div><div class="casAuthors">Poulain, Laurent; Lincet, Hubert; Duigou, Franmoise; Deslandes, Edwige; Sichel, Francois; Gauduchon, Pascal; Staedeli, Cathy</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">454-463</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Chemoresistance is a major concern in cancer eradication; it involves various mechanisms, including defects in the apoptosis program induced by anticancer drugs.  In order to further explore the mechanisms underlying the development of chemoresistance in ovarian carcinoma after cisplatin treatment, we established an in vitro model, mimicking a clin. protocol of administration of cisplatin.  Therefore, IGROVI ovarian carcinoma cells were exposed for 2 h to the drug and allowed to recover for several weeks; this way of exposure was reiterated with escalating doses.  We followed changes in cytotoxicity of the drug, cell cycle kinetics and long-term survival of cells after cisplatin treatment, and found that resistance to cisplatin was not assocd. with altered apoptosis pathway, since both cisplatin sensitive and resistant cells underwent apoptosis in a similar way.  Acquisition of resistance to cisplatin was assocd. with the ability of the treated cells to progress through the cell cycle beyond the G1/S checkpoint; although most cells died by apoptosis, a few surviving cells proliferated and recolonized the cultures.  Compared to sensitive cells, the chemoresistant variants were able to override the G1S checkpoint whatever the dose, and the recurrent cells recolonized the cultures much faster.  Anal. of alterations in gene expression suggests that the defect in cell cycle regulation could take place at the level of the cdk inhibitor p21CIPI/WAFI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXebK_Xo1LmLVg90H21EOLACvtfcHk0liKQGSeR5TijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsVShtbg%253D&md5=b717c616e231b5b127177bbe0da8f9ce</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819981109%2978%3A4%3C454%3A%3AAID-IJC11%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819981109%252978%253A4%253C454%253A%253AAID-IJC11%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DPoulain%26aufirst%3DL.%26aulast%3DLincet%26aufirst%3DH.%26aulast%3DDuigou%26aufirst%3DF.%26aulast%3DDeslandes%26aufirst%3DE.%26aulast%3DSichel%26aufirst%3DF.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DStaedel%26aufirst%3DC.%26atitle%3DAcquisition%2520of%2520chemoresistance%2520in%2520a%2520human%2520ovarian%2520carcinoma%2520cell%2520is%2520linked%2520to%2520a%2520defect%2520in%2520cell%2520cycle%2520control%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1998%26volume%3D78%26spage%3D454%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Villedieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutoit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duigou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staedel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauduchon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, L.</span><span> </span><span class="NLM_article-title">Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1016%2Fj.ygyno.2006.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=17275076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVemsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2007&pages=31-44&author=M.+Villedieuauthor=M.+H.+Louisauthor=S.+Dutoitauthor=E.+Brotinauthor=H.+Lincetauthor=F.+Duigouauthor=C.+Staedelauthor=P.+Gauduchonauthor=L.+Poulain&title=Absence+of+Bcl-xL+down-regulation+in+response+to+cisplatin+is+associated+with+chemoresistance+in+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells</span></div><div class="casAuthors">Villedieu, M.; Louis, M.-H.; Dutoit, S.; Brotin, E.; Lincet, H.; Duigou, F.; Staedel, C.; Gauduchon, P.; Poulain, L.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-44</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recurrence and subsequent acquired chemoresistance to platinum-based treatments constitute major hurdles to ovarian carcinoma therapy.  Our objective was to examine the involvement of Bcl-xL anti-apoptotic protein in resistance to cisplatin.  We described the effect of cisplatin on cell cycle and apoptosis induction in sensitive (IGROV1 and OAW42) and resistant (IGROV1-R10 and SKOV3) ovarian carcinoma cell lines.  We correlated it with Bcl-xL mRNA and protein expression after exposure to cisplatin.  We then used bcl-xS gene transfer to impede Bcl-xL activity.  Our study showed that Bcl-xL basal expression was high in both sensitive and resistant cell lines, as well as in all the studied ovarian tumor samples.  Thus, Bcl-xL basal expression could not allow to predict sensitivity.  Wondering whether variation of Bcl-xL level in response to cisplatin could be a better determinant of sensitivity, we investigated the expression of this protein in the cell lines after treatment.  Cisplatin-induced down-regulation of Bcl-xL was strictly assocd. with apoptosis and absence of recurrence in vitro.  Conversely, the maintenance of Bcl-xL expression in response to cisplatin appeared as a sine qua non condition to escape to treatment.  To try to sensitize SKOV3 cells by impeding anti-apoptotic activity of Bcl-xL, we transfected bcl-x S gene in these cells.  Bcl-xS exogenous expression was only slightly cytotoxic on its own, but highly sensitized SKOV3 resistant cells to cisplatin-induced apoptosis, and delayed recurrence.  This work thus provides one more argument to put Bcl-xL forward as a pertinent target of inhibition to overcome chemoresistance of epithelial ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8kPhvixR8qLVg90H21EOLACvtfcHk0liKQGSeR5TijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVemsbg%253D&md5=2d69f78bd609ba4b49143dfe83e8d3d2</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2006.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2006.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DVilledieu%26aufirst%3DM.%26aulast%3DLouis%26aufirst%3DM.%2BH.%26aulast%3DDutoit%26aufirst%3DS.%26aulast%3DBrotin%26aufirst%3DE.%26aulast%3DLincet%26aufirst%3DH.%26aulast%3DDuigou%26aufirst%3DF.%26aulast%3DStaedel%26aufirst%3DC.%26aulast%3DGauduchon%26aufirst%3DP.%26aulast%3DPoulain%26aufirst%3DL.%26atitle%3DAbsence%2520of%2520Bcl-xL%2520down-regulation%2520in%2520response%2520to%2520cisplatin%2520is%2520associated%2520with%2520chemoresistance%2520in%2520ovarian%2520carcinoma%2520cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2007%26volume%3D105%26spage%3D31%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Terrillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayoub, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taulan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jockers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1210%2Fme.2002-0222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=12554793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=677-691&author=S.+Terrillonauthor=T.+Durrouxauthor=B.+Mouillacauthor=A.+Breitauthor=M.+A.+Ayoubauthor=M.+Taulanauthor=R.+Jockersauthor=C.+Barberisauthor=M.+Bouvier&title=Oxytocin+and+vasopressin+V1a+and+V2+receptors+form+constitutive+homo-+and+heterodimers+during+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis</span></div><div class="casAuthors">Terrillon, Sonia; Durroux, Thierry; Mouillac, Bernard; Breit, Andreas; Ayoub, Mohammed A.; Taulan, Magali; Jockers, Ralf; Barberis, Claude; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">677-691</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">G protein-coupled receptor (GPCR) oligomerization is a growing concept that has emerged from several studies suggesting that GPCRs can form both homo- and heterodimers.  Using both co-immunopptn. and bioluminescence resonance energy transfer (BRET) approaches, we established that the vasopressin V1a, V2, and the oxytocin receptors exist as homo- and heterodimers in transfected human embryonic kidney 293T cells.  Each receptor protomer had a similar propensity to form homo- and heterodimers, indicating that their relative expression levels may det. the homo-/heterodimer ratio.  The finding that immature forms of the receptor can be immunopptd. as homo- and heterodimers and the detection by BRET of such oligomer in endoplasmic reticulum-enriched fractions suggest that the oligomerization processes take place early during biosynthesis.  Treatment with agonists or antagonists did not modify the BRET among any of the vasopressin and oxytocin receptor pairs studied, indicating that the dimerization state of the receptors is not regulated by ligand binding once they have reached the cell surface.  Taken together, these results strongly support the notion that GPCR dimerization is a constitutive process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpffNYKIGDTibVg90H21EOLACvtfcHk0liKQGSeR5TijQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCksro%253D&md5=cc0bb2c4aa80353db10ad75c36388d2a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0222%26sid%3Dliteratum%253Aachs%26aulast%3DTerrillon%26aufirst%3DS.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBreit%26aufirst%3DA.%26aulast%3DAyoub%26aufirst%3DM.%2BA.%26aulast%3DTaulan%26aufirst%3DM.%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520vasopressin%2520V1a%2520and%2520V2%2520receptors%2520form%2520constitutive%2520homo-%2520and%2520heterodimers%2520during%2520biosynthesis%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D677%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Ke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abassi, Y. A.</span><span> </span><span class="NLM_article-title">The xCELLigence system for real-time and label-free monitoring of cell viability</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">740</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm500672y&amp;key=10.1007%2F978-1-61779-108-6_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm500672y&amp;key=21468966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm500672y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFylur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=740&publication_year=2011&pages=33-43&author=N.+Keauthor=X.+Wangauthor=X.+Xuauthor=Y.+A.+Abassi&title=The+xCELLigence+system+for+real-time+and+label-free+monitoring+of+cell+viability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The xCELLigence system for real-time and label-free monitoring of cell viability</span></div><div class="casAuthors">Ke, Ning; Wang, Xiaobo; Xu, Xiao; Abassi, Yama A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">740</span>
        (<span class="NLM_cas:issue">Mammalian Cell Viability</span>),
    <span class="NLM_cas:pages">33-43</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We describe here the use of the xCELLigence system for label-free and real-time monitoring of cell-viability.  The xCELLigence system uses specially designed microtiter plates contg. interdigitated gold microelectrodes to noninvasively monitor the viability of cultured cells using elec. impedance as the readout.  The continuous monitoring of cell viability by the xCELLigence system makes it possible to distinguish between different perturbations of cell viability, such as senescence, cell toxicity (cell death), and reduced proliferation (cell cycle arrest).  In addn., the time resoln. of the xCELLigence system allows for the detn. of optimal time points to perform std. cell viability assays as well as other end-point assays to understand the mode of action.  We have used the WST-1 assay (end-point viability readout), the cell index detn. (continuous monitoring of viability by xCELLigence), and the DNA fragmentation assay (end-point apoptosis assay) to systematically examine cytotoxic effects triggered by two cytotoxic compds. with different cell-killing kinetics.  Good correlation was obsd. for viability readouts between WST-1 and cell index.  The significance of time resoln. by xCELLigence readout is exemplified by its ability to pinpoint the optimal time points for conducting end point viability and apoptosis assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQt28H9IqMbVg90H21EOLACvtfcHk0lhTHWFf9KpQfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFylur7F&md5=3d6527ec0ce4efe6fb59de6fb352c5ab</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-108-6_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-108-6_6%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DAbassi%26aufirst%3DY.%2BA.%26atitle%3DThe%2520xCELLigence%2520system%2520for%2520real-time%2520and%2520label-free%2520monitoring%2520of%2520cell%2520viability%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D740%26spage%3D33%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2KBW','PDB','2KBW'); return false;">PDB: 2KBW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HW2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HW2','PDB','4HW2'); return false;">PDB: 4HW2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a href="/doi/suppl/10.1021/jm500672y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82657"></div></div></div></div></div><hr /></hr><p class="last">Pyridoclax disruption of BimL/Mcl-1 interaction as measured by BRET assay in MCF7 cells, extent of cell death after exposure to pyridoclax and MR30820, and indicators of cell death for molecules in combination with Bcl-x<sub>L</sub> targeting siRNA exposure to either Pyridoclax or MR30820 after silencing of Bcl-x<sub>L</sub>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500672y/suppl_file/jm500672y_si_001.pdf">jm500672y_si_001.pdf (448.91 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500672y&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm500672y%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-4" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500672y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bbf8283bd95a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
